data_1z2k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z2k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.392 0.615 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -138.12 158.17 44.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.46 160.43 43.46 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.59 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' OE1' ' CB ' ' A' ' 104' ' ' GLN . 35.5 tp10 -131.12 98.75 4.66 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.77 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -99.73 142.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.285 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 11' ' ' GLY . 10.9 p -129.88 143.13 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.162 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.666 ' H ' HG23 ' A' ' 107' ' ' ILE . . . -154.13 163.14 30.89 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.335 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 7.4 p -123.57 97.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.849 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 12' ' ' VAL . 14.2 m 38.82 75.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' C ' ' HD3' ' A' ' 16' ' ' PRO . . . 142.36 64.39 0.03 OUTLIER Glycine 0 C--N 1.293 -1.842 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 7.1 tppt? -121.11 56.18 5.38 Favored Pre-proline 0 C--O 1.209 -1.065 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -70.15 132.31 22.44 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 N-CA-C 105.585 -2.506 . . . . 0.0 105.585 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.56 161.74 3.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 117.338 -1.745 . . . . 0.0 112.811 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -107.68 106.02 16.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mp -88.89 127.44 35.64 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -151.42 96.46 3.21 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 116.169 -2.213 . . . . 0.0 116.911 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HB3' ' CE ' ' A' ' 101' ' ' LYS . 2.7 Cg_exo -71.43 147.83 53.21 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.031 1.154 . . . . 0.0 110.041 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.496 1.834 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.761 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 49' ' ' TRP . 1.6 t -102.07 137.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.299 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -150.41 130.46 13.48 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.973 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.587 ' HE1' ' CB ' ' A' ' 47' ' ' LEU . 2.7 p-90 -141.56 108.02 5.3 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -100.79 161.0 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HZ3' HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -147.11 160.6 42.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.987 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.487 1.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.301 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -88.64 150.73 22.88 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.332 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 46' ' ' ILE . 87.8 mt -144.86 147.68 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.667 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 11.7 mp0 -96.66 -24.12 16.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.521 HD12 ' HZ3' ' A' ' 35' ' ' LYS . 22.6 mm 68.22 -107.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.587 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -112.9 154.87 25.69 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' ND2' ' OG ' ' A' ' 55' ' ' SER . 1.8 p30 -139.88 98.95 3.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.089 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.491 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.1 t90 -94.76 129.95 41.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.458 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.6 p90 -149.76 100.38 2.96 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.93 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 1.5 t-20 51.13 83.89 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.239 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 26.2 t70 45.34 27.45 0.36 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.78 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.06 79.13 0.36 Allowed Glycine 0 N--CA 1.507 3.367 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.723 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 15.0 Cg_endo -87.76 120.15 1.39 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.362 2.041 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.47 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -129.71 155.03 46.56 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.851 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.499 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 44.2 m95 -102.62 164.34 11.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.888 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' OE1' ' A' ' 45' ' ' GLU . 38.8 t -158.51 79.39 0.8 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 118.215 -1.394 . . . . 0.0 113.248 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.4 t30 158.77 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.558 1.161 . . . . 0.0 109.461 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -47.07 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 58' ' ' ASN . 0.6 OUTLIER 174.4 2.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.369 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 20.9 m-30 -79.71 38.33 0.38 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.278 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 t -78.51 -7.68 57.75 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 61' ' ' PHE . 4.2 t0 -150.53 95.03 2.18 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.714 -2.948 . . . . 0.0 105.76 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.636 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 1.4 tp -151.82 -174.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.636 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.01 161.69 26.09 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 112.944 -1.934 . . . . 0.0 113.78 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.05 137.32 9.38 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 154.77 19.86 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.275 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -137.3 145.77 43.84 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -97.09 -179.27 4.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.36 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 119.28 1.95 13.78 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 105.604 -2.998 . . . . 0.0 105.604 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.6 m-20 156.43 -99.06 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.959 -2.12 . . . . 0.0 105.905 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 78.1 m-85 -153.34 102.46 2.6 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.978 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.84 150.5 31.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.343 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.516 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 1.2 pp -144.87 146.03 31.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 m -120.25 146.01 46.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.6 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.05 130.87 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.992 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -140.99 92.87 2.53 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 80' ' ' LYS . 31.1 t -151.71 -33.84 0.14 Allowed 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.743 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.523 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 48.7 15.82 0.1 Allowed 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 112.398 -2.183 . . . . 0.0 112.593 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' GLN . 10.5 mmtm -99.61 142.22 31.38 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tp -44.08 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.269 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 pt20 -65.81 -22.53 66.56 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.413 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.6 OUTLIER -59.38 -33.9 71.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.207 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.502 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 58.4 p -45.89 100.06 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.63 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.58 162.14 35.18 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.457 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -87.1 107.76 18.59 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.796 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.8 m-30 -87.78 151.12 23.13 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.642 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 109.03 5.68 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.742 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.87 126.71 35.81 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.887 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' N ' HD13 ' A' ' 89' ' ' LEU . 4.1 pt-20 -143.6 137.23 28.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 N--CA 1.485 1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.665 0.269 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.401 ' CE ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -145.51 155.18 42.93 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.348 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -134.12 124.69 26.53 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.283 -0.967 . . . . 0.0 112.413 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.1 118.96 38.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.403 ' CB ' ' OE1' ' A' ' 8' ' ' GLU . 49.4 mt-30 -89.36 120.3 30.58 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.219 -0.993 . . . . 0.0 112.069 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 9' ' ' VAL . 2.8 mm? -108.4 123.71 49.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tp -139.75 99.01 3.6 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.666 HG23 ' H ' ' A' ' 11' ' ' GLY . 11.0 pt -124.45 164.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.841 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 108' ' ' LEU . 3.4 mm? -108.53 -175.32 2.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.905 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.475 ' C ' ' OG ' ' A' ' 13' ' ' SER . 15.5 t70 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.882 0.373 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -125.46 123.09 38.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -136.61 160.39 38.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.06 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pp20? -143.0 109.22 5.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.82 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.435 ' CG2' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.92 156.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.319 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' O ' ' NZ ' ' A' ' 15' ' ' LYS . 14.2 p -121.45 151.2 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.972 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 10' ' ' VAL . . . -152.59 167.27 31.46 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.067 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -142.56 97.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.097 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 83.9 p 35.19 81.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.846 0.832 . . . . 0.0 108.853 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.42 ' C ' ' HD3' ' A' ' 16' ' ' PRO . . . 131.7 68.58 0.09 OUTLIER Glycine 0 C--N 1.29 -1.994 0 N-CA-C 104.401 -3.48 . . . . 0.0 104.401 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 tpmt? -119.54 79.48 21.83 Favored Pre-proline 0 C--O 1.204 -1.307 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 19.3 Cg_endo -93.65 95.88 0.14 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 N-CA-C 104.831 -2.796 . . . . 0.0 104.831 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.89 161.58 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -109.95 100.08 9.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' LEU . 2.7 tp -88.76 107.56 19.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -135.54 101.33 10.93 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -67.44 125.55 13.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 O-C-N 122.893 0.944 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.485 1.295 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.179 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 36.3 t -123.31 135.94 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -149.92 139.27 21.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.525 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.505 ' CH2' HD13 ' A' ' 74' ' ' LEU . 10.1 p-90 -142.56 112.98 7.23 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HB3' ' HZ1' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -98.12 159.81 14.7 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.515 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.727 ' NZ ' ' HH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.34 159.25 44.44 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.125 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.394 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.453 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.12 138.43 31.56 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.025 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.702 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -151.79 168.67 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.847 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 3.7 mp0 -83.9 -22.44 31.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.673 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.702 ' H ' ' CG2' ' A' ' 44' ' ' ILE . 4.0 mm 70.2 -109.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.532 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -99.47 151.07 21.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.664 ' ND2' ' HG ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -140.5 100.77 3.95 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.276 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -100.65 130.55 46.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.757 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.7 t80 -137.03 97.69 3.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.147 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.54 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER 65.38 -60.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.128 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.8 p30 -159.81 32.18 0.18 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.101 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.86 87.17 0.39 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.532 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -87.83 108.08 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.512 2.142 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.664 ' HG ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -132.38 143.73 50.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.501 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 3.6 m95 -87.85 161.43 17.52 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.163 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 46' ' ' ILE . 52.7 m -124.92 78.71 1.72 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.542 ' ND2' ' C ' ' A' ' 57' ' ' SER . 1.2 m-80 70.71 -40.84 0.48 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.822 ' O ' ' N ' ' A' ' 61' ' ' PHE . 1.5 t -43.52 117.04 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.166 -3.311 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.352 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 62' ' ' SER . 22.8 t -18.14 54.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.822 ' N ' ' O ' ' A' ' 59' ' ' VAL . 17.7 m-85 -63.12 76.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 117.491 -1.684 . . . . 0.0 112.377 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 60' ' ' SER . 0.3 OUTLIER -148.23 -22.49 0.34 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 62' ' ' SER . 18.7 t0 -147.79 90.94 1.89 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.777 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -156.87 -171.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 117.119 -1.832 . . . . 0.0 115.892 -178.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.777 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.65 163.5 21.27 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 111.186 -2.734 . . . . 0.0 114.935 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.09 127.55 5.17 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.3 t80 -93.97 158.94 15.4 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.535 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 3.7 m-20 -145.01 151.46 38.61 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.343 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 61.1 t80 -107.93 174.05 6.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.483 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.774 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 123.84 -7.78 8.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 105.931 -2.868 . . . . 0.0 105.931 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 7.0 t70 173.92 -103.49 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 111.515 -2.342 . . . . 0.0 104.855 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 87.0 m-85 -152.55 109.08 3.43 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.54 145.1 40.29 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.185 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.539 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -151.14 117.82 5.77 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.858 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -109.18 139.83 43.58 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.977 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.519 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.51 130.37 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -142.61 94.56 2.66 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.887 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -151.74 -31.84 0.15 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.825 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 55.12 40.43 31.83 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 112.664 -2.062 . . . . 0.0 114.791 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 82' ' ' GLN . 4.2 mtpp -142.0 158.87 43.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.795 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 10.9 mp -43.48 -23.19 0.06 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 51.0 mt-30 -52.4 -32.81 40.72 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 117.654 -1.618 . . . . 0.0 107.832 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.7 m-20 -66.51 -41.03 89.45 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -57.49 105.04 0.21 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.269 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 164.95 37.06 Favored Glycine 0 C--N 1.284 -2.348 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.694 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 102' ' ' ASN . 13.1 t-160 -86.14 105.22 16.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.649 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.727 ' HH ' ' NZ ' ' A' ' 35' ' ' LYS . 2.2 m-30 -88.39 155.22 19.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.307 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' C ' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -145.64 105.22 3.97 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.29 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.46 122.81 33.01 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.923 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -143.83 139.63 29.41 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.01 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.533 ' N ' ' OE2' ' A' ' 90' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -144.61 160.44 41.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.819 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -121.16 127.19 51.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.496 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.31 139.4 41.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.504 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.26 107.66 14.69 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.095 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.435 ' CD1' ' CG2' ' A' ' 9' ' ' VAL . 2.4 mm? -89.05 125.49 35.03 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.438 ' HA ' ' HG ' ' A' ' 84' ' ' SER . 0.4 OUTLIER -130.61 98.05 4.55 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.537 ' N ' ' OG ' ' A' ' 84' ' ' SER . 1.2 pt -122.6 162.62 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 28.8 tp -150.67 151.13 32.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.379 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 40.3 t0 . . . . . 0 C--N 1.307 -1.267 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.988 0.423 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 m -150.08 109.39 3.96 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.433 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.65 147.68 50.21 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -104.5 104.78 14.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' CG2' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -93.31 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.846 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.39 151.79 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.975 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.54 30.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.855 ' N ' ' HZ2' ' A' ' 15' ' ' LYS . 7.5 p -147.6 96.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.156 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.798 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . 54.3 p 33.61 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 122.235 1.016 . . . . 0.0 108.706 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.718 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . . . 124.21 62.71 0.19 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 103.362 -3.895 . . . . 0.0 103.362 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.855 ' HZ2' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -119.44 60.34 5.63 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.81 97.0 0.62 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 N-CA-C 104.767 -2.82 . . . . 0.0 104.767 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.92 161.19 3.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.966 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.75 109.46 15.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.885 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -87.21 124.21 33.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -136.83 93.39 13.75 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 116.923 -1.911 . . . . 0.0 115.337 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.36 104.61 1.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 O-C-N 123.448 1.236 . . . . 0.0 109.468 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.867 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.484 0.183 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.513 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 4.4 t -106.66 135.06 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.188 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -150.14 127.84 11.66 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.231 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 47' ' ' LEU . 1.5 p-90 -131.49 147.06 52.51 Favored 'General case' 0 C--O 1.193 -1.876 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.212 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -137.47 154.26 49.93 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HD2' ' CG ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -153.43 158.6 41.65 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 117.865 -1.534 . . . . 0.0 113.718 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 179.28 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 43' ' ' LYS . 5.3 tpm_? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.53 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -86.7 131.37 34.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.195 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.579 ' CD1' ' ND2' ' A' ' 58' ' ' ASN . 4.4 mm -131.25 146.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.97 -24.94 13.93 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 8.3 mm 62.64 -111.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.581 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -107.51 154.94 20.65 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 47' ' ' LEU . 1.1 t-20 -137.41 98.58 3.74 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.298 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.528 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 3.7 t90 -92.58 133.02 36.36 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.665 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -140.36 98.36 3.41 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 3.0 t30 68.54 -55.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.204 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -171.14 31.3 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.21 90.02 0.42 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.49 101.65 0.6 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.203 1.935 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.417 ' H ' ' HG ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -116.94 140.2 49.74 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.52 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 7.9 m95 -90.18 162.2 15.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.6 p -151.83 80.5 1.27 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.665 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.579 ' ND2' ' CD1' ' A' ' 44' ' ' ILE . 2.5 t30 175.58 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 124.623 1.202 . . . . 0.0 112.594 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 58' ' ' ASN . 4.5 m 31.45 31.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 58' ' ' ASN . 89.3 p -122.89 6.13 9.34 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 20.4 m-85 -71.46 45.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -15.42 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.62 95.95 2.3 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.72 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.98 -173.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 117.238 -1.785 . . . . 0.0 115.294 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.72 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -70.14 163.58 26.0 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 111.786 -2.461 . . . . 0.0 115.276 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.1 116.22 2.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.15 -2.38 . . . . 0.0 107.15 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 68' ' ' ASP . 42.3 t80 -99.1 158.94 15.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.505 ' N ' ' CG ' ' A' ' 67' ' ' PHE . 17.3 m-20 -143.18 141.32 31.11 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.984 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -107.24 177.61 4.8 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.584 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.32 81.81 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 104.961 -3.255 . . . . 0.0 104.961 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 2.5 t0 167.87 130.33 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -81.21 112.58 18.67 Favored 'General case' 0 C--N 1.259 -3.352 0 C-N-CA 117.59 -1.644 . . . . 0.0 109.86 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.83 111.43 5.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.288 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.603 HD21 ' H ' ' A' ' 75' ' ' SER . 3.4 tm? -104.59 146.89 28.27 Favored 'General case' 0 C--O 1.199 -1.589 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.603 ' H ' HD21 ' A' ' 74' ' ' LEU . 48.6 p -140.31 130.58 25.14 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.344 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 HD13 ' HZ1' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -88.6 130.93 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.055 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.99 93.94 2.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.963 1.363 . . . . 0.0 108.27 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.41 ' HG ' ' HB3' ' A' ' 83' ' ' ASP . 89.1 p -151.77 -39.98 0.11 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.535 -2.121 . . . . 0.0 105.819 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 53.8 20.57 2.34 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 111.321 -2.672 . . . . 0.0 115.104 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 83' ' ' ASP . 32.9 mmtt -98.96 142.95 29.81 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 80' ' ' LYS . 12.0 tp -45.04 -31.77 1.46 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.624 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -59.52 -34.83 73.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.074 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -53.26 -47.66 68.9 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.908 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.529 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -37.07 124.57 0.92 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.228 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . -173.05 166.47 39.02 Favored Glycine 0 C--N 1.278 -2.686 0 C-N-CA 118.394 -1.86 . . . . 0.0 110.784 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -88.27 106.32 18.14 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.544 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.774 ' HH ' ' CB ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -110.45 150.9 28.19 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.083 -1.047 . . . . 0.0 113.503 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' CD2' ' C ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -150.8 142.14 23.33 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.035 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 146.15 24.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.791 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HG2' ' ND2' ' A' ' 100' ' ' ASN . 40.0 mt-10 -143.34 124.24 14.31 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.62 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.489 1.52 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.434 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' A' ' 90' ' ' GLU . 29.7 m120 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 2.0 mptt -102.77 106.01 16.54 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.747 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 88' ' ' LEU . 2.1 m120 -88.45 160.18 17.65 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.592 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' TYR . 62.6 m-85 -150.08 129.71 13.14 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.277 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.67 106.42 16.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.722 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.774 ' CB ' ' HH ' ' A' ' 87' ' ' TYR . 2.6 mm? -97.92 98.4 9.77 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tp -107.21 100.16 9.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.397 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.584 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -113.6 164.07 10.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.97 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.27 -154.61 0.53 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.448 0.642 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 p -147.61 98.88 3.04 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.668 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' OE2' ' C ' ' A' ' 8' ' ' GLU . 6.5 tm-20 -115.03 154.66 28.42 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.202 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' OE2' ' A' ' 7' ' ' GLU . 4.4 tm-20 -129.57 99.38 5.14 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.399 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.23 151.19 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.657 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.41 150.19 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' CA ' ' NZ ' ' A' ' 15' ' ' LYS . . . -151.79 167.39 31.02 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.656 ' H ' ' HZ2' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -140.57 107.43 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.602 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 7.82 85.54 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 122.051 0.929 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.52 53.07 0.06 OUTLIER Glycine 0 C--N 1.282 -2.424 1 N-CA-C 101.604 -4.598 . . . . 0.0 101.604 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.656 ' HZ2' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -108.08 53.69 0.22 Allowed Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.18 107.29 1.52 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 103.509 -3.304 . . . . 0.0 103.509 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.24 161.21 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 118.609 -1.237 . . . . 0.0 114.151 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.45 112.76 25.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.827 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 tp -100.16 101.18 12.15 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -123.04 97.27 43.76 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.26 114.11 3.52 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 120.844 1.029 . . . . 0.0 109.628 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.881 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 49' ' ' TRP . 2.1 t -123.09 146.08 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 119.204 -0.999 . . . . 0.0 112.47 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -150.83 127.7 11.01 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.546 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.567 ' CH2' ' CD1' ' A' ' 74' ' ' LEU . 5.0 p-90 -133.58 103.5 5.94 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 118.565 -1.254 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 15.3 tttt -94.89 160.86 14.4 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.938 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.612 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -146.17 158.89 43.9 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.486 ' HG1' ' CE ' ' A' ' 43' ' ' LYS . 2.2 m . . . . . 0 C--N 1.299 -1.599 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.88 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' CE ' ' HG1' ' A' ' 36' ' ' THR . 1.1 mtpt -88.66 154.58 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.504 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' ND2' ' A' ' 58' ' ' ASN . 39.1 mt -150.4 138.19 14.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 C-N-CA 118.018 -1.473 . . . . 0.0 113.079 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -89.25 -30.8 18.24 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 31.6 mm 72.54 -101.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 6.7 tt -125.24 153.57 42.98 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -133.17 99.05 4.43 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.817 -1.992 . . . . 0.0 106.429 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.567 ' N ' ' O ' ' A' ' 31' ' ' VAL . 3.8 t90 -89.51 121.88 32.15 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.647 -0.821 . . . . 0.0 113.089 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -135.8 98.33 3.88 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.668 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.6 t30 64.53 -168.52 0.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.93 33.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.964 -1.494 . . . . 0.0 110.292 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -127.56 85.62 0.33 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.103 -1.046 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.41 141.25 6.7 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.156 1.904 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.0 p -136.33 139.15 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.575 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 11.8 m95 -91.24 161.19 15.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.591 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.46 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 41.0 t -159.96 79.96 0.7 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.259 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.592 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 28.8 t30 -179.4 -17.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.804 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.755 ' C ' ' H ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 67.59 -37.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.109 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 58' ' ' ASN . 0.7 OUTLIER -63.15 20.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.423 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.755 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.5 m-85 -86.24 46.19 1.31 Allowed 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -95.71 -10.62 28.78 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.05 104.54 5.06 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 109.762 -3.381 . . . . 0.0 103.229 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -144.64 -176.35 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.78 162.6 13.53 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 109.48 -3.509 . . . . 0.0 112.546 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.1 126.28 6.52 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 34.5 t80 -88.05 144.94 26.22 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.044 -1.462 . . . . 0.0 112.726 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 29.4 t0 -152.06 167.07 29.63 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.003 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 3.0 m-85 88.06 131.0 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.77 -27.04 69.38 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.138 -3.185 . . . . 0.0 105.138 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 15.5 m-20 -90.43 -102.75 0.1 Allowed 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 71' ' ' ASP . 2.2 m-85 -154.04 106.44 2.82 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.426 -1.71 . . . . 0.0 112.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' CB ' ' CG ' ' A' ' 69' ' ' TYR . . . -151.87 100.1 2.63 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.073 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.567 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 2.6 pp -115.06 146.89 40.83 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 p -109.2 141.71 41.06 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -96.0 137.3 24.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.02 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -143.43 94.75 2.65 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.645 1.212 . . . . 0.0 108.766 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' LYS . 6.4 t -156.21 -26.55 0.1 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 113.188 -1.824 . . . . 0.0 107.087 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 41.63 16.05 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.475 -2.148 . . . . 0.0 113.208 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 82' ' ' GLN . 5.5 mmmt -95.12 151.18 19.43 Favored 'General case' 0 C--N 1.279 -2.479 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.979 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 3.0 tp -47.66 -11.84 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.226 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.598 ' H ' ' C ' ' A' ' 80' ' ' LYS . 1.5 pt20 -72.75 -23.36 60.82 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -27.85 58.35 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 118.374 -1.33 . . . . 0.0 108.423 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.612 ' HB2' ' H ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -74.01 114.55 12.45 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.657 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.48 164.19 35.79 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.52 ' NE2' ' CD ' ' A' ' 104' ' ' GLN . 45.3 m80 -85.3 104.75 15.42 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.482 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 2.5 m-30 -86.29 150.46 24.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.34 106.09 5.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.04 128.05 35.71 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.349 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.46 ' N ' HD13 ' A' ' 89' ' ' LEU . 22.7 mt-10 -148.53 160.94 42.6 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.403 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' CD1' ' CE1' ' A' ' 72' ' ' PHE . 5.2 mt . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.992 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.782 0.325 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -121.04 118.57 30.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.49 139.4 39.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.786 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.23 102.56 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.716 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CD ' ' NE2' ' A' ' 86' ' ' HIS . 46.0 tt0 -89.9 107.2 18.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.248 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.453 ' N ' HD23 ' A' ' 105' ' ' LEU . 3.9 mm? -91.92 118.57 30.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -122.8 102.27 7.93 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.612 ' H ' ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -115.0 161.62 13.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.459 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 8.0 mp -92.66 -171.0 2.61 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.419 -1.753 . . . . 0.0 110.851 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 121.242 0.544 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.6 t -134.32 141.11 46.8 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.353 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 8' ' ' GLU . 37.1 tp10 -125.17 151.54 45.68 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 36.8 mt-10 -114.27 132.05 56.29 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.68 132.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 11' ' ' GLY . 7.6 p -103.24 154.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.544 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' HG21 ' A' ' 107' ' ' ILE . . . -151.51 165.87 30.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' ' C ' ' A' ' 13' ' ' SER . 98.8 t -147.53 96.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 30.27 79.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.016 0.912 . . . . 0.0 108.63 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.552 ' H ' ' HE2' ' A' ' 15' ' ' LYS . . . 135.68 59.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 104.43 -3.468 . . . . 0.0 104.43 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HE2' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -113.13 50.81 0.44 Allowed Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.32 91.45 0.27 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 105.331 -2.603 . . . . 0.0 105.331 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 15' ' ' LYS . 6.2 p -107.7 162.07 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 75' ' ' SER . 10.7 tp-100 -112.78 106.01 14.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.996 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -87.98 103.19 15.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.66 96.55 48.83 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.75 105.39 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.125 1.217 . . . . 0.0 109.352 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.691 -179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.461 0.172 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.509 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 39.4 t -126.96 130.59 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.178 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -146.46 144.44 29.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.049 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 33' ' ' TRP . 2.3 p-90 -143.74 119.28 10.37 Favored 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.429 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -102.84 158.56 16.18 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.038 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.774 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -147.8 161.63 40.86 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.203 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.93 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.06 126.49 35.46 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.849 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 4.4 mt -137.39 163.01 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.411 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.539 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 23.8 mt-10 -86.12 -31.17 22.0 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 57' ' ' SER . 10.3 mm 83.79 -87.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 1.1 tt -143.01 150.55 39.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.74 109.1 9.92 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.109 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.509 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 6.1 t90 -88.77 145.19 25.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 52' ' ' ASP . 14.1 m-85 -141.04 96.47 3.0 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.609 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.471 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . 29.2 m120 7.09 54.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.284 1.615 . . . . 0.0 113.413 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 50' ' ' TYR . 22.6 t70 -179.81 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.621 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.18 152.43 23.61 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.489 -1.815 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -88.96 141.31 4.29 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.913 1.742 . . . . 0.0 112.371 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -127.99 137.37 52.2 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.5 m95 -89.3 161.12 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.731 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.568 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.2 m -124.07 68.51 1.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.693 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 31.33 90.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 124.932 1.395 . . . . 0.0 113.139 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.721 ' CG1' ' CZ ' ' A' ' 61' ' ' PHE . 2.3 p -122.87 -37.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.06 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.602 ' N ' ' CG1' ' A' ' 59' ' ' VAL . 1.5 t 160.84 26.28 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.721 ' CZ ' ' CG1' ' A' ' 59' ' ' VAL . 39.7 m-85 -54.47 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.091 1.425 . . . . 0.0 112.791 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 t -176.73 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.495 ' C ' ' HG ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -151.05 101.65 2.89 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.699 ' N ' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -154.87 -173.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.79 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -77.22 165.17 24.87 Favored 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 109.578 -3.465 . . . . 0.0 114.798 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.49 126.63 4.39 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 10.8 t80 -106.66 154.3 21.13 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.144 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 13.3 t70 -139.51 147.94 41.96 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 69' ' ' TYR . 12.6 p90 -102.85 174.29 5.94 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.443 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 82.68 12.18 80.48 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER 157.62 127.59 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 31' ' ' VAL . 6.9 m-30 -80.84 111.87 17.71 Favored 'General case' 0 C--N 1.264 -3.139 0 C-N-CA 117.314 -1.754 . . . . 0.0 108.684 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.24 105.56 5.75 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.6 tm? -100.54 128.99 46.43 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.051 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.493 ' N ' HD23 ' A' ' 74' ' ' LEU . 56.5 p -121.7 127.33 50.62 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.639 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.522 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -89.12 127.03 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.661 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -137.22 96.21 3.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.422 1.106 . . . . 0.0 108.459 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.495 ' HG ' ' C ' ' A' ' 63' ' ' ASP . 73.8 m -156.6 -33.8 0.08 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.81 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.42 64.9 1.41 Allowed 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 112.436 -2.165 . . . . 0.0 113.011 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 37.1 mmtt -145.48 148.29 33.1 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.013 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' O ' ' OG ' ' A' ' 84' ' ' SER . 51.8 tp -49.67 -30.93 9.96 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.991 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 3.0 pp0? -53.53 -28.45 31.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.465 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 8.9 m-20 -58.02 -57.39 13.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.379 -0.929 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.605 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.7 OUTLIER -40.87 119.89 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.885 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.01 164.41 35.72 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -85.78 103.88 14.95 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.231 -1.388 . . . . 0.0 108.273 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.774 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 1.1 m-30 -89.38 159.63 17.23 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.72 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.71 111.6 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.486 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.5 125.44 35.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -150.34 142.33 23.93 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.099 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.016 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.862 0.363 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.4 mptt -127.19 114.5 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 102' ' ' ASN . 3.9 m120 -93.38 135.54 34.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.347 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.5 105.59 7.33 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.555 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.44 99.26 12.29 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.225 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 105' ' ' LEU . 3.7 mm? -89.38 110.4 21.21 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.18 99.43 6.86 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.605 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.28 163.04 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.281 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.82 -163.86 1.03 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.791 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 p -136.72 99.25 4.0 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.241 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -103.97 148.03 26.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.414 ' CB ' ' HG3' ' A' ' 104' ' ' GLN . 2.2 pp20? -116.84 146.84 42.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.993 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.54 120.25 41.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.541 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 11' ' ' GLY . 14.5 p -89.31 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.299 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 10' ' ' VAL . . . -152.7 166.52 31.34 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.583 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' SER . 1.1 p -145.76 93.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.7 t 38.15 78.3 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 137.49 61.95 0.05 OUTLIER Glycine 0 C--N 1.284 -2.35 0 N-CA-C 104.618 -3.393 . . . . 0.0 104.618 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 9.5 tppt? -112.22 44.1 0.25 Allowed Pre-proline 0 C--O 1.208 -1.083 0 CA-C-N 114.019 -1.09 . . . . 0.0 113.666 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.9 Cg_endo -67.16 107.28 1.33 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 N-CA-C 104.469 -2.935 . . . . 0.0 104.469 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 18' ' ' GLN . 9.5 p -123.76 160.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.595 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.441 ' N ' HG21 ' A' ' 17' ' ' VAL . 11.0 mp0 -105.19 101.4 10.95 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.264 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -85.62 99.92 11.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -112.84 96.27 37.05 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.5 101.07 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.329 -1.45 . . . . 0.0 108.329 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.487 1.396 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.358 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.206 -1.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 49' ' ' TRP . 1.4 t -124.05 130.1 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.121 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -149.08 138.5 21.66 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.328 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 33' ' ' TRP . 1.3 p-90 -147.14 137.55 23.46 Favored 'General case' 0 C--O 1.183 -2.42 0 C-N-CA 118.086 -1.446 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 17.1 tttp -119.29 157.21 28.53 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.83 159.89 44.0 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.873 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.742 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.75 157.22 19.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.577 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 ' ND2' ' A' ' 58' ' ' ASN . 37.5 mt -151.22 145.81 16.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 118.21 -1.396 . . . . 0.0 113.472 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.5 -23.66 23.15 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.468 ' N ' HG23 ' A' ' 44' ' ' ILE . 9.1 mm 74.87 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 113.053 -1.885 . . . . 0.0 116.051 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.63 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -153.08 157.89 41.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 117.747 -1.581 . . . . 0.0 113.806 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.443 ' N ' HD22 ' A' ' 47' ' ' LEU . 9.2 t-20 -126.34 113.58 17.1 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.435 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.57 ' N ' ' O ' ' A' ' 31' ' ' VAL . 8.5 t90 -99.56 131.05 45.82 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.659 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CD2' ' OD1' ' A' ' 51' ' ' ASN . 41.9 t80 -144.34 98.68 3.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.742 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 1.2 p-10 39.04 84.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.193 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.48 27.5 14.1 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.867 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.65 78.1 0.39 Allowed Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.656 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -86.71 126.6 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.271 1.981 . . . . 0.0 111.535 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.11 161.85 32.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.896 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.523 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 70.6 m95 -110.38 163.79 13.32 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.668 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.4 m -159.83 83.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.2 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 44' ' ' ILE . 7.8 t-20 144.14 98.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.309 1.631 . . . . 0.0 107.734 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.09 83.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.564 1.173 . . . . 0.0 113.01 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 62' ' ' SER . 3.4 t -161.65 -6.38 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 39.0 m-85 -58.87 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.399 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.77 ' HG ' ' N ' ' A' ' 63' ' ' ASP . 52.7 p -73.85 -49.33 25.58 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.77 ' N ' ' HG ' ' A' ' 62' ' ' SER . 4.9 t0 -109.89 94.21 4.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.726 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.86 -174.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 C-N-CA 117.515 -1.674 . . . . 0.0 115.044 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.726 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.06 163.52 22.19 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 112.324 -2.216 . . . . 0.0 115.434 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.46 147.9 18.75 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.0 t80 -121.23 152.98 38.22 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.931 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -141.34 152.48 44.45 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.795 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -104.82 178.81 4.45 Favored 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.39 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 93.23 6.41 63.01 Favored Glycine 0 N--CA 1.508 3.453 0 N-CA-C 104.644 -3.382 . . . . 0.0 104.644 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 155.09 141.96 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 102.108 -3.293 . . . . 0.0 102.108 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -83.09 114.18 21.13 Favored 'General case' 1 C--N 1.241 -4.148 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.724 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.01 108.58 7.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.646 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.8 tm? -98.7 127.14 44.52 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.497 ' N ' HD22 ' A' ' 74' ' ' LEU . 11.5 t -119.97 138.13 53.66 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.34 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.624 ' CD1' ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -91.2 131.23 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.08 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -139.69 92.85 2.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.621 1.2 . . . . 0.0 107.762 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.8 t -153.71 -40.26 0.09 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 113.337 -1.756 . . . . 0.0 108.25 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 53.78 50.12 17.68 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.234 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLN . 27.9 mmtp -146.55 157.04 43.67 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.997 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.638 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -43.45 -20.16 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.326 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' LYS . 7.3 mm100 -60.31 -30.01 69.22 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -64.8 -29.39 70.36 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.205 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 81' ' ' LEU . 86.5 p -63.61 105.43 0.79 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.283 -1.367 . . . . 0.0 109.931 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -171.66 164.02 36.71 Favored Glycine 0 C--N 1.292 -1.879 0 C-N-CA 118.87 -1.634 . . . . 0.0 110.823 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -86.67 103.53 15.22 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.081 -1.048 . . . . 0.0 108.972 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 1.2 m-30 -89.99 158.07 17.54 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.363 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -150.69 111.43 4.27 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.999 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -97.42 128.22 44.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.871 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' C ' ' CD ' ' A' ' 90' ' ' GLU . 1.6 pp20? -137.61 133.27 34.17 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.841 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 N--CA 1.489 1.487 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.651 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.469 HD22 HD13 ' A' ' 88' ' ' LEU . 20.3 t-20 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.949 0.404 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -147.23 146.81 29.93 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.6 144.17 32.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.052 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.61 107.68 11.78 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.455 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 10.6 pt20 -90.0 110.37 21.35 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.157 -1.017 . . . . 0.0 113.075 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.43 116.26 27.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 tt -119.84 97.85 5.82 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.78 160.54 39.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.279 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.653 ' CD2' ' N ' ' A' ' 108' ' ' LEU . 1.4 pt? -146.93 178.93 7.96 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.048 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.881 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 t -144.17 122.68 12.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.38 155.09 42.95 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -115.61 104.81 12.08 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.51 144.28 9.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.942 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.05 145.36 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 107' ' ' ILE . . . -152.96 168.27 31.81 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.598 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 7.3 p -146.17 95.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t 41.94 79.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.441 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 132.71 63.49 0.08 OUTLIER Glycine 0 C--N 1.289 -2.055 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 8.2 tppt? -113.91 45.83 0.35 Allowed Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -67.8 110.84 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 105.581 -2.507 . . . . 0.0 105.581 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.9 161.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -105.81 110.5 22.82 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.563 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.3 mp -97.67 114.3 26.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -137.69 98.31 9.84 Favored Pre-proline 0 N--CA 1.507 2.399 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.66 140.06 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.287 -179.743 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.1 t -106.61 117.57 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.39 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -134.59 136.59 43.06 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.524 ' CH2' HD13 ' A' ' 74' ' ' LEU . 6.8 p-90 -143.96 115.38 8.06 Favored 'General case' 0 C--O 1.189 -2.088 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.698 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 6.5 tttt -103.92 160.13 15.07 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.483 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.8 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -147.81 161.06 42.02 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.267 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.193 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtm-85 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.301 0.572 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -88.77 151.11 22.6 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 45' ' ' GLU . 54.2 mt -148.21 150.26 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 118.432 -1.307 . . . . 0.0 112.468 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' N ' HG22 ' A' ' 44' ' ' ILE . 52.2 mt-10 -87.84 -38.88 15.3 Favored 'General case' 0 C--O 1.203 -1.351 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.449 ' CD1' HG23 ' A' ' 44' ' ' ILE . 11.1 mm 84.76 -97.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.486 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 5.4 tt -131.14 152.82 50.03 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.486 ' N ' HD22 ' A' ' 47' ' ' LEU . 34.1 t30 -133.29 99.58 4.58 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.746 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.542 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.9 t90 -93.99 132.02 38.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.899 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 50' ' ' TYR . 28.6 p90 -150.0 100.03 2.89 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.469 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 5.8 t30 48.57 87.27 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.398 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 74.2 m-20 45.23 26.12 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.325 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.29 79.67 0.36 Allowed Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.793 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -87.33 125.64 2.19 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.252 1.968 . . . . 0.0 110.916 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 p -138.78 145.16 39.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.635 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 40.7 m95 -89.87 164.48 14.58 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -166.01 75.68 0.21 Allowed 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.606 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 160.33 86.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.795 1.31 . . . . 0.0 109.146 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.79 108.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.778 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.569 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER 165.95 -6.45 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 36.7 m-85 -63.96 33.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.785 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.569 ' H ' ' C ' ' A' ' 60' ' ' SER . 7.2 t -86.65 -35.01 19.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -127.8 94.72 4.02 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.716 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.79 -172.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 117.553 -1.659 . . . . 0.0 115.235 -179.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.8 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.47 164.05 21.99 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 112.236 -2.256 . . . . 0.0 114.767 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.19 126.94 4.37 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 12.7 t80 -90.56 153.66 20.19 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.779 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -140.29 158.46 44.0 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -97.18 -169.17 1.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.444 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 112.47 -1.13 26.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 2.5 m-20 152.23 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CE1' ' CG2' ' A' ' 31' ' ' VAL . 10.8 m-85 -153.04 109.09 3.34 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.22 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.91 41.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.7 tm? -146.94 128.23 14.82 Favored 'General case' 0 C--O 1.197 -1.684 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.884 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' HD23 ' A' ' 74' ' ' LEU . 14.5 t -121.05 138.64 54.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.079 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.45 ' N ' ' HG ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -91.54 133.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.327 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.55 93.64 2.45 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.464 1.126 . . . . 0.0 108.755 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -153.17 -37.49 0.1 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.792 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 54.73 51.71 13.36 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.619 -2.082 . . . . 0.0 113.697 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HB2' HE21 ' A' ' 82' ' ' GLN . 37.9 mmtt -147.03 178.97 7.94 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.532 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -63.88 -24.89 67.92 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.843 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.45 HE21 ' HB2' ' A' ' 80' ' ' LYS . 26.7 mt-30 -52.03 -32.58 34.9 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 107' ' ' ILE . 70.0 m-20 -63.84 -32.23 73.68 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.846 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' LEU . 13.6 p -61.35 106.0 0.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.71 164.47 35.32 Favored Glycine 0 C--N 1.288 -2.094 0 C-N-CA 118.723 -1.703 . . . . 0.0 110.616 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -86.03 106.18 17.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.508 ' CE1' ' HE3' ' A' ' 35' ' ' LYS . 2.5 m-30 -88.38 150.32 23.25 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.48 110.68 5.06 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.746 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 100.89 13.52 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.453 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -95.07 118.99 32.83 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.095 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.308 -1.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.932 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.68 0.276 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -115.78 123.59 48.63 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -106.46 119.16 38.55 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.09 115.47 26.85 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -88.81 111.2 21.75 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.42 ' CD1' ' CG2' ' A' ' 9' ' ' VAL . 1.5 mm? -95.99 99.61 11.37 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.08 97.51 8.05 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.467 HD11 ' N ' ' A' ' 84' ' ' SER . 0.4 OUTLIER -110.94 160.67 10.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.597 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.27 -177.16 3.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.805 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.5 p -150.16 120.78 7.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.678 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 29.4 tp10 -130.12 160.12 34.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.644 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.57 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 31.8 tt0 -120.87 133.93 55.3 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.86 120.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.995 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.15 149.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.499 ' CA ' HG21 ' A' ' 107' ' ' ILE . . . -152.35 163.63 30.32 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.569 -1.3 . . . . 0.0 111.858 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -148.21 96.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.076 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' VAL . 15.2 t 41.96 79.92 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.581 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 132.63 67.64 0.08 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 8.6 tppt? -112.02 39.52 0.19 Allowed Pre-proline 0 C--O 1.208 -1.084 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.9 Cg_endo -67.56 88.42 0.34 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 N-CA-C 106.327 -2.22 . . . . 0.0 106.327 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -112.47 162.72 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.802 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -106.58 108.14 19.49 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.498 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' LEU . 4.4 tp -88.74 98.44 11.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -115.62 96.54 46.57 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.83 111.89 2.53 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.408 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' TRP . 3.3 t -143.9 134.45 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.818 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -150.24 137.8 19.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.773 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CZ3' ' CE ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -140.71 131.09 25.16 Favored 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.103 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -118.82 152.3 36.48 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.775 ' CE ' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -153.51 163.1 40.54 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.9 -1.52 . . . . 0.0 114.188 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 m . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 179.371 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 37.0 ttm180 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -87.61 144.34 26.73 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.428 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 ' ND2' ' A' ' 58' ' ' ASN . 7.8 mt -149.06 138.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.91 -1.516 . . . . 0.0 112.686 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -87.39 -33.93 18.95 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.461 HG21 ' CE2' ' A' ' 33' ' ' TRP . 10.9 mm 82.09 -93.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 114.132 -1.395 . . . . 0.0 114.335 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.663 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -152.23 159.52 43.53 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.498 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 47' ' ' LEU . 6.2 p-10 -129.37 113.8 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.397 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' VAL . 10.2 t90 -94.49 131.15 40.49 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 51' ' ' ASN . 2.3 m-85 -144.22 99.32 3.36 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.041 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.418 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 3.1 p30 40.16 85.49 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.484 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.485 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 20.2 t70 51.27 29.62 5.16 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.484 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.67 76.67 0.41 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -86.92 127.04 2.54 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.375 2.05 . . . . 0.0 111.705 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -140.58 143.38 35.26 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.933 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 21.2 m95 -91.11 164.24 14.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.402 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -164.09 76.71 0.35 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.955 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 162.65 88.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.636 1.21 . . . . 0.0 109.693 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.14 105.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.844 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 169.46 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 34.7 m-85 -63.34 31.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.223 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 60' ' ' SER . 4.1 p -86.65 -25.3 24.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.42 95.46 2.88 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.753 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -154.93 -173.28 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-O 123.566 1.65 . . . . 0.0 115.178 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.753 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.28 164.42 20.72 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.851 -2.431 . . . . 0.0 115.437 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.34 118.33 2.35 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -90.04 138.02 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.869 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.37 160.39 29.48 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 44.8 t80 -102.55 -179.15 3.89 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.806 0.812 . . . . 0.0 113.114 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.618 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 118.66 -0.92 15.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.5 OUTLIER 156.49 -96.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.902 -2.149 . . . . 0.0 105.412 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 26.0 m-85 -152.18 105.19 3.03 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.23 106.69 5.55 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.646 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 19' ' ' LEU . 3.0 tm? -111.29 126.8 55.28 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.624 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 m -115.21 134.7 54.9 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.489 HD12 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -89.88 131.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.255 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 94.68 2.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.699 1.238 . . . . 0.0 108.036 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 79' ' ' ALA . 26.9 t -156.84 -13.95 0.09 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.787 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.525 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 23.79 75.25 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 112.381 -2.191 . . . . 0.0 113.999 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HD2' ' NE2' ' A' ' 82' ' ' GLN . 12.9 mttt -174.0 172.57 3.37 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.16 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -56.03 -37.12 68.79 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.586 ' H ' ' CD ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -46.8 -30.65 2.56 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.769 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -63.81 -35.35 80.33 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.705 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.531 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -48.9 114.06 0.91 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.67 159.98 29.95 Favored Glycine 0 C--N 1.277 -2.707 0 C-N-CA 118.035 -2.031 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -91.16 107.11 18.98 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.96 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.2 m-30 -93.44 152.2 19.25 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.906 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.15 110.54 5.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.285 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.25 130.99 35.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.097 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' N ' HD11 ' A' ' 89' ' ' LEU . 73.8 mt-10 -134.23 129.25 35.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm . . . . . 0 C--N 1.307 -1.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.923 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.859 0.361 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -138.91 109.08 6.4 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.646 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -95.59 134.79 38.06 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.547 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -131.64 111.91 12.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.898 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.48 118.33 28.04 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.084 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -101.98 101.38 11.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tp -108.94 105.39 14.9 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -117.63 163.46 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.065 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 14.7 tp -149.82 147.7 28.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.548 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.448 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 11.8 m-20 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.803 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.07 0.462 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 t -149.99 125.98 10.55 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.45 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 16.7 tp10 -143.43 160.2 40.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 41.2 tt0 -119.55 109.22 15.45 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.77 132.58 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.49 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.59 ' CG2' ' N ' ' A' ' 11' ' ' GLY . 9.8 p -89.65 164.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.445 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.59 ' N ' ' CG2' ' A' ' 10' ' ' VAL . . . -150.79 169.16 30.6 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.43 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.666 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 3.1 t -145.78 98.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.434 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.624 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 3.62 80.7 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.718 0 CA-C-O 122.685 1.231 . . . . 0.0 109.498 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' C ' ' HD3' ' A' ' 16' ' ' PRO . . . 143.6 65.47 0.02 OUTLIER Glycine 0 C--N 1.278 -2.65 1 N-CA-C 101.323 -4.711 . . . . 0.0 101.323 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.666 ' NZ ' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -114.08 76.98 3.66 Favored Pre-proline 0 C--O 1.207 -1.145 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 15.5 Cg_endo -86.72 78.75 1.88 Allowed 'Trans proline' 0 N--CA 1.431 -2.19 0 N-CA-C 103.525 -3.298 . . . . 0.0 103.525 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -89.74 159.77 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.457 ' NE2' ' HD2' ' A' ' 20' ' ' ARG . 2.5 tt0 -113.97 99.39 7.62 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.129 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 74' ' ' LEU . 5.5 tp -86.05 103.78 15.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HD2' ' NE2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -122.82 97.39 44.11 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -68.38 126.52 14.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.724 0.95 . . . . 0.0 110.05 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.6 t -130.46 131.47 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.69 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -150.39 142.09 23.65 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.256 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.543 ' HE1' ' CB ' ' A' ' 47' ' ' LEU . 1.8 p-90 -142.15 141.41 32.63 Favored 'General case' 0 C--O 1.182 -2.499 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.2 ttpt -121.37 154.39 36.54 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.906 -0.717 . . . . 0.0 109.266 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.756 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.01 155.86 41.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.631 -1.227 . . . . 0.0 111.976 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.006 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.169 0 CA-C-O 121.071 0.463 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 4.1 mmtp -89.66 133.74 34.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.706 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -148.18 164.33 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.859 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 2.2 mm-40 -87.35 -15.83 36.76 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.881 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.718 ' CG2' ' H ' ' A' ' 47' ' ' LEU . 10.6 mm 62.92 -120.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.718 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -90.3 154.65 19.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -143.21 97.75 3.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.037 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.552 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 20.9 t90 -97.47 132.99 42.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.315 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.4 m-85 -140.73 97.57 3.22 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.538 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.552 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.7 OUTLIER 65.94 -57.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.446 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' TYR . 38.9 t70 -163.32 31.86 0.09 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.79 87.25 0.38 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.82 98.16 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 122.096 1.864 . . . . 0.0 110.479 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.2 p -120.27 132.82 55.49 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -89.76 162.01 15.75 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.05 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.65 ' N ' ' O ' ' A' ' 46' ' ' ILE . 38.5 m -119.46 77.17 1.19 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.684 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.479 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 4.9 m-80 34.24 102.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.647 ' CG1' ' CZ ' ' A' ' 61' ' ' PHE . 29.9 m -130.65 -44.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.671 1.224 . . . . 0.0 108.597 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 2.1 t 160.03 24.15 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 56' ' ' TRP . 56.9 m-85 -39.14 90.13 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.82 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' SER . 5.0 t -173.55 -22.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.6 111.69 7.49 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 101.114 -3.662 . . . . 0.0 101.114 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG21 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -152.78 -174.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.263 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -179.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -84.15 164.4 19.18 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 109.37 -3.559 . . . . 0.0 112.032 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.65 125.45 4.16 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.5 t80 -99.84 150.06 22.75 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 26.2 t0 -138.97 158.15 44.72 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -106.05 179.75 4.18 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.835 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.75 11.29 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 105.531 -3.028 . . . . 0.0 105.531 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 5.7 t70 170.44 -103.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.634 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 18.6 m-85 -152.84 115.47 4.51 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.17 143.75 34.41 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.392 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -148.28 127.33 12.81 Favored 'General case' 0 C--O 1.201 -1.452 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.175 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 4.5 t -123.46 136.74 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -91.04 134.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.075 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -144.2 94.48 2.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.866 1.317 . . . . 0.0 109.654 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.506 ' CB ' ' OE1' ' A' ' 82' ' ' GLN . 17.6 p -154.28 -23.54 0.13 Allowed 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.069 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 53.1 31.6 11.57 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.858 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' C ' ' N ' ' A' ' 82' ' ' GLN . 1.3 mmmt -114.23 167.1 10.99 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.024 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.1 tp -53.76 -14.47 0.94 Allowed 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.298 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 1.6 pt20 -59.68 -41.21 90.16 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 82' ' ' GLN . 26.7 m-20 -47.03 -42.29 18.11 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.58 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.664 ' H ' HD13 ' A' ' 107' ' ' ILE . 6.4 t -62.11 109.62 1.35 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.296 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.45 164.56 36.91 Favored Glycine 0 C--N 1.277 -2.732 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.724 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.777 ' NE2' ' ND2' ' A' ' 102' ' ' ASN . 30.3 t-80 -85.74 101.07 12.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.745 -1.182 . . . . 0.0 108.407 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.756 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 3.0 m-30 -88.83 154.29 20.38 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.99 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.3 tp -150.67 108.39 3.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.507 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.65 131.75 35.48 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.675 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 23.8 mp0 -142.99 141.6 31.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.08 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.057 0.456 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 89' ' ' LEU . 3.4 ptpt -140.58 124.44 17.26 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.777 ' ND2' ' NE2' ' A' ' 86' ' ' HIS . 21.7 t-20 -90.78 157.54 17.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.886 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -149.96 109.72 4.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.72 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -91.63 109.97 21.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.136 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.71 137.36 35.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -149.47 102.47 3.19 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.759 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -88.74 164.48 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.048 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.6 tp -89.59 147.47 23.91 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.327 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--N 1.304 -1.413 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.969 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.098 0.475 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -147.5 131.72 17.42 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.023 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -142.67 134.74 27.25 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -94.81 105.64 17.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.547 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 p -94.22 141.68 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.423 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 11.9 p -114.84 147.29 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.603 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA3' ' NZ ' ' A' ' 15' ' ' LYS . . . -152.13 166.01 30.92 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 13' ' ' SER . 4.8 m -137.85 90.45 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 12' ' ' VAL . 39.6 t 31.41 79.69 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 CA-C-O 122.735 1.255 . . . . 0.0 110.413 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.87 64.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 1 N-CA-C 100.066 -5.213 . . . . 0.0 100.066 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -125.05 75.6 67.27 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.51 100.76 0.27 Allowed 'Trans proline' 0 N--CA 1.439 -1.683 1 N-CA-C 97.023 -5.799 . . . . 0.0 97.023 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.13 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -115.69 98.59 6.78 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.67 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.69 140.21 29.75 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -154.6 92.27 2.95 Favored Pre-proline 0 N--CA 1.507 2.379 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.97 118.89 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 O-C-N 122.631 0.806 . . . . 0.0 110.528 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.489 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.87 140.84 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -151.88 134.99 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.991 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -140.95 136.1 31.88 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 118.451 -1.299 . . . . 0.0 109.98 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -128.37 151.62 49.14 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.838 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 141.21 34.09 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.083 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.496 1.846 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.317 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 26.9 ttt180 . . . . . 0 N--CA 1.507 2.411 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.521 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 1.8 tppp? -87.61 128.39 35.27 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 121.578 0.704 . . . . 0.0 111.118 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -131.63 128.9 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.477 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -86.37 -14.46 43.4 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.017 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm 61.07 -83.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 48' ' ' ASN 0.324 8.4 tt -145.57 159.7 42.73 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 47' ' ' LEU . 34.6 t30 -138.08 106.73 5.89 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 113.527 -1.669 . . . . 0.0 108.531 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -93.23 137.82 32.2 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.007 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -145.3 97.1 2.94 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.519 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t30 73.57 -68.0 0.24 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.099 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.47 28.55 0.07 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.95 88.9 0.36 Allowed Glycine 0 C--N 1.303 -1.283 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.146 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -83.4 138.09 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.231 1.287 . . . . 0.0 110.327 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 m -143.82 127.25 16.85 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.328 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.799 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 4.0 m95 -88.31 154.29 20.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.438 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -160.75 104.58 1.37 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.913 1.339 . . . . 0.0 112.636 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.0 m120 136.72 91.6 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 111.194 -2.73 . . . . 0.0 104.603 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.38 71.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 117.5 2.408 . . . . 0.0 117.5 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' ASN . 9.7 m -128.32 -5.04 5.44 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -63.16 75.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.188 -2.278 . . . . 0.0 113.453 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.6 t -145.44 -4.82 0.68 Allowed 'General case' 0 N--CA 1.523 3.219 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.7 106.48 5.38 Favored 'General case' 0 C--N 1.274 -2.679 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 175.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.83 -178.72 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 N-CA-C 121.034 3.716 . . . . 0.0 121.034 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -112.3 161.82 16.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 108.766 -3.834 . . . . 0.0 111.032 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.1 131.35 5.94 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.2 t80 -94.27 158.9 15.37 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.261 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.502 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 12.6 t70 -139.92 147.94 41.28 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.969 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 55.1 t80 -114.03 166.76 11.28 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 123.026 1.393 . . . . 0.0 114.433 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 149.95 -42.8 0.77 Allowed Glycine 0 N--CA 1.51 3.586 1 N-CA-C 102.293 -4.323 . . . . 0.0 102.293 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 31.5 m-20 -144.14 -106.91 0.12 Allowed 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 100.484 -3.895 . . . . 0.0 100.484 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 88.8 m-85 -154.75 105.87 2.63 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.32 148.29 46.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -147.72 137.63 22.77 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 m -131.49 141.22 49.73 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.439 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -91.55 153.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -150.17 83.92 1.38 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 179.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 m -141.41 -53.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 112.108 -2.315 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 60.32 36.21 20.61 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 111.697 -2.501 . . . . 0.0 115.38 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -140.27 162.55 35.01 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.842 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.75 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 mm? -43.32 -30.28 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.035 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.22 -29.57 68.83 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -67.63 -33.29 74.68 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.2 p -59.42 117.51 4.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.119 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.49 162.6 32.86 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -88.74 101.31 13.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -87.75 160.16 18.18 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.569 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.98 111.77 4.01 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.68 -1.6 . . . . 0.0 106.905 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.5 143.4 27.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.876 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -141.66 154.55 45.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.396 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' N ' ' NZ ' ' A' ' 101' ' ' LYS . 5.9 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.678 0.275 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.416 ' NZ ' ' N ' ' A' ' 100' ' ' ASN . 3.0 mptp? -133.4 113.74 12.89 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -93.63 138.75 31.55 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.922 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.96 108.18 5.5 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -94.72 109.54 21.48 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.4 ' HG ' ' HH ' ' A' ' 87' ' ' TYR . 4.4 mm? -88.79 100.28 13.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.79 95.53 6.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.21 161.26 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.773 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.0 tp -147.12 132.98 19.03 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.964 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.294 -1.832 0 CA-C-O 116.531 -1.699 . . . . 0.0 112.411 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 m -149.13 119.28 7.23 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.71 159.68 43.54 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -117.16 112.21 20.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.53 127.31 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.409 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG21 ' N ' ' A' ' 11' ' ' GLY . 13.6 p -90.69 149.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.225 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 10' ' ' VAL . . . -152.24 166.8 31.17 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 94.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.828 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.0 t 37.91 79.17 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.478 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 134.45 67.24 0.07 OUTLIER Glycine 0 C--N 1.288 -2.092 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.8 tppt? -114.18 46.27 0.37 Allowed Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.1 Cg_endo -67.9 99.35 0.55 Allowed 'Trans proline' 0 N--CA 1.433 -2.086 0 N-CA-C 105.615 -2.494 . . . . 0.0 105.615 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 18' ' ' GLN . 1.3 p -121.32 162.18 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.368 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.4 ' H ' HG22 ' A' ' 17' ' ' VAL . 12.2 tt0 -109.24 109.26 20.15 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.555 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -88.92 107.34 18.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -124.03 96.01 43.1 Favored Pre-proline 0 N--CA 1.506 2.35 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -74.54 124.16 8.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 N-CA-C 109.129 -1.143 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.497 1.901 0 C-N-CA 120.186 -0.605 . . . . 0.0 111.461 -179.925 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 72' ' ' PHE . 2.3 t -116.04 131.85 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.159 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -148.69 124.29 10.42 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.123 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.56 ' HE1' ' HB2' ' A' ' 47' ' ' LEU . 7.2 p-90 -136.73 130.17 31.62 Favored 'General case' 0 C--O 1.183 -2.415 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -118.01 160.26 21.78 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.678 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -148.03 158.36 44.01 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.455 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.591 179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ptt-85 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.956 0.407 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.71 148.12 24.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.901 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.483 HD13 ' ND2' ' A' ' 58' ' ' ASN . 4.3 mm -141.54 144.96 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.319 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.75 -30.55 17.93 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.454 HG22 ' CZ2' ' A' ' 33' ' ' TRP . 8.3 mm 73.33 -98.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.56 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.32 155.99 33.53 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 47' ' ' LEU . 3.1 m-80 -137.83 99.15 3.83 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.336 -2.211 . . . . 0.0 107.693 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 8.3 t90 -97.47 134.54 40.58 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.93 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' ASP . 13.3 m-85 -139.59 96.94 3.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.565 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.556 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 4.6 m-80 62.01 -64.27 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.307 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.2 m-20 -155.01 30.97 0.4 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.58 87.04 0.37 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -86.0 114.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.091 1.861 . . . . 0.0 110.289 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.08 161.57 26.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.65 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.607 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 69.5 m95 -107.55 165.33 11.49 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.036 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -150.57 67.73 0.95 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.337 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 1.8 t30 169.44 162.81 0.05 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.527 1.767 . . . . 0.0 106.305 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.48 6.23 7.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.546 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -86.44 0.61 53.78 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 25.5 m-85 -62.7 37.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.921 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 60' ' ' SER . 6.6 t -94.0 -17.93 22.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.62 94.84 2.34 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.704 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.47 -173.31 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.704 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.41 162.7 22.47 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 112.498 -2.137 . . . . 0.0 114.504 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.53 6.89 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.6 t80 -89.7 158.18 17.66 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.983 -1.087 . . . . 0.0 112.684 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 21.6 m-20 -142.66 143.36 32.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.016 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -100.98 177.62 4.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.528 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 116.75 9.26 11.24 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 106.418 -2.673 . . . . 0.0 106.418 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 1.7 m-20 153.13 -101.49 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 31' ' ' VAL . 16.3 m-85 -154.13 109.48 3.16 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.13 122.2 10.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.791 -1.164 . . . . 0.0 112.16 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.559 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -120.66 135.67 55.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.986 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.488 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.2 p -125.23 139.06 54.06 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.463 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -90.15 134.04 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.159 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -144.65 93.06 2.36 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 82' ' ' GLN . 13.2 t -155.88 -36.57 0.08 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.5 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 52.05 88.0 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.502 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER 172.02 159.2 0.1 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.432 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.72 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -47.49 -13.27 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.671 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 10.1 pt20 -69.04 -27.4 65.61 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.214 -1.394 . . . . 0.0 109.109 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.1 m-20 -70.02 -27.5 64.73 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.474 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.469 ' HG ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -66.05 103.92 1.04 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.062 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.37 163.99 36.26 Favored Glycine 0 N--CA 1.485 1.935 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -86.19 108.47 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.918 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 2.4 m-30 -91.1 153.55 20.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.447 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD22 HD22 ' A' ' 100' ' ' ASN . 0.4 OUTLIER -150.05 111.62 4.49 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.195 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 109.75 20.51 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.18 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.54 116.57 32.16 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mm . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.6 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.465 HD22 HD22 ' A' ' 88' ' ' LEU . 45.2 t30 . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.537 0.208 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -110.46 134.82 51.99 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.14 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -117.19 114.65 23.98 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -114.0 108.91 17.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.889 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -89.27 109.95 20.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.879 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -89.37 106.74 18.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.4 tp -110.61 98.48 7.65 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.469 HD13 ' HG ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -125.94 161.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.21 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.26 154.38 46.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.64 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.386 -1.769 . . . . 0.0 110.949 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.657 0.265 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 143.27 25.43 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.301 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.22 156.05 45.96 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.13 99.09 8.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.371 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG2' ' N ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.52 158.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.319 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.6 p -150.99 155.3 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.241 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.547 ' CA ' ' NZ ' ' A' ' 15' ' ' LYS . . . -152.22 171.03 31.53 Favored Glycine 0 N--CA 1.484 1.864 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.839 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' C ' ' A' ' 13' ' ' SER . 13.6 m -135.59 95.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.485 ' C ' ' O ' ' A' ' 12' ' ' VAL . 71.1 p 39.68 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.47 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 140.6 68.7 0.04 OUTLIER Glycine 0 C--N 1.291 -1.971 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' NZ ' ' CA ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -111.8 41.05 0.2 Allowed Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 2.8 Cg_endo -67.99 99.98 0.6 Allowed 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 106.141 -2.292 . . . . 0.0 106.141 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.61 160.7 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.613 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -99.93 104.66 16.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.245 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 3.1 tp -91.14 99.3 12.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -131.46 102.1 15.58 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -69.21 136.75 35.3 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.853 1.035 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.804 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' TRP . 1.5 t -96.06 136.79 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.477 -1.289 . . . . 0.0 113.127 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -149.07 124.81 10.49 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 35' ' ' LYS . 7.8 p-90 -135.02 114.27 12.29 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.126 -1.429 . . . . 0.0 112.473 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.5 tttm -100.85 157.05 17.01 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.39 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HD3' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -148.05 161.02 42.22 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.014 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.486 ' CG2' ' HZ2' ' A' ' 43' ' ' LYS . 1.7 m . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.712 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.304 0.573 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HZ2' ' CG2' ' A' ' 36' ' ' THR . 9.6 mmtt -89.85 143.46 26.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.789 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.503 HG21 ' N ' ' A' ' 45' ' ' GLU . 8.1 mt -146.37 156.7 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' N ' HG21 ' A' ' 44' ' ' ILE . 79.2 mm-40 -88.64 -39.02 14.35 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.488 HG22 ' CE2' ' A' ' 33' ' ' TRP . 15.3 mm 81.72 -98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.698 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.45 ' H ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -122.4 157.43 31.9 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -139.94 98.53 3.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.527 -2.124 . . . . 0.0 106.65 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.621 ' N ' ' O ' ' A' ' 31' ' ' VAL . 13.2 t90 -95.61 125.6 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.042 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.674 ' CE2' ' ND2' ' A' ' 51' ' ' ASN . 56.3 t80 -139.77 98.61 3.51 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.674 ' ND2' ' CE2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 61.66 -162.28 0.28 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.48 39.9 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -131.49 81.86 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.718 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -87.09 137.66 4.57 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.447 2.098 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.8 p -143.52 156.98 44.77 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.12 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.542 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 50.9 m95 -99.4 164.69 12.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.559 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -160.35 73.37 0.51 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.699 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 152.51 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.568 1.167 . . . . 0.0 108.884 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -45.65 103.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.849 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 62' ' ' SER . 89.7 p -179.74 -7.76 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 27.4 m-85 -66.95 34.58 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.542 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 60' ' ' SER . 12.0 t -84.94 -32.16 23.22 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.59 94.28 3.38 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.729 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.95 -172.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.729 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.2 163.62 22.33 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 112.222 -2.263 . . . . 0.0 115.131 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.65 122.55 3.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -89.92 143.85 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.166 -1.014 . . . . 0.0 112.643 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -131.59 160.66 34.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.778 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 20.0 t80 -95.68 -175.16 3.36 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.264 -0.974 . . . . 0.0 112.917 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 114.84 -1.37 23.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 2.0 m-20 150.61 -88.31 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 70.0 m-85 -153.58 106.25 2.9 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.491 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.21 99.79 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.151 -1.019 . . . . 0.0 112.019 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.572 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 1.3 tm? -105.9 110.75 23.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.3 m -103.28 134.99 45.75 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HD13 ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -90.21 132.18 35.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.301 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -143.12 93.27 2.48 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.553 1.168 . . . . 0.0 107.996 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' A' ' 79' ' ' ALA . 9.8 p -152.18 -42.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.218 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 58.62 28.24 16.88 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.185 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HA ' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -113.46 -167.97 1.27 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.017 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.8 tp -83.88 -14.96 49.8 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.681 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 83' ' ' ASP . 3.2 pp0? -67.25 -30.31 70.17 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.226 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -63.17 -30.25 71.44 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.946 -1.501 . . . . 0.0 108.527 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.494 ' N ' HD12 ' A' ' 107' ' ' ILE . 3.4 p -57.29 107.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.393 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.66 161.78 33.3 Favored Glycine 0 C--N 1.284 -2.324 0 C-N-CA 117.569 -2.253 . . . . 0.0 111.518 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.497 ' NE2' ' HB3' ' A' ' 102' ' ' ASN . 18.7 t-160 -89.1 101.19 13.85 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.945 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -88.79 160.53 17.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.301 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 115.18 7.03 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.669 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.427 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.16 118.34 15.52 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.088 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 72' ' ' PHE . 3.0 mt . . . . . 0 C--N 1.308 -1.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.494 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HZ1' ' HB3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -132.75 159.56 39.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.925 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 1.9 m-80 -138.08 144.16 40.79 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.71 111.57 8.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.555 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 9.7 pt20 -97.18 113.61 25.22 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.443 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.423 ' HG ' ' CG1' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.57 120.19 41.01 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 tp -117.36 98.59 6.5 Favored 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.717 -2.038 . . . . 0.0 108.734 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.586 ' CD1' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -100.01 161.35 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.324 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.463 ' CD1' ' H ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.85 150.54 24.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.952 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.463 ' H ' ' CD1' ' A' ' 108' ' ' LEU . 3.1 p30 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.858 0.361 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -130.9 153.72 48.86 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -146.18 159.9 42.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -133.63 98.92 4.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' CG2' HD11 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -99.79 141.76 16.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -114.8 151.86 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.811 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -153.11 167.01 31.7 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.54 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' SER . 7.7 p -141.45 94.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 62.2 p 36.81 78.32 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 136.94 67.47 0.05 OUTLIER Glycine 0 C--N 1.291 -1.956 0 N-CA-C 104.933 -3.267 . . . . 0.0 104.933 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.529 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 10.7 tppt? -113.64 45.32 0.32 Allowed Pre-proline 0 C--O 1.207 -1.176 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -66.75 102.88 0.65 Allowed 'Trans proline' 0 N--CA 1.436 -1.908 0 N-CA-C 105.283 -2.622 . . . . 0.0 105.283 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.98 161.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -104.51 101.66 11.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.675 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 1.8 tp -89.88 107.92 19.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -147.57 100.23 3.79 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 118.089 -1.445 . . . . 0.0 113.861 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -68.53 143.48 57.34 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 120.652 0.902 . . . . 0.0 109.949 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.249 -179.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.5 ' HG ' ' HA ' ' A' ' 50' ' ' TYR . 9.3 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 49' ' ' TRP . 2.2 t -127.96 111.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.889 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.262 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -134.9 132.81 38.94 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.445 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.579 ' CD1' ' N ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -135.32 148.18 49.39 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.66 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -133.28 158.84 41.93 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.759 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HZ3' ' CB ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.72 163.16 39.23 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.818 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.694 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 121.408 0.623 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -89.66 157.29 18.07 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 46' ' ' ILE . 36.1 mt -150.28 142.68 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 117.871 -1.532 . . . . 0.0 113.25 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -90.54 -31.13 16.86 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.521 HD11 ' HZ1' ' A' ' 35' ' ' LYS . 13.9 mm 74.48 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.637 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -151.01 159.38 44.6 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.328 -1.349 . . . . 0.0 113.415 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.76 ' ND2' ' HG ' ' A' ' 55' ' ' SER . 1.2 p-10 -127.97 118.04 22.84 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.555 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 16.9 t90 -104.48 117.61 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 52' ' ' ASP . 7.5 m-85 -124.22 97.63 5.41 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.714 ' ND2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 64.25 -60.92 0.19 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.279 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' TYR . 42.0 m-20 -159.29 33.05 0.2 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.59 85.84 0.35 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -87.12 112.35 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.276 1.984 . . . . 0.0 110.405 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.76 ' HG ' ' ND2' ' A' ' 48' ' ' ASN . 3.8 p -125.34 162.31 25.06 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.668 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 59.8 m95 -109.93 161.36 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.486 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.456 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.2 p -159.79 82.52 0.73 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.585 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.862 HD21 ' HG ' ' A' ' 60' ' ' SER . 64.0 t30 -174.1 -26.63 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.599 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.469 ' CG2' ' C ' ' A' ' 58' ' ' ASN . 0.9 OUTLIER 68.79 -4.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.795 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.862 ' HG ' HD21 ' A' ' 58' ' ' ASN . 1.0 OUTLIER -100.89 11.92 38.64 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 45.9 m-85 -72.33 42.91 0.1 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.694 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 60' ' ' SER . 19.6 t -98.5 -15.53 19.54 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -147.71 93.58 2.23 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.728 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -157.24 -173.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 117.051 -1.86 . . . . 0.0 115.724 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.728 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.81 165.4 19.79 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.89 -2.414 . . . . 0.0 114.644 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.4 131.28 5.87 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 7.2 t80 -98.26 143.83 28.34 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.231 -0.987 . . . . 0.0 113.14 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.9 t70 -133.62 156.8 47.21 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 56.1 t80 -97.03 176.55 5.91 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.286 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.723 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 127.98 -13.16 6.42 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.8 m-20 166.06 -89.4 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 47.6 m-85 -152.24 99.2 2.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.18 108.52 10.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -119.95 115.43 23.76 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.821 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 t -105.97 138.38 42.26 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.243 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.468 HD12 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -90.19 133.0 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.135 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -143.04 93.87 2.56 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.466 1.127 . . . . 0.0 108.499 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 80' ' ' LYS . 11.6 t -153.59 -25.33 0.14 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.693 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 44.01 11.67 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.393 -2.185 . . . . 0.0 114.128 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.7 mmtp -97.91 152.85 18.79 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 107' ' ' ILE . 26.6 tp -49.7 -18.63 0.49 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.894 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' LYS . 32.9 mt-30 -59.01 -22.02 59.98 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.801 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 107' ' ' ILE . 37.3 t0 -64.47 -39.93 94.73 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.056 -1.457 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 78.3 p -46.37 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -170.87 165.04 38.24 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -85.59 109.34 18.47 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.27 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.495 ' CZ ' ' HE2' ' A' ' 35' ' ' LYS . 2.6 m-30 -95.82 142.16 28.41 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.3 tp -151.9 117.19 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.703 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 88' ' ' LEU . 3.1 mt -88.51 155.73 19.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.667 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -135.38 109.44 8.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.938 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.4 tt . . . . . 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.071 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.61 0.243 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -132.72 102.95 5.87 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.189 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -98.33 146.13 25.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.38 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.97 117.16 12.64 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.651 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.87 116.92 27.5 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.78 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.423 HD11 ' CG2' ' A' ' 9' ' ' VAL . 1.6 mm? -103.97 128.33 51.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.0 tp -146.06 100.25 3.36 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -119.8 163.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.792 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 54.1 tp -104.13 159.54 15.6 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.517 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 CA-C-O 116.306 -1.807 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.893 0.378 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.9 p -140.15 110.63 6.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.34 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 31.3 tt0 -123.89 160.36 27.66 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.499 ' C ' ' CD ' ' A' ' 8' ' ' GLU . 12.3 tm-20 -126.85 121.94 33.29 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.81 136.37 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.72 152.61 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.366 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -152.23 167.61 31.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' SER . 94.8 t -147.39 97.08 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.574 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.807 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 2.0 t 27.49 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 15' ' ' LYS . . . 131.34 55.5 0.09 OUTLIER Glycine 0 C--N 1.287 -2.176 1 N-CA-C 103.025 -4.03 . . . . 0.0 103.025 -179.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.807 ' NZ ' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -118.57 57.54 3.13 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.44 112.28 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 104.96 -2.746 . . . . 0.0 104.96 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.51 161.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.521 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -105.07 112.38 25.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 5.3 tp -91.85 125.55 36.6 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -147.97 98.32 3.83 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 117.06 -1.856 . . . . 0.0 115.071 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.12 131.53 22.34 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 120.965 1.11 . . . . 0.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.54 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.4 t -105.35 119.56 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.992 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.87 131.64 37.6 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.717 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.512 ' HE1' ' HB2' ' A' ' 47' ' ' LEU . 5.5 p-90 -136.02 116.29 13.54 Favored 'General case' 0 C--O 1.184 -2.367 0 C-N-CA 118.776 -1.169 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -103.65 153.91 20.11 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.417 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.814 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -150.54 160.42 43.8 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 118.306 -1.357 . . . . 0.0 113.432 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 m . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.579 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.307 0.575 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.94 136.92 32.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.541 HG21 ' N ' ' A' ' 46' ' ' ILE . 94.3 mt -144.83 147.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.942 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -89.51 -26.78 20.71 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.229 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.541 ' N ' HG21 ' A' ' 44' ' ' ILE . 12.1 mm 72.44 -93.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.4 OUTLIER -123.54 156.84 34.91 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 47' ' ' LEU . 64.0 t30 -137.67 97.41 3.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.597 -2.092 . . . . 0.0 105.943 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.499 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 2.9 t90 -94.55 132.28 39.4 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.723 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.579 ' C ' ' ND2' ' A' ' 51' ' ' ASN . 34.3 p90 -148.52 99.87 3.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.84 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.579 ' ND2' ' C ' ' A' ' 50' ' ' TYR . 4.1 p30 44.22 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.901 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER 40.83 26.95 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.764 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -127.16 81.9 0.35 Allowed Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -87.31 127.1 2.4 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.139 1.892 . . . . 0.0 111.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.3 p -130.23 142.67 50.54 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.293 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.644 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 18.7 m95 -101.09 160.77 14.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.481 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' HZ ' ' A' ' 61' ' ' PHE . 41.3 t -158.64 82.28 0.81 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.243 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.595 ' OD1' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -176.13 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.828 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.705 ' C ' ' H ' ' A' ' 61' ' ' PHE . 1.1 t 68.08 -46.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.183 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 58' ' ' ASN . 23.8 m -62.91 15.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.78 ' O ' ' N ' ' A' ' 63' ' ' ASP . 45.9 m-85 -56.99 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.567 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 61' ' ' PHE . 39.0 p 32.77 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.78 ' N ' ' O ' ' A' ' 61' ' ' PHE . 9.6 t0 -88.77 92.03 9.05 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.682 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -154.79 -173.18 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.814 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.04 163.69 19.41 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.598 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 130.35 5.13 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 11.6 t80 -89.32 155.73 19.18 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.446 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 4.1 m-20 -142.14 152.7 43.47 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.576 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 18.9 t80 -101.06 -179.49 4.06 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.115 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 121.8 -1.97 10.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 105.07 -3.212 . . . . 0.0 105.07 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.652 ' CG ' ' N ' ' A' ' 72' ' ' PHE . 1.8 t70 161.15 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 111.159 -2.52 . . . . 0.0 105.178 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.652 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.2 m-85 -150.14 106.36 3.47 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.62 149.58 45.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.094 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.506 HD13 ' CH2' ' A' ' 33' ' ' TRP . 2.9 tm? -144.58 116.35 8.23 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.228 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.0 p -102.59 140.7 36.52 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.446 HD13 ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -95.82 125.57 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.727 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ILE . 24.5 ttpt -135.69 93.78 2.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' LYS . 3.7 t -154.96 -30.05 0.1 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 113.301 -1.772 . . . . 0.0 107.097 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 41.35 14.81 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 111.957 -2.383 . . . . 0.0 113.499 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' SER . 7.6 mmtt -103.45 148.45 25.9 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.388 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 80' ' ' LYS . 11.3 tp -41.89 -25.91 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.084 -1.047 . . . . 0.0 109.688 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' LYS . 7.5 pt20 -57.32 -17.73 13.6 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -64.59 -57.14 9.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.586 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.738 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -40.91 118.39 0.98 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.662 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.03 163.92 35.03 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -85.33 102.67 13.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.491 ' CE1' ' HE3' ' A' ' 35' ' ' LYS . 2.1 m-30 -89.27 149.6 23.0 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.656 -0.817 . . . . 0.0 112.254 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.56 110.25 5.31 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.677 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.49 100.41 13.03 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.338 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -106.63 120.49 42.09 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.104 179.792 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -133.35 130.29 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.596 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 1.9 m120 -107.01 114.34 28.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.179 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -112.67 107.12 15.68 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -90.57 101.64 14.38 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.858 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.4 mm? -91.04 113.89 26.27 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.8 tp -118.56 100.38 7.41 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.966 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.738 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -116.42 161.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.685 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD11 ' H ' ' A' ' 109' ' ' ASP . 63.8 tp -107.0 154.45 21.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.645 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.467 ' H ' HD11 ' A' ' 108' ' ' LEU . 33.1 t70 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 116.315 -1.802 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.868 ' SG ' ' N ' ' A' ' 100' ' ' ASN . 2.7 t . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 121.354 0.597 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 4.9 Cg_endo -74.92 23.68 0.39 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 121.584 1.523 . . . . 0.0 110.081 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 2' ' ' CYS . 1.2 t70 73.99 97.68 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.232 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -150.92 160.62 43.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.187 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -138.12 158.17 44.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.46 160.43 43.46 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.59 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' OE1' ' CB ' ' A' ' 104' ' ' GLN . 35.5 tp10 -131.12 98.75 4.66 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.77 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -99.73 142.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.285 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 11' ' ' GLY . 10.9 p -129.88 143.13 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.162 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.666 ' H ' HG23 ' A' ' 107' ' ' ILE . . . -154.13 163.14 30.89 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.335 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 7.4 p -123.57 97.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.849 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 12' ' ' VAL . 14.2 m 38.82 75.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' C ' ' HD3' ' A' ' 16' ' ' PRO . . . 142.36 64.39 0.03 OUTLIER Glycine 0 C--N 1.293 -1.842 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 7.1 tppt? -121.11 56.18 5.38 Favored Pre-proline 0 C--O 1.209 -1.065 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -70.15 132.31 22.44 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 N-CA-C 105.585 -2.506 . . . . 0.0 105.585 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.56 161.74 3.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 117.338 -1.745 . . . . 0.0 112.811 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -107.68 106.02 16.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mp -88.89 127.44 35.64 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -151.42 96.46 3.21 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 116.169 -2.213 . . . . 0.0 116.911 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HB3' ' CE ' ' A' ' 101' ' ' LYS . 2.7 Cg_exo -71.43 147.83 53.21 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.031 1.154 . . . . 0.0 110.041 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 t -132.59 161.12 34.67 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.761 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.34 97.35 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.696 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.51 9.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.504 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' CG ' ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER 59.95 -7.97 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.367 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.632 ' H ' ' C ' ' A' ' 24' ' ' ILE . 38.6 p 45.27 88.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.762 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.99 -174.77 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.152 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-10 -52.92 104.55 0.09 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.703 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.0 m -150.23 177.62 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.212 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -139.16 139.53 37.6 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.809 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 49' ' ' TRP . 1.6 t -102.07 137.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.299 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -150.41 130.46 13.48 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.973 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.587 ' HE1' ' CB ' ' A' ' 47' ' ' LEU . 2.7 p-90 -141.56 108.02 5.3 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -100.79 161.0 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.036 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HZ3' HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -147.11 160.6 42.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.987 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m -110.21 106.13 15.45 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.301 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -103.98 100.79 10.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.083 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.551 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 46.1 tp60 -96.79 164.66 12.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.811 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 89.08 95.41 1.06 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.07 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m 54.64 5.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.98 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.6 ' H ' ' C ' ' A' ' 39' ' ' GLY . 91.8 m-70 -121.38 -159.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -157.22 -159.8 0.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.676 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.551 ' NZ ' ' OE1' ' A' ' 38' ' ' GLN . 6.1 mmpt? -88.64 150.73 22.88 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.332 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 46' ' ' ILE . 87.8 mt -144.86 147.68 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.667 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.486 ' OE1' ' OG ' ' A' ' 57' ' ' SER . 11.7 mp0 -96.66 -24.12 16.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.521 HD12 ' HZ3' ' A' ' 35' ' ' LYS . 22.6 mm 68.22 -107.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -112.9 154.87 25.69 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' ND2' ' OG ' ' A' ' 55' ' ' SER . 1.8 p30 -139.88 98.95 3.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.089 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.1 t90 -94.76 129.95 41.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.458 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.6 p90 -149.76 100.38 2.96 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.93 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 1.5 t-20 51.13 83.89 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.239 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 26.2 t70 45.34 27.45 0.36 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.78 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.06 79.13 0.36 Allowed Glycine 0 N--CA 1.507 3.367 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.723 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 15.0 Cg_endo -87.76 120.15 1.39 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.362 2.041 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.47 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -129.71 155.03 46.56 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.851 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.499 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 44.2 m95 -102.62 164.34 11.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.888 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' OE1' ' A' ' 45' ' ' GLU . 38.8 t -158.51 79.39 0.8 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 118.215 -1.394 . . . . 0.0 113.248 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.4 t30 158.77 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.558 1.161 . . . . 0.0 109.461 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -47.07 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 58' ' ' ASN . 0.6 OUTLIER 174.4 2.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.369 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 20.9 m-30 -79.71 38.33 0.38 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.278 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 t -78.51 -7.68 57.75 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 61' ' ' PHE . 4.2 t0 -150.53 95.03 2.18 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.714 -2.948 . . . . 0.0 105.76 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.636 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 1.4 tp -151.82 -174.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.636 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.01 161.69 26.09 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 112.944 -1.934 . . . . 0.0 113.78 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.05 137.32 9.38 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 154.77 19.86 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.275 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -137.3 145.77 43.84 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -97.09 -179.27 4.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.36 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 119.28 1.95 13.78 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 105.604 -2.998 . . . . 0.0 105.604 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.6 m-20 156.43 -99.06 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.959 -2.12 . . . . 0.0 105.905 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 78.1 m-85 -153.34 102.46 2.6 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.978 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.84 150.5 31.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.343 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.516 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 1.2 pp -144.87 146.03 31.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 m -120.25 146.01 46.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.6 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.05 130.87 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.992 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -140.99 92.87 2.53 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 80' ' ' LYS . 31.1 t -151.71 -33.84 0.14 Allowed 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.743 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.523 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 48.7 15.82 0.1 Allowed 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 112.398 -2.183 . . . . 0.0 112.593 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' GLN . 10.5 mmtm -99.61 142.22 31.38 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tp -44.08 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.269 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 pt20 -65.81 -22.53 66.56 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.413 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.6 OUTLIER -59.38 -33.9 71.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.207 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.502 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 58.4 p -45.89 100.06 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.63 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.58 162.14 35.18 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.457 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -87.1 107.76 18.59 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.796 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.8 m-30 -87.78 151.12 23.13 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.642 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 109.03 5.68 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.742 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.87 126.71 35.81 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.887 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' N ' HD13 ' A' ' 89' ' ' LEU . 4.1 pt-20 -143.6 137.23 28.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.5 tt -109.58 159.87 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -87.61 159.49 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 50.57 86.8 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.472 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -82.87 162.3 21.64 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.143 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.05 111.93 0.3 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.35 -173.89 25.56 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.411 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -44.24 -34.93 2.06 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.075 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -40.14 151.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.279 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.856 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 15.0 p -168.66 -98.49 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.439 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.868 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 1.4 p30 -152.1 160.25 43.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.401 ' CE ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -145.51 155.18 42.93 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.348 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -134.12 124.69 26.53 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.283 -0.967 . . . . 0.0 112.413 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.1 118.96 38.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.403 ' CB ' ' OE1' ' A' ' 8' ' ' GLU . 49.4 mt-30 -89.36 120.3 30.58 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.219 -0.993 . . . . 0.0 112.069 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 9' ' ' VAL . 2.8 mm? -108.4 123.71 49.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tp -139.75 99.01 3.6 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.666 HG23 ' H ' ' A' ' 11' ' ' GLY . 11.0 pt -124.45 164.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.841 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 108' ' ' LEU . 3.4 mm? -108.53 -175.32 2.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.905 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' C ' ' OG ' ' A' ' 13' ' ' SER . 15.5 t70 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.2 Cg_endo -65.16 164.73 24.23 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.14 1.227 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 3' ' ' PRO . 62.7 m-20 -42.88 106.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.604 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -148.85 144.89 27.22 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.327 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -125.46 123.09 38.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -136.61 160.39 38.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.06 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pp20? -143.0 109.22 5.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.82 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 ' CG2' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.92 156.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.319 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' O ' ' NZ ' ' A' ' 15' ' ' LYS . 14.2 p -121.45 151.2 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.972 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 10' ' ' VAL . . . -152.59 167.27 31.46 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.067 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.8 OUTLIER -142.56 97.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.097 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 83.9 p 35.19 81.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.846 0.832 . . . . 0.0 108.853 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.42 ' C ' ' HD3' ' A' ' 16' ' ' PRO . . . 131.7 68.58 0.09 OUTLIER Glycine 0 C--N 1.29 -1.994 0 N-CA-C 104.401 -3.48 . . . . 0.0 104.401 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 tpmt? -119.54 79.48 21.83 Favored Pre-proline 0 C--O 1.204 -1.307 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 19.3 Cg_endo -93.65 95.88 0.14 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 N-CA-C 104.831 -2.796 . . . . 0.0 104.831 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.89 161.58 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -109.95 100.08 9.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.479 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' LEU . 2.7 tp -88.76 107.56 19.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -135.54 101.33 10.93 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -67.44 125.55 13.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 O-C-N 122.893 0.944 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 60.2 p -121.75 163.34 19.25 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.179 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 22' ' ' SER . 0.2 OUTLIER 83.76 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.71 0.631 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.577 ' CG2' ' SG ' ' A' ' 2' ' ' CYS . 1.1 pp -113.14 -170.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.557 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -160.33 3.95 0.08 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.735 -1.575 . . . . 0.0 107.653 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.423 ' OG1' ' CG2' ' A' ' 29' ' ' VAL . 2.4 t -102.63 154.2 19.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 12.7 mtmt -160.97 146.27 14.25 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.599 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER 70.6 17.99 6.54 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.84 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.578 ' CG1' ' H ' ' A' ' 30' ' ' SER . 21.7 t -96.67 178.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.608 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.578 ' H ' ' CG1' ' A' ' 29' ' ' VAL . 14.0 p -89.84 144.92 25.54 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 36.3 t -123.31 135.94 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -149.92 139.27 21.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.525 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.505 ' CH2' HD13 ' A' ' 74' ' ' LEU . 10.1 p-90 -142.56 112.98 7.23 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HB3' ' HZ1' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -98.12 159.81 14.7 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.515 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.727 ' NZ ' ' HH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.34 159.25 44.44 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.125 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -111.81 103.71 11.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.394 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' ARG . 5.3 mt-10 -100.85 100.57 11.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.419 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.648 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 12.3 tt0 -93.16 179.78 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 80.24 75.53 1.05 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.85 -7.99 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.796 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.667 ' H ' ' C ' ' A' ' 39' ' ' GLY . 82.0 m-70 -95.26 -160.99 0.82 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtt85 -153.92 167.33 30.08 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.302 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.453 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.12 138.43 31.56 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.025 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.702 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -151.79 168.67 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.847 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 3.7 mp0 -83.9 -22.44 31.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.673 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.702 ' H ' ' CG2' ' A' ' 44' ' ' ILE . 4.0 mm 70.2 -109.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.532 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -99.47 151.07 21.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.664 ' ND2' ' HG ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -140.5 100.77 3.95 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.276 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 0.6 OUTLIER -100.65 130.55 46.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.757 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.7 t80 -137.03 97.69 3.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.147 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.54 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER 65.38 -60.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.128 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.8 p30 -159.81 32.18 0.18 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.101 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.86 87.17 0.39 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.532 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -87.83 108.08 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.512 2.142 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.664 ' HG ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -132.38 143.73 50.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.501 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 3.6 m95 -87.85 161.43 17.52 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.163 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 46' ' ' ILE . 52.7 m -124.92 78.71 1.72 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.542 ' ND2' ' C ' ' A' ' 57' ' ' SER . 1.2 m-80 70.71 -40.84 0.48 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.822 ' O ' ' N ' ' A' ' 61' ' ' PHE . 1.5 t -43.52 117.04 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.166 -3.311 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.352 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 62' ' ' SER . 22.8 t -18.14 54.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.822 ' N ' ' O ' ' A' ' 59' ' ' VAL . 17.7 m-85 -63.12 76.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 117.491 -1.684 . . . . 0.0 112.377 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 60' ' ' SER . 0.3 OUTLIER -148.23 -22.49 0.34 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 62' ' ' SER . 18.7 t0 -147.79 90.94 1.89 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.777 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -156.87 -171.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 117.119 -1.832 . . . . 0.0 115.892 -178.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.777 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.65 163.5 21.27 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 111.186 -2.734 . . . . 0.0 114.935 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.09 127.55 5.17 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.3 t80 -93.97 158.94 15.4 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.535 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 3.7 m-20 -145.01 151.46 38.61 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.343 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 61.1 t80 -107.93 174.05 6.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.483 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.774 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 123.84 -7.78 8.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 105.931 -2.868 . . . . 0.0 105.931 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 7.0 t70 173.92 -103.49 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 111.515 -2.342 . . . . 0.0 104.855 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 87.0 m-85 -152.55 109.08 3.43 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.54 145.1 40.29 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.185 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.539 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -151.14 117.82 5.77 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.858 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.3 t -109.18 139.83 43.58 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.977 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.519 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.51 130.37 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -142.61 94.56 2.66 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.887 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -151.74 -31.84 0.15 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.825 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 55.12 40.43 31.83 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 112.664 -2.062 . . . . 0.0 114.791 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 82' ' ' GLN . 4.2 mtpp -142.0 158.87 43.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.795 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 10.9 mp -43.48 -23.19 0.06 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.528 ' CG ' ' CE1' ' A' ' 41' ' ' HIS . 51.0 mt-30 -52.4 -32.81 40.72 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 117.654 -1.618 . . . . 0.0 107.832 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.7 m-20 -66.51 -41.03 89.45 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -57.49 105.04 0.21 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.269 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 164.95 37.06 Favored Glycine 0 C--N 1.284 -2.348 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.694 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 102' ' ' ASN . 13.1 t-160 -86.14 105.22 16.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.649 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.727 ' HH ' ' NZ ' ' A' ' 35' ' ' LYS . 2.2 m-30 -88.39 155.22 19.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.307 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' C ' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -145.64 105.22 3.97 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.29 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.45 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.46 122.81 33.01 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.923 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -143.83 139.63 29.41 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.01 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.533 ' N ' ' OE2' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -102.68 160.88 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.708 ' CG2' ' H ' ' A' ' 93' ' ' ASN . 90.5 m 56.64 -171.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.247 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.708 ' H ' ' CG2' ' A' ' 92' ' ' THR . 37.9 m-80 -83.75 -19.95 34.22 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.443 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.502 ' HG1' ' H ' ' A' ' 95' ' ' GLY . 2.5 t -138.51 175.27 9.71 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.502 ' H ' ' HG1' ' A' ' 94' ' ' THR . . . -94.47 -164.19 35.79 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 140.54 89.24 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 96' ' ' GLY . 32.5 pttt 35.9 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.381 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.704 ' CG2' ' H ' ' A' ' 99' ' ' CYS . 6.8 p -120.87 -170.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.005 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 t -57.77 102.57 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.46 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -149.88 100.6 2.96 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.051 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -144.61 160.44 41.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.819 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -121.16 127.19 51.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.496 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.31 139.4 41.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.504 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.26 107.66 14.69 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.095 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.435 ' CD1' ' CG2' ' A' ' 9' ' ' VAL . 2.4 mm? -89.05 125.49 35.03 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.438 ' HA ' ' HG ' ' A' ' 84' ' ' SER . 0.4 OUTLIER -130.61 98.05 4.55 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.537 ' N ' ' OG ' ' A' ' 84' ' ' SER . 1.2 pt -122.6 162.62 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 28.8 tp -150.67 151.13 32.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.379 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 40.3 t0 . . . . . 0 C--N 1.307 -1.267 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.883 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.375 0.607 . . . . 0.0 111.485 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 5.5 Cg_endo -68.07 -161.08 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 121.552 1.501 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.53 131.82 53.92 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.931 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m -137.41 132.65 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.271 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 m -150.08 109.39 3.96 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.433 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.65 147.68 50.21 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -104.5 104.78 14.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' CG2' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -93.31 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.846 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.39 151.79 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.975 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.54 30.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.855 ' N ' ' HZ2' ' A' ' 15' ' ' LYS . 7.5 p -147.6 96.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.156 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.798 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . 54.3 p 33.61 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 122.235 1.016 . . . . 0.0 108.706 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.718 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . . . 124.21 62.71 0.19 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 103.362 -3.895 . . . . 0.0 103.362 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.855 ' HZ2' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -119.44 60.34 5.63 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.81 97.0 0.62 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 N-CA-C 104.767 -2.82 . . . . 0.0 104.767 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.92 161.19 3.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.966 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.75 109.46 15.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.885 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -87.21 124.21 33.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -136.83 93.39 13.75 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 116.923 -1.911 . . . . 0.0 115.337 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.36 104.61 1.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 O-C-N 123.448 1.236 . . . . 0.0 109.468 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' CG ' ' A' ' 23' ' ' ASN . 3.6 m -129.23 97.76 4.69 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 22' ' ' SER . 70.0 m-80 -165.98 13.14 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.705 ' H ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -94.89 -161.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.263 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' N ' HG12 ' A' ' 24' ' ' ILE . 8.1 pt20 -135.62 2.76 2.96 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.758 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.542 ' H ' HG12 ' A' ' 24' ' ' ILE . 4.5 p 59.26 114.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.031 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 177.84 10.92 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.241 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.62 93.03 0.23 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.662 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -143.72 149.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.84 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 m -90.52 139.04 31.07 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.811 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.513 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 4.4 t -106.66 135.06 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.188 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -150.14 127.84 11.66 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.231 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 47' ' ' LEU . 1.5 p-90 -131.49 147.06 52.51 Favored 'General case' 0 C--O 1.193 -1.876 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.212 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -137.47 154.26 49.93 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.687 ' HZ3' ' CD ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -153.43 158.6 41.65 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 117.865 -1.534 . . . . 0.0 113.718 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.27 97.23 7.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.687 ' CD ' ' HZ3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.35 -174.85 4.23 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.908 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.798 ' NE2' ' H ' ' A' ' 39' ' ' GLY . 41.3 tp60 55.62 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.66 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.798 ' H ' ' NE2' ' A' ' 38' ' ' GLN . . . 38.14 84.42 0.01 OUTLIER Glycine 0 N--CA 1.501 2.97 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 t 47.07 34.5 2.87 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.897 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 21.9 m170 55.55 71.04 0.57 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 43' ' ' LYS . 5.3 tpm_? -86.51 174.91 8.64 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -86.7 131.37 34.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.195 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.579 ' CD1' ' ND2' ' A' ' 58' ' ' ASN . 4.4 mm -131.25 146.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.97 -24.94 13.93 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 8.3 mm 62.64 -111.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.581 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -107.51 154.94 20.65 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 47' ' ' LEU . 1.1 t-20 -137.41 98.58 3.74 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.298 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.528 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 3.7 t90 -92.58 133.02 36.36 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.665 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -140.36 98.36 3.41 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 3.0 t30 68.54 -55.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.204 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -171.14 31.3 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.21 90.02 0.42 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.49 101.65 0.6 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.203 1.935 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.417 ' H ' ' HG ' ' A' ' 55' ' ' SER . 0.2 OUTLIER -116.94 140.2 49.74 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.52 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 7.9 m95 -90.18 162.2 15.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.6 p -151.83 80.5 1.27 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.665 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.579 ' ND2' ' CD1' ' A' ' 44' ' ' ILE . 2.5 t30 175.58 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 124.623 1.202 . . . . 0.0 112.594 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 58' ' ' ASN . 4.5 m 31.45 31.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 58' ' ' ASN . 89.3 p -122.89 6.13 9.34 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 20.4 m-85 -71.46 45.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -15.42 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.62 95.95 2.3 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.72 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.98 -173.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 117.238 -1.785 . . . . 0.0 115.294 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.72 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -70.14 163.58 26.0 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 111.786 -2.461 . . . . 0.0 115.276 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.1 116.22 2.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.15 -2.38 . . . . 0.0 107.15 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 68' ' ' ASP . 42.3 t80 -99.1 158.94 15.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.505 ' N ' ' CG ' ' A' ' 67' ' ' PHE . 17.3 m-20 -143.18 141.32 31.11 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.984 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -107.24 177.61 4.8 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.584 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.32 81.81 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 104.961 -3.255 . . . . 0.0 104.961 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 71' ' ' ASP . 2.5 t0 167.87 130.33 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -81.21 112.58 18.67 Favored 'General case' 0 C--N 1.259 -3.352 0 C-N-CA 117.59 -1.644 . . . . 0.0 109.86 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.83 111.43 5.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.288 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.603 HD21 ' H ' ' A' ' 75' ' ' SER . 3.4 tm? -104.59 146.89 28.27 Favored 'General case' 0 C--O 1.199 -1.589 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.603 ' H ' HD21 ' A' ' 74' ' ' LEU . 48.6 p -140.31 130.58 25.14 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.344 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 HD13 ' HZ1' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -88.6 130.93 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.055 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.99 93.94 2.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.963 1.363 . . . . 0.0 108.27 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.41 ' HG ' ' HB3' ' A' ' 83' ' ' ASP . 89.1 p -151.77 -39.98 0.11 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.535 -2.121 . . . . 0.0 105.819 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 53.8 20.57 2.34 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 111.321 -2.672 . . . . 0.0 115.104 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 83' ' ' ASP . 32.9 mmtt -98.96 142.95 29.81 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 80' ' ' LYS . 12.0 tp -45.04 -31.77 1.46 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.624 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -59.52 -34.83 73.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.074 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -53.26 -47.66 68.9 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.908 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.529 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -37.07 124.57 0.92 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.228 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . -173.05 166.47 39.02 Favored Glycine 0 C--N 1.278 -2.686 0 C-N-CA 118.394 -1.86 . . . . 0.0 110.784 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -88.27 106.32 18.14 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.544 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.774 ' HH ' ' CB ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -110.45 150.9 28.19 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.083 -1.047 . . . . 0.0 113.503 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' CD2' ' C ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -150.8 142.14 23.33 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.035 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 146.15 24.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.791 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HG2' ' ND2' ' A' ' 100' ' ' ASN . 40.0 mt-10 -143.34 124.24 14.31 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.62 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt -101.25 160.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.434 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 93' ' ' ASN . 13.9 t -53.48 177.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 92' ' ' THR . 2.5 t30 71.15 157.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.567 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 5.1 t -155.92 175.85 13.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.941 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . 74.35 148.25 1.45 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.503 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.11 -96.23 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.352 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -74.98 136.07 41.31 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.695 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 99' ' ' CYS . 10.1 p -62.04 -42.8 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.117 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.883 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 66.9 m 50.1 59.63 4.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.572 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' A' ' 90' ' ' GLU . 29.7 m120 -151.31 105.16 3.17 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.195 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 2.0 mptt -102.77 106.01 16.54 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.747 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 88' ' ' LEU . 2.1 m120 -88.45 160.18 17.65 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.592 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' TYR . 62.6 m-85 -150.08 129.71 13.14 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.277 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.67 106.42 16.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.722 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.774 ' CB ' ' HH ' ' A' ' 87' ' ' TYR . 2.6 mm? -97.92 98.4 9.77 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tp -107.21 100.16 9.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.397 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.584 ' CD1' ' OD1' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -113.6 164.07 10.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.97 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.27 -154.61 0.53 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.896 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 47.3 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.088 0.47 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 9.9 Cg_endo -78.82 -167.64 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.955 1.77 . . . . 0.0 111.563 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -113.41 84.37 2.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.232 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m -90.47 140.97 29.22 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.304 -0.958 . . . . 0.0 112.381 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 p -147.61 98.88 3.04 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.668 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' OE2' ' C ' ' A' ' 8' ' ' GLU . 6.5 tm-20 -115.03 154.66 28.42 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.202 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' OE2' ' A' ' 7' ' ' GLU . 4.4 tm-20 -129.57 99.38 5.14 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.399 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.23 151.19 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.657 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.41 150.19 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' CA ' ' NZ ' ' A' ' 15' ' ' LYS . . . -151.79 167.39 31.02 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.656 ' H ' ' HZ2' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -140.57 107.43 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.602 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 7.82 85.54 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 122.051 0.929 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.52 53.07 0.06 OUTLIER Glycine 0 C--N 1.282 -2.424 1 N-CA-C 101.604 -4.598 . . . . 0.0 101.604 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.656 ' HZ2' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -108.08 53.69 0.22 Allowed Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.18 107.29 1.52 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 103.509 -3.304 . . . . 0.0 103.509 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.24 161.21 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 118.609 -1.237 . . . . 0.0 114.151 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.45 112.76 25.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.827 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.4 tp -100.16 101.18 12.15 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -123.04 97.27 43.76 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.26 114.11 3.52 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 120.844 1.029 . . . . 0.0 109.628 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 35.7 t -115.16 163.01 16.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.9 t30 79.5 84.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.549 0.69 . . . . 0.0 109.751 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.482 ' N ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -137.94 -162.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.95 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' O ' ' CG ' ' A' ' 25' ' ' GLN . 3.1 tt0 -152.71 -9.0 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' OG1' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.02 125.82 48.8 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.736 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -130.99 159.27 37.97 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.376 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.57 42.01 31.99 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.484 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 ' CG2' ' OG1' ' A' ' 26' ' ' THR . 1.5 m -119.96 -179.84 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.3 m -88.53 145.33 25.79 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.367 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 49' ' ' TRP . 2.1 t -123.09 146.08 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 119.204 -0.999 . . . . 0.0 112.47 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -150.83 127.7 11.01 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.546 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.567 ' CH2' ' CD1' ' A' ' 74' ' ' LEU . 5.0 p-90 -133.58 103.5 5.94 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 118.565 -1.254 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 15.3 tttt -94.89 160.86 14.4 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.938 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.612 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -146.17 158.89 43.9 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.486 ' HG1' ' CE ' ' A' ' 43' ' ' LYS . 2.2 m -125.1 98.88 5.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.32 129.59 44.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.112 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.615 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 6.9 tt0 -93.73 179.09 5.47 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.528 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 86.79 -156.89 29.26 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 t -59.6 6.48 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.754 -1.178 . . . . 0.0 110.002 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.672 ' H ' ' C ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -88.35 -136.38 0.1 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.369 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.35 -160.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.047 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' CE ' ' HG1' ' A' ' 36' ' ' THR . 1.1 mtpt -88.66 154.58 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.504 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' ND2' ' A' ' 58' ' ' ASN . 39.1 mt -150.4 138.19 14.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 C-N-CA 118.018 -1.473 . . . . 0.0 113.079 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -89.25 -30.8 18.24 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 31.6 mm 72.54 -101.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 6.7 tt -125.24 153.57 42.98 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -133.17 99.05 4.43 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.817 -1.992 . . . . 0.0 106.429 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.567 ' N ' ' O ' ' A' ' 31' ' ' VAL . 3.8 t90 -89.51 121.88 32.15 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.647 -0.821 . . . . 0.0 113.089 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -135.8 98.33 3.88 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.668 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.6 t30 64.53 -168.52 0.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.93 33.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.964 -1.494 . . . . 0.0 110.292 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -127.56 85.62 0.33 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.103 -1.046 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.41 141.25 6.7 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.156 1.904 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.0 p -136.33 139.15 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.575 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 11.8 m95 -91.24 161.19 15.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.591 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.46 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 41.0 t -159.96 79.96 0.7 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.259 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.592 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 28.8 t30 -179.4 -17.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.804 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.755 ' C ' ' H ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 67.59 -37.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.109 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 58' ' ' ASN . 0.7 OUTLIER -63.15 20.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.423 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.755 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.5 m-85 -86.24 46.19 1.31 Allowed 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -95.71 -10.62 28.78 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.05 104.54 5.06 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 109.762 -3.381 . . . . 0.0 103.229 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -144.64 -176.35 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.78 162.6 13.53 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 109.48 -3.509 . . . . 0.0 112.546 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.1 126.28 6.52 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 34.5 t80 -88.05 144.94 26.22 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.044 -1.462 . . . . 0.0 112.726 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 29.4 t0 -152.06 167.07 29.63 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.003 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 3.0 m-85 88.06 131.0 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.77 -27.04 69.38 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.138 -3.185 . . . . 0.0 105.138 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 15.5 m-20 -90.43 -102.75 0.1 Allowed 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 71' ' ' ASP . 2.2 m-85 -154.04 106.44 2.82 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.426 -1.71 . . . . 0.0 112.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' CB ' ' CG ' ' A' ' 69' ' ' TYR . . . -151.87 100.1 2.63 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.073 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.567 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 2.6 pp -115.06 146.89 40.83 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 p -109.2 141.71 41.06 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -96.0 137.3 24.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.02 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -143.43 94.75 2.65 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.645 1.212 . . . . 0.0 108.766 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' LYS . 6.4 t -156.21 -26.55 0.1 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 113.188 -1.824 . . . . 0.0 107.087 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 41.63 16.05 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.475 -2.148 . . . . 0.0 113.208 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 82' ' ' GLN . 5.5 mmmt -95.12 151.18 19.43 Favored 'General case' 0 C--N 1.279 -2.479 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.979 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 3.0 tp -47.66 -11.84 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.226 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.598 ' H ' ' C ' ' A' ' 80' ' ' LYS . 1.5 pt20 -72.75 -23.36 60.82 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -27.85 58.35 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 118.374 -1.33 . . . . 0.0 108.423 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.612 ' HB2' ' H ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -74.01 114.55 12.45 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.657 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.48 164.19 35.79 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.52 ' NE2' ' CD ' ' A' ' 104' ' ' GLN . 45.3 m80 -85.3 104.75 15.42 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.482 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 2.5 m-30 -86.29 150.46 24.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.34 106.09 5.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.04 128.05 35.71 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.349 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.46 ' N ' HD13 ' A' ' 89' ' ' LEU . 22.7 mt-10 -148.53 160.94 42.6 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.403 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' CD1' ' CE1' ' A' ' 72' ' ' PHE . 5.2 mt -134.57 148.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.992 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.503 ' C ' ' CG ' ' A' ' 93' ' ' ASN . 18.5 m -42.82 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.503 ' CG ' ' C ' ' A' ' 92' ' ' THR . 0.4 OUTLIER 74.51 138.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.861 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 96' ' ' GLY . 10.0 t -172.08 20.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.977 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -57.43 -5.02 1.5 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.612 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 94' ' ' THR . . . -170.03 -70.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.203 -1.475 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HZ2' HE22 ' A' ' 25' ' ' GLN . 45.0 mmtt -44.81 133.13 6.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.522 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' C ' ' H ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -93.0 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.289 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.896 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -67.85 34.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.386 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.633 ' H ' ' C ' ' A' ' 98' ' ' VAL . 1.7 p30 -98.33 116.69 31.08 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.468 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -121.04 118.57 30.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.49 139.4 39.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.786 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -136.23 102.56 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.716 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CD ' ' NE2' ' A' ' 86' ' ' HIS . 46.0 tt0 -89.9 107.2 18.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.248 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.453 ' N ' HD23 ' A' ' 105' ' ' LEU . 3.9 mm? -91.92 118.57 30.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -122.8 102.27 7.93 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.612 ' H ' ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -115.0 161.62 13.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.459 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 108' ' ' LEU . 8.0 mp -92.66 -171.0 2.61 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.419 -1.753 . . . . 0.0 110.851 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 33.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.245 0.545 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 5.7 Cg_endo -74.13 162.9 37.85 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.963 1.775 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.34 102.55 10.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -150.44 160.72 43.55 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.78 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.6 t -134.32 141.11 46.8 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.353 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 8' ' ' GLU . 37.1 tp10 -125.17 151.54 45.68 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 36.8 mt-10 -114.27 132.05 56.29 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.68 132.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 11' ' ' GLY . 7.6 p -103.24 154.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.544 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' HG21 ' A' ' 107' ' ' ILE . . . -151.51 165.87 30.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' ' C ' ' A' ' 13' ' ' SER . 98.8 t -147.53 96.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 30.27 79.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.016 0.912 . . . . 0.0 108.63 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.552 ' H ' ' HE2' ' A' ' 15' ' ' LYS . . . 135.68 59.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 104.43 -3.468 . . . . 0.0 104.43 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HE2' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -113.13 50.81 0.44 Allowed Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -66.32 91.45 0.27 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 105.331 -2.603 . . . . 0.0 105.331 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 15' ' ' LYS . 6.2 p -107.7 162.07 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' NE2' ' HB3' ' A' ' 75' ' ' SER . 10.7 tp-100 -112.78 106.01 14.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.996 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -87.98 103.19 15.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.66 96.55 48.83 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.75 105.39 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.125 1.217 . . . . 0.0 109.352 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t -111.51 110.07 20.32 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.691 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 173.3 10.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.491 HG13 ' H ' ' A' ' 26' ' ' THR . 5.1 pt -107.4 177.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.198 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.779 ' H ' ' HZ2' ' A' ' 27' ' ' LYS . 6.3 pt20 -123.54 16.39 9.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.788 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.491 ' H ' HG13 ' A' ' 24' ' ' ILE . 68.9 p 45.9 91.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.512 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HZ2' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -125.16 -160.9 0.98 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.479 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -81.59 81.36 7.7 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.378 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.415 ' H ' HD22 ' A' ' 51' ' ' ASN . 35.8 m -147.31 152.95 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.069 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.454 ' OG ' ' OG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -90.03 161.48 15.82 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.871 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.509 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 39.4 t -126.96 130.59 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.178 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -146.46 144.44 29.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.049 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 33' ' ' TRP . 2.3 p-90 -143.74 119.28 10.37 Favored 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.429 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -102.84 158.56 16.18 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.038 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.774 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -147.8 161.63 40.86 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.203 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.3 m -125.23 99.65 6.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.93 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 42' ' ' ARG . 3.9 pt-20 -99.59 109.87 22.35 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.912 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -74.15 172.63 11.4 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 95.21 -165.88 25.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 m -48.89 -12.12 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.739 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.594 ' H ' ' C ' ' A' ' 39' ' ' GLY . 48.5 m-70 -82.16 -145.07 0.06 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.577 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' H ' ' HG3' ' A' ' 37' ' ' GLU . 1.7 ttp180 179.19 -172.63 0.16 Allowed 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 117.884 -1.526 . . . . 0.0 112.901 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.06 126.49 35.46 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.849 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 4.4 mt -137.39 163.01 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.411 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.539 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 23.8 mt-10 -86.12 -31.17 22.0 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 57' ' ' SER . 10.3 mm 83.79 -87.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 1.1 tt -143.01 150.55 39.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.74 109.1 9.92 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.109 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.509 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 6.1 t90 -88.77 145.19 25.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 52' ' ' ASP . 14.1 m-85 -141.04 96.47 3.0 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.609 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.471 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . 29.2 m120 7.09 54.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.284 1.615 . . . . 0.0 113.413 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 50' ' ' TYR . 22.6 t70 -179.81 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.621 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.18 152.43 23.61 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.489 -1.815 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -88.96 141.31 4.29 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.913 1.742 . . . . 0.0 112.371 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -127.99 137.37 52.2 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.5 m95 -89.3 161.12 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.731 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.568 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.2 m -124.07 68.51 1.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.693 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 31.33 90.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 124.932 1.395 . . . . 0.0 113.139 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.721 ' CG1' ' CZ ' ' A' ' 61' ' ' PHE . 2.3 p -122.87 -37.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.06 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.602 ' N ' ' CG1' ' A' ' 59' ' ' VAL . 1.5 t 160.84 26.28 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.721 ' CZ ' ' CG1' ' A' ' 59' ' ' VAL . 39.7 m-85 -54.47 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.091 1.425 . . . . 0.0 112.791 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 t -176.73 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.495 ' C ' ' HG ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -151.05 101.65 2.89 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.699 ' N ' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -154.87 -173.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.79 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -77.22 165.17 24.87 Favored 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 109.578 -3.465 . . . . 0.0 114.798 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.49 126.63 4.39 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 10.8 t80 -106.66 154.3 21.13 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.144 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 13.3 t70 -139.51 147.94 41.96 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 69' ' ' TYR . 12.6 p90 -102.85 174.29 5.94 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.443 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 82.68 12.18 80.48 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER 157.62 127.59 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 31' ' ' VAL . 6.9 m-30 -80.84 111.87 17.71 Favored 'General case' 0 C--N 1.264 -3.139 0 C-N-CA 117.314 -1.754 . . . . 0.0 108.684 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.24 105.56 5.75 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.6 tm? -100.54 128.99 46.43 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.051 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.493 ' N ' HD23 ' A' ' 74' ' ' LEU . 56.5 p -121.7 127.33 50.62 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.639 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.522 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -89.12 127.03 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.661 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -137.22 96.21 3.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.422 1.106 . . . . 0.0 108.459 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.495 ' HG ' ' C ' ' A' ' 63' ' ' ASP . 73.8 m -156.6 -33.8 0.08 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.81 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 47.42 64.9 1.41 Allowed 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 112.436 -2.165 . . . . 0.0 113.011 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 37.1 mmtt -145.48 148.29 33.1 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.013 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' O ' ' OG ' ' A' ' 84' ' ' SER . 51.8 tp -49.67 -30.93 9.96 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.991 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . 3.0 pp0? -53.53 -28.45 31.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.465 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 8.9 m-20 -58.02 -57.39 13.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.379 -0.929 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.605 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.7 OUTLIER -40.87 119.89 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.885 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.01 164.41 35.72 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -85.78 103.88 14.95 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.231 -1.388 . . . . 0.0 108.273 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.774 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 1.1 m-30 -89.38 159.63 17.23 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.72 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.71 111.6 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.486 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.5 125.44 35.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -150.34 142.33 23.93 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.099 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 92' ' ' THR . 3.6 mt -98.28 160.1 3.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 53.8 m -57.27 -56.53 20.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.469 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -153.38 159.96 42.53 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.706 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 m -163.35 -61.14 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 97' ' ' LYS . . . -162.16 -172.58 29.77 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.399 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.93 20.99 3.46 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.445 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 95' ' ' GLY . 6.3 mmpp? -94.46 -170.54 2.28 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' CG1' ' OD1' ' A' ' 100' ' ' ASN . 2.2 t -84.92 -52.5 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.308 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 4.5 t 58.47 62.21 2.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.488 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.441 ' OD1' ' CG1' ' A' ' 98' ' ' VAL . 19.4 p-10 -147.33 133.23 19.09 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.246 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.4 mptt -127.19 114.5 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 102' ' ' ASN . 3.9 m120 -93.38 135.54 34.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.347 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.5 105.59 7.33 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.555 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.44 99.26 12.29 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.225 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.432 ' N ' HD21 ' A' ' 105' ' ' LEU . 3.7 mm? -89.38 110.4 21.21 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.18 99.43 6.86 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.605 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.28 163.04 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.281 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.82 -163.86 1.03 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.791 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.5 Cg_endo -67.92 144.97 66.56 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.286 1.324 . . . . 0.0 111.326 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.39 108.53 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m -150.39 160.63 43.6 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.061 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 p -136.72 99.25 4.0 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.241 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -103.97 148.03 26.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.414 ' CB ' ' HG3' ' A' ' 104' ' ' GLN . 2.2 pp20? -116.84 146.84 42.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.993 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.54 120.25 41.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.541 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 11' ' ' GLY . 14.5 p -89.31 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.299 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 10' ' ' VAL . . . -152.7 166.52 31.34 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.583 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' SER . 1.1 p -145.76 93.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.7 t 38.15 78.3 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 137.49 61.95 0.05 OUTLIER Glycine 0 C--N 1.284 -2.35 0 N-CA-C 104.618 -3.393 . . . . 0.0 104.618 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 9.5 tppt? -112.22 44.1 0.25 Allowed Pre-proline 0 C--O 1.208 -1.083 0 CA-C-N 114.019 -1.09 . . . . 0.0 113.666 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.9 Cg_endo -67.16 107.28 1.33 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 N-CA-C 104.469 -2.935 . . . . 0.0 104.469 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG21 ' N ' ' A' ' 18' ' ' GLN . 9.5 p -123.76 160.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.595 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' N ' HG21 ' A' ' 17' ' ' VAL . 11.0 mp0 -105.19 101.4 10.95 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.264 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -85.62 99.92 11.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -112.84 96.27 37.05 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.5 101.07 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.329 -1.45 . . . . 0.0 108.329 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 23.7 t -123.36 122.66 38.86 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.358 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 22' ' ' SER . 3.8 m-20 165.19 2.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.249 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.678 ' CD1' ' H ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.36 151.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.676 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.787 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 3.0 mm-40 -47.14 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.678 ' H ' ' CD1' ' A' ' 24' ' ' ILE . 66.7 p 49.99 64.55 1.73 Allowed 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -176.07 144.17 0.58 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t70 42.05 80.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.975 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG22 ' CZ ' ' A' ' 72' ' ' PHE . 25.8 m -148.05 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.002 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t -149.27 133.35 17.22 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 49' ' ' TRP . 1.4 t -124.05 130.1 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.121 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -149.08 138.5 21.66 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.328 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.563 ' CD1' ' N ' ' A' ' 33' ' ' TRP . 1.3 p-90 -147.14 137.55 23.46 Favored 'General case' 0 C--O 1.183 -2.42 0 C-N-CA 118.086 -1.446 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 17.1 tttp -119.29 157.21 28.53 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.83 159.89 44.0 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.873 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -113.16 102.8 10.72 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.742 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.657 ' CD ' ' HZ3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.07 96.18 9.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 44.7 -167.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.061 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.26 -47.62 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -66.23 -27.75 68.21 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.692 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.54 ' CE1' ' OE1' ' A' ' 82' ' ' GLN . 18.2 m-70 -78.5 -124.99 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.782 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -152.06 157.07 41.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.39 -1.724 . . . . 0.0 113.056 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.75 157.22 19.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.577 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 ' ND2' ' A' ' 58' ' ' ASN . 37.5 mt -151.22 145.81 16.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 118.21 -1.396 . . . . 0.0 113.472 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.5 -23.66 23.15 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' N ' HG23 ' A' ' 44' ' ' ILE . 9.1 mm 74.87 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 113.053 -1.885 . . . . 0.0 116.051 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.63 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -153.08 157.89 41.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 117.747 -1.581 . . . . 0.0 113.806 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.443 ' N ' HD22 ' A' ' 47' ' ' LEU . 9.2 t-20 -126.34 113.58 17.1 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.435 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.57 ' N ' ' O ' ' A' ' 31' ' ' VAL . 8.5 t90 -99.56 131.05 45.82 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.659 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CD2' ' OD1' ' A' ' 51' ' ' ASN . 41.9 t80 -144.34 98.68 3.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.742 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 1.2 p-10 39.04 84.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.193 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.48 27.5 14.1 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.867 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.65 78.1 0.39 Allowed Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.656 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -86.71 126.6 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.271 1.981 . . . . 0.0 111.535 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.11 161.85 32.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.896 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.523 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 70.6 m95 -110.38 163.79 13.32 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.668 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.4 m -159.83 83.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.2 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 44' ' ' ILE . 7.8 t-20 144.14 98.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.309 1.631 . . . . 0.0 107.734 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.09 83.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.564 1.173 . . . . 0.0 113.01 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 62' ' ' SER . 3.4 t -161.65 -6.38 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 39.0 m-85 -58.87 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.399 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.77 ' HG ' ' N ' ' A' ' 63' ' ' ASP . 52.7 p -73.85 -49.33 25.58 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.77 ' N ' ' HG ' ' A' ' 62' ' ' SER . 4.9 t0 -109.89 94.21 4.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.726 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.86 -174.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 C-N-CA 117.515 -1.674 . . . . 0.0 115.044 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.726 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.06 163.52 22.19 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 112.324 -2.216 . . . . 0.0 115.434 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.46 147.9 18.75 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.0 t80 -121.23 152.98 38.22 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.931 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -141.34 152.48 44.45 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.795 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -104.82 178.81 4.45 Favored 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.39 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 93.23 6.41 63.01 Favored Glycine 0 N--CA 1.508 3.453 0 N-CA-C 104.644 -3.382 . . . . 0.0 104.644 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 155.09 141.96 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 102.108 -3.293 . . . . 0.0 102.108 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 29' ' ' VAL . 51.3 m-85 -83.09 114.18 21.13 Favored 'General case' 1 C--N 1.241 -4.148 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.724 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.01 108.58 7.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.646 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 19' ' ' LEU . 1.8 tm? -98.7 127.14 44.52 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.497 ' N ' HD22 ' A' ' 74' ' ' LEU . 11.5 t -119.97 138.13 53.66 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.34 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.624 ' CD1' ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -91.2 131.23 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.08 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -139.69 92.85 2.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.621 1.2 . . . . 0.0 107.762 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.8 t -153.71 -40.26 0.09 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 113.337 -1.756 . . . . 0.0 108.25 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 53.78 50.12 17.68 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.234 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLN . 27.9 mmtp -146.55 157.04 43.67 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.997 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.638 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -43.45 -20.16 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.326 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.54 ' OE1' ' CE1' ' A' ' 41' ' ' HIS . 7.3 mm100 -60.31 -30.01 69.22 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -64.8 -29.39 70.36 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.205 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 81' ' ' LEU . 86.5 p -63.61 105.43 0.79 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.283 -1.367 . . . . 0.0 109.931 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -171.66 164.02 36.71 Favored Glycine 0 C--N 1.292 -1.879 0 C-N-CA 118.87 -1.634 . . . . 0.0 110.823 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -86.67 103.53 15.22 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.081 -1.048 . . . . 0.0 108.972 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 1.2 m-30 -89.99 158.07 17.54 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.363 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -150.69 111.43 4.27 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.999 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -97.42 128.22 44.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.871 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' C ' ' CD ' ' A' ' 90' ' ' GLU . 1.6 pp20? -137.61 133.27 34.17 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.841 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' THR . 4.6 mt -102.98 161.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.651 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.581 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 10.5 t 42.05 -157.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.619 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' N ' ' OG1' ' A' ' 92' ' ' THR . 4.9 m120 -61.73 172.02 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -88.69 -19.74 25.76 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.11 165.17 3.42 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.137 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 -143.7 43.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.36 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . 2.8 ttmp? -169.95 -119.81 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.752 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 14.3 p 35.88 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.594 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 24.0 m -163.09 41.58 0.11 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.489 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.469 HD22 HD13 ' A' ' 88' ' ' LEU . 20.3 t-20 -150.18 130.45 13.69 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -147.23 146.81 29.93 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.6 144.17 32.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.052 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.61 107.68 11.78 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.455 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 10.6 pt20 -90.0 110.37 21.35 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.157 -1.017 . . . . 0.0 113.075 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.43 116.26 27.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 tt -119.84 97.85 5.82 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.78 160.54 39.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.279 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.653 ' CD2' ' N ' ' A' ' 108' ' ' LEU . 1.4 pt? -146.93 178.93 7.96 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.048 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.881 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.878 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.728 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 4.6 Cg_exo -66.73 178.29 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.336 1.357 . . . . 0.0 111.255 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.76 79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 3' ' ' PRO . 5.9 m -97.94 105.03 17.11 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.527 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 t -144.17 122.68 12.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.38 155.09 42.95 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -115.61 104.81 12.08 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.51 144.28 9.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.942 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.05 145.36 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 107' ' ' ILE . . . -152.96 168.27 31.81 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.598 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 12' ' ' VAL . 7.3 p -146.17 95.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t 41.94 79.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.441 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 132.71 63.49 0.08 OUTLIER Glycine 0 C--N 1.289 -2.055 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 8.2 tppt? -113.91 45.83 0.35 Allowed Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -67.8 110.84 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 105.581 -2.507 . . . . 0.0 105.581 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.9 161.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.39 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -105.81 110.5 22.82 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.563 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.3 mp -97.67 114.3 26.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -137.69 98.31 9.84 Favored Pre-proline 0 N--CA 1.507 2.399 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.66 140.06 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 39.3 m -148.98 162.82 39.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.287 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 22' ' ' SER . 2.7 p-10 97.97 32.92 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 O-C-N 124.747 1.279 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.501 HD13 ' CD2' ' A' ' 72' ' ' PHE . 29.7 pt -94.32 -150.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.088 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.408 ' H ' ' H ' ' A' ' 26' ' ' THR . 4.0 pt20 -160.6 -5.64 0.05 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.076 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.408 ' H ' ' H ' ' A' ' 25' ' ' GLN . 3.9 p 56.34 111.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.249 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -152.6 82.92 1.23 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.209 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 45.14 51.75 8.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.917 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' CG2' ' N ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -109.37 164.11 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.881 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.613 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 1.5 m -128.57 144.13 51.09 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.879 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.1 t -106.61 117.57 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.39 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -134.59 136.59 43.06 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.524 ' CH2' HD13 ' A' ' 74' ' ' LEU . 6.8 p-90 -143.96 115.38 8.06 Favored 'General case' 0 C--O 1.189 -2.088 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.698 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 6.5 tttt -103.92 160.13 15.07 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.483 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.8 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -147.81 161.06 42.02 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.267 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -115.84 108.78 16.75 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 42' ' ' ARG . 3.0 mt-10 -102.77 90.43 3.8 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.35 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' SER . 23.6 tt0 -89.01 -43.57 11.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.723 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 41' ' ' HIS . . . -42.41 91.74 0.01 OUTLIER Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.721 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.1 p 46.74 35.76 3.33 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 39' ' ' GLY . 58.6 m-70 -142.11 -145.76 0.18 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 37' ' ' GLU . 57.4 mtm-85 -150.31 -171.72 3.99 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.495 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -88.77 151.11 22.6 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 45' ' ' GLU . 54.2 mt -148.21 150.26 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 118.432 -1.307 . . . . 0.0 112.468 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' N ' HG22 ' A' ' 44' ' ' ILE . 52.2 mt-10 -87.84 -38.88 15.3 Favored 'General case' 0 C--O 1.203 -1.351 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.449 ' CD1' HG23 ' A' ' 44' ' ' ILE . 11.1 mm 84.76 -97.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.486 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 5.4 tt -131.14 152.82 50.03 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.486 ' N ' HD22 ' A' ' 47' ' ' LEU . 34.1 t30 -133.29 99.58 4.58 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.746 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.542 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.9 t90 -93.99 132.02 38.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.899 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 50' ' ' TYR . 28.6 p90 -150.0 100.03 2.89 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.469 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 5.8 t30 48.57 87.27 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.398 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 74.2 m-20 45.23 26.12 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.325 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.29 79.67 0.36 Allowed Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.793 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -87.33 125.64 2.19 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.252 1.968 . . . . 0.0 110.916 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 p -138.78 145.16 39.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.635 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 40.7 m95 -89.87 164.48 14.58 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -166.01 75.68 0.21 Allowed 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.606 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 160.33 86.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.795 1.31 . . . . 0.0 109.146 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.79 108.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.778 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.569 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER 165.95 -6.45 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 36.7 m-85 -63.96 33.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.785 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.569 ' H ' ' C ' ' A' ' 60' ' ' SER . 7.2 t -86.65 -35.01 19.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -127.8 94.72 4.02 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.716 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.79 -172.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 117.553 -1.659 . . . . 0.0 115.235 -179.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.8 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -68.47 164.05 21.99 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 112.236 -2.256 . . . . 0.0 114.767 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.19 126.94 4.37 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 12.7 t80 -90.56 153.66 20.19 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.779 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -140.29 158.46 44.0 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -97.18 -169.17 1.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.444 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 112.47 -1.13 26.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 2.5 m-20 152.23 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD2' HD13 ' A' ' 24' ' ' ILE . 10.8 m-85 -153.04 109.09 3.34 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.22 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.91 41.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.7 tm? -146.94 128.23 14.82 Favored 'General case' 0 C--O 1.197 -1.684 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.884 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.461 ' N ' HD23 ' A' ' 74' ' ' LEU . 14.5 t -121.05 138.64 54.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.079 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 ' N ' ' HG ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -91.54 133.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.327 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.55 93.64 2.45 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.464 1.126 . . . . 0.0 108.755 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -153.17 -37.49 0.1 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.792 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 54.73 51.71 13.36 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.619 -2.082 . . . . 0.0 113.697 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HB2' HE21 ' A' ' 82' ' ' GLN . 37.9 mmtt -147.03 178.97 7.94 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.532 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -63.88 -24.89 67.92 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.843 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' HA ' ' CD2' ' A' ' 41' ' ' HIS . 26.7 mt-30 -52.03 -32.58 34.9 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 107' ' ' ILE . 70.0 m-20 -63.84 -32.23 73.68 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.846 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' LEU . 13.6 p -61.35 106.0 0.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.71 164.47 35.32 Favored Glycine 0 C--N 1.288 -2.094 0 C-N-CA 118.723 -1.703 . . . . 0.0 110.616 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -86.03 106.18 17.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.508 ' CE1' ' HE3' ' A' ' 35' ' ' LYS . 2.5 m-30 -88.38 150.32 23.25 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.48 110.68 5.06 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.746 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 100.89 13.52 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.453 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -95.07 118.99 32.83 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.095 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -99.98 119.2 47.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.932 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.406 ' HB ' ' H ' ' A' ' 30' ' ' SER . 35.4 m -46.27 163.05 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.737 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m120 65.46 134.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.493 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.6 p -149.14 -178.66 6.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 97' ' ' LYS . . . -173.74 73.3 0.09 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.667 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.55 -63.06 0.17 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.686 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 95' ' ' GLY . 11.7 ttmm -59.38 150.46 26.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.856 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.6 148.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.736 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.878 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 36.3 m -146.43 43.85 1.2 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.601 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -147.71 147.82 30.34 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.489 ' NZ ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -115.78 123.59 48.63 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -106.46 119.16 38.55 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.09 115.47 26.85 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -88.81 111.2 21.75 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.42 ' CD1' ' CG2' ' A' ' 9' ' ' VAL . 1.5 mm? -95.99 99.61 11.37 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.08 97.51 8.05 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.467 HD11 ' N ' ' A' ' 84' ' ' SER . 0.4 OUTLIER -110.94 160.67 10.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.597 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.27 -177.16 3.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.805 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.209 -1.03 0 CA-C-O 120.803 0.335 . . . . 0.0 111.763 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.1 Cg_endo -72.29 155.69 55.73 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.304 1.336 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -57.77 123.9 17.31 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.469 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t -148.12 147.11 29.14 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.191 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.5 p -150.16 120.78 7.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.678 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 29.4 tp10 -130.12 160.12 34.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.644 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.57 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 31.8 tt0 -120.87 133.93 55.3 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.86 120.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.995 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.15 149.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' CA ' HG21 ' A' ' 107' ' ' ILE . . . -152.35 163.63 30.32 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.569 -1.3 . . . . 0.0 111.858 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -148.21 96.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.076 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' VAL . 15.2 t 41.96 79.92 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.581 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 132.63 67.64 0.08 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 8.6 tppt? -112.02 39.52 0.19 Allowed Pre-proline 0 C--O 1.208 -1.084 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.9 Cg_endo -67.56 88.42 0.34 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 N-CA-C 106.327 -2.22 . . . . 0.0 106.327 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -112.47 162.72 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.802 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -106.58 108.14 19.49 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.498 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' LEU . 4.4 tp -88.74 98.44 11.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -115.62 96.54 46.57 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.83 111.89 2.53 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m -134.49 98.99 4.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.408 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -169.88 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.777 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.501 HG12 ' H ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -72.26 149.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.707 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.605 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 2.4 pm0 -72.6 8.25 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.755 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 27' ' ' LYS . 2.1 p 55.31 -125.25 2.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.755 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.664 ' N ' ' OG1' ' A' ' 26' ' ' THR . 3.6 mtpt 75.85 48.58 0.08 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.475 0.484 . . . . 0.0 111.896 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 t70 58.51 105.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.792 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG13 ' N ' ' A' ' 30' ' ' SER . 5.5 t -149.07 167.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 29' ' ' VAL . 1.8 t -89.08 160.69 16.93 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.53 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' TRP . 3.3 t -143.9 134.45 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.818 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -150.24 137.8 19.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.773 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CZ3' ' CE ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -140.71 131.09 25.16 Favored 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.103 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -118.82 152.3 36.48 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.775 ' CE ' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -153.51 163.1 40.54 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.9 -1.52 . . . . 0.0 114.188 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 m -107.38 97.11 6.9 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 42' ' ' ARG . 6.5 pt-20 -153.53 -163.23 1.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.278 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' HIS . 18.5 tp60 86.51 174.14 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . -43.24 144.79 1.31 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p 49.84 13.04 0.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.702 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.561 ' NE2' ' OG ' ' A' ' 84' ' ' SER . 25.1 m170 52.53 75.06 0.25 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 37' ' ' GLU . 37.0 ttm180 -87.07 174.96 8.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 118.709 -1.197 . . . . 0.0 110.022 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -87.61 144.34 26.73 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.428 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 ' ND2' ' A' ' 58' ' ' ASN . 7.8 mt -149.06 138.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.91 -1.516 . . . . 0.0 112.686 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -87.39 -33.93 18.95 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG21 ' CE2' ' A' ' 33' ' ' TRP . 10.9 mm 82.09 -93.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 114.132 -1.395 . . . . 0.0 114.335 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.663 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -152.23 159.52 43.53 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.498 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 47' ' ' LEU . 6.2 p-10 -129.37 113.8 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.397 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' VAL . 10.2 t90 -94.49 131.15 40.49 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 51' ' ' ASN . 2.3 m-85 -144.22 99.32 3.36 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.041 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 3.1 p30 40.16 85.49 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.484 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.485 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 20.2 t70 51.27 29.62 5.16 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.484 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.67 76.67 0.41 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -86.92 127.04 2.54 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.375 2.05 . . . . 0.0 111.705 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -140.58 143.38 35.26 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.933 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 21.2 m95 -91.11 164.24 14.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.402 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -164.09 76.71 0.35 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.955 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 162.65 88.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.636 1.21 . . . . 0.0 109.693 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -44.14 105.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.844 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 169.46 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 34.7 m-85 -63.34 31.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.223 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 60' ' ' SER . 4.1 p -86.65 -25.3 24.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.42 95.46 2.88 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.753 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -154.93 -173.28 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-O 123.566 1.65 . . . . 0.0 115.178 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.753 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.28 164.42 20.72 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.851 -2.431 . . . . 0.0 115.437 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.34 118.33 2.35 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -90.04 138.02 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.869 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.37 160.39 29.48 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 44.8 t80 -102.55 -179.15 3.89 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.806 0.812 . . . . 0.0 113.114 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.618 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 118.66 -0.92 15.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.5 OUTLIER 156.49 -96.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.902 -2.149 . . . . 0.0 105.412 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 26.0 m-85 -152.18 105.19 3.03 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.23 106.69 5.55 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.646 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 19' ' ' LEU . 3.0 tm? -111.29 126.8 55.28 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.624 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 m -115.21 134.7 54.9 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.489 HD12 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -89.88 131.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.255 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 94.68 2.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.699 1.238 . . . . 0.0 108.036 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 79' ' ' ALA . 26.9 t -156.84 -13.95 0.09 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.787 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.525 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 23.79 75.25 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 112.381 -2.191 . . . . 0.0 113.999 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HD2' ' NE2' ' A' ' 82' ' ' GLN . 12.9 mttt -174.0 172.57 3.37 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.16 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -56.03 -37.12 68.79 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.586 ' H ' ' CD ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -46.8 -30.65 2.56 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.769 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -63.81 -35.35 80.33 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.705 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.561 ' OG ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -48.9 114.06 0.91 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.67 159.98 29.95 Favored Glycine 0 C--N 1.277 -2.707 0 C-N-CA 118.035 -2.031 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -91.16 107.11 18.98 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.96 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.2 m-30 -93.44 152.2 19.25 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.906 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.15 110.54 5.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.285 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.25 130.99 35.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.097 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' N ' HD11 ' A' ' 89' ' ' LEU . 73.8 mt-10 -134.23 129.25 35.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' CG2' HG11 ' A' ' 29' ' ' VAL . 6.2 mm -107.57 99.36 8.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.923 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.4 p -46.11 145.9 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.645 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -168.04 140.38 3.04 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.6 m -45.46 -34.19 3.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.88 -54.47 4.87 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.356 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.18 99.54 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -72.41 -109.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.957 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ASN . 4.1 m -98.01 27.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 4.2 m -57.37 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.297 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' VAL . 18.1 m120 -150.76 136.32 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -138.91 109.08 6.4 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.646 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -95.59 134.79 38.06 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.547 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -131.64 111.91 12.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.898 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.48 118.33 28.04 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.084 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -101.98 101.38 11.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tp -108.94 105.39 14.9 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -117.63 163.46 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.065 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 14.7 tp -149.82 147.7 28.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.548 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 11.8 m-20 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.803 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.894 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.675 0.274 . . . . 0.0 111.53 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.6 Cg_endo -65.88 156.2 65.5 Favored 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.225 1.284 . . . . 0.0 111.293 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -44.42 114.19 0.65 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 m -144.78 129.44 18.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.976 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 t -149.99 125.98 10.55 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.45 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 16.7 tp10 -143.43 160.2 40.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 41.2 tt0 -119.55 109.22 15.45 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.77 132.58 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.49 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.59 ' CG2' ' N ' ' A' ' 11' ' ' GLY . 9.8 p -89.65 164.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.445 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.59 ' N ' ' CG2' ' A' ' 10' ' ' VAL . . . -150.79 169.16 30.6 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.43 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.666 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 3.1 t -145.78 98.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.434 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.624 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 3.62 80.7 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.718 0 CA-C-O 122.685 1.231 . . . . 0.0 109.498 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' C ' ' HD3' ' A' ' 16' ' ' PRO . . . 143.6 65.47 0.02 OUTLIER Glycine 0 C--N 1.278 -2.65 1 N-CA-C 101.323 -4.711 . . . . 0.0 101.323 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.666 ' NZ ' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -114.08 76.98 3.66 Favored Pre-proline 0 C--O 1.207 -1.145 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 15.5 Cg_endo -86.72 78.75 1.88 Allowed 'Trans proline' 0 N--CA 1.431 -2.19 0 N-CA-C 103.525 -3.298 . . . . 0.0 103.525 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -89.74 159.77 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.457 ' NE2' ' HD2' ' A' ' 20' ' ' ARG . 2.5 tt0 -113.97 99.39 7.62 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.129 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 74' ' ' LEU . 5.5 tp -86.05 103.78 15.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HD2' ' NE2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -122.82 97.39 44.11 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -68.38 126.52 14.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.724 0.95 . . . . 0.0 110.05 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 55.8 m -141.03 120.1 12.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.613 ' ND2' ' H ' ' A' ' 2' ' ' CYS . 0.2 OUTLIER 162.01 17.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 25' ' ' GLN . 2.2 pt -99.22 -154.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.5 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 24' ' ' ILE . 10.4 pt20 -151.27 0.63 0.38 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 p 55.09 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.859 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -148.82 40.96 0.92 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.821 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.43 95.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.406 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 m -150.91 161.49 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.798 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.89 160.2 17.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.014 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.6 t -130.46 131.47 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.69 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -150.39 142.09 23.65 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.256 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.543 ' HE1' ' CB ' ' A' ' 47' ' ' LEU . 1.8 p-90 -142.15 141.41 32.63 Favored 'General case' 0 C--O 1.182 -2.499 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.2 ttpt -121.37 154.39 36.54 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.906 -0.717 . . . . 0.0 109.266 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.756 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.01 155.86 41.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.631 -1.227 . . . . 0.0 111.976 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.4 100.12 9.67 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.614 ' CG ' ' HZ1' ' A' ' 35' ' ' LYS . 38.3 mt-10 -97.34 107.86 20.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.677 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.558 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 37.2 tt0 -100.16 172.02 7.44 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.521 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 76.59 95.23 0.18 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m 58.55 -0.25 0.13 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.731 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.646 ' H ' ' C ' ' A' ' 39' ' ' GLY . 93.6 m-70 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -154.61 -176.2 5.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.43 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 4.1 mmtp -89.66 133.74 34.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.706 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -148.18 164.33 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.859 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 2.2 mm-40 -87.35 -15.83 36.76 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.881 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.718 ' CG2' ' H ' ' A' ' 47' ' ' LEU . 10.6 mm 62.92 -120.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.718 ' H ' ' CG2' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -90.3 154.65 19.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -143.21 97.75 3.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.037 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.552 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 20.9 t90 -97.47 132.99 42.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.315 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.4 m-85 -140.73 97.57 3.22 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.538 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.552 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.7 OUTLIER 65.94 -57.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.446 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' TYR . 38.9 t70 -163.32 31.86 0.09 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.79 87.25 0.38 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.82 98.16 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 122.096 1.864 . . . . 0.0 110.479 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.2 p -120.27 132.82 55.49 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -89.76 162.01 15.75 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.05 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.65 ' N ' ' O ' ' A' ' 46' ' ' ILE . 38.5 m -119.46 77.17 1.19 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.684 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.479 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 4.9 m-80 34.24 102.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.647 ' CG1' ' CZ ' ' A' ' 61' ' ' PHE . 29.9 m -130.65 -44.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.671 1.224 . . . . 0.0 108.597 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.644 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 2.1 t 160.03 24.15 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 56' ' ' TRP . 56.9 m-85 -39.14 90.13 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.82 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' SER . 5.0 t -173.55 -22.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.6 111.69 7.49 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 101.114 -3.662 . . . . 0.0 101.114 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG21 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -152.78 -174.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.263 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -179.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.777 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -84.15 164.4 19.18 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 109.37 -3.559 . . . . 0.0 112.032 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.65 125.45 4.16 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.5 t80 -99.84 150.06 22.75 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 26.2 t0 -138.97 158.15 44.72 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -106.05 179.75 4.18 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.835 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.75 11.29 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 105.531 -3.028 . . . . 0.0 105.531 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 5.7 t70 170.44 -103.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.634 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 18.6 m-85 -152.84 115.47 4.51 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.17 143.75 34.41 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.392 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -148.28 127.33 12.81 Favored 'General case' 0 C--O 1.201 -1.452 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.175 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 4.5 t -123.46 136.74 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -91.04 134.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.075 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -144.2 94.48 2.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.866 1.317 . . . . 0.0 109.654 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.506 ' CB ' ' OE1' ' A' ' 82' ' ' GLN . 17.6 p -154.28 -23.54 0.13 Allowed 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.069 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 53.1 31.6 11.57 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.858 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' C ' ' N ' ' A' ' 82' ' ' GLN . 1.3 mmmt -114.23 167.1 10.99 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.024 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.1 tp -53.76 -14.47 0.94 Allowed 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.298 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 1.6 pt20 -59.68 -41.21 90.16 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 82' ' ' GLN . 26.7 m-20 -47.03 -42.29 18.11 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.58 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.664 ' H ' HD13 ' A' ' 107' ' ' ILE . 6.4 t -62.11 109.62 1.35 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.296 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.45 164.56 36.91 Favored Glycine 0 C--N 1.277 -2.732 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.724 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.777 ' NE2' ' ND2' ' A' ' 102' ' ' ASN . 30.3 t-80 -85.74 101.07 12.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.745 -1.182 . . . . 0.0 108.407 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.756 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 3.0 m-30 -88.83 154.29 20.38 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.99 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.3 tp -150.67 108.39 3.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.507 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -89.65 131.75 35.48 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.675 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 23.8 mp0 -142.99 141.6 31.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -109.21 132.59 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.08 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m 51.99 -87.96 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.032 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 94' ' ' THR . 9.4 t30 -158.83 -143.59 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.286 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.679 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 3.7 m -73.65 -138.98 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.478 ' H ' HG21 ' A' ' 94' ' ' THR . . . 156.51 -135.03 4.3 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.489 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.24 -117.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.698 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.459 ' HB3' ' HZ1' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.87 -57.24 5.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.878 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 m -150.89 165.57 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.954 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.894 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 14.7 t -160.07 12.22 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.061 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -113.64 160.41 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.24 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 89' ' ' LEU . 3.4 ptpt -140.58 124.44 17.26 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.777 ' ND2' ' NE2' ' A' ' 86' ' ' HIS . 21.7 t-20 -90.78 157.54 17.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.886 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -149.96 109.72 4.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.72 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -91.63 109.97 21.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.136 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.71 137.36 35.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -149.47 102.47 3.19 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.759 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -88.74 164.48 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.048 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.6 tp -89.59 147.47 23.91 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.327 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--N 1.304 -1.413 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.969 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.704 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 111.328 0.121 . . . . 0.0 111.328 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 15.6 Cg_exo -67.96 168.83 17.79 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.046 1.164 . . . . 0.0 111.649 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -84.19 122.5 28.94 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.525 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -144.76 156.66 44.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.877 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -147.5 131.72 17.42 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.023 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -142.67 134.74 27.25 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -94.81 105.64 17.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.547 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 p -94.22 141.68 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.423 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 11.9 p -114.84 147.29 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.603 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA3' ' NZ ' ' A' ' 15' ' ' LYS . . . -152.13 166.01 30.92 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 13' ' ' SER . 4.8 m -137.85 90.45 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 12' ' ' VAL . 39.6 t 31.41 79.69 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 CA-C-O 122.735 1.255 . . . . 0.0 110.413 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.87 64.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 1 N-CA-C 100.066 -5.213 . . . . 0.0 100.066 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -125.05 75.6 67.27 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.51 100.76 0.27 Allowed 'Trans proline' 0 N--CA 1.439 -1.683 1 N-CA-C 97.023 -5.799 . . . . 0.0 97.023 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.13 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -115.69 98.59 6.78 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.67 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.69 140.21 29.75 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -154.6 92.27 2.95 Favored Pre-proline 0 N--CA 1.507 2.379 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.97 118.89 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 O-C-N 122.631 0.806 . . . . 0.0 110.528 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -111.95 162.56 15.21 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.489 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 59.82 80.62 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.97 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -162.29 147.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.461 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 25' ' ' GLN . 15.4 mm100 -46.45 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.331 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.8 p -75.94 71.06 2.73 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.865 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -143.58 -177.74 5.55 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.383 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.29 117.68 3.23 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.819 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 p -153.96 152.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -88.52 140.7 29.19 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.596 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.87 140.84 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -151.88 134.99 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.991 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -140.95 136.1 31.88 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 118.451 -1.299 . . . . 0.0 109.98 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -128.37 151.62 49.14 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.838 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 141.21 34.09 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.083 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.1 m -95.85 101.18 12.83 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.317 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.37 103.81 15.84 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -103.22 156.74 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.323 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.53 -60.97 0.64 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m -155.02 -21.57 0.12 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -74.52 -145.04 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.072 -1.876 . . . . 0.0 110.602 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 26.9 ttt180 -168.24 -150.9 0.1 Allowed 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.669 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 1.8 tppp? -87.61 128.39 35.27 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 121.578 0.704 . . . . 0.0 111.118 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -131.63 128.9 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.477 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -86.37 -14.46 43.4 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.017 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm 61.07 -83.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 48' ' ' ASN 0.324 8.4 tt -145.57 159.7 42.73 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 47' ' ' LEU . 34.6 t30 -138.08 106.73 5.89 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 113.527 -1.669 . . . . 0.0 108.531 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -93.23 137.82 32.2 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.007 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -145.3 97.1 2.94 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.519 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t30 73.57 -68.0 0.24 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.099 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.47 28.55 0.07 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.95 88.9 0.36 Allowed Glycine 0 C--N 1.303 -1.283 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.146 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -83.4 138.09 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.231 1.287 . . . . 0.0 110.327 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 m -143.82 127.25 16.85 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.328 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.799 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 4.0 m95 -88.31 154.29 20.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.438 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -160.75 104.58 1.37 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.913 1.339 . . . . 0.0 112.636 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.0 m120 136.72 91.6 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 111.194 -2.73 . . . . 0.0 104.603 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.38 71.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 117.5 2.408 . . . . 0.0 117.5 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' ASN . 9.7 m -128.32 -5.04 5.44 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -63.16 75.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.188 -2.278 . . . . 0.0 113.453 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.6 t -145.44 -4.82 0.68 Allowed 'General case' 0 N--CA 1.523 3.219 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.7 106.48 5.38 Favored 'General case' 0 C--N 1.274 -2.679 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 175.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.83 -178.72 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 N-CA-C 121.034 3.716 . . . . 0.0 121.034 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -112.3 161.82 16.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 108.766 -3.834 . . . . 0.0 111.032 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.1 131.35 5.94 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.2 t80 -94.27 158.9 15.37 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.261 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.502 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 12.6 t70 -139.92 147.94 41.28 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.969 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 55.1 t80 -114.03 166.76 11.28 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 123.026 1.393 . . . . 0.0 114.433 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 149.95 -42.8 0.77 Allowed Glycine 0 N--CA 1.51 3.586 1 N-CA-C 102.293 -4.323 . . . . 0.0 102.293 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 31.5 m-20 -144.14 -106.91 0.12 Allowed 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 100.484 -3.895 . . . . 0.0 100.484 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 88.8 m-85 -154.75 105.87 2.63 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.32 148.29 46.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.422 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -147.72 137.63 22.77 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.6 m -131.49 141.22 49.73 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.439 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -91.55 153.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -150.17 83.92 1.38 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 179.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 m -141.41 -53.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 112.108 -2.315 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 60.32 36.21 20.61 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 111.697 -2.501 . . . . 0.0 115.38 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -140.27 162.55 35.01 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.842 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.75 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 mm? -43.32 -30.28 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.035 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.22 -29.57 68.83 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -67.63 -33.29 74.68 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.2 p -59.42 117.51 4.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.119 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.49 162.6 32.86 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -88.74 101.31 13.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -87.75 160.16 18.18 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.569 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.98 111.77 4.01 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.68 -1.6 . . . . 0.0 106.905 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.5 143.4 27.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.876 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -141.66 154.55 45.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.396 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.7 tt -136.32 151.81 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m 57.99 -126.04 1.59 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.267 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -160.92 89.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.896 -1.121 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 50.1 m -158.02 115.84 3.01 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.64 -160.15 19.32 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.337 -1.411 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -153.58 45.52 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.349 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.08 178.74 3.09 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.492 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.589 ' C ' HD21 ' A' ' 100' ' ' ASN . 2.8 t 62.4 157.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.651 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.47 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 85.5 m 48.7 50.04 17.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.589 HD21 ' C ' ' A' ' 98' ' ' VAL . 5.9 p30 -151.11 130.4 12.8 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.183 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.416 ' NZ ' ' N ' ' A' ' 100' ' ' ASN . 3.0 mptp? -133.4 113.74 12.89 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -93.63 138.75 31.55 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.922 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.96 108.18 5.5 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -94.72 109.54 21.48 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.4 ' HG ' ' HH ' ' A' ' 87' ' ' TYR . 4.4 mm? -88.79 100.28 13.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.79 95.53 6.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.21 161.26 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.773 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.0 tp -147.12 132.98 19.03 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.964 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.294 -1.832 0 CA-C-O 116.531 -1.699 . . . . 0.0 112.411 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.212 -0.897 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.9 Cg_endo -71.38 166.79 28.22 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 121.481 1.454 . . . . 0.0 111.466 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 129.55 42.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -146.75 114.24 6.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 m -149.13 119.28 7.23 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.71 159.68 43.54 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -117.16 112.21 20.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.53 127.31 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.409 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG21 ' N ' ' A' ' 11' ' ' GLY . 13.6 p -90.69 149.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.225 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 10' ' ' VAL . . . -152.24 166.8 31.17 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 94.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.828 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.0 t 37.91 79.17 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.478 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 134.45 67.24 0.07 OUTLIER Glycine 0 C--N 1.288 -2.092 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.8 tppt? -114.18 46.27 0.37 Allowed Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.1 Cg_endo -67.9 99.35 0.55 Allowed 'Trans proline' 0 N--CA 1.433 -2.086 0 N-CA-C 105.615 -2.494 . . . . 0.0 105.615 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 18' ' ' GLN . 1.3 p -121.32 162.18 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.368 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.4 ' H ' HG22 ' A' ' 17' ' ' VAL . 12.2 tt0 -109.24 109.26 20.15 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.555 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -88.92 107.34 18.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -124.03 96.01 43.1 Favored Pre-proline 0 N--CA 1.506 2.35 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -74.54 124.16 8.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 N-CA-C 109.129 -1.143 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 66.5 p -125.89 161.04 28.36 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.186 -0.605 . . . . 0.0 111.461 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.4 t-20 75.98 83.78 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.516 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -176.65 152.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.623 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' N ' HG12 ' A' ' 24' ' ' ILE . 6.3 pt20 -64.06 69.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -86.51 91.11 8.45 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.707 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' CG ' ' C ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -172.42 15.61 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.19 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -176.78 2.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 15.1 m -101.98 153.71 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.736 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.463 ' H ' ' HB ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -94.01 160.85 14.54 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.217 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 72' ' ' PHE . 2.3 t -116.04 131.85 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.159 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -148.69 124.29 10.42 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.123 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.56 ' HE1' ' HB2' ' A' ' 47' ' ' LEU . 7.2 p-90 -136.73 130.17 31.62 Favored 'General case' 0 C--O 1.183 -2.415 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -118.01 160.26 21.78 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.678 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -148.03 158.36 44.01 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.455 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 m -111.8 113.97 26.65 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.591 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.617 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 2.8 mt-10 -106.57 104.68 14.42 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.339 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -105.2 -167.82 1.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.453 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.54 -46.55 2.78 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -169.56 -10.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -93.63 -137.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.25 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 37' ' ' GLU . 12.0 ptt-85 -166.61 -161.98 0.48 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.323 -1.351 . . . . 0.0 111.749 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.71 148.12 24.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.901 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD13 ' ND2' ' A' ' 58' ' ' ASN . 4.3 mm -141.54 144.96 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.319 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.75 -30.55 17.93 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.454 HG22 ' CZ2' ' A' ' 33' ' ' TRP . 8.3 mm 73.33 -98.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.32 155.99 33.53 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 47' ' ' LEU . 3.1 m-80 -137.83 99.15 3.83 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.336 -2.211 . . . . 0.0 107.693 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 8.3 t90 -97.47 134.54 40.58 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.93 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' ASP . 13.3 m-85 -139.59 96.94 3.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.565 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.556 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 4.6 m-80 62.01 -64.27 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.307 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.2 m-20 -155.01 30.97 0.4 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.58 87.04 0.37 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -86.0 114.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.091 1.861 . . . . 0.0 110.289 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.08 161.57 26.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.65 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.607 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 69.5 m95 -107.55 165.33 11.49 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.036 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -150.57 67.73 0.95 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.337 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 1.8 t30 169.44 162.81 0.05 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.527 1.767 . . . . 0.0 106.305 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.48 6.23 7.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.546 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -86.44 0.61 53.78 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 25.5 m-85 -62.7 37.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.921 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 60' ' ' SER . 6.6 t -94.0 -17.93 22.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.62 94.84 2.34 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.704 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.47 -173.31 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.704 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.41 162.7 22.47 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 112.498 -2.137 . . . . 0.0 114.504 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.53 6.89 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.6 t80 -89.7 158.18 17.66 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.983 -1.087 . . . . 0.0 112.684 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 21.6 m-20 -142.66 143.36 32.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.016 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -100.98 177.62 4.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.528 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 116.75 9.26 11.24 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 106.418 -2.673 . . . . 0.0 106.418 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 1.7 m-20 153.13 -101.49 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 31' ' ' VAL . 16.3 m-85 -154.13 109.48 3.16 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.13 122.2 10.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.791 -1.164 . . . . 0.0 112.16 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.559 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -120.66 135.67 55.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.986 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.488 ' N ' HD12 ' A' ' 74' ' ' LEU . 12.2 p -125.23 139.06 54.06 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.463 HD11 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -90.15 134.04 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.159 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -144.65 93.06 2.36 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 82' ' ' GLN . 13.2 t -155.88 -36.57 0.08 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.5 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 52.05 88.0 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.502 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER 172.02 159.2 0.1 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.432 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.72 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -47.49 -13.27 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.671 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 10.1 pt20 -69.04 -27.4 65.61 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.214 -1.394 . . . . 0.0 109.109 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.1 m-20 -70.02 -27.5 64.73 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.474 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.469 ' HG ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -66.05 103.92 1.04 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.062 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.37 163.99 36.26 Favored Glycine 0 N--CA 1.485 1.935 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -86.19 108.47 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.918 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 2.4 m-30 -91.1 153.55 20.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.447 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD22 HD22 ' A' ' 100' ' ' ASN . 0.4 OUTLIER -150.05 111.62 4.49 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.195 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.94 109.75 20.51 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.18 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.54 116.57 32.16 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.73 119.28 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.6 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.516 ' C ' HD21 ' A' ' 93' ' ' ASN . 93.2 m -47.82 168.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.005 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.516 HD21 ' C ' ' A' ' 92' ' ' THR . 1.5 m-80 60.72 95.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.218 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 2.0 t -98.18 -174.83 2.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.717 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . -170.81 -176.46 40.11 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.454 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -44.28 -26.0 0.86 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -80.97 -154.22 0.1 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.77 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.39 80.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 21.3 m -71.68 78.17 0.83 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.774 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.465 HD22 HD22 ' A' ' 88' ' ' LEU . 45.2 t30 -150.09 119.08 6.68 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.551 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -110.46 134.82 51.99 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.14 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -117.19 114.65 23.98 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -114.0 108.91 17.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.889 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -89.27 109.95 20.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.879 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -89.37 106.74 18.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.4 tp -110.61 98.48 7.65 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.469 HD13 ' HG ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -125.94 161.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.21 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.26 154.38 46.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.64 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.386 -1.769 . . . . 0.0 110.949 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.88 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 6.3 Cg_exo -61.91 155.88 52.4 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.302 1.335 . . . . 0.0 111.479 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.52 114.06 3.03 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -148.56 150.27 33.05 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.318 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 143.27 25.43 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.301 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.22 156.05 45.96 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.13 99.09 8.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.371 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG2' ' N ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.52 158.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.319 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 11' ' ' GLY . 3.6 p -150.99 155.3 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.241 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.547 ' CA ' ' NZ ' ' A' ' 15' ' ' LYS . . . -152.22 171.03 31.53 Favored Glycine 0 N--CA 1.484 1.864 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.839 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' C ' ' A' ' 13' ' ' SER . 13.6 m -135.59 95.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.485 ' C ' ' O ' ' A' ' 12' ' ' VAL . 71.1 p 39.68 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.47 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 140.6 68.7 0.04 OUTLIER Glycine 0 C--N 1.291 -1.971 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' NZ ' ' CA ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -111.8 41.05 0.2 Allowed Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 2.8 Cg_endo -67.99 99.98 0.6 Allowed 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 106.141 -2.292 . . . . 0.0 106.141 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.61 160.7 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.613 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -99.93 104.66 16.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.245 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 3.1 tp -91.14 99.3 12.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -131.46 102.1 15.58 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -69.21 136.75 35.3 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.853 1.035 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.3 p -143.22 102.79 4.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.804 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 2.6 t30 -173.62 -7.29 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.891 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.734 ' CG1' ' H ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -102.01 153.56 5.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.247 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.458 ' C ' ' CG2' ' A' ' 26' ' ' THR . 11.7 pt20 -90.88 3.21 55.14 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.303 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.734 ' H ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 p 63.54 130.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.209 0.528 . . . . 0.0 111.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 28' ' ' ASP . 8.5 pttt -177.91 100.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.398 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER 38.15 70.46 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.891 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 3.1 m -117.98 176.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.759 0.79 . . . . 0.0 112.601 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.4 121.96 12.49 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.498 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 49' ' ' TRP . 1.5 t -96.06 136.79 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.477 -1.289 . . . . 0.0 113.127 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -149.07 124.81 10.49 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 35' ' ' LYS . 7.8 p-90 -135.02 114.27 12.29 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.126 -1.429 . . . . 0.0 112.473 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.5 tttm -100.85 157.05 17.01 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.39 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HD3' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -148.05 161.02 42.22 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.014 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.486 ' CG2' ' HZ2' ' A' ' 43' ' ' LYS . 1.7 m -119.97 103.38 9.26 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.712 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 1.7 pt-20 -100.5 108.8 20.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -111.47 148.67 32.65 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 129.52 -5.57 6.25 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 163.51 -9.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.446 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 82' ' ' GLN . 90.0 m-70 -114.45 -132.54 0.33 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -174.25 -151.98 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.715 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' HZ2' ' CG2' ' A' ' 36' ' ' THR . 9.6 mmtt -89.85 143.46 26.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.789 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 HG21 ' N ' ' A' ' 45' ' ' GLU . 8.1 mt -146.37 156.7 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' N ' HG21 ' A' ' 44' ' ' ILE . 79.2 mm-40 -88.64 -39.02 14.35 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.488 HG22 ' CE2' ' A' ' 33' ' ' TRP . 15.3 mm 81.72 -98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.698 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.45 ' H ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -122.4 157.43 31.9 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -139.94 98.53 3.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.527 -2.124 . . . . 0.0 106.65 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.621 ' N ' ' O ' ' A' ' 31' ' ' VAL . 13.2 t90 -95.61 125.6 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.042 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.674 ' CE2' ' ND2' ' A' ' 51' ' ' ASN . 56.3 t80 -139.77 98.61 3.51 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.674 ' ND2' ' CE2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 61.66 -162.28 0.28 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.48 39.9 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -131.49 81.86 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.718 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -87.09 137.66 4.57 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.447 2.098 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.8 p -143.52 156.98 44.77 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.12 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.542 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 50.9 m95 -99.4 164.69 12.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.559 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -160.35 73.37 0.51 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.699 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 152.51 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.568 1.167 . . . . 0.0 108.884 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -45.65 103.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.849 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 62' ' ' SER . 89.7 p -179.74 -7.76 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 27.4 m-85 -66.95 34.58 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.542 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 60' ' ' SER . 12.0 t -84.94 -32.16 23.22 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.59 94.28 3.38 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.729 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.95 -172.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.729 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.2 163.62 22.33 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 112.222 -2.263 . . . . 0.0 115.131 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.65 122.55 3.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -89.92 143.85 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.166 -1.014 . . . . 0.0 112.643 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -131.59 160.66 34.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.778 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 20.0 t80 -95.68 -175.16 3.36 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.264 -0.974 . . . . 0.0 112.917 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 114.84 -1.37 23.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 2.0 m-20 150.61 -88.31 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.484 ' CZ ' HD12 ' A' ' 24' ' ' ILE . 70.0 m-85 -153.58 106.25 2.9 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.491 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.21 99.79 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.151 -1.019 . . . . 0.0 112.019 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.572 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 1.3 tm? -105.9 110.75 23.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.3 m -103.28 134.99 45.75 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.458 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HD13 ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -90.21 132.18 35.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.301 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -143.12 93.27 2.48 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.553 1.168 . . . . 0.0 107.996 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' A' ' 79' ' ' ALA . 9.8 p -152.18 -42.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.218 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 58.62 28.24 16.88 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.185 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HA ' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -113.46 -167.97 1.27 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.017 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.8 tp -83.88 -14.96 49.8 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.681 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.495 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . 3.2 pp0? -67.25 -30.31 70.17 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.226 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -63.17 -30.25 71.44 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.946 -1.501 . . . . 0.0 108.527 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.494 ' N ' HD12 ' A' ' 107' ' ' ILE . 3.4 p -57.29 107.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.393 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.66 161.78 33.3 Favored Glycine 0 C--N 1.284 -2.324 0 C-N-CA 117.569 -2.253 . . . . 0.0 111.518 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.497 ' NE2' ' HB3' ' A' ' 102' ' ' ASN . 18.7 t-160 -89.1 101.19 13.85 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.945 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -88.79 160.53 17.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.301 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 115.18 7.03 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.669 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.427 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.16 118.34 15.52 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.088 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 72' ' ' PHE . 3.0 mt -108.47 113.77 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.494 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.1 m -63.6 130.92 46.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -161.76 -101.68 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.063 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.3 p -61.31 -13.56 20.13 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.23 60.17 3.38 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.529 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.19 -154.86 14.66 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.366 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -75.91 -142.12 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t 47.1 28.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.083 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.88 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.7 OUTLIER -158.76 15.88 0.19 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.687 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -111.25 130.17 55.74 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.044 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' CE ' ' N ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -132.75 159.56 39.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.925 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 1.9 m-80 -138.08 144.16 40.79 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.71 111.57 8.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.555 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 9.7 pt20 -97.18 113.61 25.22 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.443 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.423 ' HG ' ' CG1' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.57 120.19 41.01 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 tp -117.36 98.59 6.5 Favored 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.717 -2.038 . . . . 0.0 108.734 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.586 ' CD1' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -100.01 161.35 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.324 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.463 ' CD1' ' H ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.85 150.54 24.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.952 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.463 ' H ' ' CD1' ' A' ' 108' ' ' LEU . 3.1 p30 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.9 Cg_endo -68.09 145.54 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.221 1.281 . . . . 0.0 111.247 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' C ' ' HG ' ' A' ' 5' ' ' SER . 12.4 p-10 -67.03 126.88 30.55 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.796 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.469 ' HG ' ' C ' ' A' ' 4' ' ' ASP . 8.4 m -150.02 144.57 25.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.089 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -130.9 153.72 48.86 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -146.18 159.9 42.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -133.63 98.92 4.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' CG2' HD11 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -99.79 141.76 16.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -114.8 151.86 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.811 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -153.11 167.01 31.7 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.54 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' SER . 7.7 p -141.45 94.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 62.2 p 36.81 78.32 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 16' ' ' PRO . . . 136.94 67.47 0.05 OUTLIER Glycine 0 C--N 1.291 -1.956 0 N-CA-C 104.933 -3.267 . . . . 0.0 104.933 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.529 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 10.7 tppt? -113.64 45.32 0.32 Allowed Pre-proline 0 C--O 1.207 -1.176 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -66.75 102.88 0.65 Allowed 'Trans proline' 0 N--CA 1.436 -1.908 0 N-CA-C 105.283 -2.622 . . . . 0.0 105.283 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.98 161.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -104.51 101.66 11.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.675 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 1.8 tp -89.88 107.92 19.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -147.57 100.23 3.79 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 118.089 -1.445 . . . . 0.0 113.861 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -68.53 143.48 57.34 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 120.652 0.902 . . . . 0.0 109.949 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -147.68 105.18 3.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.249 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -179.98 0.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.473 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.587 ' CG1' ' H ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -102.43 142.66 16.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.948 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.633 HE21 ' HZ2' ' A' ' 27' ' ' LYS . 10.3 pt20 -76.26 27.85 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.613 ' CG2' ' OD1' ' A' ' 71' ' ' ASP . 33.0 p 42.11 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.553 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HZ2' HE21 ' A' ' 25' ' ' GLN . 3.4 mmpt? -119.79 -174.72 2.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -67.38 100.32 0.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.609 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 30' ' ' SER . 3.9 m -148.07 -155.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.475 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.5 ' HG ' ' HA ' ' A' ' 50' ' ' TYR . 9.3 m -150.09 161.67 41.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.2 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 49' ' ' TRP . 2.2 t -127.96 111.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.889 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.262 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -134.9 132.81 38.94 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.445 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.579 ' CD1' ' N ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -135.32 148.18 49.39 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.66 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -133.28 158.84 41.93 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.759 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HZ3' ' CB ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -150.72 163.16 39.23 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.818 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.99 108.73 10.92 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.694 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 4.5 pt-20 -107.38 121.66 45.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.48 -166.2 1.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.361 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' C ' ' OG ' ' A' ' 40' ' ' SER . . . 87.17 -9.1 74.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' OG ' ' C ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 163.89 -13.02 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.995 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.526 ' CE1' ' HA ' ' A' ' 82' ' ' GLN . 16.6 m-70 -101.59 -144.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HG2' ' C ' ' A' ' 41' ' ' HIS . 11.3 mmt180 -151.54 -163.8 1.84 Allowed 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.538 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -89.66 157.29 18.07 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 46' ' ' ILE . 36.1 mt -150.28 142.68 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 117.871 -1.532 . . . . 0.0 113.25 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -90.54 -31.13 16.86 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.521 HD11 ' HZ1' ' A' ' 35' ' ' LYS . 13.9 mm 74.48 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.637 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -151.01 159.38 44.6 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.328 -1.349 . . . . 0.0 113.415 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.76 ' ND2' ' HG ' ' A' ' 55' ' ' SER . 1.2 p-10 -127.97 118.04 22.84 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.555 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 16.9 t90 -104.48 117.61 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 52' ' ' ASP . 7.5 m-85 -124.22 97.63 5.41 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.714 ' ND2' ' N ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 64.25 -60.92 0.19 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.279 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' TYR . 42.0 m-20 -159.29 33.05 0.2 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.59 85.84 0.35 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -87.12 112.35 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.276 1.984 . . . . 0.0 110.405 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.76 ' HG ' ' ND2' ' A' ' 48' ' ' ASN . 3.8 p -125.34 162.31 25.06 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.668 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 59.8 m95 -109.93 161.36 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.486 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.456 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.2 p -159.79 82.52 0.73 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.585 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.862 HD21 ' HG ' ' A' ' 60' ' ' SER . 64.0 t30 -174.1 -26.63 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.599 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.469 ' CG2' ' C ' ' A' ' 58' ' ' ASN . 0.9 OUTLIER 68.79 -4.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.795 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.862 ' HG ' HD21 ' A' ' 58' ' ' ASN . 1.0 OUTLIER -100.89 11.92 38.64 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 56' ' ' TRP . 45.9 m-85 -72.33 42.91 0.1 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.694 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 60' ' ' SER . 19.6 t -98.5 -15.53 19.54 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -147.71 93.58 2.23 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.728 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -157.24 -173.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 117.051 -1.86 . . . . 0.0 115.724 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.728 ' N ' ' CG2' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.81 165.4 19.79 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.89 -2.414 . . . . 0.0 114.644 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.4 131.28 5.87 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 7.2 t80 -98.26 143.83 28.34 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.231 -0.987 . . . . 0.0 113.14 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.9 t70 -133.62 156.8 47.21 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 56.1 t80 -97.03 176.55 5.91 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.286 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.723 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 127.98 -13.16 6.42 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.613 ' OD1' ' CG2' ' A' ' 26' ' ' THR . 1.8 m-20 166.06 -89.4 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.451 ' CZ ' HD11 ' A' ' 24' ' ' ILE . 47.6 m-85 -152.24 99.2 2.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.18 108.52 10.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -119.95 115.43 23.76 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.821 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 t -105.97 138.38 42.26 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.243 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.468 HD12 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -90.19 133.0 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.135 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -143.04 93.87 2.56 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.466 1.127 . . . . 0.0 108.499 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 80' ' ' LYS . 11.6 t -153.59 -25.33 0.14 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.693 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 44.01 11.67 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.393 -2.185 . . . . 0.0 114.128 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.7 mmtp -97.91 152.85 18.79 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 107' ' ' ILE . 26.6 tp -49.7 -18.63 0.49 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.894 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.526 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 32.9 mt-30 -59.01 -22.02 59.98 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.801 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 107' ' ' ILE . 37.3 t0 -64.47 -39.93 94.73 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.056 -1.457 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.455 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 78.3 p -46.37 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -170.87 165.04 38.24 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -85.59 109.34 18.47 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.27 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.495 ' CZ ' ' HE2' ' A' ' 35' ' ' LYS . 2.6 m-30 -95.82 142.16 28.41 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.3 tp -151.9 117.19 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.703 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 88' ' ' LEU . 3.1 mt -88.51 155.73 19.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.667 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -135.38 109.44 8.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.938 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.4 tt -89.17 154.56 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.071 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.525 ' CG2' ' H ' ' A' ' 93' ' ' ASN . 4.9 m 58.03 -147.72 0.5 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.46 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.525 ' H ' ' CG2' ' A' ' 92' ' ' THR . 65.4 m-80 -142.42 -32.02 0.51 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.678 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.1 m -146.42 135.38 22.48 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.582 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.71 123.06 1.08 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.384 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.23 -26.5 21.25 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.297 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.65 175.85 6.02 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.3 61.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.72 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.5 m -69.0 84.77 0.33 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.38 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -150.58 139.26 20.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.507 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -132.72 102.95 5.87 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.189 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -98.33 146.13 25.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.38 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.97 117.16 12.64 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.651 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.87 116.92 27.5 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.78 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.423 HD11 ' CG2' ' A' ' 9' ' ' VAL . 1.6 mm? -103.97 128.33 51.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.0 tp -146.06 100.25 3.36 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -119.8 163.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.792 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 54.1 tp -104.13 159.54 15.6 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.517 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 CA-C-O 116.306 -1.807 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 5.0 Cg_exo -65.36 133.58 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.334 1.356 . . . . 0.0 111.003 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -43.06 122.05 2.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.972 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.8 p -146.25 137.24 24.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.9 p -140.15 110.63 6.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.34 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 31.3 tt0 -123.89 160.36 27.66 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' C ' ' CD ' ' A' ' 8' ' ' GLU . 12.3 tm-20 -126.85 121.94 33.29 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.81 136.37 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.72 152.61 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.366 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 107' ' ' ILE . . . -152.23 167.61 31.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' SER . 94.8 t -147.39 97.08 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.574 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.807 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 2.0 t 27.49 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 15' ' ' LYS . . . 131.34 55.5 0.09 OUTLIER Glycine 0 C--N 1.287 -2.176 1 N-CA-C 103.025 -4.03 . . . . 0.0 103.025 -179.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.807 ' NZ ' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -118.57 57.54 3.13 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.44 112.28 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 104.96 -2.746 . . . . 0.0 104.96 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.51 161.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.521 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -105.07 112.38 25.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 5.3 tp -91.85 125.55 36.6 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -147.97 98.32 3.83 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 117.06 -1.856 . . . . 0.0 115.071 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.12 131.53 22.34 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 120.965 1.11 . . . . 0.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.8 m -116.01 162.08 17.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 64.73 83.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.85 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.474 ' H ' HD12 ' A' ' 24' ' ' ILE . 1.1 pp -119.31 -179.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.209 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 26' ' ' THR . 8.1 tt0 -138.88 -12.03 1.28 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.209 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.747 ' CG2' ' H ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -19.18 -99.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.859 -1.519 . . . . 0.0 113.504 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.747 ' H ' ' CG2' ' A' ' 26' ' ' THR . 11.8 mtmt 44.15 18.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.3 OUTLIER 166.6 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.0 175.84 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -115.47 148.03 39.93 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.192 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.4 t -105.35 119.56 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.992 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.87 131.64 37.6 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.717 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.512 ' HE1' ' HB2' ' A' ' 47' ' ' LEU . 5.5 p-90 -136.02 116.29 13.54 Favored 'General case' 0 C--O 1.184 -2.367 0 C-N-CA 118.776 -1.169 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -103.65 153.91 20.11 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.417 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.814 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -150.54 160.42 43.8 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 118.306 -1.357 . . . . 0.0 113.432 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 m -113.37 99.99 8.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.07 137.1 34.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -97.53 147.77 23.93 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.688 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.763 ' H ' ' CD2' ' A' ' 41' ' ' HIS . . . 122.91 -33.73 3.97 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -130.71 -5.17 4.1 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.763 ' CD2' ' H ' ' A' ' 39' ' ' GLY . 1.3 m80 36.94 46.92 0.54 Allowed 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 112.566 -2.107 . . . . 0.0 111.67 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -108.76 145.58 34.92 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.966 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.94 136.92 32.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.541 HG21 ' N ' ' A' ' 46' ' ' ILE . 94.3 mt -144.83 147.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.942 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -89.51 -26.78 20.71 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.229 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.541 ' N ' HG21 ' A' ' 44' ' ' ILE . 12.1 mm 72.44 -93.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.4 OUTLIER -123.54 156.84 34.91 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 47' ' ' LEU . 64.0 t30 -137.67 97.41 3.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.597 -2.092 . . . . 0.0 105.943 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.499 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 2.9 t90 -94.55 132.28 39.4 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.723 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.579 ' C ' ' ND2' ' A' ' 51' ' ' ASN . 34.3 p90 -148.52 99.87 3.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.84 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.579 ' ND2' ' C ' ' A' ' 50' ' ' TYR . 4.1 p30 44.22 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.901 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER 40.83 26.95 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.764 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -127.16 81.9 0.35 Allowed Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -87.31 127.1 2.4 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.139 1.892 . . . . 0.0 111.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.3 p -130.23 142.67 50.54 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.293 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.644 ' N ' ' CD1' ' A' ' 56' ' ' TRP . 18.7 m95 -101.09 160.77 14.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.481 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' HZ ' ' A' ' 61' ' ' PHE . 41.3 t -158.64 82.28 0.81 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.243 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.595 ' OD1' ' CD2' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -176.13 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.828 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.705 ' C ' ' H ' ' A' ' 61' ' ' PHE . 1.1 t 68.08 -46.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.183 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 58' ' ' ASN . 23.8 m -62.91 15.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.78 ' O ' ' N ' ' A' ' 63' ' ' ASP . 45.9 m-85 -56.99 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.567 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.488 ' C ' ' O ' ' A' ' 61' ' ' PHE . 39.0 p 32.77 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.78 ' N ' ' O ' ' A' ' 61' ' ' PHE . 9.6 t0 -88.77 92.03 9.05 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.682 ' CG2' ' N ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -154.79 -173.18 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.814 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.04 163.69 19.41 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.598 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 130.35 5.13 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 11.6 t80 -89.32 155.73 19.18 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.446 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 4.1 m-20 -142.14 152.7 43.47 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.576 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 18.9 t80 -101.06 -179.49 4.06 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.115 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 121.8 -1.97 10.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 105.07 -3.212 . . . . 0.0 105.07 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.652 ' CG ' ' N ' ' A' ' 72' ' ' PHE . 1.8 t70 161.15 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 111.159 -2.52 . . . . 0.0 105.178 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.652 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.2 m-85 -150.14 106.36 3.47 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.62 149.58 45.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.094 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.506 HD13 ' CH2' ' A' ' 33' ' ' TRP . 2.9 tm? -144.58 116.35 8.23 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.228 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.0 p -102.59 140.7 36.52 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 HD13 ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -95.82 125.57 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.727 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ILE . 24.5 ttpt -135.69 93.78 2.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' LYS . 3.7 t -154.96 -30.05 0.1 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 113.301 -1.772 . . . . 0.0 107.097 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 41.35 14.81 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 111.957 -2.383 . . . . 0.0 113.499 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' SER . 7.6 mmtt -103.45 148.45 25.9 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.388 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 80' ' ' LYS . 11.3 tp -41.89 -25.91 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.084 -1.047 . . . . 0.0 109.688 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' LYS . 7.5 pt20 -57.32 -17.73 13.6 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -64.59 -57.14 9.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.586 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.738 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -40.91 118.39 0.98 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.662 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.03 163.92 35.03 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -85.33 102.67 13.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.491 ' CE1' ' HE3' ' A' ' 35' ' ' LYS . 2.1 m-30 -89.27 149.6 23.0 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.656 -0.817 . . . . 0.0 112.254 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.56 110.25 5.31 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.677 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.49 100.41 13.03 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.338 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -106.63 120.49 42.09 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mm -97.13 109.45 23.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.104 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.9 m 52.59 -101.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.271 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.773 HD21 ' N ' ' A' ' 94' ' ' THR . 0.5 OUTLIER -173.73 -37.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.1 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.773 ' N ' HD21 ' A' ' 93' ' ' ASN . 11.1 p 44.35 -154.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.13 170.52 43.62 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.668 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.06 -83.16 0.41 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.45 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -78.46 176.25 9.55 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 99' ' ' CYS . 15.0 p -95.05 152.43 3.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.066 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 34.3 m -156.05 58.33 0.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.741 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.37 160.2 43.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -133.35 130.29 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.596 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 1.9 m120 -107.01 114.34 28.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.179 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -112.67 107.12 15.68 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -90.57 101.64 14.38 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.858 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 105' ' ' LEU . 3.4 mm? -91.04 113.89 26.27 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.8 tp -118.56 100.38 7.41 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.966 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.738 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -116.42 161.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.685 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD11 ' H ' ' A' ' 109' ' ' ASP . 63.8 tp -107.0 154.45 21.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.645 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.467 ' H ' HD11 ' A' ' 108' ' ' LEU . 33.1 t70 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 116.315 -1.802 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.392 0.615 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -138.12 158.17 44.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.46 160.43 43.46 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.59 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' OE1' ' CB ' ' A' ' 104' ' ' GLN . 35.5 tp10 -131.12 98.75 4.66 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.77 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -99.73 142.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.285 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 106' ' ' LEU . 10.9 p -129.88 143.13 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.162 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.765 ' H ' HG22 ' A' ' 107' ' ' ILE . . . -154.13 163.14 30.89 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.335 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.4 p -123.57 97.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.849 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 12' ' ' VAL . 14.2 m 38.82 75.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.711 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 142.36 64.39 0.03 OUTLIER Glycine 0 C--N 1.293 -1.842 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.58 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 7.1 tppt? -121.11 56.18 5.38 Favored Pre-proline 0 C--O 1.209 -1.065 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -70.15 132.31 22.44 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 N-CA-C 105.585 -2.506 . . . . 0.0 105.585 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG12 ' HB ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -150.56 161.74 3.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 117.338 -1.745 . . . . 0.0 112.811 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -107.68 106.02 16.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mp -88.89 127.44 35.64 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -151.42 96.46 3.21 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 116.169 -2.213 . . . . 0.0 116.911 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' CE ' ' A' ' 101' ' ' LYS . 2.7 Cg_exo -71.43 147.83 53.21 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.031 1.154 . . . . 0.0 110.041 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.496 1.834 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.761 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.6 t -102.07 137.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.299 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -150.41 130.46 13.48 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.973 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.747 ' CH2' HD13 ' A' ' 74' ' ' LEU . 2.7 p-90 -141.56 108.02 5.3 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.8 pttp -100.79 161.0 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.036 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.786 ' NZ ' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -147.11 160.6 42.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.987 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.487 1.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.301 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 43' ' ' LYS . 49.4 mtt180 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 42' ' ' ARG . 6.1 mmpt? -88.64 150.73 22.88 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.332 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 46' ' ' ILE . 87.8 mt -144.86 147.68 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.667 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.7 mp0 -96.66 -24.12 16.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.803 HD12 ' CE2' ' A' ' 65' ' ' TYR . 22.6 mm 68.22 -107.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -112.9 154.87 25.69 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.48 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.8 p30 -139.88 98.95 3.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.089 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.491 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.1 t90 -94.76 129.95 41.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.458 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.6 p90 -149.76 100.38 2.96 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.93 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 40.8 t30 51.13 83.89 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.239 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 26.2 t70 45.34 27.45 0.36 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.78 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.06 79.13 0.36 Allowed Glycine 0 N--CA 1.507 3.367 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.723 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 15.0 Cg_endo -87.76 120.15 1.39 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.362 2.041 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.47 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -129.71 155.03 46.56 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.851 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.499 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 44.2 m95 -102.62 164.34 11.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.888 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 38.8 t -158.51 79.39 0.8 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 118.215 -1.394 . . . . 0.0 113.248 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.4 t30 158.77 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.558 1.161 . . . . 0.0 109.461 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -47.07 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.34 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 58' ' ' ASN . 0.6 OUTLIER 174.4 2.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.369 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 64' ' ' ILE . 20.9 m-30 -79.71 38.33 0.38 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.278 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 t -78.51 -7.68 57.75 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.2 t0 -150.53 95.03 2.18 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.714 -2.948 . . . . 0.0 105.76 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.838 HG23 ' N ' ' A' ' 65' ' ' TYR . 1.4 tp -151.82 -174.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.838 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.01 161.69 26.09 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 112.944 -1.934 . . . . 0.0 113.78 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.05 137.32 9.38 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 154.77 19.86 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.275 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -137.3 145.77 43.84 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -97.09 -179.27 4.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.36 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 119.28 1.95 13.78 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 105.604 -2.998 . . . . 0.0 105.604 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.6 m-20 156.43 -99.06 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.959 -2.12 . . . . 0.0 105.905 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 78.1 m-85 -153.34 102.46 2.6 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.978 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.84 150.5 31.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.343 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.747 HD13 ' CH2' ' A' ' 33' ' ' TRP . 1.2 pp -144.87 146.03 31.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 m -120.25 146.01 46.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.6 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.548 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -92.05 130.87 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.992 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -140.99 92.87 2.53 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 80' ' ' LYS . 31.1 t -151.71 -33.84 0.14 Allowed 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.743 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.711 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 48.7 15.82 0.1 Allowed 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 112.398 -2.183 . . . . 0.0 112.593 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' GLN . 10.5 mmtm -99.61 142.22 31.38 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 81' ' ' LEU . 2.6 tp -44.08 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 pt20 -65.81 -22.53 66.56 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.413 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.6 OUTLIER -59.38 -33.9 71.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.207 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 58.4 p -45.89 100.06 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.63 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.58 162.14 35.18 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.457 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -87.1 107.76 18.59 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.796 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 76' ' ' ILE . 1.8 m-30 -87.78 151.12 23.13 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.642 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -141.16 109.03 5.68 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.87 126.71 35.81 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.887 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.6 137.23 28.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 N--CA 1.485 1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.665 0.269 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' CE ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -145.51 155.18 42.93 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.348 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -134.12 124.69 26.53 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.283 -0.967 . . . . 0.0 112.413 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.1 118.96 38.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.403 ' CB ' ' OE1' ' A' ' 8' ' ' GLU . 49.4 mt-30 -89.36 120.3 30.58 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.219 -0.993 . . . . 0.0 112.069 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.553 HD13 ' CG2' ' A' ' 9' ' ' VAL . 2.8 mm? -108.4 123.71 49.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.1 tp -139.75 99.01 3.6 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.765 HG22 ' H ' ' A' ' 11' ' ' GLY . 11.0 pt -124.45 164.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.841 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 HD22 ' C ' ' A' ' 107' ' ' ILE . 3.4 mm? -108.53 -175.32 2.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.905 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.475 ' C ' ' OG ' ' A' ' 13' ' ' SER . 15.5 t70 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.882 0.373 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -125.46 123.09 38.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -136.61 160.39 38.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.06 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pp20? -143.0 109.22 5.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.82 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.92 156.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.319 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' O ' ' NZ ' ' A' ' 15' ' ' LYS . 14.2 p -121.45 151.2 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.972 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.59 167.27 31.46 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.067 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -142.56 97.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.097 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 83.9 p 35.19 81.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.846 0.832 . . . . 0.0 108.853 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.7 68.58 0.09 OUTLIER Glycine 0 C--N 1.29 -1.994 0 N-CA-C 104.401 -3.48 . . . . 0.0 104.401 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.56 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 tpmt? -119.54 79.48 21.83 Favored Pre-proline 0 C--O 1.204 -1.307 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 19.3 Cg_endo -93.65 95.88 0.14 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 N-CA-C 104.831 -2.796 . . . . 0.0 104.831 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 18' ' ' GLN . 9.3 p -112.89 161.58 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.1 tt0 -109.95 100.08 9.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.479 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' LEU . 2.7 tp -88.76 107.56 19.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -135.54 101.33 10.93 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -67.44 125.55 13.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 O-C-N 122.893 0.944 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.485 1.295 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.179 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 36.3 t -123.31 135.94 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -149.92 139.27 21.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.525 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.639 ' HB3' HD22 ' A' ' 89' ' ' LEU . 10.1 p-90 -142.56 112.98 7.23 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -98.12 159.81 14.7 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.515 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.586 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.34 159.25 44.44 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.125 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.394 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.475 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.12 138.43 31.56 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.025 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -151.79 168.67 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.847 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 3.7 mp0 -83.9 -22.44 31.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.673 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.742 ' H ' ' CG2' ' A' ' 44' ' ' ILE . 4.0 mm 70.2 -109.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -99.47 151.07 21.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.545 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -140.5 100.77 3.95 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.276 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.581 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.65 130.55 46.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.757 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.7 t80 -137.03 97.69 3.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.147 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.54 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 11.8 t-20 65.38 -60.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.128 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.8 p30 -159.81 32.18 0.18 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.101 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.86 87.17 0.39 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.532 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -87.83 108.08 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.512 2.142 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.42 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -132.38 143.73 50.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.501 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.6 m95 -87.85 161.43 17.52 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.163 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 46' ' ' ILE . 52.7 m -124.92 78.71 1.72 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.572 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 1.2 m-80 70.71 -40.84 0.48 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.822 ' O ' ' N ' ' A' ' 61' ' ' PHE . 1.5 t -43.52 117.04 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.166 -3.311 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.352 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 62' ' ' SER . 22.8 t -18.14 54.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.822 ' N ' ' O ' ' A' ' 59' ' ' VAL . 17.7 m-85 -63.12 76.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 117.491 -1.684 . . . . 0.0 112.377 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 60' ' ' SER . 0.3 OUTLIER -148.23 -22.49 0.34 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.7 t0 -147.79 90.94 1.89 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -156.87 -171.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 117.119 -1.832 . . . . 0.0 115.892 -178.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.883 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.65 163.5 21.27 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 111.186 -2.734 . . . . 0.0 114.935 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.09 127.55 5.17 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.3 t80 -93.97 158.94 15.4 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.535 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 3.7 m-20 -145.01 151.46 38.61 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.343 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 61.1 t80 -107.93 174.05 6.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.483 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.774 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 123.84 -7.78 8.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 105.931 -2.868 . . . . 0.0 105.931 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 7.0 t70 173.92 -103.49 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 111.515 -2.342 . . . . 0.0 104.855 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 87.0 m-85 -152.55 109.08 3.43 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' ASP . . . -138.54 145.1 40.29 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.185 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -151.14 117.82 5.77 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.858 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.566 ' N ' HD13 ' A' ' 74' ' ' LEU . 33.3 t -109.18 139.83 43.58 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.508 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -95.51 130.37 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -142.61 94.56 2.66 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.887 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -151.74 -31.84 0.15 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.825 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 55.12 40.43 31.83 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 112.664 -2.062 . . . . 0.0 114.791 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 82' ' ' GLN . 4.2 mtpp -142.0 158.87 43.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.795 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 81' ' ' LEU . 10.9 mp -43.48 -23.19 0.06 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 51.0 mt-30 -52.4 -32.81 40.72 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 117.654 -1.618 . . . . 0.0 107.832 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.7 m-20 -66.51 -41.03 89.45 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.737 ' HG ' ' H ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -57.49 105.04 0.21 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.269 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 164.95 37.06 Favored Glycine 0 C--N 1.284 -2.348 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.694 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.463 ' NE2' ' HB2' ' A' ' 102' ' ' ASN . 13.1 t-160 -86.14 105.22 16.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.649 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 2.2 m-30 -88.39 155.22 19.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.307 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -145.64 105.22 3.97 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.29 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.46 122.81 33.01 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.923 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -143.83 139.63 29.41 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.01 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.533 ' N ' ' OE2' ' A' ' 90' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -144.61 160.44 41.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.819 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.463 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 13.9 p-10 -121.16 127.19 51.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.496 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.31 139.4 41.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.504 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -117.26 107.66 14.69 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.095 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 9' ' ' VAL . 2.4 mm? -89.05 125.49 35.03 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.61 98.05 4.55 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.737 ' H ' ' HG ' ' A' ' 84' ' ' SER . 1.2 pt -122.6 162.62 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 28.8 tp -150.67 151.13 32.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.379 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.465 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 40.3 t0 . . . . . 0 C--N 1.307 -1.267 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.988 0.423 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 m -150.08 109.39 3.96 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.433 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.65 147.68 50.21 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -104.5 104.78 14.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -93.31 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.846 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.39 151.79 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.975 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.54 30.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.101 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 7.5 p -147.6 96.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.156 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.819 ' N ' ' HZ1' ' A' ' 15' ' ' LYS . 54.3 p 33.61 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 122.235 1.016 . . . . 0.0 108.706 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.069 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . . . 124.21 62.71 0.19 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 103.362 -3.895 . . . . 0.0 103.362 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 1.101 ' HZ1' ' C ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -119.44 60.34 5.63 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.0 Cg_endo -69.81 97.0 0.62 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 N-CA-C 104.767 -2.82 . . . . 0.0 104.767 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -101.92 161.19 3.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.966 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -120.75 109.46 15.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.885 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -87.21 124.21 33.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -136.83 93.39 13.75 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 116.923 -1.911 . . . . 0.0 115.337 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.36 104.61 1.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 O-C-N 123.448 1.236 . . . . 0.0 109.468 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.867 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.484 0.183 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 4.4 t -106.66 135.06 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.188 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -150.14 127.84 11.66 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.231 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.732 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.5 p-90 -131.49 147.06 52.51 Favored 'General case' 0 C--O 1.193 -1.876 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.212 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -137.47 154.26 49.93 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.43 158.6 41.65 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 117.865 -1.534 . . . . 0.0 113.718 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 179.28 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 43' ' ' LYS . 5.3 tpm_? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -86.7 131.37 34.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.195 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.597 HG21 HD13 ' A' ' 46' ' ' ILE . 4.4 mm -131.25 146.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.97 -24.94 13.93 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.769 HD12 ' CE2' ' A' ' 65' ' ' TYR . 8.3 mm 62.64 -111.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -107.51 154.94 20.65 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.683 ' N ' HD23 ' A' ' 47' ' ' LEU . 49.6 t30 -137.41 98.58 3.74 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.298 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.617 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 3.7 t90 -92.58 133.02 36.36 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.665 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 52' ' ' ASP . 24.3 t80 -140.36 98.36 3.41 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.682 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 3.0 t30 68.54 -55.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.204 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' TYR . 24.5 t0 -171.14 31.3 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.21 90.02 0.42 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.49 101.65 0.6 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.203 1.935 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.94 140.2 49.74 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.52 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 7.9 m95 -90.18 162.2 15.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.6 p -151.83 80.5 1.27 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.665 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER 175.58 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 124.623 1.202 . . . . 0.0 112.594 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 58' ' ' ASN . 4.5 m 31.45 31.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 58' ' ' ASN . 89.3 p -122.89 6.13 9.34 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.705 ' HA ' HD13 ' A' ' 64' ' ' ILE . 20.4 m-85 -71.46 45.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -15.42 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -150.62 95.95 2.3 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.87 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.98 -173.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 117.238 -1.785 . . . . 0.0 115.294 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.87 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -70.14 163.58 26.0 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 111.786 -2.461 . . . . 0.0 115.276 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.1 116.22 2.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.15 -2.38 . . . . 0.0 107.15 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 68' ' ' ASP . 42.3 t80 -99.1 158.94 15.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.505 ' N ' ' CG ' ' A' ' 67' ' ' PHE . 17.3 m-20 -143.18 141.32 31.11 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.984 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -107.24 177.61 4.8 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.584 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.32 81.81 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 104.961 -3.255 . . . . 0.0 104.961 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 71' ' ' ASP . 2.5 t0 167.87 130.33 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -81.21 112.58 18.67 Favored 'General case' 0 C--N 1.259 -3.352 0 C-N-CA 117.59 -1.644 . . . . 0.0 109.86 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.83 111.43 5.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.288 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 75' ' ' SER . 3.4 tm? -104.59 146.89 28.27 Favored 'General case' 0 C--O 1.199 -1.589 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.81 ' N ' HD13 ' A' ' 74' ' ' LEU . 48.6 p -140.31 130.58 25.14 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.344 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -88.6 130.93 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.055 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.99 93.94 2.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.963 1.363 . . . . 0.0 108.27 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.1 p -151.77 -39.98 0.11 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.535 -2.121 . . . . 0.0 105.819 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.814 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.8 20.57 2.34 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 111.321 -2.672 . . . . 0.0 115.104 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 83' ' ' ASP . 32.9 mmtt -98.96 142.95 29.81 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 80' ' ' LYS . 12.0 tp -45.04 -31.77 1.46 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.624 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -59.52 -34.83 73.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.074 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -53.26 -47.66 68.9 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.908 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.627 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -37.07 124.57 0.92 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.228 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . -173.05 166.47 39.02 Favored Glycine 0 C--N 1.278 -2.686 0 C-N-CA 118.394 -1.86 . . . . 0.0 110.784 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -88.27 106.32 18.14 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.544 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.45 150.9 28.19 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.083 -1.047 . . . . 0.0 113.503 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.782 HD22 ' C ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -150.8 142.14 23.33 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.035 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -95.6 146.15 24.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.791 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' H ' HD13 ' A' ' 89' ' ' LEU . 40.0 mt-10 -143.34 124.24 14.31 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.62 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.489 1.52 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.434 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.519 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 2.0 mptt -102.77 106.01 16.54 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.747 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.45 160.18 17.65 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' TYR . 62.6 m-85 -150.08 129.71 13.14 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.277 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.67 106.42 16.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.722 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.57 HD22 HG22 ' A' ' 9' ' ' VAL . 2.6 mm? -97.92 98.4 9.77 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tp -107.21 100.16 9.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.397 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.6 164.07 10.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.97 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.27 -154.61 0.53 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.448 0.642 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 p -147.61 98.88 3.04 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.668 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' OE2' ' C ' ' A' ' 8' ' ' GLU . 6.5 tm-20 -115.03 154.66 28.42 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.202 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' OE2' ' A' ' 7' ' ' GLU . 4.4 tm-20 -129.57 99.38 5.14 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.399 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -100.23 151.19 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.657 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.41 150.19 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -151.79 167.39 31.02 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.625 ' H ' ' HZ1' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -140.57 107.43 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.602 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 7.82 85.54 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 122.051 0.929 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.807 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.52 53.07 0.06 OUTLIER Glycine 0 C--N 1.282 -2.424 1 N-CA-C 101.604 -4.598 . . . . 0.0 101.604 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -108.08 53.69 0.22 Allowed Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 1.6 Cg_endo -68.18 107.29 1.52 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 103.509 -3.304 . . . . 0.0 103.509 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 18' ' ' GLN . 3.6 p -129.24 161.21 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 118.609 -1.237 . . . . 0.0 114.151 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.409 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -102.45 112.76 25.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.827 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.517 HD11 ' CG ' ' A' ' 103' ' ' PHE . 28.4 tp -100.16 101.18 12.15 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -123.04 97.27 43.76 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.26 114.11 3.52 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 120.844 1.029 . . . . 0.0 109.628 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.881 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 49' ' ' TRP . 2.1 t -123.09 146.08 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 119.204 -0.999 . . . . 0.0 112.47 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -150.83 127.7 11.01 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.546 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.792 ' CE2' HD22 ' A' ' 74' ' ' LEU . 5.0 p-90 -133.58 103.5 5.94 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 118.565 -1.254 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 15.3 tttt -94.89 160.86 14.4 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.938 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.612 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -146.17 158.89 43.9 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.299 -1.599 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.88 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -88.66 154.58 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.504 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.615 HG23 ' CG ' ' A' ' 58' ' ' ASN . 39.1 mt -150.4 138.19 14.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 C-N-CA 118.018 -1.473 . . . . 0.0 113.079 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 18.2 mm-40 -89.25 -30.8 18.24 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 47' ' ' LEU . 31.6 mm 72.54 -101.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 46' ' ' ILE . 6.7 tt -125.24 153.57 42.98 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.8 t30 -133.17 99.05 4.43 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.817 -1.992 . . . . 0.0 106.429 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.567 ' N ' ' O ' ' A' ' 31' ' ' VAL . 3.8 t90 -89.51 121.88 32.15 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.647 -0.821 . . . . 0.0 113.089 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -135.8 98.33 3.88 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.631 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.6 t30 64.53 -168.52 0.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.93 33.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.964 -1.494 . . . . 0.0 110.292 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -127.56 85.62 0.33 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.103 -1.046 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.41 141.25 6.7 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.156 1.904 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.0 p -136.33 139.15 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.575 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 11.8 m95 -91.24 161.19 15.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.591 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.46 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 41.0 t -159.96 79.96 0.7 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.259 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.726 ' C ' HG23 ' A' ' 59' ' ' VAL . 6.0 t-20 -179.4 -17.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.804 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.754 ' C ' ' H ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 67.59 -37.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.109 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.532 ' H ' ' C ' ' A' ' 58' ' ' ASN . 0.7 OUTLIER -63.15 20.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.423 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.754 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.5 m-85 -86.24 46.19 1.31 Allowed 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -95.71 -10.62 28.78 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.05 104.54 5.06 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 109.762 -3.381 . . . . 0.0 103.229 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -144.64 -176.35 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.78 162.6 13.53 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 109.48 -3.509 . . . . 0.0 112.546 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.1 126.28 6.52 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 34.5 t80 -88.05 144.94 26.22 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.044 -1.462 . . . . 0.0 112.726 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 29.4 t0 -152.06 167.07 29.63 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.003 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 3.0 m-85 88.06 131.0 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.77 -27.04 69.38 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.138 -3.185 . . . . 0.0 105.138 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 15.5 m-20 -90.43 -102.75 0.1 Allowed 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.814 ' CE1' HD11 ' A' ' 91' ' ' ILE . 2.2 m-85 -154.04 106.44 2.82 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.426 -1.71 . . . . 0.0 112.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HB3' ' CG ' ' A' ' 69' ' ' TYR . . . -151.87 100.1 2.63 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.073 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 33' ' ' TRP . 2.6 pp -115.06 146.89 40.83 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 p -109.2 141.71 41.06 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -96.0 137.3 24.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.02 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -143.43 94.75 2.65 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.645 1.212 . . . . 0.0 108.766 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' LYS . 6.4 t -156.21 -26.55 0.1 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 113.188 -1.824 . . . . 0.0 107.087 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.807 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.63 16.05 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.475 -2.148 . . . . 0.0 113.208 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLN . 5.5 mmmt -95.12 151.18 19.43 Favored 'General case' 0 C--N 1.279 -2.479 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.979 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.0 tp -47.66 -11.84 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.226 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.5 pt20 -72.75 -23.36 60.82 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -27.85 58.35 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 118.374 -1.33 . . . . 0.0 108.423 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.668 ' HB2' ' H ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -74.01 114.55 12.45 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.657 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.48 164.19 35.79 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.52 ' NE2' ' CD ' ' A' ' 104' ' ' GLN . 45.3 m80 -85.3 104.75 15.42 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.5 m-30 -86.29 150.46 24.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -139.34 106.09 5.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.476 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.04 128.05 35.71 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.349 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -148.53 160.94 42.6 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.403 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.814 HD11 ' CE1' ' A' ' 72' ' ' PHE . 5.2 mt . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.992 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.782 0.325 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -121.04 118.57 30.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.49 139.4 39.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.786 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 19' ' ' LEU . 58.8 m-85 -136.23 102.56 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.716 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CD ' ' NE2' ' A' ' 86' ' ' HIS . 46.0 tt0 -89.9 107.2 18.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.248 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 9' ' ' VAL . 3.9 mm? -91.92 118.57 30.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -122.8 102.27 7.93 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.668 ' H ' ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -115.0 161.62 13.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.459 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.0 mp -92.66 -171.0 2.61 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.419 -1.753 . . . . 0.0 110.851 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 121.242 0.544 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.6 t -134.32 141.11 46.8 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.353 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 8' ' ' GLU . 37.1 tp10 -125.17 151.54 45.68 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 36.8 mt-10 -114.27 132.05 56.29 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.634 HG13 HD13 ' A' ' 105' ' ' LEU . 1.5 p -136.68 132.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.562 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.24 154.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.544 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -151.51 165.87 30.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' ' C ' ' A' ' 13' ' ' SER . 98.8 t -147.53 96.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 30.27 79.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.016 0.912 . . . . 0.0 108.63 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.629 ' H ' ' HE2' ' A' ' 15' ' ' LYS . . . 135.68 59.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 104.43 -3.468 . . . . 0.0 104.43 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HE2' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -113.13 50.81 0.44 Allowed Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.3 Cg_endo -66.32 91.45 0.27 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 105.331 -2.603 . . . . 0.0 105.331 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 18' ' ' GLN . 6.2 p -107.7 162.07 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 75' ' ' SER . 10.7 tp-100 -112.78 106.01 14.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.996 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -87.98 103.19 15.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.66 96.55 48.83 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.75 105.39 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.125 1.217 . . . . 0.0 109.352 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.691 -179.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.461 0.172 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 39.4 t -126.96 130.59 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.178 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -146.46 144.44 29.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.049 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.695 ' HB3' HD22 ' A' ' 89' ' ' LEU . 2.3 p-90 -143.74 119.28 10.37 Favored 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.429 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -102.84 158.56 16.18 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.038 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.774 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -147.8 161.63 40.86 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.203 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 43' ' ' LYS . 2.3 m . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.93 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.06 126.49 35.46 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.849 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.856 HD13 ' HA ' ' A' ' 59' ' ' VAL . 4.4 mt -137.39 163.01 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.411 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 23.8 mt-10 -86.12 -31.17 22.0 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.874 HD13 HG21 ' A' ' 59' ' ' VAL . 10.3 mm 83.79 -87.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 47' ' ' LEU . 1.1 tt -143.01 150.55 39.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.648 ' N ' HD23 ' A' ' 47' ' ' LEU . 35.5 t-20 -131.74 109.1 9.92 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.109 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.611 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 6.1 t90 -88.77 145.19 25.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 52' ' ' ASP . 14.1 m-85 -141.04 96.47 3.0 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.609 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . 29.2 m120 7.09 54.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.284 1.615 . . . . 0.0 113.413 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 50' ' ' TYR . 22.6 t70 -179.81 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.621 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.18 152.43 23.61 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.489 -1.815 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -88.96 141.31 4.29 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.913 1.742 . . . . 0.0 112.371 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -127.99 137.37 52.2 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.5 m95 -89.3 161.12 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.731 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.2 m -124.07 68.51 1.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.693 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 31.33 90.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 124.932 1.395 . . . . 0.0 113.139 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 46' ' ' ILE . 2.3 p -122.87 -37.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.06 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.602 ' N ' ' CG1' ' A' ' 59' ' ' VAL . 1.5 t 160.84 26.28 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.802 ' CD1' HG21 ' A' ' 64' ' ' ILE . 39.7 m-85 -54.47 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.091 1.425 . . . . 0.0 112.791 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.449 ' H ' ' H ' ' A' ' 63' ' ' ASP . 19.9 t -176.73 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.05 101.65 2.89 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.987 ' H ' HD12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -154.87 -173.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.82 ' CZ ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -77.22 165.17 24.87 Favored 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 109.578 -3.465 . . . . 0.0 114.798 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.49 126.63 4.39 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 10.8 t80 -106.66 154.3 21.13 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.144 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 13.3 t70 -139.51 147.94 41.96 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 69' ' ' TYR . 12.6 p90 -102.85 174.29 5.94 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.443 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 82.68 12.18 80.48 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER 157.62 127.59 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HE2' HD11 ' A' ' 91' ' ' ILE . 6.9 m-30 -80.84 111.87 17.71 Favored 'General case' 0 C--N 1.264 -3.139 0 C-N-CA 117.314 -1.754 . . . . 0.0 108.684 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.24 105.56 5.75 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.6 tm? -100.54 128.99 46.43 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.051 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' HD22 ' A' ' 74' ' ' LEU . 56.5 p -121.7 127.33 50.62 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.639 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.503 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -89.12 127.03 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.661 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -137.22 96.21 3.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.422 1.106 . . . . 0.0 108.459 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 64' ' ' ILE . 73.8 m -156.6 -33.8 0.08 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.81 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 47.42 64.9 1.41 Allowed 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 112.436 -2.165 . . . . 0.0 113.011 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.475 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 37.1 mmtt -145.48 148.29 33.1 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.013 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 107' ' ' ILE . 51.8 tp -49.67 -30.93 9.96 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.991 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -53.53 -28.45 31.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.125 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 8.9 m-20 -58.02 -57.39 13.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.379 -0.929 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.667 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.7 OUTLIER -40.87 119.89 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.885 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.01 164.41 35.72 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -85.78 103.88 14.95 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.231 -1.388 . . . . 0.0 108.273 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.774 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 1.1 m-30 -89.38 159.63 17.23 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.72 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.71 111.6 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.486 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.5 125.44 35.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -150.34 142.33 23.93 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.099 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.633 HD11 ' HE2' ' A' ' 72' ' ' PHE . 3.6 mt . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.016 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.632 HD21 ' N ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.862 0.363 . . . . 0.0 111.246 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.4 mptt -127.19 114.5 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -93.38 135.54 34.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.5 105.59 7.33 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.555 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.44 99.26 12.29 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.225 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.634 HD13 HG13 ' A' ' 9' ' ' VAL . 3.7 mm? -89.38 110.4 21.21 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.18 99.43 6.86 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.667 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.28 163.04 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.281 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.82 -163.86 1.03 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.791 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 p -136.72 99.25 4.0 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.241 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -103.97 148.03 26.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' CB ' ' HG3' ' A' ' 104' ' ' GLN . 2.2 pp20? -116.84 146.84 42.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.993 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.416 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.54 120.25 41.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.541 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.31 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.299 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.7 166.52 31.34 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.583 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.1 p -145.76 93.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.7 t 38.15 78.3 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 137.49 61.95 0.05 OUTLIER Glycine 0 C--N 1.284 -2.35 0 N-CA-C 104.618 -3.393 . . . . 0.0 104.618 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 9.5 tppt? -112.22 44.1 0.25 Allowed Pre-proline 0 C--O 1.208 -1.083 0 CA-C-N 114.019 -1.09 . . . . 0.0 113.666 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.9 Cg_endo -67.16 107.28 1.33 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 N-CA-C 104.469 -2.935 . . . . 0.0 104.469 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' HB ' ' A' ' 76' ' ' ILE . 9.5 p -123.76 160.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.595 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.463 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.0 mp0 -105.19 101.4 10.95 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.264 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -85.62 99.92 11.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -112.84 96.27 37.05 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.5 101.07 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.329 -1.45 . . . . 0.0 108.329 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.487 1.396 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.358 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.206 -1.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.4 t -124.05 130.1 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.121 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -149.08 138.5 21.66 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.328 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.778 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.3 p-90 -147.14 137.55 23.46 Favored 'General case' 0 C--O 1.183 -2.42 0 C-N-CA 118.086 -1.446 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 17.1 tttp -119.29 157.21 28.53 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.83 159.89 44.0 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.873 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.742 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.75 157.22 19.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.577 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.782 HG22 ' H ' ' A' ' 46' ' ' ILE . 37.5 mt -151.22 145.81 16.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 118.21 -1.396 . . . . 0.0 113.472 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.5 -23.66 23.15 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.782 ' H ' HG22 ' A' ' 44' ' ' ILE . 9.1 mm 74.87 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 113.053 -1.885 . . . . 0.0 116.051 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.938 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -153.08 157.89 41.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 117.747 -1.581 . . . . 0.0 113.806 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.607 ' N ' HD23 ' A' ' 47' ' ' LEU . 44.7 t30 -126.34 113.58 17.1 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.435 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.48 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.5 t90 -99.56 131.05 45.82 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.659 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CD2' ' OD1' ' A' ' 51' ' ' ASN . 41.9 t80 -144.34 98.68 3.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.742 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 1.2 p-10 39.04 84.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.193 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' C ' ' HD3' ' A' ' 54' ' ' PRO . 3.1 m-20 57.48 27.5 14.1 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.867 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.65 78.1 0.39 Allowed Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.656 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -86.71 126.6 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.271 1.981 . . . . 0.0 111.535 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.11 161.85 32.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.896 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 70.6 m95 -110.38 163.79 13.32 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.668 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.4 m -159.83 83.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.2 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.727 ' CB ' HG23 ' A' ' 44' ' ' ILE . 7.8 t-20 144.14 98.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.309 1.631 . . . . 0.0 107.734 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.09 83.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.564 1.173 . . . . 0.0 113.01 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 62' ' ' SER . 3.4 t -161.65 -6.38 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.824 ' HA ' HD13 ' A' ' 64' ' ' ILE . 39.0 m-85 -58.87 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.399 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 60' ' ' SER . 52.7 p -73.85 -49.33 25.58 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.594 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.9 t0 -109.89 94.21 4.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.874 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.86 -174.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 C-N-CA 117.515 -1.674 . . . . 0.0 115.044 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.874 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.06 163.52 22.19 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 112.324 -2.216 . . . . 0.0 115.434 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.46 147.9 18.75 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.0 t80 -121.23 152.98 38.22 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.931 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.754 ' OD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -141.34 152.48 44.45 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.795 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -104.82 178.81 4.45 Favored 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.39 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 93.23 6.41 63.01 Favored Glycine 0 N--CA 1.508 3.453 0 N-CA-C 104.644 -3.382 . . . . 0.0 104.644 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 155.09 141.96 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 102.108 -3.293 . . . . 0.0 102.108 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -83.09 114.18 21.13 Favored 'General case' 1 C--N 1.241 -4.148 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.724 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . . . -135.01 108.58 7.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.646 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.775 HD11 ' CH2' ' A' ' 33' ' ' TRP . 1.8 tm? -98.7 127.14 44.52 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 11.5 t -119.97 138.13 53.66 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.34 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.536 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -91.2 131.23 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.08 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -139.69 92.85 2.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.621 1.2 . . . . 0.0 107.762 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.8 t -153.71 -40.26 0.09 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 113.337 -1.756 . . . . 0.0 108.25 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.78 50.12 17.68 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.234 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLN . 27.9 mmtp -146.55 157.04 43.67 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.997 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -43.45 -20.16 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.326 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' LYS . 33.5 mm-40 -60.31 -30.01 69.22 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -64.8 -29.39 70.36 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.205 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.5 p -63.61 105.43 0.79 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.283 -1.367 . . . . 0.0 109.931 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -171.66 164.02 36.71 Favored Glycine 0 C--N 1.292 -1.879 0 C-N-CA 118.87 -1.634 . . . . 0.0 110.823 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -86.67 103.53 15.22 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.081 -1.048 . . . . 0.0 108.972 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 1.2 m-30 -89.99 158.07 17.54 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.363 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -150.69 111.43 4.27 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.999 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -97.42 128.22 44.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.871 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' CD ' ' C ' ' A' ' 90' ' ' GLU . 1.6 pp20? -137.61 133.27 34.17 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.841 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 N--CA 1.489 1.487 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.651 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.0 t30 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.949 0.404 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.58 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -147.23 146.81 29.93 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.6 144.17 32.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.052 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.61 107.68 11.78 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.466 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 10.6 pt20 -90.0 110.37 21.35 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.157 -1.017 . . . . 0.0 113.075 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 15' ' ' LYS . 1.9 mm? -89.43 116.26 27.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.648 ' O ' HD23 ' A' ' 106' ' ' LEU . 8.5 tt -119.84 97.85 5.82 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.409 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -128.78 160.54 39.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.279 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.97 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -146.93 178.93 7.96 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.048 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.881 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 t -144.17 122.68 12.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.38 155.09 42.95 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -115.61 104.81 12.08 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.51 144.28 9.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.942 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.05 145.36 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 107' ' ' ILE . . . -152.96 168.27 31.81 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.598 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.742 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.3 p -146.17 95.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t 41.94 79.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.441 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.71 63.49 0.08 OUTLIER Glycine 0 C--N 1.289 -2.055 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.513 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 tppt? -113.91 45.83 0.35 Allowed Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -67.8 110.84 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 105.581 -2.507 . . . . 0.0 105.581 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' A' ' 76' ' ' ILE . 8.4 p -128.9 161.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.39 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.457 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.5 tt0 -105.81 110.5 22.82 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.563 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.3 mp -97.67 114.3 26.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HG2' ' CB ' ' A' ' 73' ' ' ALA . 32.3 mtp180 -137.69 98.31 9.84 Favored Pre-proline 0 N--CA 1.507 2.399 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.66 140.06 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.287 -179.743 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.1 t -106.61 117.57 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.39 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -134.59 136.59 43.06 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.732 ' HB3' HD22 ' A' ' 89' ' ' LEU . 6.8 p-90 -143.96 115.38 8.06 Favored 'General case' 0 C--O 1.189 -2.088 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.698 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 6.5 tttt -103.92 160.13 15.07 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.483 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.8 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -147.81 161.06 42.02 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.267 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.193 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtm-85 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.301 0.572 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -88.77 151.11 22.6 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.848 HG23 ' CB ' ' A' ' 58' ' ' ASN . 54.2 mt -148.21 150.26 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 118.432 -1.307 . . . . 0.0 112.468 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 52.2 mt-10 -87.84 -38.88 15.3 Favored 'General case' 0 C--O 1.203 -1.351 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.695 HG21 ' CE2' ' A' ' 33' ' ' TRP . 11.1 mm 84.76 -97.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 5.4 tt -131.14 152.82 50.03 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' N ' HD23 ' A' ' 47' ' ' LEU . 16.9 t-20 -133.29 99.58 4.58 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.746 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.578 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.9 t90 -93.99 132.02 38.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.899 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 28.6 p90 -150.0 100.03 2.89 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.469 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 5.8 t30 48.57 87.27 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.398 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 74.2 m-20 45.23 26.12 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.325 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.29 79.67 0.36 Allowed Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.793 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -87.33 125.64 2.19 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.252 1.968 . . . . 0.0 110.916 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 p -138.78 145.16 39.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.635 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 40.7 m95 -89.87 164.48 14.58 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -166.01 75.68 0.21 Allowed 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.606 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.848 ' CB ' HG23 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 160.33 86.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.795 1.31 . . . . 0.0 109.146 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.79 108.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.778 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER 165.95 -6.45 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 64' ' ' ILE . 36.7 m-85 -63.96 33.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.785 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' SER . 7.2 t -86.65 -35.01 19.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 64' ' ' ILE . 3.2 t0 -127.8 94.72 4.02 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.873 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.79 -172.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 117.553 -1.659 . . . . 0.0 115.235 -179.106 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.873 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.47 164.05 21.99 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 112.236 -2.256 . . . . 0.0 114.767 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.19 126.94 4.37 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 12.7 t80 -90.56 153.66 20.19 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.779 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -140.29 158.46 44.0 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -97.18 -169.17 1.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.444 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 112.47 -1.13 26.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 2.5 m-20 152.23 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CE1' ' CG2' ' A' ' 31' ' ' VAL . 10.8 m-85 -153.04 109.09 3.34 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.22 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . . . -137.51 143.91 41.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.871 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.7 tm? -146.94 128.23 14.82 Favored 'General case' 0 C--O 1.197 -1.684 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.884 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 74' ' ' LEU . 14.5 t -121.05 138.64 54.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.079 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -91.54 133.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.327 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.55 93.64 2.45 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.464 1.126 . . . . 0.0 108.755 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -153.17 -37.49 0.1 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.792 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 54.73 51.71 13.36 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.619 -2.082 . . . . 0.0 113.697 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -147.03 178.97 7.94 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.532 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -63.88 -24.89 67.92 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.843 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' H ' ' HG3' ' A' ' 82' ' ' GLN . 34.6 mt-30 -52.03 -32.58 34.9 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 107' ' ' ILE . 70.0 m-20 -63.84 -32.23 73.68 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.846 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' LEU . 13.6 p -61.35 106.0 0.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.71 164.47 35.32 Favored Glycine 0 C--N 1.288 -2.094 0 C-N-CA 118.723 -1.703 . . . . 0.0 110.616 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -86.03 106.18 17.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.517 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.5 m-30 -88.38 150.32 23.25 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.48 110.68 5.06 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.746 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.84 100.89 13.52 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.453 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -95.07 118.99 32.83 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.095 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.308 -1.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.932 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.68 0.276 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -115.78 123.59 48.63 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -106.46 119.16 38.55 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.09 115.47 26.85 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -88.81 111.2 21.75 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.584 HD22 HG22 ' A' ' 9' ' ' VAL . 1.5 mm? -95.99 99.61 11.37 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.08 97.51 8.05 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -110.94 160.67 10.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.597 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.27 -177.16 3.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.805 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.5 p -150.16 120.78 7.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.678 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 29.4 tp10 -130.12 160.12 34.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.644 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 31.8 tt0 -120.87 133.93 55.3 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.86 120.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.995 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.15 149.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.773 ' CA ' HG22 ' A' ' 107' ' ' ILE . . . -152.35 163.63 30.32 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.569 -1.3 . . . . 0.0 111.858 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -148.21 96.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.076 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' VAL . 15.2 t 41.96 79.92 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.581 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.63 67.64 0.08 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.557 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 8.6 tppt? -112.02 39.52 0.19 Allowed Pre-proline 0 C--O 1.208 -1.084 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.9 Cg_endo -67.56 88.42 0.34 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 N-CA-C 106.327 -2.22 . . . . 0.0 106.327 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -112.47 162.72 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.802 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -106.58 108.14 19.49 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.498 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' LEU . 4.4 tp -88.74 98.44 11.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -115.62 96.54 46.57 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.83 111.89 2.53 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.408 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 49' ' ' TRP . 3.3 t -143.9 134.45 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.818 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -150.24 137.8 19.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.773 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CZ3' ' CE ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -140.71 131.09 25.16 Favored 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.103 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -118.82 152.3 36.48 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.775 ' CE ' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -153.51 163.1 40.54 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.9 -1.52 . . . . 0.0 114.188 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 m . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 179.371 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.498 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 37.0 ttm180 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -87.61 144.34 26.73 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.428 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.637 ' CG2' HD13 ' A' ' 46' ' ' ILE . 7.8 mt -149.06 138.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.91 -1.516 . . . . 0.0 112.686 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -87.39 -33.93 18.95 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CE2' ' A' ' 33' ' ' TRP . 10.9 mm 82.09 -93.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 114.132 -1.395 . . . . 0.0 114.335 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.954 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -152.23 159.52 43.53 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.498 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.67 ' N ' HD23 ' A' ' 47' ' ' LEU . 6.2 p-10 -129.37 113.8 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.397 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' VAL . 10.2 t90 -94.49 131.15 40.49 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 51' ' ' ASN . 2.3 m-85 -144.22 99.32 3.36 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.041 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.418 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 3.1 p30 40.16 85.49 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.484 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 20.2 t70 51.27 29.62 5.16 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.484 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.67 76.67 0.41 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.6 Cg_endo -86.92 127.04 2.54 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.375 2.05 . . . . 0.0 111.705 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -140.58 143.38 35.26 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.933 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.64 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 21.2 m95 -91.11 164.24 14.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.402 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -164.09 76.71 0.35 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.955 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.556 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 162.65 88.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.636 1.21 . . . . 0.0 109.693 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -44.14 105.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.844 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 169.46 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.755 ' HA ' HD13 ' A' ' 64' ' ' ILE . 34.7 m-85 -63.34 31.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.223 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' SER . 4.1 p -86.65 -25.3 24.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -140.42 95.46 2.88 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -154.93 -173.28 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-O 123.566 1.65 . . . . 0.0 115.178 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.888 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.28 164.42 20.72 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.851 -2.431 . . . . 0.0 115.437 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.34 118.33 2.35 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -90.04 138.02 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.869 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.37 160.39 29.48 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 44.8 t80 -102.55 -179.15 3.89 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.806 0.812 . . . . 0.0 113.114 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.625 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 118.66 -0.92 15.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.5 OUTLIER 156.49 -96.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.902 -2.149 . . . . 0.0 105.412 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 26.0 m-85 -152.18 105.19 3.03 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.23 106.69 5.55 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.646 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -111.29 126.8 55.28 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.624 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.59 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.8 m -115.21 134.7 54.9 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.562 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -89.88 131.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.255 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 94.68 2.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.699 1.238 . . . . 0.0 108.036 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 79' ' ' ALA . 26.9 t -156.84 -13.95 0.09 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.787 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 23.79 75.25 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 112.381 -2.191 . . . . 0.0 113.999 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' A' ' 82' ' ' GLN . 12.9 mttt -174.0 172.57 3.37 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.16 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -56.03 -37.12 68.79 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.672 ' CD ' ' H ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -46.8 -30.65 2.56 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.769 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -63.81 -35.35 80.33 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.705 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.909 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -48.9 114.06 0.91 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.67 159.98 29.95 Favored Glycine 0 C--N 1.277 -2.707 0 C-N-CA 118.035 -2.031 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -91.16 107.11 18.98 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.96 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -93.44 152.2 19.25 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.906 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.15 110.54 5.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.285 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.25 130.99 35.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.097 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -134.23 129.25 35.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.182 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm . . . . . 0 C--N 1.307 -1.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.923 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.859 0.361 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -138.91 109.08 6.4 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.646 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -95.59 134.79 38.06 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.547 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -131.64 111.91 12.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.898 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -88.48 118.33 28.04 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.084 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -101.98 101.38 11.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tp -108.94 105.39 14.9 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.909 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -117.63 163.46 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.065 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 14.7 tp -149.82 147.7 28.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.548 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 11.8 m-20 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.803 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.07 0.462 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 t -149.99 125.98 10.55 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.45 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 16.7 tp10 -143.43 160.2 40.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 41.2 tt0 -119.55 109.22 15.45 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -100.77 132.58 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.49 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 11' ' ' GLY . 9.8 p -89.65 164.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.445 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.742 ' N ' HG22 ' A' ' 10' ' ' VAL . . . -150.79 169.16 30.6 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.43 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.648 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 3.1 t -145.78 98.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.434 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.624 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 3.62 80.7 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.718 0 CA-C-O 122.685 1.231 . . . . 0.0 109.498 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 143.6 65.47 0.02 OUTLIER Glycine 0 C--N 1.278 -2.65 1 N-CA-C 101.323 -4.711 . . . . 0.0 101.323 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' NZ ' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -114.08 76.98 3.66 Favored Pre-proline 0 C--O 1.207 -1.145 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 15.5 Cg_endo -86.72 78.75 1.88 Allowed 'Trans proline' 0 N--CA 1.431 -2.19 0 N-CA-C 103.525 -3.298 . . . . 0.0 103.525 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.74 159.77 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.97 99.39 7.62 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.129 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 74' ' ' LEU . 5.5 tp -86.05 103.78 15.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.82 97.39 44.11 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -68.38 126.52 14.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.724 0.95 . . . . 0.0 110.05 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 t -130.46 131.47 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.69 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -150.39 142.09 23.65 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.256 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 89' ' ' LEU . 1.8 p-90 -142.15 141.41 32.63 Favored 'General case' 0 C--O 1.182 -2.499 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.2 ttpt -121.37 154.39 36.54 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.906 -0.717 . . . . 0.0 109.266 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.737 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -149.01 155.86 41.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.631 -1.227 . . . . 0.0 111.976 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.626 HG23 ' CD ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.169 0 CA-C-O 121.071 0.463 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' CD ' HG23 ' A' ' 36' ' ' THR . 4.1 mmtp -89.66 133.74 34.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -148.18 164.33 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.859 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 2.2 mm-40 -87.35 -15.83 36.76 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.881 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.851 HG22 ' N ' ' A' ' 47' ' ' LEU . 10.6 mm 62.92 -120.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.851 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -90.3 154.65 19.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.565 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.6 t30 -143.21 97.75 3.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.037 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.552 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 20.9 t90 -97.47 132.99 42.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.315 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.4 m-85 -140.73 97.57 3.22 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.538 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.552 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.7 OUTLIER 65.94 -57.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.446 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' TYR . 38.9 t70 -163.32 31.86 0.09 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.79 87.25 0.38 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.82 98.16 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 122.096 1.864 . . . . 0.0 110.479 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.2 p -120.27 132.82 55.49 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -89.76 162.01 15.75 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.05 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.65 ' N ' ' O ' ' A' ' 46' ' ' ILE . 38.5 m -119.46 77.17 1.19 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.684 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.524 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 4.9 m-80 34.24 102.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.873 HG13 ' CZ ' ' A' ' 61' ' ' PHE . 29.9 m -130.65 -44.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.671 1.224 . . . . 0.0 108.597 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.712 ' N ' HG23 ' A' ' 59' ' ' VAL . 2.1 t 160.03 24.15 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.873 ' CZ ' HG13 ' A' ' 59' ' ' VAL . 56.9 m-85 -39.14 90.13 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.82 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' SER . 5.0 t -173.55 -22.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.6 111.69 7.49 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 101.114 -3.662 . . . . 0.0 101.114 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.71 HD13 ' HD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -152.78 -174.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.263 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -179.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.777 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -84.15 164.4 19.18 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 109.37 -3.559 . . . . 0.0 112.032 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.65 125.45 4.16 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.5 t80 -99.84 150.06 22.75 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 26.2 t0 -138.97 158.15 44.72 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -106.05 179.75 4.18 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.835 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.75 11.29 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 105.531 -3.028 . . . . 0.0 105.531 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 5.7 t70 170.44 -103.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.634 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 18.6 m-85 -152.84 115.47 4.51 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.17 143.75 34.41 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.392 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.841 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -148.28 127.33 12.81 Favored 'General case' 0 C--O 1.201 -1.452 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.175 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.614 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.5 t -123.46 136.74 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -91.04 134.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.075 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -144.2 94.48 2.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.866 1.317 . . . . 0.0 109.654 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.506 ' CB ' ' OE1' ' A' ' 82' ' ' GLN . 17.6 p -154.28 -23.54 0.13 Allowed 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.069 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.1 31.6 11.57 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.858 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' C ' ' N ' ' A' ' 82' ' ' GLN . 1.3 mmmt -114.23 167.1 10.99 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.024 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 81' ' ' LEU . 38.1 tp -53.76 -14.47 0.94 Allowed 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.298 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 1.6 pt20 -59.68 -41.21 90.16 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 82' ' ' GLN . 26.7 m-20 -47.03 -42.29 18.11 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.58 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.638 ' H ' HD11 ' A' ' 107' ' ' ILE . 6.4 t -62.11 109.62 1.35 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.296 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.45 164.56 36.91 Favored Glycine 0 C--N 1.277 -2.732 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.724 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.627 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 30.3 t-80 -85.74 101.07 12.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.745 -1.182 . . . . 0.0 108.407 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.737 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 3.0 m-30 -88.83 154.29 20.38 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.99 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 102' ' ' ASN . 14.3 tp -150.67 108.39 3.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.507 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.65 131.75 35.48 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.675 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 23.8 mp0 -142.99 141.6 31.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.492 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.057 0.456 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 89' ' ' LEU . 3.4 ptpt -140.58 124.44 17.26 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.627 ' OD1' ' NE2' ' A' ' 86' ' ' HIS . 37.0 t30 -90.78 157.54 17.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.886 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -149.96 109.72 4.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.72 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -91.63 109.97 21.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.136 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -96.71 137.36 35.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -149.47 102.47 3.19 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.759 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -88.74 164.48 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.048 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.6 tp -89.59 147.47 23.91 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.327 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--N 1.304 -1.413 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.969 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.098 0.475 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -147.5 131.72 17.42 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.023 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -142.67 134.74 27.25 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -94.81 105.64 17.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.547 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 105' ' ' LEU . 1.1 p -94.22 141.68 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.84 147.29 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.603 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HZ2' ' A' ' 15' ' ' LYS . . . -152.13 166.01 30.92 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 13' ' ' SER . 4.8 m -137.85 90.45 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 12' ' ' VAL . 39.6 t 31.41 79.69 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 CA-C-O 122.735 1.255 . . . . 0.0 110.413 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.657 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 146.87 64.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 1 N-CA-C 100.066 -5.213 . . . . 0.0 100.066 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.651 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -125.05 75.6 67.27 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.51 100.76 0.27 Allowed 'Trans proline' 0 N--CA 1.439 -1.683 1 N-CA-C 97.023 -5.799 . . . . 0.0 97.023 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.13 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -115.69 98.59 6.78 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.67 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 19' ' ' LEU . 2.7 tp -87.69 140.21 29.75 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -154.6 92.27 2.95 Favored Pre-proline 0 N--CA 1.507 2.379 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.97 118.89 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 O-C-N 122.631 0.806 . . . . 0.0 110.528 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.489 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.87 140.84 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -151.88 134.99 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.991 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.558 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 10.8 p-90 -140.95 136.1 31.88 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 118.451 -1.299 . . . . 0.0 109.98 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -128.37 151.62 49.14 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.838 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 141.21 34.09 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.083 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.496 1.846 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.317 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 26.9 ttt180 . . . . . 0 N--CA 1.507 2.411 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 1.8 tppp? -87.61 128.39 35.27 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 121.578 0.704 . . . . 0.0 111.118 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG23 ' CB ' ' A' ' 58' ' ' ASN . 5.1 mt -131.63 128.9 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.477 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -86.37 -14.46 43.4 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.017 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.558 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 10.4 mm 61.07 -83.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 48' ' ' ASN 0.324 8.4 tt -145.57 159.7 42.73 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 47' ' ' LEU . 34.6 t30 -138.08 106.73 5.89 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 113.527 -1.669 . . . . 0.0 108.531 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -93.23 137.82 32.2 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.007 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -145.3 97.1 2.94 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.519 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t30 73.57 -68.0 0.24 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.099 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.47 28.55 0.07 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.95 88.9 0.36 Allowed Glycine 0 C--N 1.303 -1.283 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.146 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -83.4 138.09 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.231 1.287 . . . . 0.0 110.327 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 m -143.82 127.25 16.85 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.328 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.799 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 4.0 m95 -88.31 154.29 20.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.438 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -160.75 104.58 1.37 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.913 1.339 . . . . 0.0 112.636 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.0 m120 136.72 91.6 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 111.194 -2.73 . . . . 0.0 104.603 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.38 71.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 117.5 2.408 . . . . 0.0 117.5 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' ASN . 9.7 m -128.32 -5.04 5.44 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -63.16 75.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.188 -2.278 . . . . 0.0 113.453 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 63' ' ' ASP . 41.6 t -145.44 -4.82 0.68 Allowed 'General case' 0 N--CA 1.523 3.219 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' H ' ' H ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -139.7 106.48 5.38 Favored 'General case' 0 C--N 1.274 -2.679 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 175.95 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.83 -178.72 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 N-CA-C 121.034 3.716 . . . . 0.0 121.034 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -112.3 161.82 16.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 108.766 -3.834 . . . . 0.0 111.032 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.1 131.35 5.94 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.2 t80 -94.27 158.9 15.37 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.261 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.502 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 12.6 t70 -139.92 147.94 41.28 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.969 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 55.1 t80 -114.03 166.76 11.28 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 123.026 1.393 . . . . 0.0 114.433 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 149.95 -42.8 0.77 Allowed Glycine 0 N--CA 1.51 3.586 1 N-CA-C 102.293 -4.323 . . . . 0.0 102.293 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 31.5 m-20 -144.14 -106.91 0.12 Allowed 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 100.484 -3.895 . . . . 0.0 100.484 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 88.8 m-85 -154.75 105.87 2.63 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.32 148.29 46.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -147.72 137.63 22.77 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.471 ' N ' HD13 ' A' ' 74' ' ' LEU . 59.6 m -131.49 141.22 49.73 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.439 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -91.55 153.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -150.17 83.92 1.38 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 m -141.41 -53.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 112.108 -2.315 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.657 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 60.32 36.21 20.61 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 111.697 -2.501 . . . . 0.0 115.38 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -140.27 162.55 35.01 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.842 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.818 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 mm? -43.32 -30.28 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.035 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.22 -29.57 68.83 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -67.63 -33.29 74.68 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.2 p -59.42 117.51 4.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.119 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.49 162.6 32.86 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -88.74 101.31 13.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -87.75 160.16 18.18 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.569 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.98 111.77 4.01 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.68 -1.6 . . . . 0.0 106.905 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.559 HD13 ' H ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -87.5 143.4 27.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.876 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.559 ' H ' HD13 ' A' ' 89' ' ' LEU . 49.0 mt-10 -141.66 154.55 45.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.396 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.834 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.763 ' N ' ' HZ3' ' A' ' 101' ' ' LYS . 5.9 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.678 0.275 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.763 ' HZ3' ' N ' ' A' ' 100' ' ' ASN . 3.0 mptp? -133.4 113.74 12.89 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.63 138.75 31.55 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.922 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.96 108.18 5.5 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -94.72 109.54 21.48 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 HG13 ' A' ' 9' ' ' VAL . 4.4 mm? -88.79 100.28 13.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.79 95.53 6.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -117.21 161.26 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.773 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.0 tp -147.12 132.98 19.03 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.964 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.294 -1.832 0 CA-C-O 116.531 -1.699 . . . . 0.0 112.411 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 m -149.13 119.28 7.23 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.71 159.68 43.54 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -117.16 112.21 20.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -92.53 127.31 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.409 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.69 149.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.225 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.24 166.8 31.17 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 94.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.828 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.0 t 37.91 79.17 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.478 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 134.45 67.24 0.07 OUTLIER Glycine 0 C--N 1.288 -2.092 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.8 tppt? -114.18 46.27 0.37 Allowed Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 3.1 Cg_endo -67.9 99.35 0.55 Allowed 'Trans proline' 0 N--CA 1.433 -2.086 0 N-CA-C 105.615 -2.494 . . . . 0.0 105.615 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 p -121.32 162.18 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.368 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.24 109.26 20.15 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.555 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -88.92 107.34 18.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -124.03 96.01 43.1 Favored Pre-proline 0 N--CA 1.506 2.35 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -74.54 124.16 8.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 N-CA-C 109.129 -1.143 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.497 1.901 0 C-N-CA 120.186 -0.605 . . . . 0.0 111.461 -179.925 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.3 t -116.04 131.85 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.159 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -148.69 124.29 10.42 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.123 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.751 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 7.2 p-90 -136.73 130.17 31.62 Favored 'General case' 0 C--O 1.183 -2.415 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -118.01 160.26 21.78 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.678 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -148.03 158.36 44.01 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.455 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.591 179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ptt-85 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.956 0.407 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.71 148.12 24.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.901 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 46' ' ' ILE . 4.3 mm -141.54 144.96 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.319 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.75 -30.55 17.93 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 8.3 mm 73.33 -98.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.631 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.32 155.99 33.53 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.1 m-80 -137.83 99.15 3.83 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.336 -2.211 . . . . 0.0 107.693 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 8.3 t90 -97.47 134.54 40.58 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.93 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' ASP . 13.3 m-85 -139.59 96.94 3.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.565 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.556 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 4.0 m120 62.01 -64.27 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.307 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.2 m-20 -155.01 30.97 0.4 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.58 87.04 0.37 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -86.0 114.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.091 1.861 . . . . 0.0 110.289 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.08 161.57 26.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.65 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 69.5 m95 -107.55 165.33 11.49 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.036 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -150.57 67.73 0.95 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.337 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER 169.44 162.81 0.05 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.527 1.767 . . . . 0.0 106.305 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.48 6.23 7.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.546 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -86.44 0.61 53.78 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 64' ' ' ILE . 25.5 m-85 -62.7 37.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.921 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 60' ' ' SER . 6.6 t -94.0 -17.93 22.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -148.62 94.84 2.34 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.861 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.47 -173.31 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.861 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.41 162.7 22.47 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 112.498 -2.137 . . . . 0.0 114.504 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.53 6.89 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.6 t80 -89.7 158.18 17.66 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.983 -1.087 . . . . 0.0 112.684 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 21.6 m-20 -142.66 143.36 32.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.016 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -100.98 177.62 4.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.528 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 116.75 9.26 11.24 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 106.418 -2.673 . . . . 0.0 106.418 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 1.7 m-20 153.13 -101.49 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 71' ' ' ASP . 16.3 m-85 -154.13 109.48 3.16 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.13 122.2 10.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.791 -1.164 . . . . 0.0 112.16 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.843 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -120.66 135.67 55.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.986 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.801 ' N ' HD13 ' A' ' 74' ' ' LEU . 12.2 p -125.23 139.06 54.06 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.614 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -90.15 134.04 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.159 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -144.65 93.06 2.36 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 82' ' ' GLN . 13.2 t -155.88 -36.57 0.08 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.5 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 52.05 88.0 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER 172.02 159.2 0.1 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.432 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.865 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -47.49 -13.27 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.671 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 10.1 pt20 -69.04 -27.4 65.61 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.214 -1.394 . . . . 0.0 109.109 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.1 m-20 -70.02 -27.5 64.73 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.474 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 103.92 1.04 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.062 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.37 163.99 36.26 Favored Glycine 0 N--CA 1.485 1.935 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -86.19 108.47 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.918 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 2.4 m-30 -91.1 153.55 20.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.447 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.745 HD21 HD21 ' A' ' 100' ' ' ASN . 0.4 OUTLIER -150.05 111.62 4.49 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.195 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.94 109.75 20.51 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.18 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.54 116.57 32.16 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mm . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.6 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.745 HD21 HD21 ' A' ' 88' ' ' LEU . 45.2 t30 . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.537 0.208 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -110.46 134.82 51.99 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.14 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -117.19 114.65 23.98 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -114.0 108.91 17.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.889 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -89.27 109.95 20.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.879 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 9' ' ' VAL . 2.0 mm? -89.37 106.74 18.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.4 tp -110.61 98.48 7.65 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -125.94 161.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.21 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.26 154.38 46.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.64 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.386 -1.769 . . . . 0.0 110.949 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.657 0.265 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 143.27 25.43 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.301 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.22 156.05 45.96 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.13 99.09 8.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.371 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HG ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -93.52 158.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.319 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 106' ' ' LEU . 3.6 p -150.99 155.3 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.241 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -152.22 171.03 31.53 Favored Glycine 0 N--CA 1.484 1.864 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.839 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.6 m -135.59 95.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.485 ' C ' ' O ' ' A' ' 12' ' ' VAL . 71.1 p 39.68 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.555 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 140.6 68.7 0.04 OUTLIER Glycine 0 C--N 1.291 -1.971 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -111.8 41.05 0.2 Allowed Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 2.8 Cg_endo -67.99 99.98 0.6 Allowed 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 106.141 -2.292 . . . . 0.0 106.141 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.61 160.7 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.613 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -99.93 104.66 16.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.245 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 3.1 tp -91.14 99.3 12.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -131.46 102.1 15.58 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -69.21 136.75 35.3 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.853 1.035 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.804 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.5 t -96.06 136.79 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.477 -1.289 . . . . 0.0 113.127 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -149.07 124.81 10.49 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.691 ' CZ2' HD21 ' A' ' 74' ' ' LEU . 7.8 p-90 -135.02 114.27 12.29 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.126 -1.429 . . . . 0.0 112.473 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.5 tttm -100.85 157.05 17.01 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.39 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.05 161.02 42.22 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.014 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.413 HG23 ' HD3' ' A' ' 43' ' ' LYS . 1.7 m . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.712 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.304 0.573 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 9.6 mmtt -89.85 143.46 26.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.789 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.559 HG23 ' CB ' ' A' ' 58' ' ' ASN . 8.1 mt -146.37 156.7 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 79.2 mm-40 -88.64 -39.02 14.35 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 33' ' ' TRP . 15.3 mm 81.72 -98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.698 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -122.4 157.43 31.9 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 36.3 t30 -139.94 98.53 3.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.527 -2.124 . . . . 0.0 106.65 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.567 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 13.2 t90 -95.61 125.6 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.042 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.674 ' CE2' ' ND2' ' A' ' 51' ' ' ASN . 56.3 t80 -139.77 98.61 3.51 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.674 ' ND2' ' CE2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 61.66 -162.28 0.28 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.48 39.9 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -131.49 81.86 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.718 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -87.09 137.66 4.57 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.447 2.098 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.8 p -143.52 156.98 44.77 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.12 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 50.9 m95 -99.4 164.69 12.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.559 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -160.35 73.37 0.51 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.699 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.559 ' CB ' HG23 ' A' ' 44' ' ' ILE . 1.7 m120 152.51 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.568 1.167 . . . . 0.0 108.884 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -45.65 103.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.849 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 62' ' ' SER . 89.7 p -179.74 -7.76 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 64' ' ' ILE . 27.4 m-85 -66.95 34.58 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.542 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 60' ' ' SER . 12.0 t -84.94 -32.16 23.22 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -132.59 94.28 3.38 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.886 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.95 -172.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.886 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.2 163.62 22.33 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 112.222 -2.263 . . . . 0.0 115.131 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.65 122.55 3.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -89.92 143.85 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.166 -1.014 . . . . 0.0 112.643 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 32.3 t70 -131.59 160.66 34.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 20.0 t80 -95.68 -175.16 3.36 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.264 -0.974 . . . . 0.0 112.917 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 114.84 -1.37 23.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 2.0 m-20 150.61 -88.31 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 70.0 m-85 -153.58 106.25 2.9 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.491 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . . . -132.21 99.79 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.151 -1.019 . . . . 0.0 112.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 74' ' ' LEU . 1.3 tm? -105.9 110.75 23.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 74' ' ' LEU . 16.3 m -103.28 134.99 45.75 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.458 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -90.21 132.18 35.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.301 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -143.12 93.27 2.48 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.553 1.168 . . . . 0.0 107.996 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.8 p -152.18 -42.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.218 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.555 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 58.62 28.24 16.88 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.185 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -113.46 -167.97 1.27 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.017 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 81' ' ' LEU . 32.8 tp -83.88 -14.96 49.8 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.681 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -67.25 -30.31 70.17 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -63.17 -30.25 71.44 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.946 -1.501 . . . . 0.0 108.527 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.508 ' CB ' HG13 ' A' ' 107' ' ' ILE . 3.4 p -57.29 107.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.393 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.66 161.78 33.3 Favored Glycine 0 C--N 1.284 -2.324 0 C-N-CA 117.569 -2.253 . . . . 0.0 111.518 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.507 ' NE2' ' HB3' ' A' ' 102' ' ' ASN . 18.7 t-160 -89.1 101.19 13.85 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.945 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -88.79 160.53 17.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.301 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 115.18 7.03 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.669 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.573 HD22 ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.427 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.16 118.34 15.52 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.088 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.407 ' CD1' ' CE1' ' A' ' 72' ' ' PHE . 3.0 mt . . . . . 0 C--N 1.308 -1.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.494 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' C ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -132.75 159.56 39.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.925 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 1.9 m-80 -138.08 144.16 40.79 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.71 111.57 8.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.555 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 9.7 pt20 -97.18 113.61 25.22 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.443 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.741 ' HG ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.57 120.19 41.01 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.5 tp -117.36 98.59 6.5 Favored 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.717 -2.038 . . . . 0.0 108.734 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.586 ' CD1' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -100.01 161.35 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.324 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.85 150.54 24.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.952 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.739 ' H ' HD13 ' A' ' 108' ' ' LEU . 3.1 p30 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.858 0.361 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -130.9 153.72 48.86 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -146.18 159.9 42.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -133.63 98.92 4.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -99.79 141.76 16.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -114.8 151.86 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.811 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -153.11 167.01 31.7 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.54 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.7 p -141.45 94.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 62.2 p 36.81 78.32 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.627 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.94 67.47 0.05 OUTLIER Glycine 0 C--N 1.291 -1.956 0 N-CA-C 104.933 -3.267 . . . . 0.0 104.933 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 10.7 tppt? -113.64 45.32 0.32 Allowed Pre-proline 0 C--O 1.207 -1.176 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -66.75 102.88 0.65 Allowed 'Trans proline' 0 N--CA 1.436 -1.908 0 N-CA-C 105.283 -2.622 . . . . 0.0 105.283 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 18' ' ' GLN . 8.6 p -121.98 161.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.504 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.1 tt0 -104.51 101.66 11.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.675 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 1.8 tp -89.88 107.92 19.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -147.57 100.23 3.79 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 118.089 -1.445 . . . . 0.0 113.861 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -68.53 143.48 57.34 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 120.652 0.902 . . . . 0.0 109.949 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.249 -179.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 49' ' ' TRP . 2.2 t -127.96 111.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.889 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.262 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -134.9 132.81 38.94 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.445 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.779 ' CE2' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -135.32 148.18 49.39 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.66 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -133.28 158.84 41.93 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.759 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.704 ' CE ' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -150.72 163.16 39.23 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.818 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 36' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.694 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 121.408 0.623 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -89.66 157.29 18.07 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 46' ' ' ILE . 36.1 mt -150.28 142.68 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 117.871 -1.532 . . . . 0.0 113.25 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -90.54 -31.13 16.86 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 33' ' ' TRP . 13.9 mm 74.48 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.943 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -151.01 159.38 44.6 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.328 -1.349 . . . . 0.0 113.415 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.656 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.2 p-10 -127.97 118.04 22.84 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.555 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 16.9 t90 -104.48 117.61 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 52' ' ' ASP . 7.5 m-85 -124.22 97.63 5.41 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 64.25 -60.92 0.19 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.279 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' TYR . 42.0 m-20 -159.29 33.05 0.2 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.59 85.84 0.35 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -87.12 112.35 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.276 1.984 . . . . 0.0 110.405 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.601 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 3.8 p -125.34 162.31 25.06 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.668 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 59.8 m95 -109.93 161.36 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.486 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.456 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.2 p -159.79 82.52 0.73 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.585 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.747 ' C ' HG23 ' A' ' 59' ' ' VAL . 6.3 t-20 -174.1 -26.63 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.599 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.747 HG23 ' C ' ' A' ' 58' ' ' ASN . 0.9 OUTLIER 68.79 -4.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.795 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -100.89 11.92 38.64 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 64' ' ' ILE . 45.9 m-85 -72.33 42.91 0.1 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.694 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 t -98.5 -15.53 19.54 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.548 ' O ' HD12 ' A' ' 64' ' ' ILE . 7.6 t0 -147.71 93.58 2.23 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.88 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -157.24 -173.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 117.051 -1.86 . . . . 0.0 115.724 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.88 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.81 165.4 19.79 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.89 -2.414 . . . . 0.0 114.644 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.4 131.28 5.87 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 7.2 t80 -98.26 143.83 28.34 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.231 -0.987 . . . . 0.0 113.14 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.9 t70 -133.62 156.8 47.21 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 56.1 t80 -97.03 176.55 5.91 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.286 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.723 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 127.98 -13.16 6.42 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.8 m-20 166.06 -89.4 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 47.6 m-85 -152.24 99.2 2.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.18 108.52 10.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.79 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -119.95 115.43 23.76 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.821 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 t -105.97 138.38 42.26 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.243 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.501 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -90.19 133.0 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.135 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -143.04 93.87 2.56 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.466 1.127 . . . . 0.0 108.499 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 80' ' ' LYS . 11.6 t -153.59 -25.33 0.14 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.693 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 44.01 11.67 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.393 -2.185 . . . . 0.0 114.128 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.7 mmtp -97.91 152.85 18.79 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 107' ' ' ILE . 26.6 tp -49.7 -18.63 0.49 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.894 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' LYS . 11.6 mt-30 -59.01 -22.02 59.98 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.801 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 107' ' ' ILE . 37.3 t0 -64.47 -39.93 94.73 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.056 -1.457 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 78.3 p -46.37 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -170.87 165.04 38.24 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -85.59 109.34 18.47 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.27 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.6 m-30 -95.82 142.16 28.41 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.3 tp -151.9 117.19 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.703 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 3.1 mt -88.51 155.73 19.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.667 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -135.38 109.44 8.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.938 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.4 tt . . . . . 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.071 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.61 0.243 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.2 mttt -132.72 102.95 5.87 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -98.33 146.13 25.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.38 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.97 117.16 12.64 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.651 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.87 116.92 27.5 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.78 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.545 HD13 ' CG2' ' A' ' 9' ' ' VAL . 1.6 mm? -103.97 128.33 51.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.0 tp -146.06 100.25 3.36 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -119.8 163.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.792 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 54.1 tp -104.13 159.54 15.6 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.517 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 CA-C-O 116.306 -1.807 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.893 0.378 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.9 p -140.15 110.63 6.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.34 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 31.3 tt0 -123.89 160.36 27.66 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.499 ' C ' ' CD ' ' A' ' 8' ' ' GLU . 12.3 tm-20 -126.85 121.94 33.29 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.521 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -114.81 136.37 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 11' ' ' GLY . 14.8 p -102.72 152.61 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.366 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.23 167.61 31.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' SER . 94.8 t -147.39 97.08 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.574 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.837 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 2.0 t 27.49 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.908 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.34 55.5 0.09 OUTLIER Glycine 0 C--N 1.287 -2.176 1 N-CA-C 103.025 -4.03 . . . . 0.0 103.025 -179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.837 ' NZ ' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -118.57 57.54 3.13 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 4.1 Cg_endo -69.44 112.28 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 104.96 -2.746 . . . . 0.0 104.96 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.51 161.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.521 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -105.07 112.38 25.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 103' ' ' PHE . 5.3 tp -91.85 125.55 36.6 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -147.97 98.32 3.83 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 117.06 -1.856 . . . . 0.0 115.071 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.12 131.53 22.34 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 120.965 1.11 . . . . 0.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.54 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.594 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.4 t -105.35 119.56 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.992 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.87 131.64 37.6 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.717 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.805 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 5.5 p-90 -136.02 116.29 13.54 Favored 'General case' 0 C--O 1.184 -2.367 0 C-N-CA 118.776 -1.169 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -103.65 153.91 20.11 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.417 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.814 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -150.54 160.42 43.8 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 118.306 -1.357 . . . . 0.0 113.432 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 m . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.579 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.307 0.575 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.94 136.92 32.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.835 HD13 HD22 ' A' ' 58' ' ' ASN . 94.3 mt -144.83 147.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.942 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -89.51 -26.78 20.71 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.229 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.805 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 12.1 mm 72.44 -93.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.4 OUTLIER -123.54 156.84 34.91 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 47' ' ' LEU . 64.0 t30 -137.67 97.41 3.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.597 -2.092 . . . . 0.0 105.943 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.594 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 2.9 t90 -94.55 132.28 39.4 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.723 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.3 p90 -148.52 99.87 3.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.84 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 50' ' ' TYR . 6.8 p-10 44.22 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.901 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER 40.83 26.95 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.764 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -127.16 81.9 0.35 Allowed Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -87.31 127.1 2.4 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.139 1.892 . . . . 0.0 111.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.3 p -130.23 142.67 50.54 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.293 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 18.7 m95 -101.09 160.77 14.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.481 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.521 ' H ' ' HZ ' ' A' ' 61' ' ' PHE . 41.3 t -158.64 82.28 0.81 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.243 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.835 HD22 HD13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -176.13 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.828 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.722 HG23 ' C ' ' A' ' 58' ' ' ASN . 1.1 t 68.08 -46.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.183 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASN . 23.8 m -62.91 15.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.78 ' O ' ' N ' ' A' ' 63' ' ' ASP . 45.9 m-85 -56.99 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.567 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 63' ' ' ASP . 39.0 p 32.77 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.78 ' N ' ' O ' ' A' ' 61' ' ' PHE . 9.6 t0 -88.77 92.03 9.05 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.881 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -154.79 -173.18 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.881 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.04 163.69 19.41 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.598 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 130.35 5.13 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 11.6 t80 -89.32 155.73 19.18 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.446 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 4.1 m-20 -142.14 152.7 43.47 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.576 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.521 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 18.9 t80 -101.06 -179.49 4.06 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.115 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 121.8 -1.97 10.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 105.07 -3.212 . . . . 0.0 105.07 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.652 ' CG ' ' N ' ' A' ' 72' ' ' PHE . 1.8 t70 161.15 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 111.159 -2.52 . . . . 0.0 105.178 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.652 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.2 m-85 -150.14 106.36 3.47 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.62 149.58 45.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.094 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -144.58 116.35 8.23 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.228 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.417 ' H ' ' HG ' ' A' ' 75' ' ' SER . 30.0 p -102.59 140.7 36.52 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.114 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -95.82 125.57 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.727 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ILE . 24.5 ttpt -135.69 93.78 2.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' LYS . 3.7 t -154.96 -30.05 0.1 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 113.301 -1.772 . . . . 0.0 107.097 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.908 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.35 14.81 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 111.957 -2.383 . . . . 0.0 113.499 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' SER . 7.6 mmtt -103.45 148.45 25.9 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.388 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 80' ' ' LYS . 11.3 tp -41.89 -25.91 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.084 -1.047 . . . . 0.0 109.688 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.4 pt20 -57.32 -17.73 13.6 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -64.59 -57.14 9.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.586 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.793 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -40.91 118.39 0.98 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.662 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.03 163.92 35.03 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -85.33 102.67 13.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.553 ' OH ' HD11 ' A' ' 76' ' ' ILE . 2.1 m-30 -89.27 149.6 23.0 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.656 -0.817 . . . . 0.0 112.254 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.56 110.25 5.31 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.677 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -88.49 100.41 13.03 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.338 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -106.63 120.49 42.09 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.104 179.792 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -133.35 130.29 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.596 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 1.9 m120 -107.01 114.34 28.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.179 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.638 ' CD2' HD11 ' A' ' 19' ' ' LEU . 7.1 m-85 -112.67 107.12 15.68 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -90.57 101.64 14.38 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.858 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 9' ' ' VAL . 3.4 mm? -91.04 113.89 26.27 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.8 tp -118.56 100.38 7.41 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.966 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.793 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -116.42 161.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.685 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 63.8 tp -107.0 154.45 21.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.645 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 33.1 t70 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 116.315 -1.802 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.868 ' SG ' ' N ' ' A' ' 100' ' ' ASN . 2.7 t . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 121.354 0.597 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 4.9 Cg_endo -74.92 23.68 0.39 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 121.584 1.523 . . . . 0.0 110.081 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 2' ' ' CYS . 1.2 t70 73.99 97.68 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.232 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -150.92 160.62 43.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.187 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -138.12 158.17 44.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.46 160.43 43.46 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.59 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' OE1' ' CB ' ' A' ' 104' ' ' GLN . 35.5 tp10 -131.12 98.75 4.66 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.77 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -99.73 142.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.285 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 106' ' ' LEU . 10.9 p -129.88 143.13 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.162 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.765 ' H ' HG22 ' A' ' 107' ' ' ILE . . . -154.13 163.14 30.89 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.335 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.4 p -123.57 97.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.849 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 12' ' ' VAL . 14.2 m 38.82 75.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.711 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 142.36 64.39 0.03 OUTLIER Glycine 0 C--N 1.293 -1.842 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.58 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 7.1 tppt? -121.11 56.18 5.38 Favored Pre-proline 0 C--O 1.209 -1.065 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -70.15 132.31 22.44 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 N-CA-C 105.585 -2.506 . . . . 0.0 105.585 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG12 ' HB ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -150.56 161.74 3.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 117.338 -1.745 . . . . 0.0 112.811 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -107.68 106.02 16.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mp -88.89 127.44 35.64 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -151.42 96.46 3.21 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 116.169 -2.213 . . . . 0.0 116.911 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' CE ' ' A' ' 101' ' ' LYS . 2.7 Cg_exo -71.43 147.83 53.21 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.031 1.154 . . . . 0.0 110.041 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 t -132.59 161.12 34.67 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.761 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.34 97.35 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.51 9.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.504 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' CG ' ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER 59.95 -7.97 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.367 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.581 ' H ' HG12 ' A' ' 24' ' ' ILE . 38.6 p 45.27 88.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.762 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -141.99 -174.77 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.152 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-10 -52.92 104.55 0.09 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.703 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 27' ' ' LYS . 26.0 m -150.23 177.62 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -139.16 139.53 37.6 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.809 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.6 t -102.07 137.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.299 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -150.41 130.46 13.48 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.973 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.747 ' CH2' HD13 ' A' ' 74' ' ' LEU . 2.7 p-90 -141.56 108.02 5.3 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.8 pttp -100.79 161.0 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.036 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.838 ' HZ2' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -147.11 160.6 42.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.987 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m -110.21 106.13 15.45 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.301 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -103.98 100.79 10.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.083 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.544 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 46.1 tp60 -96.79 164.66 12.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.811 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 89.08 95.41 1.06 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.07 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m 54.64 5.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.98 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.559 ' H ' ' C ' ' A' ' 39' ' ' GLY . 41.1 m80 -121.38 -159.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 43' ' ' LYS . 49.4 mtt180 -157.22 -159.8 0.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.544 ' NZ ' ' OE1' ' A' ' 38' ' ' GLN . 6.1 mmpt? -88.64 150.73 22.88 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.332 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 46' ' ' ILE . 87.8 mt -144.86 147.68 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.667 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.7 mp0 -96.66 -24.12 16.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.838 HD11 ' HZ2' ' A' ' 35' ' ' LYS . 22.6 mm 68.22 -107.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -112.9 154.87 25.69 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.48 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.8 p30 -139.88 98.95 3.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.089 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.1 t90 -94.76 129.95 41.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.458 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.6 p90 -149.76 100.38 2.96 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.93 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 40.8 t30 51.13 83.89 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.239 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 26.2 t70 45.34 27.45 0.36 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.78 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.06 79.13 0.36 Allowed Glycine 0 N--CA 1.507 3.367 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.723 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 15.0 Cg_endo -87.76 120.15 1.39 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.362 2.041 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.47 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -129.71 155.03 46.56 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.851 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.499 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 44.2 m95 -102.62 164.34 11.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.888 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 38.8 t -158.51 79.39 0.8 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 118.215 -1.394 . . . . 0.0 113.248 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.4 t30 158.77 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.558 1.161 . . . . 0.0 109.461 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -47.07 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.34 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 58' ' ' ASN . 0.6 OUTLIER 174.4 2.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.369 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 64' ' ' ILE . 20.9 m-30 -79.71 38.33 0.38 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.278 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 t -78.51 -7.68 57.75 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.2 t0 -150.53 95.03 2.18 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.714 -2.948 . . . . 0.0 105.76 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.838 HG23 ' N ' ' A' ' 65' ' ' TYR . 1.4 tp -151.82 -174.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.838 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.01 161.69 26.09 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 112.944 -1.934 . . . . 0.0 113.78 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.05 137.32 9.38 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 154.77 19.86 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.275 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -137.3 145.77 43.84 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -97.09 -179.27 4.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.36 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 119.28 1.95 13.78 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 105.604 -2.998 . . . . 0.0 105.604 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.6 m-20 156.43 -99.06 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.959 -2.12 . . . . 0.0 105.905 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 78.1 m-85 -153.34 102.46 2.6 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.978 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.84 150.5 31.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.343 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.747 HD13 ' CH2' ' A' ' 33' ' ' TRP . 1.2 pp -144.87 146.03 31.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 m -120.25 146.01 46.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.6 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.548 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -92.05 130.87 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.992 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -140.99 92.87 2.53 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 80' ' ' LYS . 31.1 t -151.71 -33.84 0.14 Allowed 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.743 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.711 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 48.7 15.82 0.1 Allowed 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 112.398 -2.183 . . . . 0.0 112.593 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' GLN . 10.5 mmtm -99.61 142.22 31.38 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 81' ' ' LEU . 2.6 tp -44.08 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 pt20 -65.81 -22.53 66.56 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.413 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.6 OUTLIER -59.38 -33.9 71.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.207 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 58.4 p -45.89 100.06 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.63 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.58 162.14 35.18 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.457 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -87.1 107.76 18.59 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.796 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 76' ' ' ILE . 1.8 m-30 -87.78 151.12 23.13 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.642 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -141.16 109.03 5.68 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.87 126.71 35.81 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.887 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.6 137.23 28.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 29' ' ' VAL . 18.5 tt -109.58 159.87 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -87.61 159.49 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 50.57 86.8 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.472 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -82.87 162.3 21.64 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.143 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.05 111.93 0.3 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.35 -173.89 25.56 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.411 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -44.24 -34.93 2.06 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.075 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -40.14 151.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.279 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.72 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 15.0 p -168.66 -98.49 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.439 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.868 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 9.5 p-10 -152.1 160.25 43.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' CE ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -145.51 155.18 42.93 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.348 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -134.12 124.69 26.53 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.283 -0.967 . . . . 0.0 112.413 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.1 118.96 38.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.403 ' CB ' ' OE1' ' A' ' 8' ' ' GLU . 49.4 mt-30 -89.36 120.3 30.58 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.219 -0.993 . . . . 0.0 112.069 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.553 HD13 ' CG2' ' A' ' 9' ' ' VAL . 2.8 mm? -108.4 123.71 49.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.1 tp -139.75 99.01 3.6 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.765 HG22 ' H ' ' A' ' 11' ' ' GLY . 11.0 pt -124.45 164.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.841 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 HD22 ' C ' ' A' ' 107' ' ' ILE . 3.4 mm? -108.53 -175.32 2.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.905 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' C ' ' OG ' ' A' ' 13' ' ' SER . 15.5 t70 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 2' ' ' CYS . 2.2 Cg_endo -65.16 164.73 24.23 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.14 1.227 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 3' ' ' PRO . 62.7 m-20 -42.88 106.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.604 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -148.85 144.89 27.22 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.327 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -125.46 123.09 38.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -136.61 160.39 38.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.06 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pp20? -143.0 109.22 5.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.82 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.92 156.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.319 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' O ' ' NZ ' ' A' ' 15' ' ' LYS . 14.2 p -121.45 151.2 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.972 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.59 167.27 31.46 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.067 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -142.56 97.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.097 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 83.9 p 35.19 81.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.846 0.832 . . . . 0.0 108.853 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.7 68.58 0.09 OUTLIER Glycine 0 C--N 1.29 -1.994 0 N-CA-C 104.401 -3.48 . . . . 0.0 104.401 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.56 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 tpmt? -119.54 79.48 21.83 Favored Pre-proline 0 C--O 1.204 -1.307 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 19.3 Cg_endo -93.65 95.88 0.14 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 N-CA-C 104.831 -2.796 . . . . 0.0 104.831 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 18' ' ' GLN . 9.3 p -112.89 161.58 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.1 tt0 -109.95 100.08 9.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.479 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' LEU . 2.7 tp -88.76 107.56 19.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -135.54 101.33 10.93 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -67.44 125.55 13.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 O-C-N 122.893 0.944 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 60.2 p -121.75 163.34 19.25 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.179 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 22' ' ' SER . 6.6 t-20 83.76 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.71 0.631 . . . . 0.0 109.349 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.577 ' CG2' ' SG ' ' A' ' 2' ' ' CYS . 1.1 pp -113.14 -170.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.557 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -160.33 3.95 0.08 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.735 -1.575 . . . . 0.0 107.653 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.631 ' OG1' HG21 ' A' ' 29' ' ' VAL . 2.4 t -102.63 154.2 19.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 12.7 mtmt -160.97 146.27 14.25 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.599 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER 70.6 17.99 6.54 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.84 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.79 HG12 ' H ' ' A' ' 30' ' ' SER . 21.7 t -96.67 178.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.608 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.79 ' H ' HG12 ' A' ' 29' ' ' VAL . 14.0 p -89.84 144.92 25.54 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 36.3 t -123.31 135.94 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -149.92 139.27 21.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.525 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.639 ' HB3' HD22 ' A' ' 89' ' ' LEU . 10.1 p-90 -142.56 112.98 7.23 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -98.12 159.81 14.7 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.515 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.586 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.34 159.25 44.44 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.125 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -111.81 103.71 11.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.394 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' ARG . 5.3 mt-10 -100.85 100.57 11.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.419 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.618 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 12.3 tt0 -93.16 179.78 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 80.24 75.53 1.05 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.85 -7.99 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.796 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.675 ' CD2' ' HG2' ' A' ' 82' ' ' GLN . 38.4 m80 -95.26 -160.99 0.82 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtt85 -153.92 167.33 30.08 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.302 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.12 138.43 31.56 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.025 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -151.79 168.67 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.847 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 3.7 mp0 -83.9 -22.44 31.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.673 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.742 ' H ' ' CG2' ' A' ' 44' ' ' ILE . 4.0 mm 70.2 -109.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -99.47 151.07 21.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.545 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -140.5 100.77 3.95 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.276 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.581 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.65 130.55 46.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.757 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.7 t80 -137.03 97.69 3.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.147 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.54 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 11.8 t-20 65.38 -60.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.128 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.8 p30 -159.81 32.18 0.18 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.101 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.86 87.17 0.39 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.532 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -87.83 108.08 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.512 2.142 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.42 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -132.38 143.73 50.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.501 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.6 m95 -87.85 161.43 17.52 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.163 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 46' ' ' ILE . 52.7 m -124.92 78.71 1.72 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.572 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 1.2 m-80 70.71 -40.84 0.48 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.822 ' O ' ' N ' ' A' ' 61' ' ' PHE . 1.5 t -43.52 117.04 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.166 -3.311 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.352 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 62' ' ' SER . 22.8 t -18.14 54.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.822 ' N ' ' O ' ' A' ' 59' ' ' VAL . 17.7 m-85 -63.12 76.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 117.491 -1.684 . . . . 0.0 112.377 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 60' ' ' SER . 0.3 OUTLIER -148.23 -22.49 0.34 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.7 t0 -147.79 90.94 1.89 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -156.87 -171.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 117.119 -1.832 . . . . 0.0 115.892 -178.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.883 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.65 163.5 21.27 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 111.186 -2.734 . . . . 0.0 114.935 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.09 127.55 5.17 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.3 t80 -93.97 158.94 15.4 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.535 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 3.7 m-20 -145.01 151.46 38.61 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.343 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 61.1 t80 -107.93 174.05 6.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.483 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.774 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 123.84 -7.78 8.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 105.931 -2.868 . . . . 0.0 105.931 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 7.0 t70 173.92 -103.49 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 111.515 -2.342 . . . . 0.0 104.855 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 87.0 m-85 -152.55 109.08 3.43 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' ASP . . . -138.54 145.1 40.29 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.185 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -151.14 117.82 5.77 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.858 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.566 ' N ' HD13 ' A' ' 74' ' ' LEU . 33.3 t -109.18 139.83 43.58 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.508 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -95.51 130.37 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -142.61 94.56 2.66 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.887 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -151.74 -31.84 0.15 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.825 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 55.12 40.43 31.83 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 112.664 -2.062 . . . . 0.0 114.791 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 82' ' ' GLN . 4.2 mtpp -142.0 158.87 43.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.795 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 81' ' ' LEU . 10.9 mp -43.48 -23.19 0.06 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.675 ' HG2' ' CD2' ' A' ' 41' ' ' HIS . 51.0 mt-30 -52.4 -32.81 40.72 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 117.654 -1.618 . . . . 0.0 107.832 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.7 m-20 -66.51 -41.03 89.45 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.737 ' HG ' ' H ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -57.49 105.04 0.21 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.269 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 164.95 37.06 Favored Glycine 0 C--N 1.284 -2.348 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.694 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.463 ' NE2' ' HB2' ' A' ' 102' ' ' ASN . 13.1 t-160 -86.14 105.22 16.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.649 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 2.2 m-30 -88.39 155.22 19.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.307 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -145.64 105.22 3.97 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.29 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.46 122.81 33.01 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.923 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -143.83 139.63 29.41 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.01 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.533 ' N ' ' OE2' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -102.68 160.88 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 1.027 HG22 ' H ' ' A' ' 93' ' ' ASN . 90.5 m 56.64 -171.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.247 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 1.027 ' H ' HG22 ' A' ' 92' ' ' THR . 37.9 m-80 -83.75 -19.95 34.22 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.443 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 2.5 t -138.51 175.27 9.71 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.472 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . -94.47 -164.19 35.79 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 140.54 89.24 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 96' ' ' GLY . 32.5 pttt 35.9 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.381 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.06 HG22 ' H ' ' A' ' 99' ' ' CYS . 6.8 p -120.87 -170.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.005 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 1.06 ' H ' HG22 ' A' ' 98' ' ' VAL . 5.7 t -57.77 102.57 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.46 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -149.88 100.6 2.96 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.051 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -144.61 160.44 41.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.819 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.463 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 13.9 p-10 -121.16 127.19 51.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.496 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.31 139.4 41.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.504 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -117.26 107.66 14.69 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.095 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 9' ' ' VAL . 2.4 mm? -89.05 125.49 35.03 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.61 98.05 4.55 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.737 ' H ' ' HG ' ' A' ' 84' ' ' SER . 1.2 pt -122.6 162.62 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 28.8 tp -150.67 151.13 32.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.379 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.465 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 40.3 t0 . . . . . 0 C--N 1.307 -1.267 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.375 0.607 . . . . 0.0 111.485 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 5.5 Cg_endo -68.07 -161.08 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 121.552 1.501 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.53 131.82 53.92 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.931 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m -137.41 132.65 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.271 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 m -150.08 109.39 3.96 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.433 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.65 147.68 50.21 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -104.5 104.78 14.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -93.31 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.846 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.39 151.79 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.975 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.54 30.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.101 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 7.5 p -147.6 96.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.156 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.819 ' N ' ' HZ1' ' A' ' 15' ' ' LYS . 54.3 p 33.61 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 122.235 1.016 . . . . 0.0 108.706 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.069 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . . . 124.21 62.71 0.19 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 103.362 -3.895 . . . . 0.0 103.362 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 1.101 ' HZ1' ' C ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -119.44 60.34 5.63 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.0 Cg_endo -69.81 97.0 0.62 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 N-CA-C 104.767 -2.82 . . . . 0.0 104.767 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -101.92 161.19 3.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.966 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -120.75 109.46 15.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.885 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -87.21 124.21 33.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -136.83 93.39 13.75 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 116.923 -1.911 . . . . 0.0 115.337 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.36 104.61 1.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 O-C-N 123.448 1.236 . . . . 0.0 109.468 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' CG ' ' A' ' 23' ' ' ASN . 3.6 m -129.23 97.76 4.69 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 22' ' ' SER . 70.0 m-80 -165.98 13.14 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.795 ' CD1' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -94.89 -161.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.263 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.484 ' N ' HG12 ' A' ' 24' ' ' ILE . 8.1 pt20 -135.62 2.76 2.96 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.758 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.577 ' H ' HG12 ' A' ' 24' ' ' ILE . 4.5 p 59.26 114.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.031 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 177.84 10.92 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.241 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.62 93.03 0.23 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.662 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 91' ' ' ILE . 18.9 m -143.72 149.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 m -90.52 139.04 31.07 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.811 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 4.4 t -106.66 135.06 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.188 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -150.14 127.84 11.66 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.231 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.732 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.5 p-90 -131.49 147.06 52.51 Favored 'General case' 0 C--O 1.193 -1.876 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.212 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -137.47 154.26 49.93 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.642 ' HZ2' ' HG2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -153.43 158.6 41.65 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 117.865 -1.534 . . . . 0.0 113.718 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.27 97.23 7.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.642 ' HG2' ' HZ2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.35 -174.85 4.23 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.908 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.648 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 5.9 tp-100 55.62 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.66 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.648 ' H ' ' CD ' ' A' ' 38' ' ' GLN . . . 38.14 84.42 0.01 OUTLIER Glycine 0 N--CA 1.501 2.97 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 t 47.07 34.5 2.87 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.897 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 55.55 71.04 0.57 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 43' ' ' LYS . 5.3 tpm_? -86.51 174.91 8.64 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -86.7 131.37 34.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.195 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.597 HG21 HD13 ' A' ' 46' ' ' ILE . 4.4 mm -131.25 146.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.97 -24.94 13.93 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.769 HD12 ' CE2' ' A' ' 65' ' ' TYR . 8.3 mm 62.64 -111.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -107.51 154.94 20.65 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.683 ' N ' HD23 ' A' ' 47' ' ' LEU . 49.6 t30 -137.41 98.58 3.74 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.298 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.617 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 3.7 t90 -92.58 133.02 36.36 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.665 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 52' ' ' ASP . 24.3 t80 -140.36 98.36 3.41 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.682 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 3.0 t30 68.54 -55.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.204 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' TYR . 24.5 t0 -171.14 31.3 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.21 90.02 0.42 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.49 101.65 0.6 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.203 1.935 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.94 140.2 49.74 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.52 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 7.9 m95 -90.18 162.2 15.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.6 p -151.83 80.5 1.27 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.665 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER 175.58 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 124.623 1.202 . . . . 0.0 112.594 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 58' ' ' ASN . 4.5 m 31.45 31.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 58' ' ' ASN . 89.3 p -122.89 6.13 9.34 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.705 ' HA ' HD13 ' A' ' 64' ' ' ILE . 20.4 m-85 -71.46 45.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -15.42 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -150.62 95.95 2.3 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.87 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.98 -173.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 117.238 -1.785 . . . . 0.0 115.294 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.87 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -70.14 163.58 26.0 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 111.786 -2.461 . . . . 0.0 115.276 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.1 116.22 2.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.15 -2.38 . . . . 0.0 107.15 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 68' ' ' ASP . 42.3 t80 -99.1 158.94 15.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.505 ' N ' ' CG ' ' A' ' 67' ' ' PHE . 17.3 m-20 -143.18 141.32 31.11 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.984 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -107.24 177.61 4.8 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.584 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.32 81.81 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 104.961 -3.255 . . . . 0.0 104.961 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 71' ' ' ASP . 2.5 t0 167.87 130.33 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -81.21 112.58 18.67 Favored 'General case' 0 C--N 1.259 -3.352 0 C-N-CA 117.59 -1.644 . . . . 0.0 109.86 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.83 111.43 5.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.288 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 75' ' ' SER . 3.4 tm? -104.59 146.89 28.27 Favored 'General case' 0 C--O 1.199 -1.589 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.81 ' N ' HD13 ' A' ' 74' ' ' LEU . 48.6 p -140.31 130.58 25.14 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.344 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -88.6 130.93 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.055 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.99 93.94 2.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.963 1.363 . . . . 0.0 108.27 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.1 p -151.77 -39.98 0.11 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.535 -2.121 . . . . 0.0 105.819 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.814 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.8 20.57 2.34 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 111.321 -2.672 . . . . 0.0 115.104 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 83' ' ' ASP . 32.9 mmtt -98.96 142.95 29.81 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 80' ' ' LYS . 12.0 tp -45.04 -31.77 1.46 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.624 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -59.52 -34.83 73.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.074 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -53.26 -47.66 68.9 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.908 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.627 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -37.07 124.57 0.92 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.228 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . -173.05 166.47 39.02 Favored Glycine 0 C--N 1.278 -2.686 0 C-N-CA 118.394 -1.86 . . . . 0.0 110.784 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -88.27 106.32 18.14 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.544 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.45 150.9 28.19 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.083 -1.047 . . . . 0.0 113.503 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.782 HD22 ' C ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -150.8 142.14 23.33 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.035 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -95.6 146.15 24.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.791 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' H ' HD13 ' A' ' 89' ' ' LEU . 40.0 mt-10 -143.34 124.24 14.31 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.62 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 29' ' ' VAL . 2.0 tt -101.25 160.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.434 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 93' ' ' ASN . 13.9 t -53.48 177.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 92' ' ' THR . 2.5 t30 71.15 157.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.567 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 5.1 t -155.92 175.85 13.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.941 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . 74.35 148.25 1.45 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.503 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.11 -96.23 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.352 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -74.98 136.07 41.31 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.695 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 99' ' ' CYS . 10.1 p -62.04 -42.8 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.117 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 66.9 m 50.1 59.63 4.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.572 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.442 HD22 ' HG2' ' A' ' 90' ' ' GLU . 29.7 m120 -151.31 105.16 3.17 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.195 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.519 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 2.0 mptt -102.77 106.01 16.54 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.747 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.45 160.18 17.65 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' TYR . 62.6 m-85 -150.08 129.71 13.14 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.277 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.67 106.42 16.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.722 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.57 HD22 HG22 ' A' ' 9' ' ' VAL . 2.6 mm? -97.92 98.4 9.77 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tp -107.21 100.16 9.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.397 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.6 164.07 10.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.97 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.27 -154.61 0.53 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.896 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 47.3 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.088 0.47 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 9.9 Cg_endo -78.82 -167.64 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.955 1.77 . . . . 0.0 111.563 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -113.41 84.37 2.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.232 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m -90.47 140.97 29.22 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.304 -0.958 . . . . 0.0 112.381 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 p -147.61 98.88 3.04 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.668 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' OE2' ' C ' ' A' ' 8' ' ' GLU . 6.5 tm-20 -115.03 154.66 28.42 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.202 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' OE2' ' A' ' 7' ' ' GLU . 4.4 tm-20 -129.57 99.38 5.14 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.399 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -100.23 151.19 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.657 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.41 150.19 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -151.79 167.39 31.02 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.625 ' H ' ' HZ1' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -140.57 107.43 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.602 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 7.82 85.54 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 122.051 0.929 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.807 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.52 53.07 0.06 OUTLIER Glycine 0 C--N 1.282 -2.424 1 N-CA-C 101.604 -4.598 . . . . 0.0 101.604 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -108.08 53.69 0.22 Allowed Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 1.6 Cg_endo -68.18 107.29 1.52 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 103.509 -3.304 . . . . 0.0 103.509 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 18' ' ' GLN . 3.6 p -129.24 161.21 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 118.609 -1.237 . . . . 0.0 114.151 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.409 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -102.45 112.76 25.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.827 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.517 HD11 ' CG ' ' A' ' 103' ' ' PHE . 28.4 tp -100.16 101.18 12.15 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -123.04 97.27 43.76 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.26 114.11 3.52 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 120.844 1.029 . . . . 0.0 109.628 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 35.7 t -115.16 163.01 16.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.3 t-20 79.5 84.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.549 0.69 . . . . 0.0 109.751 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -137.94 -162.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.95 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' O ' ' CG ' ' A' ' 25' ' ' GLN . 18.4 tt0 -152.71 -9.0 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.8 ' OG1' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.02 125.82 48.8 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.736 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -130.99 159.27 37.97 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.376 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.57 42.01 31.99 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.484 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG21 ' OG1' ' A' ' 26' ' ' THR . 1.5 m -119.96 -179.84 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.566 ' HG ' ' HD1' ' A' ' 50' ' ' TYR . 73.3 m -88.53 145.33 25.79 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.367 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 49' ' ' TRP . 2.1 t -123.09 146.08 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 119.204 -0.999 . . . . 0.0 112.47 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -150.83 127.7 11.01 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.546 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.792 ' CE2' HD22 ' A' ' 74' ' ' LEU . 5.0 p-90 -133.58 103.5 5.94 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 118.565 -1.254 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 15.3 tttt -94.89 160.86 14.4 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.938 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.612 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -146.17 158.89 43.9 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -125.1 98.88 5.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.88 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -97.32 129.59 44.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.112 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.594 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 6.9 tt0 -93.73 179.09 5.47 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.528 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 86.79 -156.89 29.26 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 t -59.6 6.48 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.754 -1.178 . . . . 0.0 110.002 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.655 ' H ' ' C ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -88.35 -136.38 0.1 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.369 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.35 -160.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.047 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -88.66 154.58 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.504 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.615 HG23 ' CG ' ' A' ' 58' ' ' ASN . 39.1 mt -150.4 138.19 14.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 C-N-CA 118.018 -1.473 . . . . 0.0 113.079 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 18.2 mm-40 -89.25 -30.8 18.24 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 47' ' ' LEU . 31.6 mm 72.54 -101.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 46' ' ' ILE . 6.7 tt -125.24 153.57 42.98 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.8 t30 -133.17 99.05 4.43 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.817 -1.992 . . . . 0.0 106.429 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.567 ' N ' ' O ' ' A' ' 31' ' ' VAL . 3.8 t90 -89.51 121.88 32.15 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.647 -0.821 . . . . 0.0 113.089 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.566 ' HD1' ' HG ' ' A' ' 30' ' ' SER . 72.9 t80 -135.8 98.33 3.88 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.631 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.6 t30 64.53 -168.52 0.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.93 33.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.964 -1.494 . . . . 0.0 110.292 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -127.56 85.62 0.33 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.103 -1.046 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.41 141.25 6.7 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.156 1.904 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.0 p -136.33 139.15 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.575 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 11.8 m95 -91.24 161.19 15.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.591 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.46 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 41.0 t -159.96 79.96 0.7 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.259 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.726 ' C ' HG23 ' A' ' 59' ' ' VAL . 6.0 t-20 -179.4 -17.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.804 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.754 ' C ' ' H ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 67.59 -37.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.109 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.532 ' H ' ' C ' ' A' ' 58' ' ' ASN . 0.7 OUTLIER -63.15 20.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.423 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.754 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.5 m-85 -86.24 46.19 1.31 Allowed 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -95.71 -10.62 28.78 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.05 104.54 5.06 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 109.762 -3.381 . . . . 0.0 103.229 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -144.64 -176.35 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.78 162.6 13.53 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 109.48 -3.509 . . . . 0.0 112.546 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.1 126.28 6.52 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 34.5 t80 -88.05 144.94 26.22 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.044 -1.462 . . . . 0.0 112.726 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 29.4 t0 -152.06 167.07 29.63 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.003 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 3.0 m-85 88.06 131.0 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.77 -27.04 69.38 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.138 -3.185 . . . . 0.0 105.138 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 15.5 m-20 -90.43 -102.75 0.1 Allowed 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.814 ' CE1' HD11 ' A' ' 91' ' ' ILE . 2.2 m-85 -154.04 106.44 2.82 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.426 -1.71 . . . . 0.0 112.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HB3' ' CG ' ' A' ' 69' ' ' TYR . . . -151.87 100.1 2.63 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.073 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 33' ' ' TRP . 2.6 pp -115.06 146.89 40.83 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 p -109.2 141.71 41.06 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -96.0 137.3 24.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.02 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -143.43 94.75 2.65 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.645 1.212 . . . . 0.0 108.766 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' LYS . 6.4 t -156.21 -26.55 0.1 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 113.188 -1.824 . . . . 0.0 107.087 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.807 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.63 16.05 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.475 -2.148 . . . . 0.0 113.208 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLN . 5.5 mmmt -95.12 151.18 19.43 Favored 'General case' 0 C--N 1.279 -2.479 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.979 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.0 tp -47.66 -11.84 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.226 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.5 pt20 -72.75 -23.36 60.82 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -27.85 58.35 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 118.374 -1.33 . . . . 0.0 108.423 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.668 ' HB2' ' H ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -74.01 114.55 12.45 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.657 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.48 164.19 35.79 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.52 ' NE2' ' CD ' ' A' ' 104' ' ' GLN . 45.3 m80 -85.3 104.75 15.42 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.5 m-30 -86.29 150.46 24.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -139.34 106.09 5.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.476 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.04 128.05 35.71 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.349 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -148.53 160.94 42.6 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.403 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.814 HD11 ' CE1' ' A' ' 72' ' ' PHE . 5.2 mt -134.57 148.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.992 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.503 ' C ' ' CG ' ' A' ' 93' ' ' ASN . 18.5 m -42.82 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.503 ' CG ' ' C ' ' A' ' 92' ' ' THR . 0.4 OUTLIER 74.51 138.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.861 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 96' ' ' GLY . 10.0 t -172.08 20.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.977 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -57.43 -5.02 1.5 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.612 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 94' ' ' THR . . . -170.03 -70.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.203 -1.475 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -44.81 133.13 6.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.522 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.604 ' C ' ' H ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -93.0 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.289 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.896 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -67.85 34.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.386 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -98.33 116.69 31.08 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.468 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -121.04 118.57 30.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.49 139.4 39.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.786 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 19' ' ' LEU . 58.8 m-85 -136.23 102.56 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.716 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CD ' ' NE2' ' A' ' 86' ' ' HIS . 46.0 tt0 -89.9 107.2 18.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.248 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 9' ' ' VAL . 3.9 mm? -91.92 118.57 30.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -122.8 102.27 7.93 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.668 ' H ' ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -115.0 161.62 13.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.459 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.0 mp -92.66 -171.0 2.61 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.419 -1.753 . . . . 0.0 110.851 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 33.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.245 0.545 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 5.7 Cg_endo -74.13 162.9 37.85 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.963 1.775 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.34 102.55 10.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -150.44 160.72 43.55 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.78 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.6 t -134.32 141.11 46.8 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.353 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 8' ' ' GLU . 37.1 tp10 -125.17 151.54 45.68 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 36.8 mt-10 -114.27 132.05 56.29 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.634 HG13 HD13 ' A' ' 105' ' ' LEU . 1.5 p -136.68 132.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.562 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.24 154.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.544 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -151.51 165.87 30.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' ' C ' ' A' ' 13' ' ' SER . 98.8 t -147.53 96.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 30.27 79.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.016 0.912 . . . . 0.0 108.63 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.629 ' H ' ' HE2' ' A' ' 15' ' ' LYS . . . 135.68 59.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 104.43 -3.468 . . . . 0.0 104.43 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HE2' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -113.13 50.81 0.44 Allowed Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.3 Cg_endo -66.32 91.45 0.27 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 105.331 -2.603 . . . . 0.0 105.331 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 18' ' ' GLN . 6.2 p -107.7 162.07 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 75' ' ' SER . 10.7 tp-100 -112.78 106.01 14.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.996 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -87.98 103.19 15.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.66 96.55 48.83 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.75 105.39 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.125 1.217 . . . . 0.0 109.352 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t -111.51 110.07 20.32 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.691 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER 173.3 10.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.985 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.519 HG13 ' H ' ' A' ' 26' ' ' THR . 5.1 pt -107.4 177.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.198 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.787 ' H ' ' HZ3' ' A' ' 27' ' ' LYS . 6.3 pt20 -123.54 16.39 9.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.788 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.519 ' H ' HG13 ' A' ' 24' ' ' ILE . 68.9 p 45.9 91.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.512 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.787 ' HZ3' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -125.16 -160.9 0.98 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.479 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -81.59 81.36 7.7 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.378 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.31 152.95 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.03 161.48 15.82 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 39.4 t -126.96 130.59 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.178 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -146.46 144.44 29.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.049 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.695 ' HB3' HD22 ' A' ' 89' ' ' LEU . 2.3 p-90 -143.74 119.28 10.37 Favored 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.429 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -102.84 158.56 16.18 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.038 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.774 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -147.8 161.63 40.86 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.203 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 43' ' ' LYS . 2.3 m -125.23 99.65 6.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.93 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HG3' ' H ' ' A' ' 42' ' ' ARG . 3.9 pt-20 -99.59 109.87 22.35 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.912 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -74.15 172.63 11.4 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' C ' ' N ' ' A' ' 41' ' ' HIS . . . 95.21 -165.88 25.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 m -48.89 -12.12 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.739 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.548 ' N ' ' C ' ' A' ' 39' ' ' GLY . 17.8 m80 -82.16 -145.07 0.06 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.577 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' A' ' 37' ' ' GLU . 1.7 ttp180 179.19 -172.63 0.16 Allowed 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 117.884 -1.526 . . . . 0.0 112.901 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.06 126.49 35.46 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.849 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.856 HD13 ' HA ' ' A' ' 59' ' ' VAL . 4.4 mt -137.39 163.01 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.411 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 23.8 mt-10 -86.12 -31.17 22.0 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.874 HD13 HG21 ' A' ' 59' ' ' VAL . 10.3 mm 83.79 -87.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 47' ' ' LEU . 1.1 tt -143.01 150.55 39.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.648 ' N ' HD23 ' A' ' 47' ' ' LEU . 35.5 t-20 -131.74 109.1 9.92 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.109 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.611 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 6.1 t90 -88.77 145.19 25.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 52' ' ' ASP . 14.1 m-85 -141.04 96.47 3.0 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.609 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . 69.4 m-80 7.09 54.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.284 1.615 . . . . 0.0 113.413 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 50' ' ' TYR . 22.6 t70 -179.81 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.621 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.18 152.43 23.61 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.489 -1.815 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -88.96 141.31 4.29 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.913 1.742 . . . . 0.0 112.371 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -127.99 137.37 52.2 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.5 m95 -89.3 161.12 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.731 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.2 m -124.07 68.51 1.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.693 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 31.33 90.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 124.932 1.395 . . . . 0.0 113.139 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 46' ' ' ILE . 2.3 p -122.87 -37.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.06 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.602 ' N ' ' CG1' ' A' ' 59' ' ' VAL . 1.5 t 160.84 26.28 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.802 ' CD1' HG21 ' A' ' 64' ' ' ILE . 39.7 m-85 -54.47 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.091 1.425 . . . . 0.0 112.791 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.449 ' H ' ' H ' ' A' ' 63' ' ' ASP . 19.9 t -176.73 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.05 101.65 2.89 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.987 ' H ' HD12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -154.87 -173.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.82 ' CZ ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -77.22 165.17 24.87 Favored 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 109.578 -3.465 . . . . 0.0 114.798 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.49 126.63 4.39 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 10.8 t80 -106.66 154.3 21.13 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.144 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 13.3 t70 -139.51 147.94 41.96 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 69' ' ' TYR . 12.6 p90 -102.85 174.29 5.94 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.443 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 82.68 12.18 80.48 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER 157.62 127.59 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HE2' HD11 ' A' ' 91' ' ' ILE . 6.9 m-30 -80.84 111.87 17.71 Favored 'General case' 0 C--N 1.264 -3.139 0 C-N-CA 117.314 -1.754 . . . . 0.0 108.684 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.24 105.56 5.75 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.6 tm? -100.54 128.99 46.43 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.051 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' HD22 ' A' ' 74' ' ' LEU . 56.5 p -121.7 127.33 50.62 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.639 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.503 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -89.12 127.03 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.661 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -137.22 96.21 3.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.422 1.106 . . . . 0.0 108.459 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 64' ' ' ILE . 73.8 m -156.6 -33.8 0.08 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.81 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 47.42 64.9 1.41 Allowed 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 112.436 -2.165 . . . . 0.0 113.011 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.475 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 37.1 mmtt -145.48 148.29 33.1 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.013 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 107' ' ' ILE . 51.8 tp -49.67 -30.93 9.96 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.991 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -53.53 -28.45 31.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.125 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 8.9 m-20 -58.02 -57.39 13.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.379 -0.929 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.667 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.7 OUTLIER -40.87 119.89 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.885 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.01 164.41 35.72 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -85.78 103.88 14.95 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.231 -1.388 . . . . 0.0 108.273 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.774 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 1.1 m-30 -89.38 159.63 17.23 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.72 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.71 111.6 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.486 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.5 125.44 35.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -150.34 142.33 23.93 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.099 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.633 HD11 ' HE2' ' A' ' 72' ' ' PHE . 3.6 mt -98.28 160.1 3.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 53.8 m -57.27 -56.53 20.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.469 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.452 ' N ' HG22 ' A' ' 91' ' ' ILE . 42.6 t30 -153.38 159.96 42.53 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.706 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.415 HG21 ' SG ' ' A' ' 2' ' ' CYS . 20.2 m -163.35 -61.14 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 97' ' ' LYS . . . -162.16 -172.58 29.77 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.399 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.93 20.99 3.46 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.445 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 95' ' ' GLY . 6.3 mmpp? -94.46 -170.54 2.28 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' CG1' ' OD1' ' A' ' 100' ' ' ASN . 2.2 t -84.92 -52.5 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.308 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 4.5 t 58.47 62.21 2.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.488 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.441 ' OD1' ' CG1' ' A' ' 98' ' ' VAL . 19.4 p-10 -147.33 133.23 19.09 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.246 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.4 mptt -127.19 114.5 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -93.38 135.54 34.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.347 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.5 105.59 7.33 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.555 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.44 99.26 12.29 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.225 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD13 HG13 ' A' ' 9' ' ' VAL . 3.7 mm? -89.38 110.4 21.21 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.18 99.43 6.86 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.667 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.28 163.04 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.281 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.82 -163.86 1.03 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.791 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.5 Cg_endo -67.92 144.97 66.56 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.286 1.324 . . . . 0.0 111.326 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.39 108.53 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m -150.39 160.63 43.6 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.061 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 p -136.72 99.25 4.0 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.241 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -103.97 148.03 26.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' CB ' ' HG3' ' A' ' 104' ' ' GLN . 2.2 pp20? -116.84 146.84 42.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.993 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.416 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.54 120.25 41.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.541 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.31 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.299 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.7 166.52 31.34 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.583 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.1 p -145.76 93.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.7 t 38.15 78.3 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 137.49 61.95 0.05 OUTLIER Glycine 0 C--N 1.284 -2.35 0 N-CA-C 104.618 -3.393 . . . . 0.0 104.618 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 9.5 tppt? -112.22 44.1 0.25 Allowed Pre-proline 0 C--O 1.208 -1.083 0 CA-C-N 114.019 -1.09 . . . . 0.0 113.666 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.9 Cg_endo -67.16 107.28 1.33 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 N-CA-C 104.469 -2.935 . . . . 0.0 104.469 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' HB ' ' A' ' 76' ' ' ILE . 9.5 p -123.76 160.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.595 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.463 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.0 mp0 -105.19 101.4 10.95 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.264 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -85.62 99.92 11.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -112.84 96.27 37.05 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.5 101.07 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.329 -1.45 . . . . 0.0 108.329 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 23.7 t -123.36 122.66 38.86 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.358 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 22' ' ' SER . 3.8 m-20 165.19 2.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.249 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.132 HD13 ' H ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.36 151.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.676 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.629 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.5 mm100 -47.14 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 1.132 ' H ' HD13 ' A' ' 24' ' ' ILE . 66.7 p 49.99 64.55 1.73 Allowed 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 29' ' ' VAL . 12.7 pttt -176.07 144.17 0.58 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.449 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t70 42.05 80.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.975 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG21 ' CZ ' ' A' ' 72' ' ' PHE . 25.8 m -148.05 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.002 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t -149.27 133.35 17.22 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.4 t -124.05 130.1 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.121 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -149.08 138.5 21.66 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.328 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.778 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.3 p-90 -147.14 137.55 23.46 Favored 'General case' 0 C--O 1.183 -2.42 0 C-N-CA 118.086 -1.446 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 17.1 tttp -119.29 157.21 28.53 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.83 159.89 44.0 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.873 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -113.16 102.8 10.72 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.742 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.07 96.18 9.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 44.7 -167.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.061 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.26 -47.62 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -66.23 -27.75 68.21 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.692 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.484 ' NE2' ' NE2' ' A' ' 82' ' ' GLN . 14.3 m170 -78.5 -124.99 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.782 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.06 157.07 41.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.39 -1.724 . . . . 0.0 113.056 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.75 157.22 19.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.577 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.782 HG22 ' H ' ' A' ' 46' ' ' ILE . 37.5 mt -151.22 145.81 16.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 118.21 -1.396 . . . . 0.0 113.472 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.5 -23.66 23.15 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.782 ' H ' HG22 ' A' ' 44' ' ' ILE . 9.1 mm 74.87 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 113.053 -1.885 . . . . 0.0 116.051 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.938 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -153.08 157.89 41.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 117.747 -1.581 . . . . 0.0 113.806 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.607 ' N ' HD23 ' A' ' 47' ' ' LEU . 44.7 t30 -126.34 113.58 17.1 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.435 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.48 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.5 t90 -99.56 131.05 45.82 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.659 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CD2' ' OD1' ' A' ' 51' ' ' ASN . 41.9 t80 -144.34 98.68 3.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.742 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 1.2 p-10 39.04 84.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.193 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' C ' ' HD3' ' A' ' 54' ' ' PRO . 3.1 m-20 57.48 27.5 14.1 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.867 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.65 78.1 0.39 Allowed Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.656 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -86.71 126.6 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.271 1.981 . . . . 0.0 111.535 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.11 161.85 32.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.896 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 70.6 m95 -110.38 163.79 13.32 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.668 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.4 m -159.83 83.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.2 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.727 ' CB ' HG23 ' A' ' 44' ' ' ILE . 7.8 t-20 144.14 98.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.309 1.631 . . . . 0.0 107.734 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.09 83.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.564 1.173 . . . . 0.0 113.01 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 62' ' ' SER . 3.4 t -161.65 -6.38 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.824 ' HA ' HD13 ' A' ' 64' ' ' ILE . 39.0 m-85 -58.87 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.399 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 60' ' ' SER . 52.7 p -73.85 -49.33 25.58 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.594 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.9 t0 -109.89 94.21 4.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.874 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.86 -174.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 C-N-CA 117.515 -1.674 . . . . 0.0 115.044 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.874 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.06 163.52 22.19 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 112.324 -2.216 . . . . 0.0 115.434 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.46 147.9 18.75 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.0 t80 -121.23 152.98 38.22 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.931 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.754 ' OD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -141.34 152.48 44.45 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.795 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -104.82 178.81 4.45 Favored 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.39 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 93.23 6.41 63.01 Favored Glycine 0 N--CA 1.508 3.453 0 N-CA-C 104.644 -3.382 . . . . 0.0 104.644 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 155.09 141.96 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 102.108 -3.293 . . . . 0.0 102.108 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 51.3 m-85 -83.09 114.18 21.13 Favored 'General case' 1 C--N 1.241 -4.148 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.724 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . . . -135.01 108.58 7.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.646 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.775 HD11 ' CH2' ' A' ' 33' ' ' TRP . 1.8 tm? -98.7 127.14 44.52 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 11.5 t -119.97 138.13 53.66 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.34 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.536 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -91.2 131.23 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.08 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -139.69 92.85 2.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.621 1.2 . . . . 0.0 107.762 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.8 t -153.71 -40.26 0.09 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 113.337 -1.756 . . . . 0.0 108.25 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.78 50.12 17.68 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.234 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLN . 27.9 mmtp -146.55 157.04 43.67 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.997 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -43.45 -20.16 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.326 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' LYS . 33.5 mm-40 -60.31 -30.01 69.22 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -64.8 -29.39 70.36 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.205 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 81' ' ' LEU . 86.5 p -63.61 105.43 0.79 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.283 -1.367 . . . . 0.0 109.931 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -171.66 164.02 36.71 Favored Glycine 0 C--N 1.292 -1.879 0 C-N-CA 118.87 -1.634 . . . . 0.0 110.823 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -86.67 103.53 15.22 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.081 -1.048 . . . . 0.0 108.972 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 1.2 m-30 -89.99 158.07 17.54 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.363 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -150.69 111.43 4.27 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.999 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -97.42 128.22 44.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.871 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' CD ' ' C ' ' A' ' 90' ' ' GLU . 1.6 pp20? -137.61 133.27 34.17 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.841 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' THR . 4.6 mt -102.98 161.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.651 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.581 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 10.5 t 42.05 -157.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.619 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' N ' ' OG1' ' A' ' 92' ' ' THR . 4.9 m120 -61.73 172.02 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -88.69 -19.74 25.76 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.11 165.17 3.42 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.137 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 -143.7 43.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.36 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . 2.8 ttmp? -169.95 -119.81 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.752 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 98' ' ' VAL . 14.3 p 35.88 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.594 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 24.0 m -163.09 41.58 0.11 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.489 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -150.18 130.45 13.69 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.981 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.58 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -147.23 146.81 29.93 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.6 144.17 32.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.052 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.61 107.68 11.78 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.466 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 10.6 pt20 -90.0 110.37 21.35 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.157 -1.017 . . . . 0.0 113.075 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 15' ' ' LYS . 1.9 mm? -89.43 116.26 27.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.648 ' O ' HD23 ' A' ' 106' ' ' LEU . 8.5 tt -119.84 97.85 5.82 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.409 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -128.78 160.54 39.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.279 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.97 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -146.93 178.93 7.96 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.048 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.881 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.728 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 4.6 Cg_exo -66.73 178.29 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.336 1.357 . . . . 0.0 111.255 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.76 79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 3' ' ' PRO . 5.9 m -97.94 105.03 17.11 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.527 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 t -144.17 122.68 12.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.38 155.09 42.95 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -115.61 104.81 12.08 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.51 144.28 9.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.942 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.05 145.36 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 107' ' ' ILE . . . -152.96 168.27 31.81 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.598 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.742 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.3 p -146.17 95.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t 41.94 79.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.441 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.71 63.49 0.08 OUTLIER Glycine 0 C--N 1.289 -2.055 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 tppt? -113.91 45.83 0.35 Allowed Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -67.8 110.84 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 105.581 -2.507 . . . . 0.0 105.581 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' A' ' 76' ' ' ILE . 8.4 p -128.9 161.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.39 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.457 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.5 tt0 -105.81 110.5 22.82 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.563 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.3 mp -97.67 114.3 26.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HG2' ' CB ' ' A' ' 73' ' ' ALA . 32.3 mtp180 -137.69 98.31 9.84 Favored Pre-proline 0 N--CA 1.507 2.399 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.66 140.06 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 39.3 m -148.98 162.82 39.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.287 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.563 ' C ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER 97.97 32.92 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 O-C-N 124.747 1.279 . . . . 0.0 111.083 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.647 HD13 ' CD2' ' A' ' 72' ' ' PHE . 29.7 pt -94.32 -150.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.088 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' C ' HG23 ' A' ' 26' ' ' THR . 4.0 pt20 -160.6 -5.64 0.05 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.076 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.42 HG23 ' C ' ' A' ' 25' ' ' GLN . 3.9 p 56.34 111.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.249 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -152.6 82.92 1.23 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.209 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 45.14 51.75 8.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.917 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' CG2' ' N ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -109.37 164.11 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.881 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.613 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 1.5 m -128.57 144.13 51.09 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.879 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.1 t -106.61 117.57 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.39 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -134.59 136.59 43.06 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.732 ' HB3' HD22 ' A' ' 89' ' ' LEU . 6.8 p-90 -143.96 115.38 8.06 Favored 'General case' 0 C--O 1.189 -2.088 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.698 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 6.5 tttt -103.92 160.13 15.07 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.483 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.8 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -147.81 161.06 42.02 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.267 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -115.84 108.78 16.75 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 42' ' ' ARG . 3.0 mt-10 -102.77 90.43 3.8 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.35 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' SER . 23.6 tt0 -89.01 -43.57 11.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.723 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 41' ' ' HIS . . . -42.41 91.74 0.01 OUTLIER Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.721 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.1 p 46.74 35.76 3.33 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 39' ' ' GLY . 58.6 m-70 -142.11 -145.76 0.18 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 37' ' ' GLU . 57.4 mtm-85 -150.31 -171.72 3.99 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.495 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -88.77 151.11 22.6 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.848 HG23 ' CB ' ' A' ' 58' ' ' ASN . 54.2 mt -148.21 150.26 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 118.432 -1.307 . . . . 0.0 112.468 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 52.2 mt-10 -87.84 -38.88 15.3 Favored 'General case' 0 C--O 1.203 -1.351 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.695 HG21 ' CE2' ' A' ' 33' ' ' TRP . 11.1 mm 84.76 -97.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 5.4 tt -131.14 152.82 50.03 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' N ' HD23 ' A' ' 47' ' ' LEU . 16.9 t-20 -133.29 99.58 4.58 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.746 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.578 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.9 t90 -93.99 132.02 38.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.899 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 28.6 p90 -150.0 100.03 2.89 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.469 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 5.8 t30 48.57 87.27 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.398 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 74.2 m-20 45.23 26.12 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.325 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.29 79.67 0.36 Allowed Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.793 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -87.33 125.64 2.19 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.252 1.968 . . . . 0.0 110.916 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 p -138.78 145.16 39.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.635 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 40.7 m95 -89.87 164.48 14.58 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -166.01 75.68 0.21 Allowed 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.606 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.848 ' CB ' HG23 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 160.33 86.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.795 1.31 . . . . 0.0 109.146 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.79 108.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.778 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER 165.95 -6.45 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 64' ' ' ILE . 36.7 m-85 -63.96 33.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.785 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' SER . 7.2 t -86.65 -35.01 19.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 64' ' ' ILE . 3.2 t0 -127.8 94.72 4.02 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.873 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.79 -172.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 117.553 -1.659 . . . . 0.0 115.235 -179.106 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.873 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.47 164.05 21.99 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 112.236 -2.256 . . . . 0.0 114.767 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.19 126.94 4.37 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 12.7 t80 -90.56 153.66 20.19 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.779 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -140.29 158.46 44.0 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -97.18 -169.17 1.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.444 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 112.47 -1.13 26.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 2.5 m-20 152.23 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.647 ' CD2' HD13 ' A' ' 24' ' ' ILE . 10.8 m-85 -153.04 109.09 3.34 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.22 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . . . -137.51 143.91 41.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.871 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.7 tm? -146.94 128.23 14.82 Favored 'General case' 0 C--O 1.197 -1.684 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.884 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 74' ' ' LEU . 14.5 t -121.05 138.64 54.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.079 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -91.54 133.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.327 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.55 93.64 2.45 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.464 1.126 . . . . 0.0 108.755 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -153.17 -37.49 0.1 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.792 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 54.73 51.71 13.36 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.619 -2.082 . . . . 0.0 113.697 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -147.03 178.97 7.94 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.532 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -63.88 -24.89 67.92 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.843 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' HA ' ' CD2' ' A' ' 41' ' ' HIS . 34.6 mt-30 -52.03 -32.58 34.9 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 107' ' ' ILE . 70.0 m-20 -63.84 -32.23 73.68 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.846 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' LEU . 13.6 p -61.35 106.0 0.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.71 164.47 35.32 Favored Glycine 0 C--N 1.288 -2.094 0 C-N-CA 118.723 -1.703 . . . . 0.0 110.616 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -86.03 106.18 17.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.517 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.5 m-30 -88.38 150.32 23.25 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.48 110.68 5.06 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.746 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.84 100.89 13.52 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.453 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -95.07 118.99 32.83 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.095 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -99.98 119.2 47.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.932 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 93' ' ' ASN . 35.4 m -46.27 163.05 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.737 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.432 ' N ' HG22 ' A' ' 92' ' ' THR . 2.2 m120 65.46 134.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.493 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.6 p -149.14 -178.66 6.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' LYS . . . -173.74 73.3 0.09 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.667 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.55 -63.06 0.17 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.686 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 11.7 ttmm -59.38 150.46 26.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.856 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.6 148.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.736 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 36.3 m -146.43 43.85 1.2 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.601 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -147.71 147.82 30.34 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' NZ ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -115.78 123.59 48.63 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -106.46 119.16 38.55 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.09 115.47 26.85 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -88.81 111.2 21.75 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.584 HD22 HG22 ' A' ' 9' ' ' VAL . 1.5 mm? -95.99 99.61 11.37 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.08 97.51 8.05 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -110.94 160.67 10.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.597 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.27 -177.16 3.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.805 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.209 -1.03 0 CA-C-O 120.803 0.335 . . . . 0.0 111.763 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.1 Cg_endo -72.29 155.69 55.73 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.304 1.336 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -57.77 123.9 17.31 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.469 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t -148.12 147.11 29.14 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.191 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.5 p -150.16 120.78 7.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.678 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 29.4 tp10 -130.12 160.12 34.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.644 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 31.8 tt0 -120.87 133.93 55.3 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.86 120.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.995 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.15 149.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.773 ' CA ' HG22 ' A' ' 107' ' ' ILE . . . -152.35 163.63 30.32 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.569 -1.3 . . . . 0.0 111.858 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -148.21 96.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.076 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' VAL . 15.2 t 41.96 79.92 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.581 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.63 67.64 0.08 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.557 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 8.6 tppt? -112.02 39.52 0.19 Allowed Pre-proline 0 C--O 1.208 -1.084 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.9 Cg_endo -67.56 88.42 0.34 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 N-CA-C 106.327 -2.22 . . . . 0.0 106.327 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -112.47 162.72 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.802 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -106.58 108.14 19.49 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.498 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' LEU . 4.4 tp -88.74 98.44 11.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -115.62 96.54 46.57 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.83 111.89 2.53 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m -134.49 98.99 4.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.408 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -169.88 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.777 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG12 ' H ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -72.26 149.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.707 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.669 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -72.6 8.25 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.755 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 27' ' ' LYS . 2.1 p 55.31 -125.25 2.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.755 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.664 ' N ' ' OG1' ' A' ' 26' ' ' THR . 3.6 mtpt 75.85 48.58 0.08 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.475 0.484 . . . . 0.0 111.896 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 t70 58.51 105.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.792 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 30' ' ' SER . 5.5 t -149.07 167.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 29' ' ' VAL . 1.8 t -89.08 160.69 16.93 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.53 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 49' ' ' TRP . 3.3 t -143.9 134.45 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.818 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -150.24 137.8 19.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.773 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CZ3' ' CE ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -140.71 131.09 25.16 Favored 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.103 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -118.82 152.3 36.48 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.775 ' CE ' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -153.51 163.1 40.54 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.9 -1.52 . . . . 0.0 114.188 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 m -107.38 97.11 6.9 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.552 ' HG3' ' N ' ' A' ' 38' ' ' GLN . 6.5 pt-20 -153.53 -163.23 1.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.278 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.552 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 18.5 tp60 86.51 174.14 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . . . -43.24 144.79 1.31 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p 49.84 13.04 0.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.702 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.558 ' NE2' ' OG ' ' A' ' 84' ' ' SER . 25.1 m170 52.53 75.06 0.25 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 37' ' ' GLU . 37.0 ttm180 -87.07 174.96 8.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 118.709 -1.197 . . . . 0.0 110.022 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -87.61 144.34 26.73 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.428 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.637 ' CG2' HD13 ' A' ' 46' ' ' ILE . 7.8 mt -149.06 138.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.91 -1.516 . . . . 0.0 112.686 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -87.39 -33.93 18.95 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CE2' ' A' ' 33' ' ' TRP . 10.9 mm 82.09 -93.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 114.132 -1.395 . . . . 0.0 114.335 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.954 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -152.23 159.52 43.53 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.498 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' N ' HD23 ' A' ' 47' ' ' LEU . 6.2 p-10 -129.37 113.8 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.397 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' VAL . 10.2 t90 -94.49 131.15 40.49 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 51' ' ' ASN . 2.3 m-85 -144.22 99.32 3.36 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.041 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 3.1 p30 40.16 85.49 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.484 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 20.2 t70 51.27 29.62 5.16 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.484 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.67 76.67 0.41 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.6 Cg_endo -86.92 127.04 2.54 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.375 2.05 . . . . 0.0 111.705 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -140.58 143.38 35.26 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.933 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.64 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 21.2 m95 -91.11 164.24 14.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.402 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -164.09 76.71 0.35 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.955 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.556 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 162.65 88.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.636 1.21 . . . . 0.0 109.693 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -44.14 105.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.844 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 169.46 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.755 ' HA ' HD13 ' A' ' 64' ' ' ILE . 34.7 m-85 -63.34 31.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.223 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' SER . 4.1 p -86.65 -25.3 24.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -140.42 95.46 2.88 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -154.93 -173.28 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-O 123.566 1.65 . . . . 0.0 115.178 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.888 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.28 164.42 20.72 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.851 -2.431 . . . . 0.0 115.437 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.34 118.33 2.35 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -90.04 138.02 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.869 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.37 160.39 29.48 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 44.8 t80 -102.55 -179.15 3.89 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.806 0.812 . . . . 0.0 113.114 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.625 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 118.66 -0.92 15.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.5 OUTLIER 156.49 -96.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.902 -2.149 . . . . 0.0 105.412 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 26.0 m-85 -152.18 105.19 3.03 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.23 106.69 5.55 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.646 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -111.29 126.8 55.28 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.624 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.59 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.8 m -115.21 134.7 54.9 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.562 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -89.88 131.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.255 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 94.68 2.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.699 1.238 . . . . 0.0 108.036 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 79' ' ' ALA . 26.9 t -156.84 -13.95 0.09 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.787 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 23.79 75.25 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 112.381 -2.191 . . . . 0.0 113.999 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' A' ' 82' ' ' GLN . 12.9 mttt -174.0 172.57 3.37 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.16 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -56.03 -37.12 68.79 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.672 ' CD ' ' H ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -46.8 -30.65 2.56 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.769 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -63.81 -35.35 80.33 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.705 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.909 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -48.9 114.06 0.91 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.67 159.98 29.95 Favored Glycine 0 C--N 1.277 -2.707 0 C-N-CA 118.035 -2.031 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -91.16 107.11 18.98 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.96 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -93.44 152.2 19.25 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.906 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.15 110.54 5.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.285 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.25 130.99 35.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.097 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -134.23 129.25 35.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.182 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.508 ' CG2' HG11 ' A' ' 29' ' ' VAL . 6.2 mm -107.57 99.36 8.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.923 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 92' ' ' THR . 30.4 p -46.11 145.9 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.645 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -168.04 140.38 3.04 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.6 m -45.46 -34.19 3.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.88 -54.47 4.87 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.356 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.18 99.54 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -72.41 -109.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.957 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ASN . 4.1 m -98.01 27.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 4.2 m -57.37 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.297 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' VAL . 18.1 m120 -150.76 136.32 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -138.91 109.08 6.4 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.646 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -95.59 134.79 38.06 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.547 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -131.64 111.91 12.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.898 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -88.48 118.33 28.04 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.084 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -101.98 101.38 11.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tp -108.94 105.39 14.9 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.909 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -117.63 163.46 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.065 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 14.7 tp -149.82 147.7 28.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.548 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 11.8 m-20 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.803 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.675 0.274 . . . . 0.0 111.53 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 2' ' ' CYS . 1.6 Cg_endo -65.88 156.2 65.5 Favored 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.225 1.284 . . . . 0.0 111.293 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -44.42 114.19 0.65 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 m -144.78 129.44 18.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.976 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 t -149.99 125.98 10.55 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.45 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 16.7 tp10 -143.43 160.2 40.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 41.2 tt0 -119.55 109.22 15.45 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -100.77 132.58 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.49 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 11' ' ' GLY . 9.8 p -89.65 164.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.445 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.742 ' N ' HG22 ' A' ' 10' ' ' VAL . . . -150.79 169.16 30.6 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.43 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.648 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 3.1 t -145.78 98.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.434 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.624 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 3.62 80.7 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.718 0 CA-C-O 122.685 1.231 . . . . 0.0 109.498 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 143.6 65.47 0.02 OUTLIER Glycine 0 C--N 1.278 -2.65 1 N-CA-C 101.323 -4.711 . . . . 0.0 101.323 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' NZ ' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -114.08 76.98 3.66 Favored Pre-proline 0 C--O 1.207 -1.145 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 15.5 Cg_endo -86.72 78.75 1.88 Allowed 'Trans proline' 0 N--CA 1.431 -2.19 0 N-CA-C 103.525 -3.298 . . . . 0.0 103.525 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.74 159.77 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.97 99.39 7.62 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.129 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 74' ' ' LEU . 5.5 tp -86.05 103.78 15.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.82 97.39 44.11 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -68.38 126.52 14.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.724 0.95 . . . . 0.0 110.05 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 55.8 m -141.03 120.1 12.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.2 p30 162.01 17.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.639 HD11 ' OD2' ' A' ' 71' ' ' ASP . 2.2 pt -99.22 -154.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.5 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' N ' HG13 ' A' ' 24' ' ' ILE . 10.4 pt20 -151.27 0.63 0.38 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 p 55.09 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.859 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -148.82 40.96 0.92 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.821 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.43 95.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.406 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 m -150.91 161.49 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.798 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.89 160.2 17.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.014 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 t -130.46 131.47 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.69 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -150.39 142.09 23.65 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.256 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 89' ' ' LEU . 1.8 p-90 -142.15 141.41 32.63 Favored 'General case' 0 C--O 1.182 -2.499 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.2 ttpt -121.37 154.39 36.54 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.906 -0.717 . . . . 0.0 109.266 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.737 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -149.01 155.86 41.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.631 -1.227 . . . . 0.0 111.976 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.626 HG23 ' CD ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -106.4 100.12 9.67 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.006 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 42' ' ' ARG . 38.3 mt-10 -97.34 107.86 20.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.677 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.558 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 37.2 tt0 -100.16 172.02 7.44 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.521 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 76.59 95.23 0.18 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m 58.55 -0.25 0.13 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.731 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 39' ' ' GLY . 41.7 m80 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -154.61 -176.2 5.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.43 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' CD ' HG23 ' A' ' 36' ' ' THR . 4.1 mmtp -89.66 133.74 34.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -148.18 164.33 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.859 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 2.2 mm-40 -87.35 -15.83 36.76 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.881 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.851 HG22 ' N ' ' A' ' 47' ' ' LEU . 10.6 mm 62.92 -120.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.851 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -90.3 154.65 19.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.565 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.6 t30 -143.21 97.75 3.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.037 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.552 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 20.9 t90 -97.47 132.99 42.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.315 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.4 m-85 -140.73 97.57 3.22 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.538 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.552 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.7 OUTLIER 65.94 -57.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.446 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' TYR . 38.9 t70 -163.32 31.86 0.09 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.79 87.25 0.38 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.82 98.16 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 122.096 1.864 . . . . 0.0 110.479 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.2 p -120.27 132.82 55.49 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -89.76 162.01 15.75 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.05 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.65 ' N ' ' O ' ' A' ' 46' ' ' ILE . 38.5 m -119.46 77.17 1.19 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.684 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.524 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 4.9 m-80 34.24 102.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.873 HG13 ' CZ ' ' A' ' 61' ' ' PHE . 29.9 m -130.65 -44.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.671 1.224 . . . . 0.0 108.597 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.712 ' N ' HG23 ' A' ' 59' ' ' VAL . 2.1 t 160.03 24.15 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.873 ' CZ ' HG13 ' A' ' 59' ' ' VAL . 56.9 m-85 -39.14 90.13 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.82 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' SER . 5.0 t -173.55 -22.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.6 111.69 7.49 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 101.114 -3.662 . . . . 0.0 101.114 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.71 HD13 ' HD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -152.78 -174.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.263 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -179.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.777 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -84.15 164.4 19.18 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 109.37 -3.559 . . . . 0.0 112.032 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.65 125.45 4.16 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.5 t80 -99.84 150.06 22.75 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 26.2 t0 -138.97 158.15 44.72 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -106.05 179.75 4.18 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.835 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.75 11.29 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 105.531 -3.028 . . . . 0.0 105.531 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.639 ' OD2' HD11 ' A' ' 24' ' ' ILE . 5.7 t70 170.44 -103.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.634 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 18.6 m-85 -152.84 115.47 4.51 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.17 143.75 34.41 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.392 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.841 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -148.28 127.33 12.81 Favored 'General case' 0 C--O 1.201 -1.452 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.175 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.614 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.5 t -123.46 136.74 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -91.04 134.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.075 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -144.2 94.48 2.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.866 1.317 . . . . 0.0 109.654 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.506 ' CB ' ' OE1' ' A' ' 82' ' ' GLN . 17.6 p -154.28 -23.54 0.13 Allowed 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.069 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.1 31.6 11.57 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.858 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' C ' ' N ' ' A' ' 82' ' ' GLN . 1.3 mmmt -114.23 167.1 10.99 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.024 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 81' ' ' LEU . 38.1 tp -53.76 -14.47 0.94 Allowed 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.298 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 1.6 pt20 -59.68 -41.21 90.16 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 82' ' ' GLN . 26.7 m-20 -47.03 -42.29 18.11 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.58 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.638 ' H ' HD11 ' A' ' 107' ' ' ILE . 6.4 t -62.11 109.62 1.35 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.296 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.45 164.56 36.91 Favored Glycine 0 C--N 1.277 -2.732 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.724 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.627 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 30.3 t-80 -85.74 101.07 12.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.745 -1.182 . . . . 0.0 108.407 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.737 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 3.0 m-30 -88.83 154.29 20.38 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.99 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 102' ' ' ASN . 14.3 tp -150.67 108.39 3.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.507 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.65 131.75 35.48 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.675 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 23.8 mp0 -142.99 141.6 31.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -109.21 132.59 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.08 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 93' ' ' ASN . 8.9 m 51.99 -87.96 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.032 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' ILE . 3.9 t-20 -158.83 -143.59 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.286 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.511 HG22 ' H ' ' A' ' 95' ' ' GLY . 3.7 m -73.65 -138.98 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 94' ' ' THR . . . 156.51 -135.03 4.3 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.489 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.24 -117.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.698 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HZ2' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.87 -57.24 5.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.878 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 m -150.89 165.57 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.954 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 14.7 t -160.07 12.22 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.061 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -113.64 160.41 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.24 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.625 ' HZ1' ' N ' ' A' ' 2' ' ' CYS . 3.4 ptpt -140.58 124.44 17.26 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.627 ' OD1' ' NE2' ' A' ' 86' ' ' HIS . 37.0 t30 -90.78 157.54 17.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.886 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -149.96 109.72 4.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.72 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -91.63 109.97 21.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.136 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -96.71 137.36 35.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -149.47 102.47 3.19 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.759 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -88.74 164.48 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.048 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.6 tp -89.59 147.47 23.91 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.327 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--N 1.304 -1.413 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.969 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.704 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 111.328 0.121 . . . . 0.0 111.328 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 15.6 Cg_exo -67.96 168.83 17.79 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.046 1.164 . . . . 0.0 111.649 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -84.19 122.5 28.94 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.525 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -144.76 156.66 44.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.877 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -147.5 131.72 17.42 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.023 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -142.67 134.74 27.25 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -94.81 105.64 17.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.547 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 105' ' ' LEU . 1.1 p -94.22 141.68 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.84 147.29 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.603 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HZ2' ' A' ' 15' ' ' LYS . . . -152.13 166.01 30.92 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 13' ' ' SER . 4.8 m -137.85 90.45 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 12' ' ' VAL . 39.6 t 31.41 79.69 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 CA-C-O 122.735 1.255 . . . . 0.0 110.413 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.657 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 146.87 64.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 1 N-CA-C 100.066 -5.213 . . . . 0.0 100.066 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.651 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -125.05 75.6 67.27 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.51 100.76 0.27 Allowed 'Trans proline' 0 N--CA 1.439 -1.683 1 N-CA-C 97.023 -5.799 . . . . 0.0 97.023 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.13 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -115.69 98.59 6.78 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.67 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 19' ' ' LEU . 2.7 tp -87.69 140.21 29.75 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -154.6 92.27 2.95 Favored Pre-proline 0 N--CA 1.507 2.379 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.97 118.89 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 O-C-N 122.631 0.806 . . . . 0.0 110.528 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -111.95 162.56 15.21 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.489 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.0 t30 59.82 80.62 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.97 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -162.29 147.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.461 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.425 ' H ' ' HG2' ' A' ' 25' ' ' GLN . 78.2 mm-40 -46.45 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.331 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.8 p -75.94 71.06 2.73 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.865 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -143.58 -177.74 5.55 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.383 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.29 117.68 3.23 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.819 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 91' ' ' ILE . 5.3 p -153.96 152.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -88.52 140.7 29.19 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.596 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.87 140.84 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -151.88 134.99 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.991 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.558 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 10.8 p-90 -140.95 136.1 31.88 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 118.451 -1.299 . . . . 0.0 109.98 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -128.37 151.62 49.14 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.838 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 141.21 34.09 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.083 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.1 m -95.85 101.18 12.83 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.317 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE1' HD12 ' A' ' 44' ' ' ILE . 42.1 mt-10 -87.37 103.81 15.84 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.101 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -103.22 156.74 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.323 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.53 -60.97 0.64 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.427 ' H ' ' H ' ' A' ' 41' ' ' HIS . 15.6 m -155.02 -21.57 0.12 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.427 ' H ' ' H ' ' A' ' 40' ' ' SER . 42.0 m80 -74.52 -145.04 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.072 -1.876 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 26.9 ttt180 -168.24 -150.9 0.1 Allowed 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.669 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 1.8 tppp? -87.61 128.39 35.27 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 121.578 0.704 . . . . 0.0 111.118 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.453 HD12 ' OE1' ' A' ' 37' ' ' GLU . 5.1 mt -131.63 128.9 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.477 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -86.37 -14.46 43.4 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.017 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.558 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 10.4 mm 61.07 -83.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 48' ' ' ASN 0.324 8.4 tt -145.57 159.7 42.73 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 47' ' ' LEU . 34.6 t30 -138.08 106.73 5.89 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 113.527 -1.669 . . . . 0.0 108.531 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -93.23 137.82 32.2 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.007 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -145.3 97.1 2.94 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.519 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t30 73.57 -68.0 0.24 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.099 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.47 28.55 0.07 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.95 88.9 0.36 Allowed Glycine 0 C--N 1.303 -1.283 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.146 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -83.4 138.09 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.231 1.287 . . . . 0.0 110.327 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 m -143.82 127.25 16.85 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.328 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.799 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 4.0 m95 -88.31 154.29 20.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.438 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -160.75 104.58 1.37 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.913 1.339 . . . . 0.0 112.636 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.0 m120 136.72 91.6 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 111.194 -2.73 . . . . 0.0 104.603 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.38 71.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 117.5 2.408 . . . . 0.0 117.5 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' ASN . 9.7 m -128.32 -5.04 5.44 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -63.16 75.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.188 -2.278 . . . . 0.0 113.453 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 63' ' ' ASP . 41.6 t -145.44 -4.82 0.68 Allowed 'General case' 0 N--CA 1.523 3.219 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' H ' ' H ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -139.7 106.48 5.38 Favored 'General case' 0 C--N 1.274 -2.679 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 175.95 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.83 -178.72 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 N-CA-C 121.034 3.716 . . . . 0.0 121.034 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -112.3 161.82 16.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 108.766 -3.834 . . . . 0.0 111.032 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.1 131.35 5.94 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.2 t80 -94.27 158.9 15.37 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.261 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.502 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 12.6 t70 -139.92 147.94 41.28 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.969 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 55.1 t80 -114.03 166.76 11.28 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 123.026 1.393 . . . . 0.0 114.433 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 149.95 -42.8 0.77 Allowed Glycine 0 N--CA 1.51 3.586 1 N-CA-C 102.293 -4.323 . . . . 0.0 102.293 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 31.5 m-20 -144.14 -106.91 0.12 Allowed 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 100.484 -3.895 . . . . 0.0 100.484 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 88.8 m-85 -154.75 105.87 2.63 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.32 148.29 46.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -147.72 137.63 22.77 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.471 ' N ' HD13 ' A' ' 74' ' ' LEU . 59.6 m -131.49 141.22 49.73 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.439 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -91.55 153.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -150.17 83.92 1.38 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 m -141.41 -53.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 112.108 -2.315 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.657 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 60.32 36.21 20.61 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 111.697 -2.501 . . . . 0.0 115.38 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -140.27 162.55 35.01 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.842 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.818 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 mm? -43.32 -30.28 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.035 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.22 -29.57 68.83 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -67.63 -33.29 74.68 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.2 p -59.42 117.51 4.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.119 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.49 162.6 32.86 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -88.74 101.31 13.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -87.75 160.16 18.18 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.569 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.98 111.77 4.01 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.68 -1.6 . . . . 0.0 106.905 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.559 HD13 ' H ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -87.5 143.4 27.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.876 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.559 ' H ' HD13 ' A' ' 89' ' ' LEU . 49.0 mt-10 -141.66 154.55 45.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.396 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.439 HD11 HG11 ' A' ' 29' ' ' VAL . 2.7 tt -136.32 151.81 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m 57.99 -126.04 1.59 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.267 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -160.92 89.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.896 -1.121 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 50.1 m -158.02 115.84 3.01 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.64 -160.15 19.32 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.337 -1.411 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -153.58 45.52 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.349 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.08 178.74 3.09 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.492 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' C ' HD22 ' A' ' 100' ' ' ASN . 2.8 t 62.4 157.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.651 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 85.5 m 48.7 50.04 17.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.611 HD22 ' C ' ' A' ' 98' ' ' VAL . 5.9 p30 -151.11 130.4 12.8 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.183 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' HZ3' ' N ' ' A' ' 100' ' ' ASN . 3.0 mptp? -133.4 113.74 12.89 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.63 138.75 31.55 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.922 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.96 108.18 5.5 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -94.72 109.54 21.48 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 HG13 ' A' ' 9' ' ' VAL . 4.4 mm? -88.79 100.28 13.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.79 95.53 6.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -117.21 161.26 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.773 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.0 tp -147.12 132.98 19.03 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.964 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.294 -1.832 0 CA-C-O 116.531 -1.699 . . . . 0.0 112.411 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.885 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.212 -0.897 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.9 Cg_endo -71.38 166.79 28.22 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 121.481 1.454 . . . . 0.0 111.466 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 129.55 42.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -146.75 114.24 6.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 m -149.13 119.28 7.23 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.71 159.68 43.54 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -117.16 112.21 20.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -92.53 127.31 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.409 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.69 149.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.225 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.24 166.8 31.17 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 94.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.828 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.0 t 37.91 79.17 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.478 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 134.45 67.24 0.07 OUTLIER Glycine 0 C--N 1.288 -2.092 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.8 tppt? -114.18 46.27 0.37 Allowed Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 3.1 Cg_endo -67.9 99.35 0.55 Allowed 'Trans proline' 0 N--CA 1.433 -2.086 0 N-CA-C 105.615 -2.494 . . . . 0.0 105.615 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 p -121.32 162.18 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.368 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.24 109.26 20.15 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.555 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -88.92 107.34 18.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -124.03 96.01 43.1 Favored Pre-proline 0 N--CA 1.506 2.35 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -74.54 124.16 8.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 N-CA-C 109.129 -1.143 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 66.5 p -125.89 161.04 28.36 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.186 -0.605 . . . . 0.0 111.461 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.4 t-20 75.98 83.78 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.516 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -176.65 152.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.623 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 24' ' ' ILE . 6.3 pt20 -64.06 69.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.892 HG21 ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.51 91.11 8.45 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.707 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' CG ' ' C ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -172.42 15.61 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.19 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -176.78 2.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.1 m -101.98 153.71 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.736 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.484 ' H ' ' HB ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -94.01 160.85 14.54 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.217 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.3 t -116.04 131.85 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.159 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -148.69 124.29 10.42 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.123 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.751 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 7.2 p-90 -136.73 130.17 31.62 Favored 'General case' 0 C--O 1.183 -2.415 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -118.01 160.26 21.78 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.678 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -148.03 158.36 44.01 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.455 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 m -111.8 113.97 26.65 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.591 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.617 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 2.8 mt-10 -106.57 104.68 14.42 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.339 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 38' ' ' GLN . 16.9 pt20 -105.2 -167.82 1.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.453 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.54 -46.55 2.78 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 41' ' ' HIS . 4.4 m -169.56 -10.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.444 ' H ' ' H ' ' A' ' 40' ' ' SER . 41.3 m80 -93.63 -137.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.25 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 37' ' ' GLU . 12.0 ptt-85 -166.61 -161.98 0.48 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.323 -1.351 . . . . 0.0 111.749 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.71 148.12 24.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.901 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 46' ' ' ILE . 4.3 mm -141.54 144.96 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.319 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.75 -30.55 17.93 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 8.3 mm 73.33 -98.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.631 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.32 155.99 33.53 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.1 m-80 -137.83 99.15 3.83 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.336 -2.211 . . . . 0.0 107.693 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 8.3 t90 -97.47 134.54 40.58 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.93 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' ASP . 13.3 m-85 -139.59 96.94 3.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.565 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.556 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 4.0 m120 62.01 -64.27 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.307 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.2 m-20 -155.01 30.97 0.4 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.58 87.04 0.37 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -86.0 114.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.091 1.861 . . . . 0.0 110.289 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.08 161.57 26.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.65 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 69.5 m95 -107.55 165.33 11.49 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.036 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -150.57 67.73 0.95 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.337 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER 169.44 162.81 0.05 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.527 1.767 . . . . 0.0 106.305 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.48 6.23 7.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.546 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -86.44 0.61 53.78 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 64' ' ' ILE . 25.5 m-85 -62.7 37.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.921 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 60' ' ' SER . 6.6 t -94.0 -17.93 22.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -148.62 94.84 2.34 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.861 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.47 -173.31 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.861 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.41 162.7 22.47 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 112.498 -2.137 . . . . 0.0 114.504 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.53 6.89 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.6 t80 -89.7 158.18 17.66 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.983 -1.087 . . . . 0.0 112.684 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 21.6 m-20 -142.66 143.36 32.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.016 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -100.98 177.62 4.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.528 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 116.75 9.26 11.24 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 106.418 -2.673 . . . . 0.0 106.418 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.892 ' OD1' HG21 ' A' ' 26' ' ' THR . 1.7 m-20 153.13 -101.49 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 71' ' ' ASP . 16.3 m-85 -154.13 109.48 3.16 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.13 122.2 10.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.791 -1.164 . . . . 0.0 112.16 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.843 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -120.66 135.67 55.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.986 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.801 ' N ' HD13 ' A' ' 74' ' ' LEU . 12.2 p -125.23 139.06 54.06 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.614 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -90.15 134.04 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.159 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -144.65 93.06 2.36 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 82' ' ' GLN . 13.2 t -155.88 -36.57 0.08 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.5 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 52.05 88.0 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER 172.02 159.2 0.1 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.432 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.865 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -47.49 -13.27 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.671 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 10.1 pt20 -69.04 -27.4 65.61 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.214 -1.394 . . . . 0.0 109.109 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.1 m-20 -70.02 -27.5 64.73 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.474 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 103.92 1.04 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.062 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.37 163.99 36.26 Favored Glycine 0 N--CA 1.485 1.935 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -86.19 108.47 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.918 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 2.4 m-30 -91.1 153.55 20.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.447 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.745 HD21 HD21 ' A' ' 100' ' ' ASN . 0.4 OUTLIER -150.05 111.62 4.49 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.195 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.94 109.75 20.51 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.18 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.54 116.57 32.16 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.73 119.28 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.6 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.599 HG22 ' N ' ' A' ' 93' ' ' ASN . 93.2 m -47.82 168.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.005 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.599 ' N ' HG22 ' A' ' 92' ' ' THR . 2.6 m120 60.72 95.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.218 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 2.0 t -98.18 -174.83 2.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.717 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . -170.81 -176.46 40.11 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.454 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -44.28 -26.0 0.86 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -80.97 -154.22 0.1 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.77 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.39 80.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.885 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 21.3 m -71.68 78.17 0.83 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.774 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.745 HD21 HD21 ' A' ' 88' ' ' LEU . 45.2 t30 -150.09 119.08 6.68 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.551 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -110.46 134.82 51.99 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.14 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -117.19 114.65 23.98 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -114.0 108.91 17.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.889 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -89.27 109.95 20.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.879 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 9' ' ' VAL . 2.0 mm? -89.37 106.74 18.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.4 tp -110.61 98.48 7.65 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -125.94 161.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.21 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.26 154.38 46.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.64 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.386 -1.769 . . . . 0.0 110.949 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 2' ' ' CYS . 6.3 Cg_exo -61.91 155.88 52.4 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.302 1.335 . . . . 0.0 111.479 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.52 114.06 3.03 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -148.56 150.27 33.05 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.318 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 143.27 25.43 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.301 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.22 156.05 45.96 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.13 99.09 8.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.371 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HG ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -93.52 158.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.319 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 106' ' ' LEU . 3.6 p -150.99 155.3 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.241 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -152.22 171.03 31.53 Favored Glycine 0 N--CA 1.484 1.864 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.839 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.6 m -135.59 95.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.485 ' C ' ' O ' ' A' ' 12' ' ' VAL . 71.1 p 39.68 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.555 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 140.6 68.7 0.04 OUTLIER Glycine 0 C--N 1.291 -1.971 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -111.8 41.05 0.2 Allowed Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 2.8 Cg_endo -67.99 99.98 0.6 Allowed 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 106.141 -2.292 . . . . 0.0 106.141 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.61 160.7 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.613 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -99.93 104.66 16.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.245 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 3.1 tp -91.14 99.3 12.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -131.46 102.1 15.58 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -69.21 136.75 35.3 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.853 1.035 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.3 p -143.22 102.79 4.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.804 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.451 ' H ' ' H ' ' A' ' 24' ' ' ILE . 20.0 t-20 -173.62 -7.29 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.891 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.791 ' CG1' ' H ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -102.01 153.56 5.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.247 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.688 ' C ' HG23 ' A' ' 26' ' ' THR . 11.7 pt20 -90.88 3.21 55.14 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.303 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.791 ' H ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 p 63.54 130.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.209 0.528 . . . . 0.0 111.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' H ' HG13 ' A' ' 29' ' ' VAL . 8.5 pttt -177.91 100.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.398 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER 38.15 70.46 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.891 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.448 HG13 ' H ' ' A' ' 27' ' ' LYS . 3.1 m -117.98 176.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.759 0.79 . . . . 0.0 112.601 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.4 121.96 12.49 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.498 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.5 t -96.06 136.79 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.477 -1.289 . . . . 0.0 113.127 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -149.07 124.81 10.49 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.691 ' CZ2' HD21 ' A' ' 74' ' ' LEU . 7.8 p-90 -135.02 114.27 12.29 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.126 -1.429 . . . . 0.0 112.473 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.5 tttm -100.85 157.05 17.01 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.39 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.05 161.02 42.22 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.014 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.413 HG23 ' HD3' ' A' ' 43' ' ' LYS . 1.7 m -119.97 103.38 9.26 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.712 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.5 108.8 20.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.781 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -111.47 148.67 32.65 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 129.52 -5.57 6.25 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 163.51 -9.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.446 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 82' ' ' GLN . 90.0 m-70 -114.45 -132.54 0.33 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -174.25 -151.98 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.715 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 9.6 mmtt -89.85 143.46 26.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.789 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.559 HG23 ' CB ' ' A' ' 58' ' ' ASN . 8.1 mt -146.37 156.7 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 79.2 mm-40 -88.64 -39.02 14.35 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 33' ' ' TRP . 15.3 mm 81.72 -98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.698 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -122.4 157.43 31.9 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 36.3 t30 -139.94 98.53 3.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.527 -2.124 . . . . 0.0 106.65 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.567 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 13.2 t90 -95.61 125.6 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.042 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.674 ' CE2' ' ND2' ' A' ' 51' ' ' ASN . 56.3 t80 -139.77 98.61 3.51 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.674 ' ND2' ' CE2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 61.66 -162.28 0.28 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.48 39.9 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -131.49 81.86 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.718 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -87.09 137.66 4.57 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.447 2.098 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.8 p -143.52 156.98 44.77 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.12 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 50.9 m95 -99.4 164.69 12.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.559 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -160.35 73.37 0.51 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.699 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.559 ' CB ' HG23 ' A' ' 44' ' ' ILE . 1.7 m120 152.51 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.568 1.167 . . . . 0.0 108.884 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -45.65 103.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.849 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 62' ' ' SER . 89.7 p -179.74 -7.76 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 64' ' ' ILE . 27.4 m-85 -66.95 34.58 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.542 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 60' ' ' SER . 12.0 t -84.94 -32.16 23.22 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -132.59 94.28 3.38 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.886 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.95 -172.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.886 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.2 163.62 22.33 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 112.222 -2.263 . . . . 0.0 115.131 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.65 122.55 3.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -89.92 143.85 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.166 -1.014 . . . . 0.0 112.643 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 32.3 t70 -131.59 160.66 34.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 20.0 t80 -95.68 -175.16 3.36 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.264 -0.974 . . . . 0.0 112.917 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 114.84 -1.37 23.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 2.0 m-20 150.61 -88.31 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 70.0 m-85 -153.58 106.25 2.9 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.491 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . . . -132.21 99.79 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.151 -1.019 . . . . 0.0 112.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 74' ' ' LEU . 1.3 tm? -105.9 110.75 23.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 74' ' ' LEU . 16.3 m -103.28 134.99 45.75 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.458 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -90.21 132.18 35.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.301 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -143.12 93.27 2.48 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.553 1.168 . . . . 0.0 107.996 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.8 p -152.18 -42.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.218 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.555 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 58.62 28.24 16.88 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.185 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -113.46 -167.97 1.27 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.017 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 81' ' ' LEU . 32.8 tp -83.88 -14.96 49.8 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.681 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -67.25 -30.31 70.17 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.226 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -63.17 -30.25 71.44 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.946 -1.501 . . . . 0.0 108.527 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.508 ' CB ' HG13 ' A' ' 107' ' ' ILE . 3.4 p -57.29 107.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.393 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.66 161.78 33.3 Favored Glycine 0 C--N 1.284 -2.324 0 C-N-CA 117.569 -2.253 . . . . 0.0 111.518 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.507 ' NE2' ' HB3' ' A' ' 102' ' ' ASN . 18.7 t-160 -89.1 101.19 13.85 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.945 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -88.79 160.53 17.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.301 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 115.18 7.03 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.669 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.573 HD22 ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.427 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.16 118.34 15.52 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.088 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG22 ' ND2' ' A' ' 93' ' ' ASN . 3.0 mt -108.47 113.77 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.494 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.1 m -63.6 130.92 46.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' ND2' HG22 ' A' ' 91' ' ' ILE . 54.9 m-20 -161.76 -101.68 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.063 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.3 p -61.31 -13.56 20.13 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.23 60.17 3.38 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.529 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.19 -154.86 14.66 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.366 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -75.91 -142.12 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t 47.1 28.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.083 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.7 OUTLIER -158.76 15.88 0.19 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.687 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -111.25 130.17 55.74 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.044 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' CE ' ' N ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -132.75 159.56 39.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.925 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 1.9 m-80 -138.08 144.16 40.79 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.71 111.57 8.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.555 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 9.7 pt20 -97.18 113.61 25.22 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.443 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.741 ' HG ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.57 120.19 41.01 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.5 tp -117.36 98.59 6.5 Favored 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.717 -2.038 . . . . 0.0 108.734 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.586 ' CD1' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -100.01 161.35 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.324 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.85 150.54 24.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.952 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.739 ' H ' HD13 ' A' ' 108' ' ' LEU . 3.1 p30 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.9 Cg_endo -68.09 145.54 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.221 1.281 . . . . 0.0 111.247 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 12.4 p-10 -67.03 126.88 30.55 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.796 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 m -150.02 144.57 25.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -130.9 153.72 48.86 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -146.18 159.9 42.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -133.63 98.92 4.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -99.79 141.76 16.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -114.8 151.86 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.811 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -153.11 167.01 31.7 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.54 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.7 p -141.45 94.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 62.2 p 36.81 78.32 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.627 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.94 67.47 0.05 OUTLIER Glycine 0 C--N 1.291 -1.956 0 N-CA-C 104.933 -3.267 . . . . 0.0 104.933 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 10.7 tppt? -113.64 45.32 0.32 Allowed Pre-proline 0 C--O 1.207 -1.176 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -66.75 102.88 0.65 Allowed 'Trans proline' 0 N--CA 1.436 -1.908 0 N-CA-C 105.283 -2.622 . . . . 0.0 105.283 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 18' ' ' GLN . 8.6 p -121.98 161.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.504 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.1 tt0 -104.51 101.66 11.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.675 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 1.8 tp -89.88 107.92 19.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -147.57 100.23 3.79 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 118.089 -1.445 . . . . 0.0 113.861 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -68.53 143.48 57.34 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 120.652 0.902 . . . . 0.0 109.949 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -147.68 105.18 3.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.249 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 24' ' ' ILE . 4.0 p30 -179.98 0.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.646 ' CG1' ' H ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -102.43 142.66 16.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.948 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 25' ' ' GLN . 7.9 pt20 -76.26 27.85 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.646 ' H ' ' CG1' ' A' ' 24' ' ' ILE . 33.0 p 42.11 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.553 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -119.79 -174.72 2.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.597 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -67.38 100.32 0.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.609 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 30' ' ' SER . 3.9 m -148.07 -155.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.475 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 29' ' ' VAL . 9.3 m -150.09 161.67 41.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.2 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 49' ' ' TRP . 2.2 t -127.96 111.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.889 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.262 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -134.9 132.81 38.94 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.445 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.779 ' CE2' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -135.32 148.18 49.39 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.66 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -133.28 158.84 41.93 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.759 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.704 ' CE ' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -150.72 163.16 39.23 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.818 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 36' ' ' THR . 1.0 OUTLIER -127.99 108.73 10.92 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.694 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -107.38 121.66 45.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.48 -166.2 1.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.361 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' C ' ' OG ' ' A' ' 40' ' ' SER . . . 87.17 -9.1 74.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' OG ' ' C ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 163.89 -13.02 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.995 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 82' ' ' GLN . 16.6 m-70 -101.59 -144.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HG2' ' C ' ' A' ' 41' ' ' HIS . 11.3 mmt180 -151.54 -163.8 1.84 Allowed 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.538 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -89.66 157.29 18.07 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 46' ' ' ILE . 36.1 mt -150.28 142.68 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 117.871 -1.532 . . . . 0.0 113.25 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -90.54 -31.13 16.86 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 33' ' ' TRP . 13.9 mm 74.48 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.943 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -151.01 159.38 44.6 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.328 -1.349 . . . . 0.0 113.415 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.656 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.2 p-10 -127.97 118.04 22.84 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.555 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 16.9 t90 -104.48 117.61 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 52' ' ' ASP . 7.5 m-85 -124.22 97.63 5.41 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 64.25 -60.92 0.19 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.279 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' TYR . 42.0 m-20 -159.29 33.05 0.2 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.59 85.84 0.35 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -87.12 112.35 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.276 1.984 . . . . 0.0 110.405 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.601 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 3.8 p -125.34 162.31 25.06 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.668 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 59.8 m95 -109.93 161.36 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.486 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.456 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.2 p -159.79 82.52 0.73 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.585 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.747 ' C ' HG23 ' A' ' 59' ' ' VAL . 6.3 t-20 -174.1 -26.63 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.599 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.747 HG23 ' C ' ' A' ' 58' ' ' ASN . 0.9 OUTLIER 68.79 -4.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.795 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -100.89 11.92 38.64 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 64' ' ' ILE . 45.9 m-85 -72.33 42.91 0.1 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.694 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 t -98.5 -15.53 19.54 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.548 ' O ' HD12 ' A' ' 64' ' ' ILE . 7.6 t0 -147.71 93.58 2.23 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.88 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -157.24 -173.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 117.051 -1.86 . . . . 0.0 115.724 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.88 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.81 165.4 19.79 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.89 -2.414 . . . . 0.0 114.644 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.4 131.28 5.87 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 7.2 t80 -98.26 143.83 28.34 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.231 -0.987 . . . . 0.0 113.14 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.9 t70 -133.62 156.8 47.21 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 56.1 t80 -97.03 176.55 5.91 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.286 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.723 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 127.98 -13.16 6.42 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.613 ' OD1' ' CG2' ' A' ' 26' ' ' THR . 1.8 m-20 166.06 -89.4 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 47.6 m-85 -152.24 99.2 2.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.18 108.52 10.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.79 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -119.95 115.43 23.76 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.821 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 t -105.97 138.38 42.26 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.243 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.501 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -90.19 133.0 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.135 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -143.04 93.87 2.56 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.466 1.127 . . . . 0.0 108.499 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 80' ' ' LYS . 11.6 t -153.59 -25.33 0.14 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.693 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 44.01 11.67 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.393 -2.185 . . . . 0.0 114.128 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.7 mmtp -97.91 152.85 18.79 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 107' ' ' ILE . 26.6 tp -49.7 -18.63 0.49 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.894 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.529 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 11.6 mt-30 -59.01 -22.02 59.98 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.801 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 107' ' ' ILE . 37.3 t0 -64.47 -39.93 94.73 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.056 -1.457 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 78.3 p -46.37 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -170.87 165.04 38.24 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -85.59 109.34 18.47 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.27 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.6 m-30 -95.82 142.16 28.41 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.3 tp -151.9 117.19 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.703 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 3.1 mt -88.51 155.73 19.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.667 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -135.38 109.44 8.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.938 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 29' ' ' VAL . 10.4 tt -89.17 154.56 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.071 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 93' ' ' ASN . 4.9 m 58.03 -147.72 0.5 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.46 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.688 ' H ' HG22 ' A' ' 92' ' ' THR . 65.4 m-80 -142.42 -32.02 0.51 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.678 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.1 m -146.42 135.38 22.48 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.582 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.71 123.06 1.08 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.384 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.23 -26.5 21.25 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.297 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.65 175.85 6.02 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 98' ' ' VAL . 11.1 m -95.3 61.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.72 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.5 m -69.0 84.77 0.33 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.38 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -150.58 139.26 20.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.507 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.2 mttt -132.72 102.95 5.87 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -98.33 146.13 25.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.38 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.97 117.16 12.64 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.651 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.87 116.92 27.5 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.78 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.545 HD13 ' CG2' ' A' ' 9' ' ' VAL . 1.6 mm? -103.97 128.33 51.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.0 tp -146.06 100.25 3.36 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -119.8 163.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.792 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 54.1 tp -104.13 159.54 15.6 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.517 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 CA-C-O 116.306 -1.807 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 5.0 Cg_exo -65.36 133.58 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.334 1.356 . . . . 0.0 111.003 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' H ' HG11 ' A' ' 98' ' ' VAL . 13.2 p-10 -43.06 122.05 2.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.972 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.8 p -146.25 137.24 24.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.9 p -140.15 110.63 6.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.34 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 31.3 tt0 -123.89 160.36 27.66 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' C ' ' CD ' ' A' ' 8' ' ' GLU . 12.3 tm-20 -126.85 121.94 33.29 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.521 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -114.81 136.37 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 11' ' ' GLY . 14.8 p -102.72 152.61 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.366 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.23 167.61 31.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' SER . 94.8 t -147.39 97.08 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.574 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.837 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 2.0 t 27.49 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.908 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.34 55.5 0.09 OUTLIER Glycine 0 C--N 1.287 -2.176 1 N-CA-C 103.025 -4.03 . . . . 0.0 103.025 -179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.837 ' NZ ' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -118.57 57.54 3.13 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 4.1 Cg_endo -69.44 112.28 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 104.96 -2.746 . . . . 0.0 104.96 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.51 161.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.521 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -105.07 112.38 25.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 103' ' ' PHE . 5.3 tp -91.85 125.55 36.6 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -147.97 98.32 3.83 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 117.06 -1.856 . . . . 0.0 115.071 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.12 131.53 22.34 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 120.965 1.11 . . . . 0.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.8 m -116.01 162.08 17.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 23' ' ' ASN . 2.7 t-20 64.73 83.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' H ' HD12 ' A' ' 24' ' ' ILE . 1.1 pp -119.31 -179.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.209 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 26' ' ' THR . 8.1 tt0 -138.88 -12.03 1.28 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.209 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.934 HG21 ' CE1' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -19.18 -99.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.859 -1.519 . . . . 0.0 113.504 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.913 ' H ' HG23 ' A' ' 26' ' ' THR . 11.8 mtmt 44.15 18.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.3 OUTLIER 166.6 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.0 175.84 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -115.47 148.03 39.93 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.192 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.594 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.4 t -105.35 119.56 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.992 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.87 131.64 37.6 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.717 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.805 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 5.5 p-90 -136.02 116.29 13.54 Favored 'General case' 0 C--O 1.184 -2.367 0 C-N-CA 118.776 -1.169 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -103.65 153.91 20.11 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.417 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.814 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -150.54 160.42 43.8 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 118.306 -1.357 . . . . 0.0 113.432 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 m -113.37 99.99 8.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.775 ' CD ' HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -95.07 137.1 34.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -97.53 147.77 23.93 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.688 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.91 -33.73 3.97 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -130.71 -5.17 4.1 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 36.94 46.92 0.54 Allowed 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 112.566 -2.107 . . . . 0.0 111.67 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -108.76 145.58 34.92 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.966 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.94 136.92 32.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.835 HD13 HD22 ' A' ' 58' ' ' ASN . 94.3 mt -144.83 147.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.942 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -89.51 -26.78 20.71 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.229 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.805 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 12.1 mm 72.44 -93.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.4 OUTLIER -123.54 156.84 34.91 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 47' ' ' LEU . 64.0 t30 -137.67 97.41 3.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.597 -2.092 . . . . 0.0 105.943 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.594 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 2.9 t90 -94.55 132.28 39.4 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.723 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.3 p90 -148.52 99.87 3.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.84 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.432 ' OD1' ' C ' ' A' ' 50' ' ' TYR . 6.8 p-10 44.22 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.901 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER 40.83 26.95 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.764 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -127.16 81.9 0.35 Allowed Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -87.31 127.1 2.4 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.139 1.892 . . . . 0.0 111.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.3 p -130.23 142.67 50.54 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.293 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 18.7 m95 -101.09 160.77 14.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.481 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.521 ' H ' ' HZ ' ' A' ' 61' ' ' PHE . 41.3 t -158.64 82.28 0.81 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.243 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.835 HD22 HD13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -176.13 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.828 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.722 HG23 ' C ' ' A' ' 58' ' ' ASN . 1.1 t 68.08 -46.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.183 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASN . 23.8 m -62.91 15.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.78 ' O ' ' N ' ' A' ' 63' ' ' ASP . 45.9 m-85 -56.99 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.567 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 63' ' ' ASP . 39.0 p 32.77 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.78 ' N ' ' O ' ' A' ' 61' ' ' PHE . 9.6 t0 -88.77 92.03 9.05 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.881 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -154.79 -173.18 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.881 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.04 163.69 19.41 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.598 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 130.35 5.13 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 11.6 t80 -89.32 155.73 19.18 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.446 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 4.1 m-20 -142.14 152.7 43.47 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.576 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.521 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 18.9 t80 -101.06 -179.49 4.06 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.115 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 121.8 -1.97 10.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 105.07 -3.212 . . . . 0.0 105.07 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.652 ' CG ' ' N ' ' A' ' 72' ' ' PHE . 1.8 t70 161.15 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 111.159 -2.52 . . . . 0.0 105.178 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.934 ' CE1' HG21 ' A' ' 26' ' ' THR . 46.2 m-85 -150.14 106.36 3.47 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.62 149.58 45.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.094 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -144.58 116.35 8.23 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.228 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.417 ' H ' ' HG ' ' A' ' 75' ' ' SER . 30.0 p -102.59 140.7 36.52 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.114 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -95.82 125.57 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.727 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ILE . 24.5 ttpt -135.69 93.78 2.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' LYS . 3.7 t -154.96 -30.05 0.1 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 113.301 -1.772 . . . . 0.0 107.097 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.908 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.35 14.81 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 111.957 -2.383 . . . . 0.0 113.499 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' SER . 7.6 mmtt -103.45 148.45 25.9 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.388 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 80' ' ' LYS . 11.3 tp -41.89 -25.91 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.084 -1.047 . . . . 0.0 109.688 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' LYS . 16.4 pt20 -57.32 -17.73 13.6 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -64.59 -57.14 9.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.586 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.793 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -40.91 118.39 0.98 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.662 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.03 163.92 35.03 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -85.33 102.67 13.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.553 ' OH ' HD11 ' A' ' 76' ' ' ILE . 2.1 m-30 -89.27 149.6 23.0 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.656 -0.817 . . . . 0.0 112.254 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.56 110.25 5.31 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.677 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -88.49 100.41 13.03 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.338 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -106.63 120.49 42.09 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mm -97.13 109.45 23.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.104 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.9 m 52.59 -101.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.271 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.621 ' OD1' ' N ' ' A' ' 94' ' ' THR . 21.8 p30 -173.73 -37.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.621 ' N ' ' OD1' ' A' ' 93' ' ' ASN . 11.1 p 44.35 -154.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.13 170.52 43.62 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.668 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.06 -83.16 0.41 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.45 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -78.46 176.25 9.55 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG11 ' H ' ' A' ' 4' ' ' ASP . 15.0 p -95.05 152.43 3.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.066 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 34.3 m -156.05 58.33 0.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.741 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.37 160.2 43.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -133.35 130.29 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.596 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 1.9 m120 -107.01 114.34 28.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.179 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.638 ' CD2' HD11 ' A' ' 19' ' ' LEU . 7.1 m-85 -112.67 107.12 15.68 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -90.57 101.64 14.38 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.858 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 9' ' ' VAL . 3.4 mm? -91.04 113.89 26.27 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.8 tp -118.56 100.38 7.41 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.966 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.793 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -116.42 161.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.685 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 63.8 tp -107.0 154.45 21.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.645 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 33.1 t70 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 116.315 -1.802 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.392 0.615 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -138.12 158.17 44.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.46 160.43 43.46 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.59 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' OE1' ' CB ' ' A' ' 104' ' ' GLN . 35.5 tp10 -131.12 98.75 4.66 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.77 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -99.73 142.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.285 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 106' ' ' LEU . 10.9 p -129.88 143.13 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.162 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.765 ' H ' HG22 ' A' ' 107' ' ' ILE . . . -154.13 163.14 30.89 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.335 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.4 p -123.57 97.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.849 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 12' ' ' VAL . 14.2 m 38.82 75.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.711 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 142.36 64.39 0.03 OUTLIER Glycine 0 C--N 1.293 -1.842 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.58 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 7.1 tppt? -121.11 56.18 5.38 Favored Pre-proline 0 C--O 1.209 -1.065 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -70.15 132.31 22.44 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 N-CA-C 105.585 -2.506 . . . . 0.0 105.585 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG12 ' HB ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -150.56 161.74 3.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 117.338 -1.745 . . . . 0.0 112.811 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -107.68 106.02 16.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mp -88.89 127.44 35.64 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -151.42 96.46 3.21 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 116.169 -2.213 . . . . 0.0 116.911 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' CE ' ' A' ' 101' ' ' LYS . 2.7 Cg_exo -71.43 147.83 53.21 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.031 1.154 . . . . 0.0 110.041 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 t . . . . . 0 N--CA 1.496 1.834 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.761 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.6 t -102.07 137.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.299 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -150.41 130.46 13.48 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.973 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.747 ' CH2' HD13 ' A' ' 74' ' ' LEU . 2.7 p-90 -141.56 108.02 5.3 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.8 pttp -100.79 161.0 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.036 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.786 ' NZ ' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -147.11 160.6 42.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.987 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.487 1.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.301 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 43' ' ' LYS . 49.4 mtt180 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 120.93 0.395 . . . . 0.0 111.676 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' A' ' 42' ' ' ARG . 6.1 mmpt? -88.64 150.73 22.88 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.332 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 46' ' ' ILE . 87.8 mt -144.86 147.68 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.667 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.7 mp0 -96.66 -24.12 16.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.803 HD12 ' CE2' ' A' ' 65' ' ' TYR . 22.6 mm 68.22 -107.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -112.9 154.87 25.69 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.48 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.8 p30 -139.88 98.95 3.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.089 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.491 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.1 t90 -94.76 129.95 41.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.458 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.6 p90 -149.76 100.38 2.96 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.93 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 1.5 t-20 51.13 83.89 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.239 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 26.2 t70 45.34 27.45 0.36 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.78 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.06 79.13 0.36 Allowed Glycine 0 N--CA 1.507 3.367 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.723 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 15.0 Cg_endo -87.76 120.15 1.39 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.362 2.041 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.47 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -129.71 155.03 46.56 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.851 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.499 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 44.2 m95 -102.62 164.34 11.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.888 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 38.8 t -158.51 79.39 0.8 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 118.215 -1.394 . . . . 0.0 113.248 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.4 t30 158.77 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.558 1.161 . . . . 0.0 109.461 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -47.07 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.34 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 58' ' ' ASN . 0.6 OUTLIER 174.4 2.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.369 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 64' ' ' ILE . 20.9 m-30 -79.71 38.33 0.38 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.278 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 t -78.51 -7.68 57.75 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.2 t0 -150.53 95.03 2.18 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.714 -2.948 . . . . 0.0 105.76 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.838 HG23 ' N ' ' A' ' 65' ' ' TYR . 1.4 tp -151.82 -174.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.838 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.01 161.69 26.09 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 112.944 -1.934 . . . . 0.0 113.78 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.05 137.32 9.38 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 154.77 19.86 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.275 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -137.3 145.77 43.84 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -97.09 -179.27 4.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.36 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 119.28 1.95 13.78 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 105.604 -2.998 . . . . 0.0 105.604 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.6 m-20 156.43 -99.06 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.959 -2.12 . . . . 0.0 105.905 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 78.1 m-85 -153.34 102.46 2.6 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.978 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.84 150.5 31.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.343 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.747 HD13 ' CH2' ' A' ' 33' ' ' TRP . 1.2 pp -144.87 146.03 31.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 m -120.25 146.01 46.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.6 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.548 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -92.05 130.87 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.992 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -140.99 92.87 2.53 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 80' ' ' LYS . 31.1 t -151.71 -33.84 0.14 Allowed 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.743 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.711 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 48.7 15.82 0.1 Allowed 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 112.398 -2.183 . . . . 0.0 112.593 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' GLN . 10.5 mmtm -99.61 142.22 31.38 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 81' ' ' LEU . 2.6 tp -44.08 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 pt20 -65.81 -22.53 66.56 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.413 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.6 OUTLIER -59.38 -33.9 71.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.207 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 58.4 p -45.89 100.06 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.63 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.58 162.14 35.18 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.457 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -87.1 107.76 18.59 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.796 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 76' ' ' ILE . 1.8 m-30 -87.78 151.12 23.13 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.642 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -141.16 109.03 5.68 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.87 126.71 35.81 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.887 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.6 137.23 28.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 N--CA 1.485 1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.665 0.269 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' CE ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -145.51 155.18 42.93 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.348 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -134.12 124.69 26.53 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.283 -0.967 . . . . 0.0 112.413 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.1 118.96 38.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.403 ' CB ' ' OE1' ' A' ' 8' ' ' GLU . 49.4 mt-30 -89.36 120.3 30.58 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.219 -0.993 . . . . 0.0 112.069 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.553 HD13 ' CG2' ' A' ' 9' ' ' VAL . 2.8 mm? -108.4 123.71 49.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.1 tp -139.75 99.01 3.6 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.765 HG22 ' H ' ' A' ' 11' ' ' GLY . 11.0 pt -124.45 164.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.841 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 HD22 ' C ' ' A' ' 107' ' ' ILE . 3.4 mm? -108.53 -175.32 2.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.905 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.475 ' C ' ' OG ' ' A' ' 13' ' ' SER . 15.5 t70 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.882 0.373 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -125.46 123.09 38.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -136.61 160.39 38.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.06 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pp20? -143.0 109.22 5.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.82 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.92 156.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.319 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' O ' ' NZ ' ' A' ' 15' ' ' LYS . 14.2 p -121.45 151.2 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.972 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.59 167.27 31.46 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.067 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -142.56 97.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.097 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 83.9 p 35.19 81.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.846 0.832 . . . . 0.0 108.853 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.7 68.58 0.09 OUTLIER Glycine 0 C--N 1.29 -1.994 0 N-CA-C 104.401 -3.48 . . . . 0.0 104.401 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.56 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 tpmt? -119.54 79.48 21.83 Favored Pre-proline 0 C--O 1.204 -1.307 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 19.3 Cg_endo -93.65 95.88 0.14 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 N-CA-C 104.831 -2.796 . . . . 0.0 104.831 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 18' ' ' GLN . 9.3 p -112.89 161.58 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.1 tt0 -109.95 100.08 9.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.479 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' LEU . 2.7 tp -88.76 107.56 19.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -135.54 101.33 10.93 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -67.44 125.55 13.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 O-C-N 122.893 0.944 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.485 1.295 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.179 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 36.3 t -123.31 135.94 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -149.92 139.27 21.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.525 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.639 ' HB3' HD22 ' A' ' 89' ' ' LEU . 10.1 p-90 -142.56 112.98 7.23 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -98.12 159.81 14.7 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.515 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.586 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.34 159.25 44.44 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.125 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.394 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 . . . . . 0 N--CA 1.509 2.523 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.475 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.12 138.43 31.56 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.025 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -151.79 168.67 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.847 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 3.7 mp0 -83.9 -22.44 31.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.673 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.742 ' H ' ' CG2' ' A' ' 44' ' ' ILE . 4.0 mm 70.2 -109.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -99.47 151.07 21.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.545 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -140.5 100.77 3.95 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.276 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.581 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.65 130.55 46.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.757 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.7 t80 -137.03 97.69 3.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.147 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.54 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER 65.38 -60.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.128 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.8 p30 -159.81 32.18 0.18 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.101 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.86 87.17 0.39 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.532 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -87.83 108.08 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.512 2.142 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.475 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -132.38 143.73 50.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.501 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.6 m95 -87.85 161.43 17.52 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.163 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 46' ' ' ILE . 52.7 m -124.92 78.71 1.72 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.572 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 1.2 m-80 70.71 -40.84 0.48 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.822 ' O ' ' N ' ' A' ' 61' ' ' PHE . 1.5 t -43.52 117.04 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.166 -3.311 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.352 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 62' ' ' SER . 22.8 t -18.14 54.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.822 ' N ' ' O ' ' A' ' 59' ' ' VAL . 17.7 m-85 -63.12 76.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 117.491 -1.684 . . . . 0.0 112.377 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 60' ' ' SER . 0.3 OUTLIER -148.23 -22.49 0.34 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.7 t0 -147.79 90.94 1.89 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -156.87 -171.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 117.119 -1.832 . . . . 0.0 115.892 -178.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.883 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.65 163.5 21.27 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 111.186 -2.734 . . . . 0.0 114.935 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.09 127.55 5.17 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.3 t80 -93.97 158.94 15.4 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.535 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 3.7 m-20 -145.01 151.46 38.61 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.343 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 61.1 t80 -107.93 174.05 6.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.483 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.774 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 123.84 -7.78 8.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 105.931 -2.868 . . . . 0.0 105.931 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 7.0 t70 173.92 -103.49 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 111.515 -2.342 . . . . 0.0 104.855 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 87.0 m-85 -152.55 109.08 3.43 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' ASP . . . -138.54 145.1 40.29 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.185 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -151.14 117.82 5.77 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.858 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.566 ' N ' HD13 ' A' ' 74' ' ' LEU . 33.3 t -109.18 139.83 43.58 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.508 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -95.51 130.37 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -142.61 94.56 2.66 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.887 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -151.74 -31.84 0.15 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.825 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 55.12 40.43 31.83 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 112.664 -2.062 . . . . 0.0 114.791 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 82' ' ' GLN . 4.2 mtpp -142.0 158.87 43.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.795 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 81' ' ' LEU . 10.9 mp -43.48 -23.19 0.06 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' LYS . 51.0 mt-30 -52.4 -32.81 40.72 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 117.654 -1.618 . . . . 0.0 107.832 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.7 m-20 -66.51 -41.03 89.45 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.737 ' HG ' ' H ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -57.49 105.04 0.21 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.269 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 164.95 37.06 Favored Glycine 0 C--N 1.284 -2.348 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.694 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.463 ' NE2' ' HB2' ' A' ' 102' ' ' ASN . 13.1 t-160 -86.14 105.22 16.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.649 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 2.2 m-30 -88.39 155.22 19.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.307 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -145.64 105.22 3.97 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.29 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.46 122.81 33.01 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.923 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -143.83 139.63 29.41 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.01 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.533 ' N ' ' OE2' ' A' ' 90' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -144.61 160.44 41.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.819 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -121.16 127.19 51.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.496 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.31 139.4 41.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.504 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.26 107.66 14.69 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.095 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 9' ' ' VAL . 2.4 mm? -89.05 125.49 35.03 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.61 98.05 4.55 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.737 ' H ' ' HG ' ' A' ' 84' ' ' SER . 1.2 pt -122.6 162.62 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 28.8 tp -150.67 151.13 32.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.379 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.465 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 40.3 t0 . . . . . 0 C--N 1.307 -1.267 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.988 0.423 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 m -150.08 109.39 3.96 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.433 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.65 147.68 50.21 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -104.5 104.78 14.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -93.31 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.846 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.39 151.79 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.975 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.54 30.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.101 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 7.5 p -147.6 96.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.156 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.819 ' N ' ' HZ1' ' A' ' 15' ' ' LYS . 54.3 p 33.61 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 122.235 1.016 . . . . 0.0 108.706 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.069 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . . . 124.21 62.71 0.19 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 103.362 -3.895 . . . . 0.0 103.362 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 1.101 ' HZ1' ' C ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -119.44 60.34 5.63 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.0 Cg_endo -69.81 97.0 0.62 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 N-CA-C 104.767 -2.82 . . . . 0.0 104.767 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -101.92 161.19 3.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.966 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.75 109.46 15.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.885 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -87.21 124.21 33.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -136.83 93.39 13.75 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 116.923 -1.911 . . . . 0.0 115.337 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.36 104.61 1.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 O-C-N 123.448 1.236 . . . . 0.0 109.468 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.867 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.484 0.183 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 4.4 t -106.66 135.06 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.188 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -150.14 127.84 11.66 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.231 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.732 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.5 p-90 -131.49 147.06 52.51 Favored 'General case' 0 C--O 1.193 -1.876 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.212 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -137.47 154.26 49.93 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -153.43 158.6 41.65 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 117.865 -1.534 . . . . 0.0 113.718 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 179.28 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 43' ' ' LYS . 5.3 tpm_? . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -86.7 131.37 34.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.195 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.597 HG21 HD13 ' A' ' 46' ' ' ILE . 4.4 mm -131.25 146.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.97 -24.94 13.93 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.769 HD12 ' CE2' ' A' ' 65' ' ' TYR . 8.3 mm 62.64 -111.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -107.51 154.94 20.65 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.683 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.1 t-20 -137.41 98.58 3.74 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.298 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.617 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 3.7 t90 -92.58 133.02 36.36 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.665 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 52' ' ' ASP . 24.3 t80 -140.36 98.36 3.41 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.682 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 3.0 t30 68.54 -55.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.204 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' TYR . 24.5 t0 -171.14 31.3 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.21 90.02 0.42 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.49 101.65 0.6 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.203 1.935 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.94 140.2 49.74 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.52 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 7.9 m95 -90.18 162.2 15.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.6 p -151.83 80.5 1.27 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.665 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.579 ' ND2' ' CD1' ' A' ' 44' ' ' ILE . 2.5 t30 175.58 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 124.623 1.202 . . . . 0.0 112.594 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 58' ' ' ASN . 4.5 m 31.45 31.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 58' ' ' ASN . 89.3 p -122.89 6.13 9.34 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.705 ' HA ' HD13 ' A' ' 64' ' ' ILE . 20.4 m-85 -71.46 45.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -15.42 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -150.62 95.95 2.3 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.87 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.98 -173.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 117.238 -1.785 . . . . 0.0 115.294 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.87 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -70.14 163.58 26.0 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 111.786 -2.461 . . . . 0.0 115.276 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.1 116.22 2.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.15 -2.38 . . . . 0.0 107.15 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 68' ' ' ASP . 42.3 t80 -99.1 158.94 15.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.505 ' N ' ' CG ' ' A' ' 67' ' ' PHE . 17.3 m-20 -143.18 141.32 31.11 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.984 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -107.24 177.61 4.8 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.584 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.32 81.81 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 104.961 -3.255 . . . . 0.0 104.961 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 71' ' ' ASP . 2.5 t0 167.87 130.33 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -81.21 112.58 18.67 Favored 'General case' 0 C--N 1.259 -3.352 0 C-N-CA 117.59 -1.644 . . . . 0.0 109.86 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.83 111.43 5.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.288 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 75' ' ' SER . 3.4 tm? -104.59 146.89 28.27 Favored 'General case' 0 C--O 1.199 -1.589 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.81 ' N ' HD13 ' A' ' 74' ' ' LEU . 48.6 p -140.31 130.58 25.14 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.344 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -88.6 130.93 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.055 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.99 93.94 2.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.963 1.363 . . . . 0.0 108.27 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.1 p -151.77 -39.98 0.11 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.535 -2.121 . . . . 0.0 105.819 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.814 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.8 20.57 2.34 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 111.321 -2.672 . . . . 0.0 115.104 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 83' ' ' ASP . 32.9 mmtt -98.96 142.95 29.81 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 80' ' ' LYS . 12.0 tp -45.04 -31.77 1.46 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.624 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -59.52 -34.83 73.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.074 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -53.26 -47.66 68.9 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.908 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.627 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -37.07 124.57 0.92 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.228 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . -173.05 166.47 39.02 Favored Glycine 0 C--N 1.278 -2.686 0 C-N-CA 118.394 -1.86 . . . . 0.0 110.784 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -88.27 106.32 18.14 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.544 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.45 150.9 28.19 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.083 -1.047 . . . . 0.0 113.503 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.782 HD22 ' C ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -150.8 142.14 23.33 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.035 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -95.6 146.15 24.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.791 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' H ' HD13 ' A' ' 89' ' ' LEU . 40.0 mt-10 -143.34 124.24 14.31 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.62 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.489 1.52 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.434 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.442 HD22 ' HG2' ' A' ' 90' ' ' GLU . 29.7 m120 . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.519 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 2.0 mptt -102.77 106.01 16.54 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.747 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.45 160.18 17.65 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' TYR . 62.6 m-85 -150.08 129.71 13.14 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.277 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.67 106.42 16.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.722 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.57 HD22 HG22 ' A' ' 9' ' ' VAL . 2.6 mm? -97.92 98.4 9.77 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tp -107.21 100.16 9.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.397 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.6 164.07 10.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.97 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.27 -154.61 0.53 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.448 0.642 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 p -147.61 98.88 3.04 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.668 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' OE2' ' C ' ' A' ' 8' ' ' GLU . 6.5 tm-20 -115.03 154.66 28.42 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.202 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' OE2' ' A' ' 7' ' ' GLU . 4.4 tm-20 -129.57 99.38 5.14 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.399 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -100.23 151.19 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.657 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.41 150.19 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -151.79 167.39 31.02 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.625 ' H ' ' HZ1' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -140.57 107.43 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.602 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 7.82 85.54 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 122.051 0.929 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.807 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.52 53.07 0.06 OUTLIER Glycine 0 C--N 1.282 -2.424 1 N-CA-C 101.604 -4.598 . . . . 0.0 101.604 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -108.08 53.69 0.22 Allowed Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 1.6 Cg_endo -68.18 107.29 1.52 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 103.509 -3.304 . . . . 0.0 103.509 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 18' ' ' GLN . 3.6 p -129.24 161.21 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 118.609 -1.237 . . . . 0.0 114.151 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.409 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -102.45 112.76 25.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.827 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.517 HD11 ' CG ' ' A' ' 103' ' ' PHE . 28.4 tp -100.16 101.18 12.15 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -123.04 97.27 43.76 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.26 114.11 3.52 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 120.844 1.029 . . . . 0.0 109.628 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.881 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 49' ' ' TRP . 2.1 t -123.09 146.08 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 119.204 -0.999 . . . . 0.0 112.47 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -150.83 127.7 11.01 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.546 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.792 ' CE2' HD22 ' A' ' 74' ' ' LEU . 5.0 p-90 -133.58 103.5 5.94 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 118.565 -1.254 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 15.3 tttt -94.89 160.86 14.4 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.938 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.612 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -146.17 158.89 43.9 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.299 -1.599 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.88 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -88.66 154.58 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.504 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.615 HG23 ' CG ' ' A' ' 58' ' ' ASN . 39.1 mt -150.4 138.19 14.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 C-N-CA 118.018 -1.473 . . . . 0.0 113.079 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 18.2 mm-40 -89.25 -30.8 18.24 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 47' ' ' LEU . 31.6 mm 72.54 -101.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 46' ' ' ILE . 6.7 tt -125.24 153.57 42.98 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.8 t30 -133.17 99.05 4.43 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.817 -1.992 . . . . 0.0 106.429 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.567 ' N ' ' O ' ' A' ' 31' ' ' VAL . 3.8 t90 -89.51 121.88 32.15 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.647 -0.821 . . . . 0.0 113.089 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -135.8 98.33 3.88 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.631 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.6 t30 64.53 -168.52 0.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.93 33.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.964 -1.494 . . . . 0.0 110.292 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -127.56 85.62 0.33 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.103 -1.046 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.41 141.25 6.7 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.156 1.904 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.0 p -136.33 139.15 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.575 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 11.8 m95 -91.24 161.19 15.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.591 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.46 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 41.0 t -159.96 79.96 0.7 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.259 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.726 ' C ' HG23 ' A' ' 59' ' ' VAL . 28.8 t30 -179.4 -17.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.804 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.754 ' C ' ' H ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 67.59 -37.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.109 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.537 ' OG ' ' ND2' ' A' ' 58' ' ' ASN . 0.7 OUTLIER -63.15 20.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.423 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.754 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.5 m-85 -86.24 46.19 1.31 Allowed 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -95.71 -10.62 28.78 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.05 104.54 5.06 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 109.762 -3.381 . . . . 0.0 103.229 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -144.64 -176.35 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.78 162.6 13.53 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 109.48 -3.509 . . . . 0.0 112.546 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.1 126.28 6.52 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 34.5 t80 -88.05 144.94 26.22 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.044 -1.462 . . . . 0.0 112.726 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 29.4 t0 -152.06 167.07 29.63 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.003 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 3.0 m-85 88.06 131.0 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.77 -27.04 69.38 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.138 -3.185 . . . . 0.0 105.138 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 15.5 m-20 -90.43 -102.75 0.1 Allowed 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.814 ' CE1' HD11 ' A' ' 91' ' ' ILE . 2.2 m-85 -154.04 106.44 2.82 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.426 -1.71 . . . . 0.0 112.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HB3' ' CG ' ' A' ' 69' ' ' TYR . . . -151.87 100.1 2.63 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.073 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 33' ' ' TRP . 2.6 pp -115.06 146.89 40.83 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 p -109.2 141.71 41.06 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -96.0 137.3 24.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.02 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -143.43 94.75 2.65 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.645 1.212 . . . . 0.0 108.766 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' LYS . 6.4 t -156.21 -26.55 0.1 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 113.188 -1.824 . . . . 0.0 107.087 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.807 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.63 16.05 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.475 -2.148 . . . . 0.0 113.208 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLN . 5.5 mmmt -95.12 151.18 19.43 Favored 'General case' 0 C--N 1.279 -2.479 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.979 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.0 tp -47.66 -11.84 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.226 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.5 pt20 -72.75 -23.36 60.82 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -27.85 58.35 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 118.374 -1.33 . . . . 0.0 108.423 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.668 ' HB2' ' H ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -74.01 114.55 12.45 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.657 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.48 164.19 35.79 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.52 ' NE2' ' CD ' ' A' ' 104' ' ' GLN . 45.3 m80 -85.3 104.75 15.42 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.5 m-30 -86.29 150.46 24.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -139.34 106.09 5.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.476 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.04 128.05 35.71 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.349 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -148.53 160.94 42.6 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.403 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.814 HD11 ' CE1' ' A' ' 72' ' ' PHE . 5.2 mt . . . . . 0 N--CA 1.486 1.327 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.992 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.782 0.325 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -121.04 118.57 30.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.49 139.4 39.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.786 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 19' ' ' LEU . 58.8 m-85 -136.23 102.56 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.716 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CD ' ' NE2' ' A' ' 86' ' ' HIS . 46.0 tt0 -89.9 107.2 18.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.248 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 9' ' ' VAL . 3.9 mm? -91.92 118.57 30.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -122.8 102.27 7.93 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.668 ' H ' ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -115.0 161.62 13.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.459 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.0 mp -92.66 -171.0 2.61 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.419 -1.753 . . . . 0.0 110.851 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 121.242 0.544 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.6 t -134.32 141.11 46.8 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.353 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 8' ' ' GLU . 37.1 tp10 -125.17 151.54 45.68 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 36.8 mt-10 -114.27 132.05 56.29 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.634 HG13 HD13 ' A' ' 105' ' ' LEU . 1.5 p -136.68 132.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.562 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.24 154.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.544 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -151.51 165.87 30.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' ' C ' ' A' ' 13' ' ' SER . 98.8 t -147.53 96.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 30.27 79.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.016 0.912 . . . . 0.0 108.63 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.629 ' H ' ' HE2' ' A' ' 15' ' ' LYS . . . 135.68 59.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 104.43 -3.468 . . . . 0.0 104.43 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HE2' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -113.13 50.81 0.44 Allowed Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.3 Cg_endo -66.32 91.45 0.27 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 105.331 -2.603 . . . . 0.0 105.331 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 18' ' ' GLN . 6.2 p -107.7 162.07 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 75' ' ' SER . 10.7 tp-100 -112.78 106.01 14.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.996 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -87.98 103.19 15.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.66 96.55 48.83 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.75 105.39 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.125 1.217 . . . . 0.0 109.352 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.691 -179.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.461 0.172 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 39.4 t -126.96 130.59 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.178 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -146.46 144.44 29.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.049 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.695 ' HB3' HD22 ' A' ' 89' ' ' LEU . 2.3 p-90 -143.74 119.28 10.37 Favored 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.429 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -102.84 158.56 16.18 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.038 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.774 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -147.8 161.63 40.86 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.203 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 43' ' ' LYS . 2.3 m . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.93 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.06 126.49 35.46 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.849 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.856 HD13 ' HA ' ' A' ' 59' ' ' VAL . 4.4 mt -137.39 163.01 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.411 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 23.8 mt-10 -86.12 -31.17 22.0 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.874 HD13 HG21 ' A' ' 59' ' ' VAL . 10.3 mm 83.79 -87.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 47' ' ' LEU . 1.1 tt -143.01 150.55 39.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.648 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.74 109.1 9.92 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.109 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.611 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 6.1 t90 -88.77 145.19 25.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 52' ' ' ASP . 14.1 m-85 -141.04 96.47 3.0 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.609 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . 29.2 m120 7.09 54.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.284 1.615 . . . . 0.0 113.413 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 50' ' ' TYR . 22.6 t70 -179.81 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.621 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.18 152.43 23.61 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.489 -1.815 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -88.96 141.31 4.29 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.913 1.742 . . . . 0.0 112.371 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -127.99 137.37 52.2 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.5 m95 -89.3 161.12 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.731 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.2 m -124.07 68.51 1.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.693 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 31.33 90.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 124.932 1.395 . . . . 0.0 113.139 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 46' ' ' ILE . 2.3 p -122.87 -37.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.06 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.602 ' N ' ' CG1' ' A' ' 59' ' ' VAL . 1.5 t 160.84 26.28 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.802 ' CD1' HG21 ' A' ' 64' ' ' ILE . 39.7 m-85 -54.47 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.091 1.425 . . . . 0.0 112.791 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.449 ' H ' ' H ' ' A' ' 63' ' ' ASP . 19.9 t -176.73 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.05 101.65 2.89 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.987 ' H ' HD12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -154.87 -173.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.82 ' CZ ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -77.22 165.17 24.87 Favored 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 109.578 -3.465 . . . . 0.0 114.798 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.49 126.63 4.39 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 10.8 t80 -106.66 154.3 21.13 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.144 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 13.3 t70 -139.51 147.94 41.96 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 69' ' ' TYR . 12.6 p90 -102.85 174.29 5.94 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.443 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 82.68 12.18 80.48 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER 157.62 127.59 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HE2' HD11 ' A' ' 91' ' ' ILE . 6.9 m-30 -80.84 111.87 17.71 Favored 'General case' 0 C--N 1.264 -3.139 0 C-N-CA 117.314 -1.754 . . . . 0.0 108.684 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.24 105.56 5.75 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.6 tm? -100.54 128.99 46.43 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.051 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' HD22 ' A' ' 74' ' ' LEU . 56.5 p -121.7 127.33 50.62 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.639 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.503 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -89.12 127.03 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.661 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -137.22 96.21 3.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.422 1.106 . . . . 0.0 108.459 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 64' ' ' ILE . 73.8 m -156.6 -33.8 0.08 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.81 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 47.42 64.9 1.41 Allowed 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 112.436 -2.165 . . . . 0.0 113.011 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.475 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 37.1 mmtt -145.48 148.29 33.1 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.013 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 107' ' ' ILE . 51.8 tp -49.67 -30.93 9.96 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.991 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 3.0 pp0? -53.53 -28.45 31.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 8.9 m-20 -58.02 -57.39 13.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.379 -0.929 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.667 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.7 OUTLIER -40.87 119.89 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.885 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.01 164.41 35.72 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -85.78 103.88 14.95 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.231 -1.388 . . . . 0.0 108.273 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.774 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 1.1 m-30 -89.38 159.63 17.23 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.72 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.71 111.6 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.486 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.5 125.44 35.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -150.34 142.33 23.93 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.099 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.633 HD11 ' HE2' ' A' ' 72' ' ' PHE . 3.6 mt . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.016 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.862 0.363 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.4 mptt -127.19 114.5 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' N ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m120 -93.38 135.54 34.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.347 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.5 105.59 7.33 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.555 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.44 99.26 12.29 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.225 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.634 HD13 HG13 ' A' ' 9' ' ' VAL . 3.7 mm? -89.38 110.4 21.21 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.18 99.43 6.86 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.667 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.28 163.04 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.281 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.82 -163.86 1.03 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.791 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.911 0.386 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 p -136.72 99.25 4.0 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.241 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -103.97 148.03 26.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' CB ' ' HG3' ' A' ' 104' ' ' GLN . 2.2 pp20? -116.84 146.84 42.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.993 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.416 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.54 120.25 41.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.541 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.31 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.299 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.7 166.52 31.34 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.583 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.1 p -145.76 93.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.7 t 38.15 78.3 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 137.49 61.95 0.05 OUTLIER Glycine 0 C--N 1.284 -2.35 0 N-CA-C 104.618 -3.393 . . . . 0.0 104.618 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 9.5 tppt? -112.22 44.1 0.25 Allowed Pre-proline 0 C--O 1.208 -1.083 0 CA-C-N 114.019 -1.09 . . . . 0.0 113.666 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.9 Cg_endo -67.16 107.28 1.33 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 N-CA-C 104.469 -2.935 . . . . 0.0 104.469 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' HB ' ' A' ' 76' ' ' ILE . 9.5 p -123.76 160.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.595 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.463 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.0 mp0 -105.19 101.4 10.95 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.264 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -85.62 99.92 11.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -112.84 96.27 37.05 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.5 101.07 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.329 -1.45 . . . . 0.0 108.329 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.487 1.396 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.358 -179.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.206 -1.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.4 t -124.05 130.1 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.121 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -149.08 138.5 21.66 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.328 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.778 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.3 p-90 -147.14 137.55 23.46 Favored 'General case' 0 C--O 1.183 -2.42 0 C-N-CA 118.086 -1.446 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 17.1 tttp -119.29 157.21 28.53 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.83 159.89 44.0 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.873 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.742 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.75 157.22 19.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.577 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.782 HG22 ' H ' ' A' ' 46' ' ' ILE . 37.5 mt -151.22 145.81 16.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 118.21 -1.396 . . . . 0.0 113.472 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.5 -23.66 23.15 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.782 ' H ' HG22 ' A' ' 44' ' ' ILE . 9.1 mm 74.87 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 113.053 -1.885 . . . . 0.0 116.051 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.938 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -153.08 157.89 41.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 117.747 -1.581 . . . . 0.0 113.806 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.607 ' N ' HD23 ' A' ' 47' ' ' LEU . 9.2 t-20 -126.34 113.58 17.1 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.435 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.48 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.5 t90 -99.56 131.05 45.82 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.659 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CD2' ' OD1' ' A' ' 51' ' ' ASN . 41.9 t80 -144.34 98.68 3.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.742 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 1.2 p-10 39.04 84.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.193 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' C ' ' HD3' ' A' ' 54' ' ' PRO . 3.1 m-20 57.48 27.5 14.1 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.867 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.65 78.1 0.39 Allowed Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.656 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -86.71 126.6 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.271 1.981 . . . . 0.0 111.535 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.11 161.85 32.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.896 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 70.6 m95 -110.38 163.79 13.32 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.668 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.4 m -159.83 83.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.2 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.727 ' CB ' HG23 ' A' ' 44' ' ' ILE . 7.8 t-20 144.14 98.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.309 1.631 . . . . 0.0 107.734 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.09 83.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.564 1.173 . . . . 0.0 113.01 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 62' ' ' SER . 3.4 t -161.65 -6.38 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.824 ' HA ' HD13 ' A' ' 64' ' ' ILE . 39.0 m-85 -58.87 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.399 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 60' ' ' SER . 52.7 p -73.85 -49.33 25.58 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.594 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.9 t0 -109.89 94.21 4.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.874 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.86 -174.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 C-N-CA 117.515 -1.674 . . . . 0.0 115.044 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.874 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.06 163.52 22.19 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 112.324 -2.216 . . . . 0.0 115.434 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.46 147.9 18.75 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.0 t80 -121.23 152.98 38.22 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.931 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.754 ' OD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -141.34 152.48 44.45 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.795 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -104.82 178.81 4.45 Favored 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.39 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 93.23 6.41 63.01 Favored Glycine 0 N--CA 1.508 3.453 0 N-CA-C 104.644 -3.382 . . . . 0.0 104.644 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 155.09 141.96 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 102.108 -3.293 . . . . 0.0 102.108 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -83.09 114.18 21.13 Favored 'General case' 1 C--N 1.241 -4.148 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.724 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . . . -135.01 108.58 7.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.646 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.775 HD11 ' CH2' ' A' ' 33' ' ' TRP . 1.8 tm? -98.7 127.14 44.52 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 11.5 t -119.97 138.13 53.66 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.34 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.536 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -91.2 131.23 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.08 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -139.69 92.85 2.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.621 1.2 . . . . 0.0 107.762 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.8 t -153.71 -40.26 0.09 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 113.337 -1.756 . . . . 0.0 108.25 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.78 50.12 17.68 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.234 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLN . 27.9 mmtp -146.55 157.04 43.67 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.997 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -43.45 -20.16 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.326 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' LYS . 7.3 mm100 -60.31 -30.01 69.22 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -64.8 -29.39 70.36 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.205 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.5 p -63.61 105.43 0.79 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.283 -1.367 . . . . 0.0 109.931 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -171.66 164.02 36.71 Favored Glycine 0 C--N 1.292 -1.879 0 C-N-CA 118.87 -1.634 . . . . 0.0 110.823 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -86.67 103.53 15.22 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.081 -1.048 . . . . 0.0 108.972 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 1.2 m-30 -89.99 158.07 17.54 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.363 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -150.69 111.43 4.27 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.999 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -97.42 128.22 44.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.871 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' CD ' ' C ' ' A' ' 90' ' ' GLU . 1.6 pp20? -137.61 133.27 34.17 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.841 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 N--CA 1.489 1.487 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.651 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.494 HD21 HD11 ' A' ' 88' ' ' LEU . 20.3 t-20 . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.949 0.404 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.58 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -147.23 146.81 29.93 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.6 144.17 32.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.052 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.61 107.68 11.78 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.466 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 10.6 pt20 -90.0 110.37 21.35 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.157 -1.017 . . . . 0.0 113.075 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 15' ' ' LYS . 1.9 mm? -89.43 116.26 27.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.648 ' O ' HD23 ' A' ' 106' ' ' LEU . 8.5 tt -119.84 97.85 5.82 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.409 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -128.78 160.54 39.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.279 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.97 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -146.93 178.93 7.96 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.048 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.881 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 t -144.17 122.68 12.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.38 155.09 42.95 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -115.61 104.81 12.08 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.51 144.28 9.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.942 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.05 145.36 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 107' ' ' ILE . . . -152.96 168.27 31.81 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.598 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.742 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.3 p -146.17 95.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t 41.94 79.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.441 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.71 63.49 0.08 OUTLIER Glycine 0 C--N 1.289 -2.055 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.513 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 tppt? -113.91 45.83 0.35 Allowed Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -67.8 110.84 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 105.581 -2.507 . . . . 0.0 105.581 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' A' ' 76' ' ' ILE . 8.4 p -128.9 161.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.39 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.457 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.5 tt0 -105.81 110.5 22.82 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.563 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.3 mp -97.67 114.3 26.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HG2' ' CB ' ' A' ' 73' ' ' ALA . 32.3 mtp180 -137.69 98.31 9.84 Favored Pre-proline 0 N--CA 1.507 2.399 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.66 140.06 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.287 -179.743 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.1 t -106.61 117.57 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.39 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -134.59 136.59 43.06 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.732 ' HB3' HD22 ' A' ' 89' ' ' LEU . 6.8 p-90 -143.96 115.38 8.06 Favored 'General case' 0 C--O 1.189 -2.088 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.698 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 6.5 tttt -103.92 160.13 15.07 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.483 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.8 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -147.81 161.06 42.02 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.267 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.193 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.4 mtm-85 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.301 0.572 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -88.77 151.11 22.6 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.848 HG23 ' CB ' ' A' ' 58' ' ' ASN . 54.2 mt -148.21 150.26 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 118.432 -1.307 . . . . 0.0 112.468 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 52.2 mt-10 -87.84 -38.88 15.3 Favored 'General case' 0 C--O 1.203 -1.351 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.695 HG21 ' CE2' ' A' ' 33' ' ' TRP . 11.1 mm 84.76 -97.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 5.4 tt -131.14 152.82 50.03 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' N ' HD23 ' A' ' 47' ' ' LEU . 34.1 t30 -133.29 99.58 4.58 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.746 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.578 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.9 t90 -93.99 132.02 38.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.899 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 28.6 p90 -150.0 100.03 2.89 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.469 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 5.8 t30 48.57 87.27 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.398 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 74.2 m-20 45.23 26.12 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.325 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.29 79.67 0.36 Allowed Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.793 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -87.33 125.64 2.19 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.252 1.968 . . . . 0.0 110.916 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 p -138.78 145.16 39.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.635 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 40.7 m95 -89.87 164.48 14.58 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -166.01 75.68 0.21 Allowed 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.606 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.848 ' CB ' HG23 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 160.33 86.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.795 1.31 . . . . 0.0 109.146 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.79 108.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.778 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER 165.95 -6.45 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 64' ' ' ILE . 36.7 m-85 -63.96 33.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.785 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' SER . 7.2 t -86.65 -35.01 19.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 64' ' ' ILE . 3.2 t0 -127.8 94.72 4.02 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.873 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.79 -172.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 117.553 -1.659 . . . . 0.0 115.235 -179.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.873 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.47 164.05 21.99 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 112.236 -2.256 . . . . 0.0 114.767 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.19 126.94 4.37 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 12.7 t80 -90.56 153.66 20.19 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.779 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -140.29 158.46 44.0 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -97.18 -169.17 1.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.444 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 112.47 -1.13 26.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 2.5 m-20 152.23 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' CE1' ' CG2' ' A' ' 31' ' ' VAL . 10.8 m-85 -153.04 109.09 3.34 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.22 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . . . -137.51 143.91 41.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.871 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.7 tm? -146.94 128.23 14.82 Favored 'General case' 0 C--O 1.197 -1.684 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.884 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 74' ' ' LEU . 14.5 t -121.05 138.64 54.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.079 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -91.54 133.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.327 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.55 93.64 2.45 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.464 1.126 . . . . 0.0 108.755 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -153.17 -37.49 0.1 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.792 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 54.73 51.71 13.36 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.619 -2.082 . . . . 0.0 113.697 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' HE21 ' A' ' 82' ' ' GLN . 37.9 mmtt -147.03 178.97 7.94 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.532 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -63.88 -24.89 67.92 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.843 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.508 HE21 ' HB2' ' A' ' 80' ' ' LYS . 26.7 mt-30 -52.03 -32.58 34.9 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 107' ' ' ILE . 70.0 m-20 -63.84 -32.23 73.68 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.846 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' LEU . 13.6 p -61.35 106.0 0.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.71 164.47 35.32 Favored Glycine 0 C--N 1.288 -2.094 0 C-N-CA 118.723 -1.703 . . . . 0.0 110.616 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -86.03 106.18 17.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.517 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.5 m-30 -88.38 150.32 23.25 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.48 110.68 5.06 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.746 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.84 100.89 13.52 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.453 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -95.07 118.99 32.83 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.095 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.308 -1.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.932 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.68 0.276 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -115.78 123.59 48.63 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -106.46 119.16 38.55 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.09 115.47 26.85 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -88.81 111.2 21.75 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.584 HD22 HG22 ' A' ' 9' ' ' VAL . 1.5 mm? -95.99 99.61 11.37 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.08 97.51 8.05 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -110.94 160.67 10.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.597 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.27 -177.16 3.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.805 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.5 p -150.16 120.78 7.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.678 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 29.4 tp10 -130.12 160.12 34.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.644 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 31.8 tt0 -120.87 133.93 55.3 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.86 120.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.995 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.15 149.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.773 ' CA ' HG22 ' A' ' 107' ' ' ILE . . . -152.35 163.63 30.32 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.569 -1.3 . . . . 0.0 111.858 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -148.21 96.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.076 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' VAL . 15.2 t 41.96 79.92 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.581 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.63 67.64 0.08 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.557 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 8.6 tppt? -112.02 39.52 0.19 Allowed Pre-proline 0 C--O 1.208 -1.084 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.9 Cg_endo -67.56 88.42 0.34 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 N-CA-C 106.327 -2.22 . . . . 0.0 106.327 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -112.47 162.72 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.802 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -106.58 108.14 19.49 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.498 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' LEU . 4.4 tp -88.74 98.44 11.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -115.62 96.54 46.57 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.83 111.89 2.53 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.408 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 49' ' ' TRP . 3.3 t -143.9 134.45 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.818 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -150.24 137.8 19.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.773 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CZ3' ' CE ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -140.71 131.09 25.16 Favored 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.103 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -118.82 152.3 36.48 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.775 ' CE ' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -153.51 163.1 40.54 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.9 -1.52 . . . . 0.0 114.188 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 m . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 179.371 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.498 ' HG2' ' N ' ' A' ' 43' ' ' LYS . 37.0 ttm180 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -87.61 144.34 26.73 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.428 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.637 ' CG2' HD13 ' A' ' 46' ' ' ILE . 7.8 mt -149.06 138.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.91 -1.516 . . . . 0.0 112.686 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -87.39 -33.93 18.95 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CE2' ' A' ' 33' ' ' TRP . 10.9 mm 82.09 -93.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 114.132 -1.395 . . . . 0.0 114.335 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.954 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -152.23 159.52 43.53 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.498 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.67 ' N ' HD23 ' A' ' 47' ' ' LEU . 6.2 p-10 -129.37 113.8 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.397 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' VAL . 10.2 t90 -94.49 131.15 40.49 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 51' ' ' ASN . 2.3 m-85 -144.22 99.32 3.36 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.041 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.418 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 3.1 p30 40.16 85.49 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.484 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 20.2 t70 51.27 29.62 5.16 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.484 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.67 76.67 0.41 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.6 Cg_endo -86.92 127.04 2.54 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.375 2.05 . . . . 0.0 111.705 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -140.58 143.38 35.26 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.933 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.64 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 21.2 m95 -91.11 164.24 14.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.402 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -164.09 76.71 0.35 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.955 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.556 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 162.65 88.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.636 1.21 . . . . 0.0 109.693 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -44.14 105.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.844 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 169.46 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.755 ' HA ' HD13 ' A' ' 64' ' ' ILE . 34.7 m-85 -63.34 31.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.223 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' SER . 4.1 p -86.65 -25.3 24.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -140.42 95.46 2.88 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -154.93 -173.28 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-O 123.566 1.65 . . . . 0.0 115.178 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.888 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.28 164.42 20.72 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.851 -2.431 . . . . 0.0 115.437 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.34 118.33 2.35 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -90.04 138.02 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.869 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.37 160.39 29.48 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 44.8 t80 -102.55 -179.15 3.89 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.806 0.812 . . . . 0.0 113.114 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.625 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 118.66 -0.92 15.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.5 OUTLIER 156.49 -96.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.902 -2.149 . . . . 0.0 105.412 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 26.0 m-85 -152.18 105.19 3.03 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.23 106.69 5.55 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.646 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -111.29 126.8 55.28 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.624 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.59 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.8 m -115.21 134.7 54.9 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.562 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -89.88 131.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.255 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 94.68 2.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.699 1.238 . . . . 0.0 108.036 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 79' ' ' ALA . 26.9 t -156.84 -13.95 0.09 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.787 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 23.79 75.25 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 112.381 -2.191 . . . . 0.0 113.999 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' A' ' 82' ' ' GLN . 12.9 mttt -174.0 172.57 3.37 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.16 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -56.03 -37.12 68.79 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.672 ' CD ' ' H ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -46.8 -30.65 2.56 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.769 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -63.81 -35.35 80.33 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.705 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.909 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -48.9 114.06 0.91 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.67 159.98 29.95 Favored Glycine 0 C--N 1.277 -2.707 0 C-N-CA 118.035 -2.031 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -91.16 107.11 18.98 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.96 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -93.44 152.2 19.25 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.906 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.15 110.54 5.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.285 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.25 130.99 35.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.097 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -134.23 129.25 35.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.182 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm . . . . . 0 C--N 1.307 -1.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.923 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.859 0.361 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -138.91 109.08 6.4 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.646 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -95.59 134.79 38.06 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.547 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -131.64 111.91 12.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.898 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.48 118.33 28.04 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.084 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -101.98 101.38 11.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tp -108.94 105.39 14.9 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.909 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -117.63 163.46 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.065 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 14.7 tp -149.82 147.7 28.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.548 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 11.8 m-20 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.803 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 121.07 0.462 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 t -149.99 125.98 10.55 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.45 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 16.7 tp10 -143.43 160.2 40.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 41.2 tt0 -119.55 109.22 15.45 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -100.77 132.58 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.49 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 11' ' ' GLY . 9.8 p -89.65 164.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.445 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.742 ' N ' HG22 ' A' ' 10' ' ' VAL . . . -150.79 169.16 30.6 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.43 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.648 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 3.1 t -145.78 98.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.434 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.624 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 3.62 80.7 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.718 0 CA-C-O 122.685 1.231 . . . . 0.0 109.498 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 143.6 65.47 0.02 OUTLIER Glycine 0 C--N 1.278 -2.65 1 N-CA-C 101.323 -4.711 . . . . 0.0 101.323 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' NZ ' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -114.08 76.98 3.66 Favored Pre-proline 0 C--O 1.207 -1.145 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 15.5 Cg_endo -86.72 78.75 1.88 Allowed 'Trans proline' 0 N--CA 1.431 -2.19 0 N-CA-C 103.525 -3.298 . . . . 0.0 103.525 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.74 159.77 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.471 ' NE2' ' HD2' ' A' ' 20' ' ' ARG . 2.5 tt0 -113.97 99.39 7.62 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.129 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 74' ' ' LEU . 5.5 tp -86.05 103.78 15.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HD2' ' NE2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -122.82 97.39 44.11 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -68.38 126.52 14.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.724 0.95 . . . . 0.0 110.05 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 t -130.46 131.47 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.69 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -150.39 142.09 23.65 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.256 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 89' ' ' LEU . 1.8 p-90 -142.15 141.41 32.63 Favored 'General case' 0 C--O 1.182 -2.499 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.2 ttpt -121.37 154.39 36.54 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.906 -0.717 . . . . 0.0 109.266 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.737 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -149.01 155.86 41.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.631 -1.227 . . . . 0.0 111.976 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.626 HG23 ' CD ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.169 0 CA-C-O 121.071 0.463 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' CD ' HG23 ' A' ' 36' ' ' THR . 4.1 mmtp -89.66 133.74 34.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -148.18 164.33 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.859 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 2.2 mm-40 -87.35 -15.83 36.76 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.881 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.851 HG22 ' N ' ' A' ' 47' ' ' LEU . 10.6 mm 62.92 -120.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.851 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -90.3 154.65 19.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.565 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.6 t30 -143.21 97.75 3.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.037 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.552 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 20.9 t90 -97.47 132.99 42.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.315 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.4 m-85 -140.73 97.57 3.22 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.538 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.552 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.7 OUTLIER 65.94 -57.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.446 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' TYR . 38.9 t70 -163.32 31.86 0.09 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.79 87.25 0.38 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.82 98.16 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 122.096 1.864 . . . . 0.0 110.479 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.2 p -120.27 132.82 55.49 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -89.76 162.01 15.75 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.05 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.65 ' N ' ' O ' ' A' ' 46' ' ' ILE . 38.5 m -119.46 77.17 1.19 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.684 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.524 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 4.9 m-80 34.24 102.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.873 HG13 ' CZ ' ' A' ' 61' ' ' PHE . 29.9 m -130.65 -44.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.671 1.224 . . . . 0.0 108.597 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.712 ' N ' HG23 ' A' ' 59' ' ' VAL . 2.1 t 160.03 24.15 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.873 ' CZ ' HG13 ' A' ' 59' ' ' VAL . 56.9 m-85 -39.14 90.13 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.82 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' SER . 5.0 t -173.55 -22.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.6 111.69 7.49 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 101.114 -3.662 . . . . 0.0 101.114 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.71 HD13 ' HD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -152.78 -174.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.263 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -179.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.777 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -84.15 164.4 19.18 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 109.37 -3.559 . . . . 0.0 112.032 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.65 125.45 4.16 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.5 t80 -99.84 150.06 22.75 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 26.2 t0 -138.97 158.15 44.72 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -106.05 179.75 4.18 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.835 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.75 11.29 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 105.531 -3.028 . . . . 0.0 105.531 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 5.7 t70 170.44 -103.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.634 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 18.6 m-85 -152.84 115.47 4.51 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.17 143.75 34.41 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.392 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.841 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -148.28 127.33 12.81 Favored 'General case' 0 C--O 1.201 -1.452 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.175 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.614 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.5 t -123.46 136.74 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -91.04 134.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.075 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -144.2 94.48 2.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.866 1.317 . . . . 0.0 109.654 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.506 ' CB ' ' OE1' ' A' ' 82' ' ' GLN . 17.6 p -154.28 -23.54 0.13 Allowed 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.069 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.1 31.6 11.57 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.858 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' C ' ' N ' ' A' ' 82' ' ' GLN . 1.3 mmmt -114.23 167.1 10.99 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.024 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 81' ' ' LEU . 38.1 tp -53.76 -14.47 0.94 Allowed 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.298 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 1.6 pt20 -59.68 -41.21 90.16 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 82' ' ' GLN . 26.7 m-20 -47.03 -42.29 18.11 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.58 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.638 ' H ' HD11 ' A' ' 107' ' ' ILE . 6.4 t -62.11 109.62 1.35 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.296 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.45 164.56 36.91 Favored Glycine 0 C--N 1.277 -2.732 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.724 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.777 ' NE2' ' ND2' ' A' ' 102' ' ' ASN . 30.3 t-80 -85.74 101.07 12.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.745 -1.182 . . . . 0.0 108.407 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.737 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 3.0 m-30 -88.83 154.29 20.38 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.99 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 102' ' ' ASN . 14.3 tp -150.67 108.39 3.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.507 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.65 131.75 35.48 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.675 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 23.8 mp0 -142.99 141.6 31.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.492 HD11 ' CE2' ' A' ' 72' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.057 0.456 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 89' ' ' LEU . 3.4 ptpt -140.58 124.44 17.26 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.777 ' ND2' ' NE2' ' A' ' 86' ' ' HIS . 21.7 t-20 -90.78 157.54 17.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.886 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -149.96 109.72 4.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.72 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -91.63 109.97 21.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.136 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -96.71 137.36 35.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -149.47 102.47 3.19 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.759 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -88.74 164.48 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.048 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.6 tp -89.59 147.47 23.91 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.327 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--N 1.304 -1.413 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.969 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.098 0.475 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -147.5 131.72 17.42 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.023 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -142.67 134.74 27.25 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -94.81 105.64 17.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.547 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 105' ' ' LEU . 1.1 p -94.22 141.68 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.84 147.29 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.603 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HZ2' ' A' ' 15' ' ' LYS . . . -152.13 166.01 30.92 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 13' ' ' SER . 4.8 m -137.85 90.45 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 12' ' ' VAL . 39.6 t 31.41 79.69 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 CA-C-O 122.735 1.255 . . . . 0.0 110.413 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.657 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 146.87 64.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 1 N-CA-C 100.066 -5.213 . . . . 0.0 100.066 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.651 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -125.05 75.6 67.27 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.51 100.76 0.27 Allowed 'Trans proline' 0 N--CA 1.439 -1.683 1 N-CA-C 97.023 -5.799 . . . . 0.0 97.023 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.13 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -115.69 98.59 6.78 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.67 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 19' ' ' LEU . 2.7 tp -87.69 140.21 29.75 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -154.6 92.27 2.95 Favored Pre-proline 0 N--CA 1.507 2.379 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.97 118.89 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 O-C-N 122.631 0.806 . . . . 0.0 110.528 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.489 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.87 140.84 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -151.88 134.99 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.991 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.558 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 10.8 p-90 -140.95 136.1 31.88 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 118.451 -1.299 . . . . 0.0 109.98 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -128.37 151.62 49.14 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.838 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 141.21 34.09 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.083 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.496 1.846 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.317 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 26.9 ttt180 . . . . . 0 N--CA 1.507 2.411 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 1.8 tppp? -87.61 128.39 35.27 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 121.578 0.704 . . . . 0.0 111.118 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG23 ' CB ' ' A' ' 58' ' ' ASN . 5.1 mt -131.63 128.9 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.477 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -86.37 -14.46 43.4 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.017 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.558 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 10.4 mm 61.07 -83.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 48' ' ' ASN 0.324 8.4 tt -145.57 159.7 42.73 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 47' ' ' LEU . 34.6 t30 -138.08 106.73 5.89 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 113.527 -1.669 . . . . 0.0 108.531 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -93.23 137.82 32.2 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.007 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -145.3 97.1 2.94 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.519 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t30 73.57 -68.0 0.24 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.099 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.47 28.55 0.07 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.95 88.9 0.36 Allowed Glycine 0 C--N 1.303 -1.283 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.146 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -83.4 138.09 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.231 1.287 . . . . 0.0 110.327 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 m -143.82 127.25 16.85 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.328 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.799 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 4.0 m95 -88.31 154.29 20.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.438 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -160.75 104.58 1.37 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.913 1.339 . . . . 0.0 112.636 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.0 m120 136.72 91.6 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 111.194 -2.73 . . . . 0.0 104.603 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.38 71.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 117.5 2.408 . . . . 0.0 117.5 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' ASN . 9.7 m -128.32 -5.04 5.44 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -63.16 75.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.188 -2.278 . . . . 0.0 113.453 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 63' ' ' ASP . 41.6 t -145.44 -4.82 0.68 Allowed 'General case' 0 N--CA 1.523 3.219 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' H ' ' H ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -139.7 106.48 5.38 Favored 'General case' 0 C--N 1.274 -2.679 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 175.95 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.83 -178.72 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 N-CA-C 121.034 3.716 . . . . 0.0 121.034 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -112.3 161.82 16.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 108.766 -3.834 . . . . 0.0 111.032 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.1 131.35 5.94 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.2 t80 -94.27 158.9 15.37 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.261 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.502 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 12.6 t70 -139.92 147.94 41.28 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.969 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 55.1 t80 -114.03 166.76 11.28 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 123.026 1.393 . . . . 0.0 114.433 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 149.95 -42.8 0.77 Allowed Glycine 0 N--CA 1.51 3.586 1 N-CA-C 102.293 -4.323 . . . . 0.0 102.293 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 31.5 m-20 -144.14 -106.91 0.12 Allowed 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 100.484 -3.895 . . . . 0.0 100.484 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 88.8 m-85 -154.75 105.87 2.63 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.32 148.29 46.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -147.72 137.63 22.77 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.471 ' N ' HD13 ' A' ' 74' ' ' LEU . 59.6 m -131.49 141.22 49.73 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.439 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -91.55 153.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -150.17 83.92 1.38 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 179.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 m -141.41 -53.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 112.108 -2.315 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.657 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 60.32 36.21 20.61 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 111.697 -2.501 . . . . 0.0 115.38 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -140.27 162.55 35.01 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.842 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.818 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 mm? -43.32 -30.28 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.035 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.22 -29.57 68.83 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -67.63 -33.29 74.68 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.2 p -59.42 117.51 4.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.119 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.49 162.6 32.86 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -88.74 101.31 13.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -87.75 160.16 18.18 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.569 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.98 111.77 4.01 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.68 -1.6 . . . . 0.0 106.905 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.559 HD13 ' H ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -87.5 143.4 27.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.876 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.559 ' H ' HD13 ' A' ' 89' ' ' LEU . 49.0 mt-10 -141.66 154.55 45.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.396 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.834 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.763 ' N ' ' HZ3' ' A' ' 101' ' ' LYS . 5.9 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.678 0.275 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.763 ' HZ3' ' N ' ' A' ' 100' ' ' ASN . 3.0 mptp? -133.4 113.74 12.89 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -93.63 138.75 31.55 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.922 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.96 108.18 5.5 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -94.72 109.54 21.48 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 HG13 ' A' ' 9' ' ' VAL . 4.4 mm? -88.79 100.28 13.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.79 95.53 6.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -117.21 161.26 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.773 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.0 tp -147.12 132.98 19.03 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.964 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.294 -1.832 0 CA-C-O 116.531 -1.699 . . . . 0.0 112.411 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 m -149.13 119.28 7.23 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.71 159.68 43.54 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -117.16 112.21 20.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -92.53 127.31 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.409 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.69 149.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.225 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.24 166.8 31.17 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 94.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.828 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.0 t 37.91 79.17 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.478 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 134.45 67.24 0.07 OUTLIER Glycine 0 C--N 1.288 -2.092 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.8 tppt? -114.18 46.27 0.37 Allowed Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 3.1 Cg_endo -67.9 99.35 0.55 Allowed 'Trans proline' 0 N--CA 1.433 -2.086 0 N-CA-C 105.615 -2.494 . . . . 0.0 105.615 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 p -121.32 162.18 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.368 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.24 109.26 20.15 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.555 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -88.92 107.34 18.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -124.03 96.01 43.1 Favored Pre-proline 0 N--CA 1.506 2.35 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -74.54 124.16 8.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 N-CA-C 109.129 -1.143 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.497 1.901 0 C-N-CA 120.186 -0.605 . . . . 0.0 111.461 -179.925 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.3 t -116.04 131.85 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.159 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -148.69 124.29 10.42 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.123 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.751 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 7.2 p-90 -136.73 130.17 31.62 Favored 'General case' 0 C--O 1.183 -2.415 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -118.01 160.26 21.78 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.678 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -148.03 158.36 44.01 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.455 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.591 179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 ptt-85 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.956 0.407 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.71 148.12 24.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.901 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 HD12 ' ND2' ' A' ' 58' ' ' ASN . 4.3 mm -141.54 144.96 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.319 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.75 -30.55 17.93 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 8.3 mm 73.33 -98.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.631 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.32 155.99 33.53 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.1 m-80 -137.83 99.15 3.83 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.336 -2.211 . . . . 0.0 107.693 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 8.3 t90 -97.47 134.54 40.58 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.93 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' ASP . 13.3 m-85 -139.59 96.94 3.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.565 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.556 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 4.6 m-80 62.01 -64.27 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.307 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.2 m-20 -155.01 30.97 0.4 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.58 87.04 0.37 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -86.0 114.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.091 1.861 . . . . 0.0 110.289 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.08 161.57 26.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.65 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 69.5 m95 -107.55 165.33 11.49 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.036 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -150.57 67.73 0.95 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.337 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 1.8 t30 169.44 162.81 0.05 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.527 1.767 . . . . 0.0 106.305 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.48 6.23 7.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.546 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -86.44 0.61 53.78 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 64' ' ' ILE . 25.5 m-85 -62.7 37.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.921 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 60' ' ' SER . 6.6 t -94.0 -17.93 22.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -148.62 94.84 2.34 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.861 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.47 -173.31 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.861 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.41 162.7 22.47 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 112.498 -2.137 . . . . 0.0 114.504 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.53 6.89 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.6 t80 -89.7 158.18 17.66 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.983 -1.087 . . . . 0.0 112.684 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 21.6 m-20 -142.66 143.36 32.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.016 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -100.98 177.62 4.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.528 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 116.75 9.26 11.24 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 106.418 -2.673 . . . . 0.0 106.418 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 1.7 m-20 153.13 -101.49 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 71' ' ' ASP . 16.3 m-85 -154.13 109.48 3.16 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.13 122.2 10.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.791 -1.164 . . . . 0.0 112.16 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.843 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -120.66 135.67 55.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.986 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.801 ' N ' HD13 ' A' ' 74' ' ' LEU . 12.2 p -125.23 139.06 54.06 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.614 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -90.15 134.04 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.159 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -144.65 93.06 2.36 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 82' ' ' GLN . 13.2 t -155.88 -36.57 0.08 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.5 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 52.05 88.0 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER 172.02 159.2 0.1 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.432 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.865 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -47.49 -13.27 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.671 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 10.1 pt20 -69.04 -27.4 65.61 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.214 -1.394 . . . . 0.0 109.109 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.1 m-20 -70.02 -27.5 64.73 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.474 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 103.92 1.04 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.062 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.37 163.99 36.26 Favored Glycine 0 N--CA 1.485 1.935 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -86.19 108.47 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.918 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 2.4 m-30 -91.1 153.55 20.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.447 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.745 HD21 HD21 ' A' ' 100' ' ' ASN . 0.4 OUTLIER -150.05 111.62 4.49 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.195 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.94 109.75 20.51 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.18 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.54 116.57 32.16 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mm . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.6 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.745 HD21 HD21 ' A' ' 88' ' ' LEU . 45.2 t30 . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.537 0.208 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -110.46 134.82 51.99 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.14 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -117.19 114.65 23.98 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -114.0 108.91 17.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.889 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -89.27 109.95 20.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.879 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 9' ' ' VAL . 2.0 mm? -89.37 106.74 18.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.4 tp -110.61 98.48 7.65 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -125.94 161.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.21 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.26 154.38 46.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.64 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.386 -1.769 . . . . 0.0 110.949 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.657 0.265 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 143.27 25.43 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.301 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.22 156.05 45.96 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.13 99.09 8.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.371 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HG ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -93.52 158.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.319 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 106' ' ' LEU . 3.6 p -150.99 155.3 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.241 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -152.22 171.03 31.53 Favored Glycine 0 N--CA 1.484 1.864 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.839 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.6 m -135.59 95.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.485 ' C ' ' O ' ' A' ' 12' ' ' VAL . 71.1 p 39.68 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.555 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 140.6 68.7 0.04 OUTLIER Glycine 0 C--N 1.291 -1.971 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -111.8 41.05 0.2 Allowed Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 2.8 Cg_endo -67.99 99.98 0.6 Allowed 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 106.141 -2.292 . . . . 0.0 106.141 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.61 160.7 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.613 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -99.93 104.66 16.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.245 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 3.1 tp -91.14 99.3 12.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -131.46 102.1 15.58 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -69.21 136.75 35.3 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.853 1.035 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.804 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.5 t -96.06 136.79 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.477 -1.289 . . . . 0.0 113.127 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -149.07 124.81 10.49 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.691 ' CZ2' HD21 ' A' ' 74' ' ' LEU . 7.8 p-90 -135.02 114.27 12.29 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.126 -1.429 . . . . 0.0 112.473 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.5 tttm -100.85 157.05 17.01 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.39 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.05 161.02 42.22 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.014 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.413 HG23 ' HD3' ' A' ' 43' ' ' LYS . 1.7 m . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.712 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.304 0.573 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 9.6 mmtt -89.85 143.46 26.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.789 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.559 HG23 ' CB ' ' A' ' 58' ' ' ASN . 8.1 mt -146.37 156.7 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 79.2 mm-40 -88.64 -39.02 14.35 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 33' ' ' TRP . 15.3 mm 81.72 -98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.698 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -122.4 157.43 31.9 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 36.3 t30 -139.94 98.53 3.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.527 -2.124 . . . . 0.0 106.65 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.567 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 13.2 t90 -95.61 125.6 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.042 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.674 ' CE2' ' ND2' ' A' ' 51' ' ' ASN . 56.3 t80 -139.77 98.61 3.51 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.674 ' ND2' ' CE2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 61.66 -162.28 0.28 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.48 39.9 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -131.49 81.86 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.718 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -87.09 137.66 4.57 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.447 2.098 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.8 p -143.52 156.98 44.77 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.12 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 50.9 m95 -99.4 164.69 12.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.559 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -160.35 73.37 0.51 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.699 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.559 ' CB ' HG23 ' A' ' 44' ' ' ILE . 1.7 m120 152.51 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.568 1.167 . . . . 0.0 108.884 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -45.65 103.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.849 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 62' ' ' SER . 89.7 p -179.74 -7.76 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 64' ' ' ILE . 27.4 m-85 -66.95 34.58 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.542 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 60' ' ' SER . 12.0 t -84.94 -32.16 23.22 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -132.59 94.28 3.38 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.886 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.95 -172.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.886 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.2 163.62 22.33 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 112.222 -2.263 . . . . 0.0 115.131 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.65 122.55 3.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -89.92 143.85 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.166 -1.014 . . . . 0.0 112.643 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 32.3 t70 -131.59 160.66 34.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 20.0 t80 -95.68 -175.16 3.36 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.264 -0.974 . . . . 0.0 112.917 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 114.84 -1.37 23.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 2.0 m-20 150.61 -88.31 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 70.0 m-85 -153.58 106.25 2.9 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.491 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . . . -132.21 99.79 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.151 -1.019 . . . . 0.0 112.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 74' ' ' LEU . 1.3 tm? -105.9 110.75 23.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 74' ' ' LEU . 16.3 m -103.28 134.99 45.75 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.458 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -90.21 132.18 35.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.301 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -143.12 93.27 2.48 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.553 1.168 . . . . 0.0 107.996 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.8 p -152.18 -42.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.218 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.555 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 58.62 28.24 16.88 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.185 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -113.46 -167.97 1.27 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.017 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 81' ' ' LEU . 32.8 tp -83.88 -14.96 49.8 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.681 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 83' ' ' ASP . 3.2 pp0? -67.25 -30.31 70.17 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.226 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -63.17 -30.25 71.44 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.946 -1.501 . . . . 0.0 108.527 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.508 ' CB ' HG13 ' A' ' 107' ' ' ILE . 3.4 p -57.29 107.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.393 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.66 161.78 33.3 Favored Glycine 0 C--N 1.284 -2.324 0 C-N-CA 117.569 -2.253 . . . . 0.0 111.518 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.507 ' NE2' ' HB3' ' A' ' 102' ' ' ASN . 18.7 t-160 -89.1 101.19 13.85 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.945 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -88.79 160.53 17.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.301 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 115.18 7.03 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.669 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.573 HD22 ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.427 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.16 118.34 15.52 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.088 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.407 ' CD1' ' CE1' ' A' ' 72' ' ' PHE . 3.0 mt . . . . . 0 C--N 1.308 -1.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.494 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' C ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -132.75 159.56 39.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.925 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 1.9 m-80 -138.08 144.16 40.79 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.71 111.57 8.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.555 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 9.7 pt20 -97.18 113.61 25.22 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.443 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.741 ' HG ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.57 120.19 41.01 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.5 tp -117.36 98.59 6.5 Favored 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.717 -2.038 . . . . 0.0 108.734 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.586 ' CD1' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -100.01 161.35 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.324 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.85 150.54 24.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.952 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.739 ' H ' HD13 ' A' ' 108' ' ' LEU . 3.1 p30 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.858 0.361 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -130.9 153.72 48.86 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -146.18 159.9 42.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -133.63 98.92 4.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -99.79 141.76 16.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -114.8 151.86 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.811 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -153.11 167.01 31.7 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.54 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.7 p -141.45 94.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 62.2 p 36.81 78.32 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.627 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.94 67.47 0.05 OUTLIER Glycine 0 C--N 1.291 -1.956 0 N-CA-C 104.933 -3.267 . . . . 0.0 104.933 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 10.7 tppt? -113.64 45.32 0.32 Allowed Pre-proline 0 C--O 1.207 -1.176 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -66.75 102.88 0.65 Allowed 'Trans proline' 0 N--CA 1.436 -1.908 0 N-CA-C 105.283 -2.622 . . . . 0.0 105.283 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 18' ' ' GLN . 8.6 p -121.98 161.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.504 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.1 tt0 -104.51 101.66 11.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.675 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 1.8 tp -89.88 107.92 19.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -147.57 100.23 3.79 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 118.089 -1.445 . . . . 0.0 113.861 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -68.53 143.48 57.34 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 120.652 0.902 . . . . 0.0 109.949 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.487 1.397 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.249 -179.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 49' ' ' TRP . 2.2 t -127.96 111.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.889 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.262 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -134.9 132.81 38.94 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.445 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.779 ' CE2' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -135.32 148.18 49.39 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.66 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -133.28 158.84 41.93 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.759 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.704 ' CE ' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -150.72 163.16 39.23 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.818 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 36' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.694 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 121.408 0.623 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -89.66 157.29 18.07 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 46' ' ' ILE . 36.1 mt -150.28 142.68 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 117.871 -1.532 . . . . 0.0 113.25 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -90.54 -31.13 16.86 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 33' ' ' TRP . 13.9 mm 74.48 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.943 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -151.01 159.38 44.6 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.328 -1.349 . . . . 0.0 113.415 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.656 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.2 p-10 -127.97 118.04 22.84 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.555 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 16.9 t90 -104.48 117.61 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 52' ' ' ASP . 7.5 m-85 -124.22 97.63 5.41 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.714 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 64.25 -60.92 0.19 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.279 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' TYR . 42.0 m-20 -159.29 33.05 0.2 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.59 85.84 0.35 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -87.12 112.35 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.276 1.984 . . . . 0.0 110.405 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.601 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 3.8 p -125.34 162.31 25.06 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.668 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 59.8 m95 -109.93 161.36 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.486 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.456 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.2 p -159.79 82.52 0.73 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.585 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.747 ' C ' HG23 ' A' ' 59' ' ' VAL . 64.0 t30 -174.1 -26.63 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.599 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.747 HG23 ' C ' ' A' ' 58' ' ' ASN . 0.9 OUTLIER 68.79 -4.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.795 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.603 ' OG ' ' ND2' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -100.89 11.92 38.64 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 64' ' ' ILE . 45.9 m-85 -72.33 42.91 0.1 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.694 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 t -98.5 -15.53 19.54 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.548 ' O ' HD12 ' A' ' 64' ' ' ILE . 7.6 t0 -147.71 93.58 2.23 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.88 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -157.24 -173.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 117.051 -1.86 . . . . 0.0 115.724 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.88 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.81 165.4 19.79 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.89 -2.414 . . . . 0.0 114.644 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.4 131.28 5.87 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 7.2 t80 -98.26 143.83 28.34 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.231 -0.987 . . . . 0.0 113.14 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.9 t70 -133.62 156.8 47.21 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 56.1 t80 -97.03 176.55 5.91 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.286 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.723 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 127.98 -13.16 6.42 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.8 m-20 166.06 -89.4 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 47.6 m-85 -152.24 99.2 2.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.18 108.52 10.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.79 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -119.95 115.43 23.76 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.821 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 t -105.97 138.38 42.26 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.243 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.501 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -90.19 133.0 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.135 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -143.04 93.87 2.56 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.466 1.127 . . . . 0.0 108.499 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 80' ' ' LYS . 11.6 t -153.59 -25.33 0.14 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.693 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 44.01 11.67 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.393 -2.185 . . . . 0.0 114.128 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.7 mmtp -97.91 152.85 18.79 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 107' ' ' ILE . 26.6 tp -49.7 -18.63 0.49 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.894 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' LYS . 32.9 mt-30 -59.01 -22.02 59.98 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.801 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 107' ' ' ILE . 37.3 t0 -64.47 -39.93 94.73 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.056 -1.457 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 78.3 p -46.37 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -170.87 165.04 38.24 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -85.59 109.34 18.47 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.27 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.6 m-30 -95.82 142.16 28.41 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.3 tp -151.9 117.19 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.703 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 3.1 mt -88.51 155.73 19.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.667 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -135.38 109.44 8.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.938 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.4 tt . . . . . 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.071 -179.874 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.61 0.243 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.2 mttt -132.72 102.95 5.87 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -98.33 146.13 25.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.38 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.97 117.16 12.64 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.651 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.87 116.92 27.5 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.78 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.545 HD13 ' CG2' ' A' ' 9' ' ' VAL . 1.6 mm? -103.97 128.33 51.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.0 tp -146.06 100.25 3.36 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -119.8 163.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.792 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 54.1 tp -104.13 159.54 15.6 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.517 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 CA-C-O 116.306 -1.807 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.893 0.378 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.9 p -140.15 110.63 6.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.34 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 31.3 tt0 -123.89 160.36 27.66 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.499 ' C ' ' CD ' ' A' ' 8' ' ' GLU . 12.3 tm-20 -126.85 121.94 33.29 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.521 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -114.81 136.37 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 11' ' ' GLY . 14.8 p -102.72 152.61 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.366 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.23 167.61 31.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' SER . 94.8 t -147.39 97.08 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.574 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.837 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 2.0 t 27.49 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.908 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.34 55.5 0.09 OUTLIER Glycine 0 C--N 1.287 -2.176 1 N-CA-C 103.025 -4.03 . . . . 0.0 103.025 -179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.837 ' NZ ' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -118.57 57.54 3.13 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 4.1 Cg_endo -69.44 112.28 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 104.96 -2.746 . . . . 0.0 104.96 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.51 161.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.521 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -105.07 112.38 25.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 103' ' ' PHE . 5.3 tp -91.85 125.55 36.6 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -147.97 98.32 3.83 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 117.06 -1.856 . . . . 0.0 115.071 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.12 131.53 22.34 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 120.965 1.11 . . . . 0.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.54 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.594 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.4 t -105.35 119.56 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.992 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.87 131.64 37.6 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.717 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.805 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 5.5 p-90 -136.02 116.29 13.54 Favored 'General case' 0 C--O 1.184 -2.367 0 C-N-CA 118.776 -1.169 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -103.65 153.91 20.11 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.417 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.814 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -150.54 160.42 43.8 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 118.306 -1.357 . . . . 0.0 113.432 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 m . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.579 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.307 0.575 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.94 136.92 32.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.835 HD13 HD22 ' A' ' 58' ' ' ASN . 94.3 mt -144.83 147.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.942 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -89.51 -26.78 20.71 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.229 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.805 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 12.1 mm 72.44 -93.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.4 OUTLIER -123.54 156.84 34.91 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 47' ' ' LEU . 64.0 t30 -137.67 97.41 3.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.597 -2.092 . . . . 0.0 105.943 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.594 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 2.9 t90 -94.55 132.28 39.4 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.723 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.579 ' C ' ' ND2' ' A' ' 51' ' ' ASN . 34.3 p90 -148.52 99.87 3.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.84 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.579 ' ND2' ' C ' ' A' ' 50' ' ' TYR . 4.1 p30 44.22 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.901 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER 40.83 26.95 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.764 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -127.16 81.9 0.35 Allowed Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -87.31 127.1 2.4 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.139 1.892 . . . . 0.0 111.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.3 p -130.23 142.67 50.54 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.293 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 18.7 m95 -101.09 160.77 14.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.481 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.521 ' H ' ' HZ ' ' A' ' 61' ' ' PHE . 41.3 t -158.64 82.28 0.81 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.243 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.835 HD22 HD13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -176.13 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.828 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.722 HG23 ' C ' ' A' ' 58' ' ' ASN . 1.1 t 68.08 -46.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.183 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASN . 23.8 m -62.91 15.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.78 ' O ' ' N ' ' A' ' 63' ' ' ASP . 45.9 m-85 -56.99 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.567 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 63' ' ' ASP . 39.0 p 32.77 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.78 ' N ' ' O ' ' A' ' 61' ' ' PHE . 9.6 t0 -88.77 92.03 9.05 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.881 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -154.79 -173.18 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.881 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.04 163.69 19.41 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.598 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 130.35 5.13 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 11.6 t80 -89.32 155.73 19.18 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.446 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 4.1 m-20 -142.14 152.7 43.47 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.576 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.521 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 18.9 t80 -101.06 -179.49 4.06 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.115 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 121.8 -1.97 10.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 105.07 -3.212 . . . . 0.0 105.07 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.652 ' CG ' ' N ' ' A' ' 72' ' ' PHE . 1.8 t70 161.15 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 111.159 -2.52 . . . . 0.0 105.178 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.652 ' N ' ' CG ' ' A' ' 71' ' ' ASP . 46.2 m-85 -150.14 106.36 3.47 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.62 149.58 45.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.094 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -144.58 116.35 8.23 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.228 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.417 ' H ' ' HG ' ' A' ' 75' ' ' SER . 30.0 p -102.59 140.7 36.52 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.114 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -95.82 125.57 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.727 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ILE . 24.5 ttpt -135.69 93.78 2.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' LYS . 3.7 t -154.96 -30.05 0.1 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 113.301 -1.772 . . . . 0.0 107.097 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.908 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.35 14.81 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 111.957 -2.383 . . . . 0.0 113.499 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' SER . 7.6 mmtt -103.45 148.45 25.9 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.388 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 80' ' ' LYS . 11.3 tp -41.89 -25.91 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.084 -1.047 . . . . 0.0 109.688 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.51 HE21 ' HB2' ' A' ' 80' ' ' LYS . 7.5 pt20 -57.32 -17.73 13.6 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -64.59 -57.14 9.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.586 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.793 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -40.91 118.39 0.98 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.662 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.03 163.92 35.03 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -85.33 102.67 13.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.553 ' OH ' HD11 ' A' ' 76' ' ' ILE . 2.1 m-30 -89.27 149.6 23.0 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.656 -0.817 . . . . 0.0 112.254 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.56 110.25 5.31 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.677 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -88.49 100.41 13.03 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.338 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -106.63 120.49 42.09 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.104 179.792 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -133.35 130.29 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.596 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 1.9 m120 -107.01 114.34 28.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.179 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.638 ' CD2' HD11 ' A' ' 19' ' ' LEU . 7.1 m-85 -112.67 107.12 15.68 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -90.57 101.64 14.38 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.858 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 9' ' ' VAL . 3.4 mm? -91.04 113.89 26.27 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.8 tp -118.56 100.38 7.41 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.966 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.793 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -116.42 161.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.685 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 63.8 tp -107.0 154.45 21.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.645 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 33.1 t70 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 116.315 -1.802 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.868 ' SG ' ' N ' ' A' ' 100' ' ' ASN . 2.7 t . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 121.354 0.597 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 4.9 Cg_endo -74.92 23.68 0.39 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 121.584 1.523 . . . . 0.0 110.081 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 2' ' ' CYS . 1.2 t70 73.99 97.68 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.232 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -150.92 160.62 43.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.187 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -138.12 158.17 44.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.46 160.43 43.46 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.59 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' OE1' ' CB ' ' A' ' 104' ' ' GLN . 35.5 tp10 -131.12 98.75 4.66 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.77 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -99.73 142.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.285 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 106' ' ' LEU . 10.9 p -129.88 143.13 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.162 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.765 ' H ' HG22 ' A' ' 107' ' ' ILE . . . -154.13 163.14 30.89 Favored Glycine 0 N--CA 1.496 2.667 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.335 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.741 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.4 p -123.57 97.44 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.849 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 12' ' ' VAL . 14.2 m 38.82 75.2 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.711 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 142.36 64.39 0.03 OUTLIER Glycine 0 C--N 1.293 -1.842 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.58 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 7.1 tppt? -121.11 56.18 5.38 Favored Pre-proline 0 C--O 1.209 -1.065 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -70.15 132.31 22.44 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 N-CA-C 105.585 -2.506 . . . . 0.0 105.585 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG12 ' HB ' ' A' ' 76' ' ' ILE . 1.0 OUTLIER -150.56 161.74 3.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 117.338 -1.745 . . . . 0.0 112.811 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -107.68 106.02 16.15 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mp -88.89 127.44 35.64 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -151.42 96.46 3.21 Favored Pre-proline 0 N--CA 1.501 2.117 0 C-N-CA 116.169 -2.213 . . . . 0.0 116.911 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB3' ' CE ' ' A' ' 101' ' ' LYS . 2.7 Cg_exo -71.43 147.83 53.21 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.031 1.154 . . . . 0.0 110.041 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 t -132.59 161.12 34.67 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.761 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.34 97.35 0.07 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -150.51 9.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.504 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' CG ' ' C ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER 59.95 -7.97 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.367 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.581 ' H ' HG12 ' A' ' 24' ' ' ILE . 38.6 p 45.27 88.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.762 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -141.99 -174.77 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.152 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 13.6 p-10 -52.92 104.55 0.09 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.703 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 27' ' ' LYS . 26.0 m -150.23 177.62 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -139.16 139.53 37.6 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.809 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.6 t -102.07 137.04 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 118.874 -1.13 . . . . 0.0 112.299 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -150.41 130.46 13.48 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.973 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.747 ' CH2' HD13 ' A' ' 74' ' ' LEU . 2.7 p-90 -141.56 108.02 5.3 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.8 pttp -100.79 161.0 13.9 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.036 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.838 ' HZ2' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -147.11 160.6 42.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.844 -1.142 . . . . 0.0 111.987 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 m -110.21 106.13 15.45 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.301 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -103.98 100.79 10.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.083 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.544 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 46.1 tp60 -96.79 164.66 12.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.811 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 89.08 95.41 1.06 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.07 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m 54.64 5.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.98 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.559 ' H ' ' C ' ' A' ' 39' ' ' GLY . 91.8 m-70 -121.38 -159.07 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 43' ' ' LYS . 49.4 mtt180 -157.22 -159.8 0.89 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.544 ' NZ ' ' OE1' ' A' ' 38' ' ' GLN . 6.1 mmpt? -88.64 150.73 22.88 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.332 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.636 HG21 HD13 ' A' ' 46' ' ' ILE . 87.8 mt -144.86 147.68 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.667 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 11.7 mp0 -96.66 -24.12 16.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.838 HD11 ' HZ2' ' A' ' 35' ' ' LYS . 22.6 mm 68.22 -107.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' CB ' ' HE1' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -112.9 154.87 25.69 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.48 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.8 p30 -139.88 98.95 3.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.089 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' CZ2' ' N ' ' A' ' 52' ' ' ASP . 8.1 t90 -94.76 129.95 41.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.458 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' O ' ' A' ' 53' ' ' GLY . 34.6 p90 -149.76 100.38 2.96 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.93 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 1.5 t-20 51.13 83.89 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.239 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 26.2 t70 45.34 27.45 0.36 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.78 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.06 79.13 0.36 Allowed Glycine 0 N--CA 1.507 3.367 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.723 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 15.0 Cg_endo -87.76 120.15 1.39 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.362 2.041 . . . . 0.0 111.717 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.47 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -129.71 155.03 46.56 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.851 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.499 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 44.2 m95 -102.62 164.34 11.71 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.888 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 38.8 t -158.51 79.39 0.8 Allowed 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 118.215 -1.394 . . . . 0.0 113.248 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.4 t30 158.77 80.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.558 1.161 . . . . 0.0 109.461 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.451 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -47.07 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.34 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 58' ' ' ASN . 0.6 OUTLIER 174.4 2.05 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.369 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HD1' HD13 ' A' ' 64' ' ' ILE . 20.9 m-30 -79.71 38.33 0.38 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.278 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 t -78.51 -7.68 57.75 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.2 t0 -150.53 95.03 2.18 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.714 -2.948 . . . . 0.0 105.76 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.838 HG23 ' N ' ' A' ' 65' ' ' TYR . 1.4 tp -151.82 -174.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.838 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.01 161.69 26.09 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 112.944 -1.934 . . . . 0.0 113.78 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.05 137.32 9.38 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 154.77 19.86 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.275 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -137.3 145.77 43.84 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -97.09 -179.27 4.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.36 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 119.28 1.95 13.78 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 105.604 -2.998 . . . . 0.0 105.604 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' C ' ' CD1' ' A' ' 72' ' ' PHE . 1.6 m-20 156.43 -99.06 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 111.959 -2.12 . . . . 0.0 105.905 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 71' ' ' ASP . 78.1 m-85 -153.34 102.46 2.6 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.978 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.84 150.5 31.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.343 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.747 HD13 ' CH2' ' A' ' 33' ' ' TRP . 1.2 pp -144.87 146.03 31.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 m -120.25 146.01 46.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.6 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.548 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -92.05 130.87 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.992 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt -140.99 92.87 2.53 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 80' ' ' LYS . 31.1 t -151.71 -33.84 0.14 Allowed 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.743 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.711 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 48.7 15.82 0.1 Allowed 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 112.398 -2.183 . . . . 0.0 112.593 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' GLN . 10.5 mmtm -99.61 142.22 31.38 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 119.054 -1.059 . . . . 0.0 110.328 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 81' ' ' LEU . 2.6 tp -44.08 -15.75 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.269 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.1 pt20 -65.81 -22.53 66.56 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.413 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.6 OUTLIER -59.38 -33.9 71.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.207 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 58.4 p -45.89 100.06 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.63 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.58 162.14 35.18 Favored Glycine 0 N--CA 1.482 1.733 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.457 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -87.1 107.76 18.59 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.796 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' OH ' HD11 ' A' ' 76' ' ' ILE . 1.8 m-30 -87.78 151.12 23.13 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.642 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -141.16 109.03 5.68 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.742 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.87 126.71 35.81 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.887 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.6 137.23 28.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 29' ' ' VAL . 18.5 tt -109.58 159.87 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -87.61 159.49 18.55 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 50.57 86.8 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.472 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -82.87 162.3 21.64 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.143 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.05 111.93 0.3 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.35 -173.89 25.56 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.411 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -44.24 -34.93 2.06 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.075 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -40.14 151.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.279 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.72 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 15.0 p -168.66 -98.49 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.439 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.868 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 1.4 p30 -152.1 160.25 43.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.422 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' CE ' ' HB3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -145.51 155.18 42.93 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.348 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -134.12 124.69 26.53 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.283 -0.967 . . . . 0.0 112.413 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.1 118.96 38.11 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.403 ' CB ' ' OE1' ' A' ' 8' ' ' GLU . 49.4 mt-30 -89.36 120.3 30.58 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.219 -0.993 . . . . 0.0 112.069 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.553 HD13 ' CG2' ' A' ' 9' ' ' VAL . 2.8 mm? -108.4 123.71 49.27 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.1 tp -139.75 99.01 3.6 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.765 HG22 ' H ' ' A' ' 11' ' ' GLY . 11.0 pt -124.45 164.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.841 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 HD22 ' C ' ' A' ' 107' ' ' ILE . 3.4 mm? -108.53 -175.32 2.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.905 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' C ' ' OG ' ' A' ' 13' ' ' SER . 15.5 t70 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.8 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 2' ' ' CYS . 2.2 Cg_endo -65.16 164.73 24.23 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 121.14 1.227 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 3' ' ' PRO . 62.7 m-20 -42.88 106.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.604 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -148.85 144.89 27.22 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.327 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -125.46 123.09 38.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -136.61 160.39 38.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.06 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 1.2 pp20? -143.0 109.22 5.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.82 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.92 156.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.319 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' O ' ' NZ ' ' A' ' 15' ' ' LYS . 14.2 p -121.45 151.2 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.972 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.59 167.27 31.46 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.067 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -142.56 97.37 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.097 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 83.9 p 35.19 81.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.846 0.832 . . . . 0.0 108.853 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.7 68.58 0.09 OUTLIER Glycine 0 C--N 1.29 -1.994 0 N-CA-C 104.401 -3.48 . . . . 0.0 104.401 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.56 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 tpmt? -119.54 79.48 21.83 Favored Pre-proline 0 C--O 1.204 -1.307 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 19.3 Cg_endo -93.65 95.88 0.14 Allowed 'Trans proline' 0 N--CA 1.439 -1.701 0 N-CA-C 104.831 -2.796 . . . . 0.0 104.831 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 18' ' ' GLN . 9.3 p -112.89 161.58 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.1 tt0 -109.95 100.08 9.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.479 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' LEU . 2.7 tp -88.76 107.56 19.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -135.54 101.33 10.93 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -67.44 125.55 13.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 O-C-N 122.893 0.944 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 60.2 p -121.75 163.34 19.25 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.179 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 22' ' ' SER . 0.2 OUTLIER 83.76 56.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 123.71 0.631 . . . . 0.0 109.349 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.577 ' CG2' ' SG ' ' A' ' 2' ' ' CYS . 1.1 pp -113.14 -170.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.557 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -160.33 3.95 0.08 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.735 -1.575 . . . . 0.0 107.653 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.631 ' OG1' HG21 ' A' ' 29' ' ' VAL . 2.4 t -102.63 154.2 19.36 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' A' ' 28' ' ' ASP . 12.7 mtmt -160.97 146.27 14.25 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.599 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER 70.6 17.99 6.54 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.84 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.79 HG12 ' H ' ' A' ' 30' ' ' SER . 21.7 t -96.67 178.52 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.608 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.79 ' H ' HG12 ' A' ' 29' ' ' VAL . 14.0 p -89.84 144.92 25.54 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.581 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 36.3 t -123.31 135.94 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -149.92 139.27 21.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.525 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.639 ' HB3' HD22 ' A' ' 89' ' ' LEU . 10.1 p-90 -142.56 112.98 7.23 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -98.12 159.81 14.7 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.515 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.586 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.34 159.25 44.44 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.125 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -111.81 103.71 11.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.394 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 42' ' ' ARG . 5.3 mt-10 -100.85 100.57 11.24 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.419 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.618 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 12.3 tt0 -93.16 179.78 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.871 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 80.24 75.53 1.05 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.85 -7.99 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.796 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.63 ' H ' ' C ' ' A' ' 39' ' ' GLY . 82.0 m-70 -95.26 -160.99 0.82 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtt85 -153.92 167.33 30.08 Favored 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 117.757 -1.577 . . . . 0.0 113.302 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -93.12 138.43 31.56 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.025 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -151.79 168.67 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.847 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 3.7 mp0 -83.9 -22.44 31.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.673 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.742 ' H ' ' CG2' ' A' ' 44' ' ' ILE . 4.0 mm 70.2 -109.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.646 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -99.47 151.07 21.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.545 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -140.5 100.77 3.95 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.276 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.581 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.65 130.55 46.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.757 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.7 t80 -137.03 97.69 3.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.147 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.54 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER 65.38 -60.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.128 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.8 p30 -159.81 32.18 0.18 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.101 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.86 87.17 0.39 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.102 -1.047 . . . . 0.0 110.532 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -87.83 108.08 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 122.512 2.142 . . . . 0.0 110.329 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.475 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -132.38 143.73 50.03 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.501 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 3.6 m95 -87.85 161.43 17.52 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.163 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.652 ' N ' ' O ' ' A' ' 46' ' ' ILE . 52.7 m -124.92 78.71 1.72 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.572 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 1.2 m-80 70.71 -40.84 0.48 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.822 ' O ' ' N ' ' A' ' 61' ' ' PHE . 1.5 t -43.52 117.04 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.166 -3.311 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.352 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 62' ' ' SER . 22.8 t -18.14 54.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.822 ' N ' ' O ' ' A' ' 59' ' ' VAL . 17.7 m-85 -63.12 76.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 117.491 -1.684 . . . . 0.0 112.377 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 60' ' ' SER . 0.3 OUTLIER -148.23 -22.49 0.34 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' ILE . 18.7 t0 -147.79 90.94 1.89 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -156.87 -171.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 117.119 -1.832 . . . . 0.0 115.892 -178.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.883 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.65 163.5 21.27 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 111.186 -2.734 . . . . 0.0 114.935 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.09 127.55 5.17 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.3 t80 -93.97 158.94 15.4 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.535 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 3.7 m-20 -145.01 151.46 38.61 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.343 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.774 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 61.1 t80 -107.93 174.05 6.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.483 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.774 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 123.84 -7.78 8.78 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 105.931 -2.868 . . . . 0.0 105.931 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 72' ' ' PHE . 7.0 t70 173.92 -103.49 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 111.515 -2.342 . . . . 0.0 104.855 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 87.0 m-85 -152.55 109.08 3.43 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 68' ' ' ASP . . . -138.54 145.1 40.29 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.185 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -151.14 117.82 5.77 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.858 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.566 ' N ' HD13 ' A' ' 74' ' ' LEU . 33.3 t -109.18 139.83 43.58 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.508 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -95.51 130.37 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.141 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -142.61 94.56 2.66 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.887 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -151.74 -31.84 0.15 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.825 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' H ' ' A' ' 15' ' ' LYS . . . 55.12 40.43 31.83 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 112.664 -2.062 . . . . 0.0 114.791 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 82' ' ' GLN . 4.2 mtpp -142.0 158.87 43.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.795 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 81' ' ' LEU . 10.9 mp -43.48 -23.19 0.06 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.528 ' CG ' ' CE1' ' A' ' 41' ' ' HIS . 51.0 mt-30 -52.4 -32.81 40.72 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 117.654 -1.618 . . . . 0.0 107.832 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.7 m-20 -66.51 -41.03 89.45 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.737 ' HG ' ' H ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -57.49 105.04 0.21 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.269 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.06 164.95 37.06 Favored Glycine 0 C--N 1.284 -2.348 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.694 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.463 ' NE2' ' HB2' ' A' ' 102' ' ' ASN . 13.1 t-160 -86.14 105.22 16.39 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.649 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 2.2 m-30 -88.39 155.22 19.81 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.307 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.562 ' C ' HD13 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -145.64 105.22 3.97 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.29 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.46 122.81 33.01 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.923 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -143.83 139.63 29.41 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.01 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.533 ' N ' ' OE2' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -102.68 160.88 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.217 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 1.027 HG22 ' H ' ' A' ' 93' ' ' ASN . 90.5 m 56.64 -171.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.247 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 1.027 ' H ' HG22 ' A' ' 92' ' ' THR . 37.9 m-80 -83.75 -19.95 34.22 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.443 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 2.5 t -138.51 175.27 9.71 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.472 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . -94.47 -164.19 35.79 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.447 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 140.54 89.24 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.176 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 96' ' ' GLY . 32.5 pttt 35.9 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.381 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.06 HG22 ' H ' ' A' ' 99' ' ' CYS . 6.8 p -120.87 -170.53 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.005 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 1.06 ' H ' HG22 ' A' ' 98' ' ' VAL . 5.7 t -57.77 102.57 0.1 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.46 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -149.88 100.6 2.96 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.051 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -144.61 160.44 41.16 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.819 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -121.16 127.19 51.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.496 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.31 139.4 41.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.504 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.26 107.66 14.69 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.095 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 9' ' ' VAL . 2.4 mm? -89.05 125.49 35.03 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.61 98.05 4.55 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.737 ' H ' ' HG ' ' A' ' 84' ' ' SER . 1.2 pt -122.6 162.62 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 28.8 tp -150.67 151.13 32.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.379 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.465 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 40.3 t0 . . . . . 0 C--N 1.307 -1.267 0 CA-C-O 116.364 -1.779 . . . . 0.0 110.855 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.375 0.607 . . . . 0.0 111.485 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 5.5 Cg_endo -68.07 -161.08 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 121.552 1.501 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.53 131.82 53.92 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.931 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 m -137.41 132.65 33.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.271 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 m -150.08 109.39 3.96 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.433 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -134.65 147.68 50.21 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.669 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -104.5 104.78 14.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.57 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -93.31 159.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.846 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.39 151.79 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.975 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.54 30.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.101 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 7.5 p -147.6 96.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.156 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.819 ' N ' ' HZ1' ' A' ' 15' ' ' LYS . 54.3 p 33.61 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 122.235 1.016 . . . . 0.0 108.706 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.069 ' N ' ' HZ3' ' A' ' 15' ' ' LYS . . . 124.21 62.71 0.19 Allowed Glycine 0 C--N 1.296 -1.693 0 N-CA-C 103.362 -3.895 . . . . 0.0 103.362 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 1.101 ' HZ1' ' C ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -119.44 60.34 5.63 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.0 Cg_endo -69.81 97.0 0.62 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 N-CA-C 104.767 -2.82 . . . . 0.0 104.767 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 ' HB ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -101.92 161.19 3.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 119.164 -1.014 . . . . 0.0 112.966 -179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.75 109.46 15.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.885 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -87.21 124.21 33.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -136.83 93.39 13.75 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 116.923 -1.911 . . . . 0.0 115.337 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -78.36 104.61 1.85 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 O-C-N 123.448 1.236 . . . . 0.0 109.468 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' ' CG ' ' A' ' 23' ' ' ASN . 3.6 m -129.23 97.76 4.69 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 22' ' ' SER . 70.0 m-80 -165.98 13.14 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.795 ' CD1' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -94.89 -161.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.263 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.484 ' N ' HG12 ' A' ' 24' ' ' ILE . 8.1 pt20 -135.62 2.76 2.96 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.758 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.577 ' H ' HG12 ' A' ' 24' ' ' ILE . 4.5 p 59.26 114.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.031 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 177.84 10.92 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.241 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.62 93.03 0.23 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.662 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 91' ' ' ILE . 18.9 m -143.72 149.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.84 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 m -90.52 139.04 31.07 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.811 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.617 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 4.4 t -106.66 135.06 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.188 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -150.14 127.84 11.66 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.231 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.732 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.5 p-90 -131.49 147.06 52.51 Favored 'General case' 0 C--O 1.193 -1.876 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.212 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -137.47 154.26 49.93 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.642 ' HZ2' ' HG2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -153.43 158.6 41.65 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 117.865 -1.534 . . . . 0.0 113.718 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.27 97.23 7.53 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.642 ' HG2' ' HZ2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.35 -174.85 4.23 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 117.78 -1.568 . . . . 0.0 113.908 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.862 ' NE2' ' H ' ' A' ' 39' ' ' GLY . 41.3 tp60 55.62 160.99 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.66 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.862 ' H ' ' NE2' ' A' ' 38' ' ' GLN . . . 38.14 84.42 0.01 OUTLIER Glycine 0 N--CA 1.501 2.97 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.8 t 47.07 34.5 2.87 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.67 -1.212 . . . . 0.0 108.897 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 21.9 m170 55.55 71.04 0.57 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 43' ' ' LYS . 5.3 tpm_? -86.51 174.91 8.64 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.029 -1.068 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' H ' ' HG3' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -86.7 131.37 34.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.195 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.597 HG21 HD13 ' A' ' 46' ' ' ILE . 4.4 mm -131.25 146.22 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.97 -24.94 13.93 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.769 HD12 ' CE2' ' A' ' 65' ' ' TYR . 8.3 mm 62.64 -111.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -107.51 154.94 20.65 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.683 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.1 t-20 -137.41 98.58 3.74 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.298 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.617 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 3.7 t90 -92.58 133.02 36.36 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.665 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 52' ' ' ASP . 24.3 t80 -140.36 98.36 3.41 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.682 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 3.0 t30 68.54 -55.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.204 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 50' ' ' TYR . 24.5 t0 -171.14 31.3 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.21 90.02 0.42 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.49 101.65 0.6 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.203 1.935 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.94 140.2 49.74 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.52 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 7.9 m95 -90.18 162.2 15.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.6 p -151.83 80.5 1.27 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.665 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.579 ' ND2' ' CD1' ' A' ' 44' ' ' ILE . 2.5 t30 175.58 11.9 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 O-C-N 124.623 1.202 . . . . 0.0 112.594 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 58' ' ' ASN . 4.5 m 31.45 31.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 58' ' ' ASN . 89.3 p -122.89 6.13 9.34 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.705 ' HA ' HD13 ' A' ' 64' ' ' ILE . 20.4 m-85 -71.46 45.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -15.42 17.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -150.62 95.95 2.3 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.87 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.98 -173.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.275 0 C-N-CA 117.238 -1.785 . . . . 0.0 115.294 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.87 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -70.14 163.58 26.0 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 111.786 -2.461 . . . . 0.0 115.276 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -127.1 116.22 2.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 107.15 -2.38 . . . . 0.0 107.15 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CG ' ' N ' ' A' ' 68' ' ' ASP . 42.3 t80 -99.1 158.94 15.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.505 ' N ' ' CG ' ' A' ' 67' ' ' PHE . 17.3 m-20 -143.18 141.32 31.11 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.984 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -107.24 177.61 4.8 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.584 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.32 81.81 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 104.961 -3.255 . . . . 0.0 104.961 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 71' ' ' ASP . 2.5 t0 167.87 130.33 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -81.21 112.58 18.67 Favored 'General case' 0 C--N 1.259 -3.352 0 C-N-CA 117.59 -1.644 . . . . 0.0 109.86 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.83 111.43 5.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.288 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 75' ' ' SER . 3.4 tm? -104.59 146.89 28.27 Favored 'General case' 0 C--O 1.199 -1.589 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.311 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.81 ' N ' HD13 ' A' ' 74' ' ' LEU . 48.6 p -140.31 130.58 25.14 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.344 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.545 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -88.6 130.93 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.055 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.99 93.94 2.83 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.963 1.363 . . . . 0.0 108.27 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.1 p -151.77 -39.98 0.11 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.535 -2.121 . . . . 0.0 105.819 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.814 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.8 20.57 2.34 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 111.321 -2.672 . . . . 0.0 115.104 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 83' ' ' ASP . 32.9 mmtt -98.96 142.95 29.81 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.329 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 80' ' ' LYS . 12.0 tp -45.04 -31.77 1.46 Allowed 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.624 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -59.52 -34.83 73.12 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.074 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.584 ' OD1' ' CD1' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -53.26 -47.66 68.9 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.908 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.627 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -37.07 124.57 0.92 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.228 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 87' ' ' TYR . . . -173.05 166.47 39.02 Favored Glycine 0 C--N 1.278 -2.686 0 C-N-CA 118.394 -1.86 . . . . 0.0 110.784 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -88.27 106.32 18.14 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.544 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.45 150.9 28.19 Favored 'General case' 0 N--CA 1.51 2.556 0 C-N-CA 119.083 -1.047 . . . . 0.0 113.503 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.782 HD22 ' C ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -150.8 142.14 23.33 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.035 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -95.6 146.15 24.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.791 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' H ' HD13 ' A' ' 89' ' ' LEU . 40.0 mt-10 -143.34 124.24 14.31 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.62 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 29' ' ' VAL . 2.0 tt -101.25 160.61 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.434 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 93' ' ' ASN . 13.9 t -53.48 177.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 92' ' ' THR . 2.5 t30 71.15 157.91 0.18 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.567 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 5.1 t -155.92 175.85 13.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.941 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.422 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . 74.35 148.25 1.45 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.503 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.11 -96.23 1.09 Allowed Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.352 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -74.98 136.07 41.31 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.695 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 99' ' ' CYS . 10.1 p -62.04 -42.8 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.117 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 66.9 m 50.1 59.63 4.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.572 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.442 HD22 ' HG2' ' A' ' 90' ' ' GLU . 29.7 m120 -151.31 105.16 3.17 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.195 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.519 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 2.0 mptt -102.77 106.01 16.54 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.747 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -88.45 160.18 17.65 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' TYR . 62.6 m-85 -150.08 129.71 13.14 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.277 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.67 106.42 16.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.722 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.57 HD22 HG22 ' A' ' 9' ' ' VAL . 2.6 mm? -97.92 98.4 9.77 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tp -107.21 100.16 9.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.397 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.627 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.6 164.07 10.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.97 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.27 -154.61 0.53 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.811 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.896 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 47.3 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.088 0.47 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 9.9 Cg_endo -78.82 -167.64 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.955 1.77 . . . . 0.0 111.563 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -113.41 84.37 2.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.232 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m -90.47 140.97 29.22 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.304 -0.958 . . . . 0.0 112.381 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 p -147.61 98.88 3.04 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.668 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' OE2' ' C ' ' A' ' 8' ' ' GLU . 6.5 tm-20 -115.03 154.66 28.42 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.202 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' OE2' ' A' ' 7' ' ' GLU . 4.4 tm-20 -129.57 99.38 5.14 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.399 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -100.23 151.19 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.657 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.41 150.19 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -151.79 167.39 31.02 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.625 ' H ' ' HZ1' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -140.57 107.43 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.579 -0.849 . . . . 0.0 110.342 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.602 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 7.82 85.54 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 122.051 0.929 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.807 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.52 53.07 0.06 OUTLIER Glycine 0 C--N 1.282 -2.424 1 N-CA-C 101.604 -4.598 . . . . 0.0 101.604 -179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.645 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -108.08 53.69 0.22 Allowed Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 1.6 Cg_endo -68.18 107.29 1.52 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 103.509 -3.304 . . . . 0.0 103.509 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 18' ' ' GLN . 3.6 p -129.24 161.21 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 118.609 -1.237 . . . . 0.0 114.151 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.409 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -102.45 112.76 25.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.827 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.517 HD11 ' CG ' ' A' ' 103' ' ' PHE . 28.4 tp -100.16 101.18 12.15 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -123.04 97.27 43.76 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.26 114.11 3.52 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 120.844 1.029 . . . . 0.0 109.628 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 35.7 t -115.16 163.01 16.26 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.9 t30 79.5 84.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.549 0.69 . . . . 0.0 109.751 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -137.94 -162.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.95 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' O ' ' CG ' ' A' ' 25' ' ' GLN . 3.1 tt0 -152.71 -9.0 0.18 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.8 ' OG1' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -102.02 125.82 48.8 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.736 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -130.99 159.27 37.97 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.376 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.57 42.01 31.99 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.484 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG21 ' OG1' ' A' ' 26' ' ' THR . 1.5 m -119.96 -179.84 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.566 ' HG ' ' HD1' ' A' ' 50' ' ' TYR . 73.3 m -88.53 145.33 25.79 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.367 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 49' ' ' TRP . 2.1 t -123.09 146.08 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 119.204 -0.999 . . . . 0.0 112.47 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -150.83 127.7 11.01 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.546 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.792 ' CE2' HD22 ' A' ' 74' ' ' LEU . 5.0 p-90 -133.58 103.5 5.94 Favored 'General case' 0 C--O 1.201 -1.49 0 C-N-CA 118.565 -1.254 . . . . 0.0 110.345 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 15.3 tttt -94.89 160.86 14.4 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.938 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.612 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -146.17 158.89 43.9 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 m -125.1 98.88 5.86 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.88 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -97.32 129.59 44.58 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.112 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.594 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 6.9 tt0 -93.73 179.09 5.47 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.528 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 86.79 -156.89 29.26 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 t -59.6 6.48 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.754 -1.178 . . . . 0.0 110.002 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.669 ' CD2' ' N ' ' A' ' 41' ' ' HIS . 0.1 OUTLIER -88.35 -136.38 0.1 Allowed 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.369 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.35 -160.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.047 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -88.66 154.58 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.504 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.615 HG23 ' CG ' ' A' ' 58' ' ' ASN . 39.1 mt -150.4 138.19 14.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 C-N-CA 118.018 -1.473 . . . . 0.0 113.079 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 18.2 mm-40 -89.25 -30.8 18.24 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 47' ' ' LEU . 31.6 mm 72.54 -101.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 46' ' ' ILE . 6.7 tt -125.24 153.57 42.98 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.8 t30 -133.17 99.05 4.43 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.817 -1.992 . . . . 0.0 106.429 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.567 ' N ' ' O ' ' A' ' 31' ' ' VAL . 3.8 t90 -89.51 121.88 32.15 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.647 -0.821 . . . . 0.0 113.089 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.566 ' HD1' ' HG ' ' A' ' 30' ' ' SER . 72.9 t80 -135.8 98.33 3.88 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.631 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.6 t30 64.53 -168.52 0.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.93 33.49 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 117.964 -1.494 . . . . 0.0 110.292 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -127.56 85.62 0.33 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 120.103 -1.046 . . . . 0.0 110.668 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.41 141.25 6.7 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.156 1.904 . . . . 0.0 110.473 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.0 p -136.33 139.15 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.575 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 11.8 m95 -91.24 161.19 15.16 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.591 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.46 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 41.0 t -159.96 79.96 0.7 Allowed 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 118.721 -1.192 . . . . 0.0 112.259 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.726 ' C ' HG23 ' A' ' 59' ' ' VAL . 28.8 t30 -179.4 -17.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.804 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.754 ' C ' ' H ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER 67.59 -37.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.109 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.537 ' OG ' ' ND2' ' A' ' 58' ' ' ASN . 0.7 OUTLIER -63.15 20.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.423 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.754 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.5 m-85 -86.24 46.19 1.31 Allowed 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -95.71 -10.62 28.78 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.05 104.54 5.06 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 109.762 -3.381 . . . . 0.0 103.229 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -144.64 -176.35 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -95.78 162.6 13.53 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 109.48 -3.509 . . . . 0.0 112.546 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.1 126.28 6.52 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 67' ' ' PHE . 34.5 t80 -88.05 144.94 26.22 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.044 -1.462 . . . . 0.0 112.726 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 29.4 t0 -152.06 167.07 29.63 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.003 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.62 ' CG ' ' HB3' ' A' ' 73' ' ' ALA . 3.0 m-85 88.06 131.0 0.04 OUTLIER 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.77 -27.04 69.38 Favored Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 105.138 -3.185 . . . . 0.0 105.138 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 15.5 m-20 -90.43 -102.75 0.1 Allowed 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.814 ' CE1' HD11 ' A' ' 91' ' ' ILE . 2.2 m-85 -154.04 106.44 2.82 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 117.426 -1.71 . . . . 0.0 112.088 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HB3' ' CG ' ' A' ' 69' ' ' TYR . . . -151.87 100.1 2.63 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.073 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.792 HD22 ' CE2' ' A' ' 33' ' ' TRP . 2.6 pp -115.06 146.89 40.83 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.259 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 p -109.2 141.71 41.06 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.354 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -96.0 137.3 24.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.02 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -143.43 94.75 2.65 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.645 1.212 . . . . 0.0 108.766 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 80' ' ' LYS . 6.4 t -156.21 -26.55 0.1 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 113.188 -1.824 . . . . 0.0 107.087 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.807 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.63 16.05 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 112.475 -2.148 . . . . 0.0 113.208 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLN . 5.5 mmmt -95.12 151.18 19.43 Favored 'General case' 0 C--N 1.279 -2.479 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.979 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 81' ' ' LEU . 3.0 tp -47.66 -11.84 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.226 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' LYS . 1.5 pt20 -72.75 -23.36 60.82 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.5 -27.85 58.35 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 118.374 -1.33 . . . . 0.0 108.423 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.668 ' HB2' ' H ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -74.01 114.55 12.45 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.657 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.48 164.19 35.79 Favored Glycine 0 C--N 1.274 -2.892 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.52 ' NE2' ' CD ' ' A' ' 104' ' ' GLN . 45.3 m80 -85.3 104.75 15.42 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 88' ' ' LEU . 2.5 m-30 -86.29 150.46 24.34 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -139.34 106.09 5.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.476 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.685 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.04 128.05 35.71 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.349 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -148.53 160.94 42.6 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.403 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.814 HD11 ' CE1' ' A' ' 72' ' ' PHE . 5.2 mt -134.57 148.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.992 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.503 ' C ' ' CG ' ' A' ' 93' ' ' ASN . 18.5 m -42.82 159.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.582 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.503 ' CG ' ' C ' ' A' ' 92' ' ' THR . 0.4 OUTLIER 74.51 138.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.861 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 96' ' ' GLY . 10.0 t -172.08 20.14 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.977 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -57.43 -5.02 1.5 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.612 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 94' ' ' THR . . . -170.03 -70.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.203 -1.475 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -44.81 133.13 6.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.522 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.604 ' C ' ' H ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -93.0 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.289 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.896 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -67.85 34.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.386 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 98' ' ' VAL . 1.7 p30 -98.33 116.69 31.08 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.468 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -121.04 118.57 30.13 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.49 139.4 39.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.786 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 19' ' ' LEU . 58.8 m-85 -136.23 102.56 5.03 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.716 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CD ' ' NE2' ' A' ' 86' ' ' HIS . 46.0 tt0 -89.9 107.2 18.96 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.248 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 9' ' ' VAL . 3.9 mm? -91.92 118.57 30.87 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -122.8 102.27 7.93 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.668 ' H ' ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -115.0 161.62 13.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.459 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 108' ' ' LEU . 8.0 mp -92.66 -171.0 2.61 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.6 t70 . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 116.419 -1.753 . . . . 0.0 110.851 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 33.3 m . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.245 0.545 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 2' ' ' CYS . 5.7 Cg_endo -74.13 162.9 37.85 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.963 1.775 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -111.34 102.55 10.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -150.44 160.72 43.55 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.78 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.6 t -134.32 141.11 46.8 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.353 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 8' ' ' GLU . 37.1 tp10 -125.17 151.54 45.68 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.864 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 36.8 mt-10 -114.27 132.05 56.29 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.634 HG13 HD13 ' A' ' 105' ' ' LEU . 1.5 p -136.68 132.29 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.562 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.24 154.26 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.544 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -151.51 165.87 30.58 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' O ' ' C ' ' A' ' 13' ' ' SER . 98.8 t -147.53 96.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 C-N-CA 119.025 -1.07 . . . . 0.0 109.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.5 t 30.27 79.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.016 0.912 . . . . 0.0 108.63 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.629 ' H ' ' HE2' ' A' ' 15' ' ' LYS . . . 135.68 59.34 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 104.43 -3.468 . . . . 0.0 104.43 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' HE2' ' H ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -113.13 50.81 0.44 Allowed Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 2.3 Cg_endo -66.32 91.45 0.27 Allowed 'Trans proline' 0 N--CA 1.441 -1.56 0 N-CA-C 105.331 -2.603 . . . . 0.0 105.331 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 18' ' ' GLN . 6.2 p -107.7 162.07 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 75' ' ' SER . 10.7 tp-100 -112.78 106.01 14.26 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.996 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.8 OUTLIER -87.98 103.19 15.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.66 96.55 48.83 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.75 105.39 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.125 1.217 . . . . 0.0 109.352 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 t -111.51 110.07 20.32 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.691 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.412 ' H ' ' H ' ' A' ' 24' ' ' ILE . 2.9 m-20 173.3 10.24 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.985 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.519 HG13 ' H ' ' A' ' 26' ' ' THR . 5.1 pt -107.4 177.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.198 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.787 ' H ' ' HZ3' ' A' ' 27' ' ' LYS . 6.3 pt20 -123.54 16.39 9.62 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.788 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.519 ' H ' HG13 ' A' ' 24' ' ' ILE . 68.9 p 45.9 91.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.512 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.787 ' HZ3' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -125.16 -160.9 0.98 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.479 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -81.59 81.36 7.7 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.378 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.458 ' H ' HD21 ' A' ' 51' ' ' ASN . 35.8 m -147.31 152.95 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.069 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.03 161.48 15.82 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 39.4 t -126.96 130.59 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.178 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -146.46 144.44 29.67 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.049 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.695 ' HB3' HD22 ' A' ' 89' ' ' LEU . 2.3 p-90 -143.74 119.28 10.37 Favored 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.429 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -102.84 158.56 16.18 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.038 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.774 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -147.8 161.63 40.86 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.203 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 43' ' ' LYS . 2.3 m -125.23 99.65 6.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.93 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HG3' ' H ' ' A' ' 42' ' ' ARG . 3.9 pt-20 -99.59 109.87 22.35 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.545 -0.862 . . . . 0.0 108.912 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -74.15 172.63 11.4 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.095 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' C ' ' N ' ' A' ' 41' ' ' HIS . . . 95.21 -165.88 25.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 m -48.89 -12.12 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.739 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.548 ' N ' ' C ' ' A' ' 39' ' ' GLY . 48.5 m-70 -82.16 -145.07 0.06 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.577 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.558 ' H ' ' HG3' ' A' ' 37' ' ' GLU . 1.7 ttp180 179.19 -172.63 0.16 Allowed 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 117.884 -1.526 . . . . 0.0 112.901 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -89.06 126.49 35.46 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.849 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.856 HD13 ' HA ' ' A' ' 59' ' ' VAL . 4.4 mt -137.39 163.01 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.411 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 23.8 mt-10 -86.12 -31.17 22.0 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.196 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.874 HD13 HG21 ' A' ' 59' ' ' VAL . 10.3 mm 83.79 -87.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.522 3.157 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.885 HD23 ' C ' ' A' ' 47' ' ' LEU . 1.1 tt -143.01 150.55 39.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.648 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -131.74 109.1 9.92 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.109 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.611 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 6.1 t90 -88.77 145.19 25.75 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 52' ' ' ASP . 14.1 m-85 -141.04 96.47 3.0 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.906 -1.117 . . . . 0.0 109.609 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . 29.2 m120 7.09 54.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.284 1.615 . . . . 0.0 113.413 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 50' ' ' TYR . 22.6 t70 -179.81 -55.23 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.621 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.18 152.43 23.61 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.489 -1.815 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -88.96 141.31 4.29 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.913 1.742 . . . . 0.0 112.371 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -127.99 137.37 52.2 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.5 m95 -89.3 161.12 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.472 -1.291 . . . . 0.0 113.731 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.2 m -124.07 68.51 1.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.862 -1.517 . . . . 0.0 110.693 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 31.33 90.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.223 0 O-C-N 124.932 1.395 . . . . 0.0 113.139 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.874 HG21 HD13 ' A' ' 46' ' ' ILE . 2.3 p -122.87 -37.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.06 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.602 ' N ' ' CG1' ' A' ' 59' ' ' VAL . 1.5 t 160.84 26.28 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.802 ' CD1' HG21 ' A' ' 64' ' ' ILE . 39.7 m-85 -54.47 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.091 1.425 . . . . 0.0 112.791 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.449 ' H ' ' H ' ' A' ' 63' ' ' ASP . 19.9 t -176.73 -21.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.05 101.65 2.89 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 102.163 -3.273 . . . . 0.0 102.163 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.987 ' H ' HD12 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -154.87 -173.3 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.82 ' CZ ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -77.22 165.17 24.87 Favored 'General case' 0 C--N 1.266 -3.041 0 CA-C-N 109.578 -3.465 . . . . 0.0 114.798 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.49 126.63 4.39 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.6 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 10.8 t80 -106.66 154.3 21.13 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.144 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 13.3 t70 -139.51 147.94 41.96 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.525 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 69' ' ' TYR . 12.6 p90 -102.85 174.29 5.94 Favored 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.443 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 82.68 12.18 80.48 Favored Glycine 0 N--CA 1.503 3.124 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER 157.62 127.59 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.633 ' HE2' HD11 ' A' ' 91' ' ' ILE . 6.9 m-30 -80.84 111.87 17.71 Favored 'General case' 0 C--N 1.264 -3.139 0 C-N-CA 117.314 -1.754 . . . . 0.0 108.684 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.24 105.56 5.75 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.6 tm? -100.54 128.99 46.43 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.051 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.524 ' N ' HD22 ' A' ' 74' ' ' LEU . 56.5 p -121.7 127.33 50.62 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.639 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.503 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -89.12 127.03 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.661 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -137.22 96.21 3.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.422 1.106 . . . . 0.0 108.459 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 64' ' ' ILE . 73.8 m -156.6 -33.8 0.08 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.81 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 47.42 64.9 1.41 Allowed 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 112.436 -2.165 . . . . 0.0 113.011 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.475 ' N ' ' HE3' ' A' ' 15' ' ' LYS . 37.1 mmtt -145.48 148.29 33.1 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.013 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 107' ' ' ILE . 51.8 tp -49.67 -30.93 9.96 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.991 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . 3.0 pp0? -53.53 -28.45 31.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 82' ' ' GLN . 8.9 m-20 -58.02 -57.39 13.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.379 -0.929 . . . . 0.0 111.479 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.667 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.7 OUTLIER -40.87 119.89 1.21 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.885 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.01 164.41 35.72 Favored Glycine 0 C--N 1.281 -2.501 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -85.78 103.88 14.95 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.231 -1.388 . . . . 0.0 108.273 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.774 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 1.1 m-30 -89.38 159.63 17.23 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.72 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.71 111.6 4.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.486 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.5 125.44 35.19 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -150.34 142.33 23.93 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.099 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.633 HD11 ' HE2' ' A' ' 72' ' ' PHE . 3.6 mt -98.28 160.1 3.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.521 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 53.8 m -57.27 -56.53 20.63 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.469 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.452 ' N ' HG22 ' A' ' 91' ' ' ILE . 42.6 t30 -153.38 159.96 42.53 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.706 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.415 HG21 ' SG ' ' A' ' 2' ' ' CYS . 20.2 m -163.35 -61.14 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 97' ' ' LYS . . . -162.16 -172.58 29.77 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.397 -1.383 . . . . 0.0 110.399 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.93 20.99 3.46 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.445 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 95' ' ' GLY . 6.3 mmpp? -94.46 -170.54 2.28 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.805 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.441 ' CG1' ' OD1' ' A' ' 100' ' ' ASN . 2.2 t -84.92 -52.5 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.308 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 4.5 t 58.47 62.21 2.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.488 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.441 ' OD1' ' CG1' ' A' ' 98' ' ' VAL . 19.4 p-10 -147.33 133.23 19.09 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.246 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.4 mptt -127.19 114.5 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' N ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m120 -93.38 135.54 34.51 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.347 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -132.5 105.59 7.33 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.555 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -89.44 99.26 12.29 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.225 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD13 HG13 ' A' ' 9' ' ' VAL . 3.7 mm? -89.38 110.4 21.21 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.18 99.43 6.86 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.518 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.667 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -113.28 163.04 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.281 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.9 mt -102.82 -163.86 1.03 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.25 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.791 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.5 Cg_endo -67.92 144.97 66.56 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.286 1.324 . . . . 0.0 111.326 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.39 108.53 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m -150.39 160.63 43.6 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.226 -0.989 . . . . 0.0 111.061 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 p -136.72 99.25 4.0 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.241 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -103.97 148.03 26.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' CB ' ' HG3' ' A' ' 104' ' ' GLN . 2.2 pp20? -116.84 146.84 42.63 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.993 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.416 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -132.54 120.25 41.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.541 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 p -89.31 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.299 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.7 166.52 31.34 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.583 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 12' ' ' VAL . 1.1 p -145.76 93.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' VAL . 1.7 t 38.15 78.3 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 137.49 61.95 0.05 OUTLIER Glycine 0 C--N 1.284 -2.35 0 N-CA-C 104.618 -3.393 . . . . 0.0 104.618 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 9.5 tppt? -112.22 44.1 0.25 Allowed Pre-proline 0 C--O 1.208 -1.083 0 CA-C-N 114.019 -1.09 . . . . 0.0 113.666 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.9 Cg_endo -67.16 107.28 1.33 Allowed 'Trans proline' 0 N--CA 1.429 -2.32 0 N-CA-C 104.469 -2.935 . . . . 0.0 104.469 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG12 ' HB ' ' A' ' 76' ' ' ILE . 9.5 p -123.76 160.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 118.543 -1.263 . . . . 0.0 113.595 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.463 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.0 mp0 -105.19 101.4 10.95 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.264 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -85.62 99.92 11.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -112.84 96.27 37.05 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -73.5 101.07 1.32 Allowed 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.329 -1.45 . . . . 0.0 108.329 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 23.7 t -123.36 122.66 38.86 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.358 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 22' ' ' SER . 3.8 m-20 165.19 2.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.249 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.132 HD13 ' H ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -117.36 151.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.676 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.787 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 3.0 mm-40 -47.14 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 1.132 ' H ' HD13 ' A' ' 24' ' ' ILE . 66.7 p 49.99 64.55 1.73 Allowed 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 29' ' ' VAL . 12.7 pttt -176.07 144.17 0.58 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.449 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t70 42.05 80.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.975 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG21 ' CZ ' ' A' ' 72' ' ' PHE . 25.8 m -148.05 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.002 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t -149.27 133.35 17.22 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.4 t -124.05 130.1 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 C-N-CA 118.502 -1.279 . . . . 0.0 113.121 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -149.08 138.5 21.66 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.328 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.778 ' CE2' HG21 ' A' ' 46' ' ' ILE . 1.3 p-90 -147.14 137.55 23.46 Favored 'General case' 0 C--O 1.183 -2.42 0 C-N-CA 118.086 -1.446 . . . . 0.0 111.188 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' CG ' ' N ' ' A' ' 35' ' ' LYS . 17.1 tttp -119.29 157.21 28.53 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CZ ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -149.83 159.89 44.0 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.873 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m -113.16 102.8 10.72 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.742 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.07 96.18 9.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 44.7 -167.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.061 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -107.26 -47.62 0.98 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -66.23 -27.75 68.21 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.692 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.54 ' CE1' ' OE1' ' A' ' 82' ' ' GLN . 18.2 m-70 -78.5 -124.99 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.782 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.06 157.07 41.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.39 -1.724 . . . . 0.0 113.056 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.75 157.22 19.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.577 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.782 HG22 ' H ' ' A' ' 46' ' ' ILE . 37.5 mt -151.22 145.81 16.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 118.21 -1.396 . . . . 0.0 113.472 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.5 -23.66 23.15 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.782 ' H ' HG22 ' A' ' 44' ' ' ILE . 9.1 mm 74.87 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-N 113.053 -1.885 . . . . 0.0 116.051 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.938 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -153.08 157.89 41.11 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 117.747 -1.581 . . . . 0.0 113.806 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.607 ' N ' HD23 ' A' ' 47' ' ' LEU . 9.2 t-20 -126.34 113.58 17.1 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.435 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.48 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.5 t90 -99.56 131.05 45.82 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.659 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.545 ' CD2' ' OD1' ' A' ' 51' ' ' ASN . 41.9 t80 -144.34 98.68 3.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.742 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 1.2 p-10 39.04 84.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.193 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' C ' ' HD3' ' A' ' 54' ' ' PRO . 3.1 m-20 57.48 27.5 14.1 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.867 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.65 78.1 0.39 Allowed Glycine 0 N--CA 1.505 3.273 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.656 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -86.71 126.6 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.271 1.981 . . . . 0.0 111.535 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.11 161.85 32.29 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.896 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 70.6 m95 -110.38 163.79 13.32 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.668 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.4 m -159.83 83.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.2 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.727 ' CB ' HG23 ' A' ' 44' ' ' ILE . 7.8 t-20 144.14 98.12 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.309 1.631 . . . . 0.0 107.734 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.09 83.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 122.564 1.173 . . . . 0.0 113.01 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 62' ' ' SER . 3.4 t -161.65 -6.38 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.824 ' HA ' HD13 ' A' ' 64' ' ' ILE . 39.0 m-85 -58.87 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.399 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 60' ' ' SER . 52.7 p -73.85 -49.33 25.58 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.594 ' O ' HD12 ' A' ' 64' ' ' ILE . 4.9 t0 -109.89 94.21 4.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.874 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.86 -174.13 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 C-N-CA 117.515 -1.674 . . . . 0.0 115.044 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.874 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.06 163.52 22.19 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-N 112.324 -2.216 . . . . 0.0 115.434 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.46 147.9 18.75 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.0 t80 -121.23 152.98 38.22 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.931 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.754 ' OD2' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -141.34 152.48 44.45 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.795 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -104.82 178.81 4.45 Favored 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 120.091 -0.644 . . . . 0.0 112.39 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 93.23 6.41 63.01 Favored Glycine 0 N--CA 1.508 3.453 0 N-CA-C 104.644 -3.382 . . . . 0.0 104.644 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 155.09 141.96 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 102.108 -3.293 . . . . 0.0 102.108 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 51.3 m-85 -83.09 114.18 21.13 Favored 'General case' 1 C--N 1.241 -4.148 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.724 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD2' ' A' ' 68' ' ' ASP . . . -135.01 108.58 7.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.646 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.775 HD11 ' CH2' ' A' ' 33' ' ' TRP . 1.8 tm? -98.7 127.14 44.52 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 11.5 t -119.97 138.13 53.66 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.34 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.536 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -91.2 131.23 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.08 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -139.69 92.85 2.6 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.621 1.2 . . . . 0.0 107.762 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.8 t -153.71 -40.26 0.09 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 113.337 -1.756 . . . . 0.0 108.25 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.78 50.12 17.68 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 113.312 -1.767 . . . . 0.0 113.234 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLN . 27.9 mmtp -146.55 157.04 43.67 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.997 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.723 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -43.45 -20.16 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.326 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.54 ' OE1' ' CE1' ' A' ' 41' ' ' HIS . 7.3 mm100 -60.31 -30.01 69.22 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.085 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -64.8 -29.39 70.36 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.205 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 81' ' ' LEU . 86.5 p -63.61 105.43 0.79 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 118.283 -1.367 . . . . 0.0 109.931 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -171.66 164.02 36.71 Favored Glycine 0 C--N 1.292 -1.879 0 C-N-CA 118.87 -1.634 . . . . 0.0 110.823 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -86.67 103.53 15.22 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.081 -1.048 . . . . 0.0 108.972 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CZ ' ' NZ ' ' A' ' 35' ' ' LYS . 1.2 m-30 -89.99 158.07 17.54 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.363 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -150.69 111.43 4.27 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.999 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -97.42 128.22 44.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.871 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' CD ' ' C ' ' A' ' 90' ' ' GLU . 1.6 pp20? -137.61 133.27 34.17 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.841 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 92' ' ' THR . 4.6 mt -102.98 161.3 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.651 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.581 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 10.5 t 42.05 -157.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.619 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' N ' ' OG1' ' A' ' 92' ' ' THR . 4.9 m120 -61.73 172.02 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 t -88.69 -19.74 25.76 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -55.11 165.17 3.42 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.137 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.37 -143.7 43.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.36 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' CYS . 2.8 ttmp? -169.95 -119.81 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.752 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 98' ' ' VAL . 14.3 p 35.88 29.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.594 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 24.0 m -163.09 41.58 0.11 Allowed 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.489 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.494 HD21 HD11 ' A' ' 88' ' ' LEU . 20.3 t-20 -150.18 130.45 13.69 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.58 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -147.23 146.81 29.93 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.6 144.17 32.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.052 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.61 107.68 11.78 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.466 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 10.6 pt20 -90.0 110.37 21.35 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.157 -1.017 . . . . 0.0 113.075 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD12 ' HG2' ' A' ' 15' ' ' LYS . 1.9 mm? -89.43 116.26 27.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.648 ' O ' HD23 ' A' ' 106' ' ' LEU . 8.5 tt -119.84 97.85 5.82 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.409 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -128.78 160.54 39.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.805 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.279 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.97 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -146.93 178.93 7.96 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.048 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.881 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.728 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 4.6 Cg_exo -66.73 178.29 2.86 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.336 1.357 . . . . 0.0 111.255 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.76 79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.037 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 3' ' ' PRO . 5.9 m -97.94 105.03 17.11 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.527 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 t -144.17 122.68 12.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.38 155.09 42.95 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -115.61 104.81 12.08 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -90.51 144.28 9.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.942 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.05 145.36 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.109 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' C ' ' CG2' ' A' ' 107' ' ' ILE . . . -152.96 168.27 31.81 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.86 -1.162 . . . . 0.0 111.598 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.742 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.3 p -146.17 95.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.1 t 41.94 79.72 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.441 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.71 63.49 0.08 OUTLIER Glycine 0 C--N 1.289 -2.055 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 8.2 tppt? -113.91 45.83 0.35 Allowed Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -67.8 110.84 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 105.581 -2.507 . . . . 0.0 105.581 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' A' ' 76' ' ' ILE . 8.4 p -128.9 161.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.39 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.457 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.5 tt0 -105.81 110.5 22.82 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.563 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 74' ' ' LEU . 1.3 mp -97.67 114.3 26.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.406 ' HG2' ' CB ' ' A' ' 73' ' ' ALA . 32.3 mtp180 -137.69 98.31 9.84 Favored Pre-proline 0 N--CA 1.507 2.399 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -69.66 140.06 42.1 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 N-CA-C 108.873 -1.241 . . . . 0.0 108.873 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 39.3 m -148.98 162.82 39.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.287 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.527 HD21 ' HD3' ' A' ' 3' ' ' PRO . 2.7 p-10 97.97 32.92 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.001 0 O-C-N 124.747 1.279 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.647 HD13 ' CD2' ' A' ' 72' ' ' PHE . 29.7 pt -94.32 -150.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.088 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' C ' HG23 ' A' ' 26' ' ' THR . 4.0 pt20 -160.6 -5.64 0.05 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.076 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.42 HG23 ' C ' ' A' ' 25' ' ' GLN . 3.9 p 56.34 111.9 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.249 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 pttt -152.6 82.92 1.23 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.209 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.2 t70 45.14 51.75 8.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.917 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' CG2' ' N ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -109.37 164.11 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.881 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.613 ' N ' ' CG2' ' A' ' 29' ' ' VAL . 1.5 m -128.57 144.13 51.09 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.879 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.1 t -106.61 117.57 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.39 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -134.59 136.59 43.06 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.732 ' HB3' HD22 ' A' ' 89' ' ' LEU . 6.8 p-90 -143.96 115.38 8.06 Favored 'General case' 0 C--O 1.189 -2.088 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.698 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 6.5 tttt -103.92 160.13 15.07 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.483 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.8 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -147.81 161.06 42.02 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.267 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -115.84 108.78 16.75 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.193 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 42' ' ' ARG . 3.0 mt-10 -102.77 90.43 3.8 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.35 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' SER . 23.6 tt0 -89.01 -43.57 11.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.723 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 41' ' ' HIS . . . -42.41 91.74 0.01 OUTLIER Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.721 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.1 p 46.74 35.76 3.33 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.559 ' CD2' ' O ' ' A' ' 39' ' ' GLY . 58.6 m-70 -142.11 -145.76 0.18 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.436 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 37' ' ' GLU . 57.4 mtm-85 -150.31 -171.72 3.99 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 118.108 -1.437 . . . . 0.0 112.495 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -88.77 151.11 22.6 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.848 HG23 ' CB ' ' A' ' 58' ' ' ASN . 54.2 mt -148.21 150.26 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 118.432 -1.307 . . . . 0.0 112.468 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 52.2 mt-10 -87.84 -38.88 15.3 Favored 'General case' 0 C--O 1.203 -1.351 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.695 HG21 ' CE2' ' A' ' 33' ' ' TRP . 11.1 mm 84.76 -97.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HB3' ' NE1' ' A' ' 33' ' ' TRP . 5.4 tt -131.14 152.82 50.03 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' N ' HD23 ' A' ' 47' ' ' LEU . 34.1 t30 -133.29 99.58 4.58 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.746 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.578 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 8.9 t90 -93.99 132.02 38.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.899 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 50' ' ' TYR . 28.6 p90 -150.0 100.03 2.89 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.469 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 5.8 t30 48.57 87.27 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.398 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 74.2 m-20 45.23 26.12 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.325 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -124.29 79.67 0.36 Allowed Glycine 0 N--CA 1.501 3.032 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.793 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.5 Cg_endo -87.33 125.64 2.19 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.252 1.968 . . . . 0.0 110.916 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 p -138.78 145.16 39.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.635 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 40.7 m95 -89.87 164.48 14.58 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.988 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -166.01 75.68 0.21 Allowed 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.606 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.848 ' CB ' HG23 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 160.33 86.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.795 1.31 . . . . 0.0 109.146 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.79 108.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.778 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.1 OUTLIER 165.95 -6.45 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.795 ' HA ' HD13 ' A' ' 64' ' ' ILE . 36.7 m-85 -63.96 33.75 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.785 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 60' ' ' SER . 7.2 t -86.65 -35.01 19.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' O ' HD12 ' A' ' 64' ' ' ILE . 3.2 t0 -127.8 94.72 4.02 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.873 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.79 -172.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 117.553 -1.659 . . . . 0.0 115.235 -179.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.873 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.47 164.05 21.99 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 112.236 -2.256 . . . . 0.0 114.767 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.19 126.94 4.37 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 12.7 t80 -90.56 153.66 20.19 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.779 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -140.29 158.46 44.0 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -97.18 -169.17 1.81 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.444 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.452 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 112.47 -1.13 26.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.457 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 2.5 m-20 152.23 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.647 ' CD2' HD13 ' A' ' 24' ' ' ILE . 10.8 m-85 -153.04 109.09 3.34 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.22 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' ' HG2' ' A' ' 20' ' ' ARG . . . -137.51 143.91 41.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.871 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 19' ' ' LEU . 2.7 tm? -146.94 128.23 14.82 Favored 'General case' 0 C--O 1.197 -1.684 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.884 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 74' ' ' LEU . 14.5 t -121.05 138.64 54.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.079 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -91.54 133.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.327 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.55 93.64 2.45 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.464 1.126 . . . . 0.0 108.755 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.1 t -153.17 -37.49 0.1 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.792 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 54.73 51.71 13.36 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 112.619 -2.082 . . . . 0.0 113.697 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HB2' HE21 ' A' ' 82' ' ' GLN . 37.9 mmtt -147.03 178.97 7.94 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.532 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -63.88 -24.89 67.92 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.843 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' HA ' ' CD2' ' A' ' 41' ' ' HIS . 26.7 mt-30 -52.03 -32.58 34.9 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 107' ' ' ILE . 70.0 m-20 -63.84 -32.23 73.68 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.846 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' LEU . 13.6 p -61.35 106.0 0.58 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.71 164.47 35.32 Favored Glycine 0 C--N 1.288 -2.094 0 C-N-CA 118.723 -1.703 . . . . 0.0 110.616 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -86.03 106.18 17.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.517 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.5 m-30 -88.38 150.32 23.25 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.48 110.68 5.06 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.746 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.84 100.89 13.52 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.453 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -95.07 118.99 32.83 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.095 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -99.98 119.2 47.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.932 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 93' ' ' ASN . 35.4 m -46.27 163.05 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.456 -0.898 . . . . 0.0 111.737 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.432 ' N ' HG22 ' A' ' 92' ' ' THR . 2.2 m120 65.46 134.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.493 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.6 p -149.14 -178.66 6.51 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' LYS . . . -173.74 73.3 0.09 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.143 -1.503 . . . . 0.0 110.667 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.55 -63.06 0.17 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.686 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 11.7 ttmm -59.38 150.46 26.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.856 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.6 148.89 9.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.736 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.869 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 36.3 m -146.43 43.85 1.2 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.601 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -147.71 147.82 30.34 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' NZ ' ' HA ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -115.78 123.59 48.63 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.729 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -106.46 119.16 38.55 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.093 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.09 115.47 26.85 Favored 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -88.81 111.2 21.75 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.584 HD22 HG22 ' A' ' 9' ' ' VAL . 1.5 mm? -95.99 99.61 11.37 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.08 97.51 8.05 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 83' ' ' ASP . 0.4 OUTLIER -110.94 160.67 10.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.597 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.27 -177.16 3.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.036 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.805 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.209 -1.03 0 CA-C-O 120.803 0.335 . . . . 0.0 111.763 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.1 Cg_endo -72.29 155.69 55.73 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.304 1.336 . . . . 0.0 111.086 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -57.77 123.9 17.31 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.469 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t -148.12 147.11 29.14 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.191 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.5 p -150.16 120.78 7.48 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.678 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 29.4 tp10 -130.12 160.12 34.72 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.644 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 31.8 tt0 -120.87 133.93 55.3 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.86 120.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.995 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.7 p -96.15 149.58 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.773 ' CA ' HG22 ' A' ' 107' ' ' ILE . . . -152.35 163.63 30.32 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.569 -1.3 . . . . 0.0 111.858 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -148.21 96.95 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.076 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' VAL . 15.2 t 41.96 79.92 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.581 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 132.63 67.64 0.08 OUTLIER Glycine 0 N--CA 1.48 1.589 0 N-CA-C 105.584 -3.006 . . . . 0.0 105.584 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.557 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 8.6 tppt? -112.02 39.52 0.19 Allowed Pre-proline 0 C--O 1.208 -1.084 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 3.9 Cg_endo -67.56 88.42 0.34 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 N-CA-C 106.327 -2.22 . . . . 0.0 106.327 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -112.47 162.72 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.802 -179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -106.58 108.14 19.49 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.498 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 74' ' ' LEU . 4.4 tp -88.74 98.44 11.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -115.62 96.54 46.57 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.83 111.89 2.53 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.7 m -134.49 98.99 4.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.408 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -169.88 -32.44 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.777 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG12 ' H ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -72.26 149.05 9.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.707 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.669 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 2.4 pm0 -72.6 8.25 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.755 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 27' ' ' LYS . 2.1 p 55.31 -125.25 2.15 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.755 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.664 ' N ' ' OG1' ' A' ' 26' ' ' THR . 3.6 mtpt 75.85 48.58 0.08 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.475 0.484 . . . . 0.0 111.896 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 t70 58.51 105.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.792 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 30' ' ' SER . 5.5 t -149.07 167.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 29' ' ' VAL . 1.8 t -89.08 160.69 16.93 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.53 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 49' ' ' TRP . 3.3 t -143.9 134.45 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.818 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -150.24 137.8 19.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.773 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CZ3' ' CE ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -140.71 131.09 25.16 Favored 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 118.805 -1.158 . . . . 0.0 110.103 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -118.82 152.3 36.48 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.775 ' CE ' ' CZ3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -153.51 163.1 40.54 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.9 -1.52 . . . . 0.0 114.188 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 m -107.38 97.11 6.9 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.552 ' HG3' ' N ' ' A' ' 38' ' ' GLN . 6.5 pt-20 -153.53 -163.23 1.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.278 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.552 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 18.5 tp60 86.51 174.14 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . . . -43.24 144.79 1.31 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p 49.84 13.04 0.08 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.702 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.558 ' NE2' ' OG ' ' A' ' 84' ' ' SER . 25.1 m170 52.53 75.06 0.25 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.083 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 37' ' ' GLU . 37.0 ttm180 -87.07 174.96 8.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 118.709 -1.197 . . . . 0.0 110.022 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -87.61 144.34 26.73 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.428 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.637 ' CG2' HD13 ' A' ' 46' ' ' ILE . 7.8 mt -149.06 138.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.91 -1.516 . . . . 0.0 112.686 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -87.39 -33.93 18.95 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CE2' ' A' ' 33' ' ' TRP . 10.9 mm 82.09 -93.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 114.132 -1.395 . . . . 0.0 114.335 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.954 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -152.23 159.52 43.53 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.597 -1.241 . . . . 0.0 112.498 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' N ' HD23 ' A' ' 47' ' ' LEU . 6.2 p-10 -129.37 113.8 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.397 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' VAL . 10.2 t90 -94.49 131.15 40.49 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 51' ' ' ASN . 2.3 m-85 -144.22 99.32 3.36 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.041 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' N ' ' CZ3' ' A' ' 49' ' ' TRP . 3.1 p30 40.16 85.49 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.484 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' N ' ' CZ2' ' A' ' 49' ' ' TRP . 20.2 t70 51.27 29.62 5.16 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.484 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.67 76.67 0.41 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 52' ' ' ASP . 13.6 Cg_endo -86.92 127.04 2.54 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.375 2.05 . . . . 0.0 111.705 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -140.58 143.38 35.26 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.933 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.64 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 21.2 m95 -91.11 164.24 14.0 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.402 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.5 m -164.09 76.71 0.35 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.955 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.556 ' ND2' HG12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER 162.65 88.17 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 124.636 1.21 . . . . 0.0 109.693 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -44.14 105.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.844 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 62' ' ' SER . 0.0 OUTLIER 169.46 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.755 ' HA ' HD13 ' A' ' 64' ' ' ILE . 34.7 m-85 -63.34 31.75 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.223 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' SER . 4.1 p -86.65 -25.3 24.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -140.42 95.46 2.88 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -154.93 -173.28 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-O 123.566 1.65 . . . . 0.0 115.178 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.888 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.28 164.42 20.72 Favored 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 111.851 -2.431 . . . . 0.0 115.437 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.34 118.33 2.35 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -90.04 138.02 31.86 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.869 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.37 160.39 29.48 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.776 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 44.8 t80 -102.55 -179.15 3.89 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.806 0.812 . . . . 0.0 113.114 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.625 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 118.66 -0.92 15.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 105.927 -2.869 . . . . 0.0 105.927 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.5 OUTLIER 156.49 -96.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.902 -2.149 . . . . 0.0 105.412 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 26.0 m-85 -152.18 105.19 3.03 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.23 106.69 5.55 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.646 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -111.29 126.8 55.28 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.624 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.59 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.8 m -115.21 134.7 54.9 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.562 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -89.88 131.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.255 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.54 94.68 2.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 122.699 1.238 . . . . 0.0 108.036 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 79' ' ' ALA . 26.9 t -156.84 -13.95 0.09 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.787 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 23.79 75.25 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 112.381 -2.191 . . . . 0.0 113.999 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' A' ' 82' ' ' GLN . 12.9 mttt -174.0 172.57 3.37 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.16 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -56.03 -37.12 68.79 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.672 ' CD ' ' H ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -46.8 -30.65 2.56 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.769 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.9 OUTLIER -63.81 -35.35 80.33 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.705 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.909 ' H ' HD11 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -48.9 114.06 0.91 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 118.252 -1.379 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.67 159.98 29.95 Favored Glycine 0 C--N 1.277 -2.707 0 C-N-CA 118.035 -2.031 . . . . 0.0 111.036 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -91.16 107.11 18.98 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.96 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -93.44 152.2 19.25 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.906 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.15 110.54 5.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.285 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.25 130.99 35.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.097 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -134.23 129.25 35.42 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.182 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.508 ' CG2' HG11 ' A' ' 29' ' ' VAL . 6.2 mm -107.57 99.36 8.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.923 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 92' ' ' THR . 30.4 p -46.11 145.9 1.46 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.645 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -168.04 140.38 3.04 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.961 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.6 m -45.46 -34.19 3.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.88 -54.47 4.87 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.356 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.18 99.54 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -72.41 -109.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.957 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ASN . 4.1 m -98.01 27.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.848 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 4.2 m -57.37 78.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.297 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' VAL . 18.1 m120 -150.76 136.32 17.99 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -138.91 109.08 6.4 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.646 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -95.59 134.79 38.06 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.547 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -131.64 111.91 12.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.898 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.48 118.33 28.04 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.084 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -101.98 101.38 11.77 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tp -108.94 105.39 14.9 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.909 HD11 ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -117.63 163.46 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.065 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 14.7 tp -149.82 147.7 28.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.548 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 11.8 m-20 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.358 -1.782 . . . . 0.0 110.803 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.675 0.274 . . . . 0.0 111.53 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 2' ' ' CYS . 1.6 Cg_endo -65.88 156.2 65.5 Favored 'Trans proline' 0 C--N 1.321 -0.875 0 C-N-CA 121.225 1.284 . . . . 0.0 111.293 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -44.42 114.19 0.65 Allowed 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.2 m -144.78 129.44 18.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.976 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 t -149.99 125.98 10.55 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.45 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 8' ' ' GLU . 16.7 tp10 -143.43 160.2 40.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 41.2 tt0 -119.55 109.22 15.45 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -100.77 132.58 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.49 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 11' ' ' GLY . 9.8 p -89.65 164.24 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.319 -0.953 . . . . 0.0 111.445 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.742 ' N ' HG22 ' A' ' 10' ' ' VAL . . . -150.79 169.16 30.6 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 119.029 -1.558 . . . . 0.0 113.43 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.648 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 3.1 t -145.78 98.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.434 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.624 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 3.62 80.7 0.0 OUTLIER 'General case' 0 N--CA 1.533 3.718 0 CA-C-O 122.685 1.231 . . . . 0.0 109.498 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 143.6 65.47 0.02 OUTLIER Glycine 0 C--N 1.278 -2.65 1 N-CA-C 101.323 -4.711 . . . . 0.0 101.323 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' NZ ' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -114.08 76.98 3.66 Favored Pre-proline 0 C--O 1.207 -1.145 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 15.5 Cg_endo -86.72 78.75 1.88 Allowed 'Trans proline' 0 N--CA 1.431 -2.19 0 N-CA-C 103.525 -3.298 . . . . 0.0 103.525 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.74 159.77 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.471 ' NE2' ' HD2' ' A' ' 20' ' ' ARG . 2.5 tt0 -113.97 99.39 7.62 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.129 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 74' ' ' LEU . 5.5 tp -86.05 103.78 15.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' HD2' ' NE2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -122.82 97.39 44.11 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -68.38 126.52 14.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.724 0.95 . . . . 0.0 110.05 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 55.8 m -141.03 120.1 12.83 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 22' ' ' SER . 0.2 OUTLIER 162.01 17.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.639 HD11 ' OD2' ' A' ' 71' ' ' ASP . 2.2 pt -99.22 -154.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 112.5 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' N ' HG13 ' A' ' 24' ' ' ILE . 10.4 pt20 -151.27 0.63 0.38 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.475 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.7 p 55.09 110.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.859 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -148.82 40.96 0.92 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.821 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.43 95.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.406 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 m -150.91 161.49 3.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.798 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.89 160.2 17.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.014 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 t -130.46 131.47 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.69 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -150.39 142.09 23.65 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.256 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 89' ' ' LEU . 1.8 p-90 -142.15 141.41 32.63 Favored 'General case' 0 C--O 1.182 -2.499 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.456 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.2 ttpt -121.37 154.39 36.54 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.906 -0.717 . . . . 0.0 109.266 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.737 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -149.01 155.86 41.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.631 -1.227 . . . . 0.0 111.976 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.626 HG23 ' CD ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -106.4 100.12 9.67 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.006 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 42' ' ' ARG . 38.3 mt-10 -97.34 107.86 20.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.677 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.558 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 37.2 tt0 -100.16 172.02 7.44 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.521 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 41' ' ' HIS . . . 76.59 95.23 0.18 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m 58.55 -0.25 0.13 Allowed 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.731 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 39' ' ' GLY . 93.6 m-70 -119.38 -168.05 1.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -154.61 -176.2 5.79 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.43 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' CD ' HG23 ' A' ' 36' ' ' THR . 4.1 mmtp -89.66 133.74 34.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.743 ' CG2' ' H ' ' A' ' 46' ' ' ILE . 0.6 OUTLIER -148.18 164.33 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.859 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 2.2 mm-40 -87.35 -15.83 36.76 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.881 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.851 HG22 ' N ' ' A' ' 47' ' ' LEU . 10.6 mm 62.92 -120.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.851 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -90.3 154.65 19.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.565 ' N ' HD23 ' A' ' 47' ' ' LEU . 22.6 t30 -143.21 97.75 3.14 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.037 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.552 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 20.9 t90 -97.47 132.99 42.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.315 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.4 m-85 -140.73 97.57 3.22 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.538 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.552 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 0.7 OUTLIER 65.94 -57.76 0.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.446 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' TYR . 38.9 t70 -163.32 31.86 0.09 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.79 87.25 0.38 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.82 98.16 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 122.096 1.864 . . . . 0.0 110.479 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.2 p -120.27 132.82 55.49 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -89.76 162.01 15.75 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.05 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.65 ' N ' ' O ' ' A' ' 46' ' ' ILE . 38.5 m -119.46 77.17 1.19 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.684 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.524 ' N ' ' HE2' ' A' ' 61' ' ' PHE . 4.9 m-80 34.24 102.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.873 HG13 ' CZ ' ' A' ' 61' ' ' PHE . 29.9 m -130.65 -44.22 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 122.671 1.224 . . . . 0.0 108.597 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.712 ' N ' HG23 ' A' ' 59' ' ' VAL . 2.1 t 160.03 24.15 0.0 OUTLIER 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.873 ' CZ ' HG13 ' A' ' 59' ' ' VAL . 56.9 m-85 -39.14 90.13 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.82 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 60' ' ' SER . 5.0 t -173.55 -22.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.6 111.69 7.49 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 101.114 -3.662 . . . . 0.0 101.114 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.71 HD13 ' HD1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -152.78 -174.39 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.466 -2.263 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -179.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.777 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -84.15 164.4 19.18 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 109.37 -3.559 . . . . 0.0 112.032 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.65 125.45 4.16 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.5 t80 -99.84 150.06 22.75 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 26.2 t0 -138.97 158.15 44.72 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -106.05 179.75 4.18 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.71 -0.796 . . . . 0.0 112.835 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.75 11.29 Favored Glycine 0 N--CA 1.499 2.849 0 N-CA-C 105.531 -3.028 . . . . 0.0 105.531 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.639 ' OD2' HD11 ' A' ' 24' ' ' ILE . 5.7 t70 170.44 -103.58 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.634 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 18.6 m-85 -152.84 115.47 4.51 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.17 143.75 34.41 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.392 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.841 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -148.28 127.33 12.81 Favored 'General case' 0 C--O 1.201 -1.452 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.175 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.614 ' N ' HD13 ' A' ' 74' ' ' LEU . 4.5 t -123.46 136.74 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -91.04 134.15 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.302 -0.959 . . . . 0.0 109.075 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -144.2 94.48 2.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 122.866 1.317 . . . . 0.0 109.654 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.506 ' CB ' ' OE1' ' A' ' 82' ' ' GLN . 17.6 p -154.28 -23.54 0.13 Allowed 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.14 -1.846 . . . . 0.0 107.069 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 53.1 31.6 11.57 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.858 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' C ' ' N ' ' A' ' 82' ' ' GLN . 1.3 mmmt -114.23 167.1 10.99 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.024 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 81' ' ' LEU . 38.1 tp -53.76 -14.47 0.94 Allowed 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.298 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CG ' ' N ' ' A' ' 83' ' ' ASP . 1.6 pt20 -59.68 -41.21 90.16 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' CG ' ' A' ' 82' ' ' GLN . 26.7 m-20 -47.03 -42.29 18.11 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.58 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.638 ' H ' HD11 ' A' ' 107' ' ' ILE . 6.4 t -62.11 109.62 1.35 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.296 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.45 164.56 36.91 Favored Glycine 0 C--N 1.277 -2.732 0 C-N-CA 119.076 -1.535 . . . . 0.0 110.724 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.777 ' NE2' ' ND2' ' A' ' 102' ' ' ASN . 30.3 t-80 -85.74 101.07 12.46 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.745 -1.182 . . . . 0.0 108.407 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.737 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 3.0 m-30 -88.83 154.29 20.38 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.99 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 102' ' ' ASN . 14.3 tp -150.67 108.39 3.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.507 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -89.65 131.75 35.48 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.675 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 23.8 mp0 -142.99 141.6 31.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -109.21 132.59 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.08 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 93' ' ' ASN . 8.9 m 51.99 -87.96 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.032 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 94' ' ' THR . 9.4 t30 -158.83 -143.59 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.286 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.712 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 3.7 m -73.65 -138.98 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 94' ' ' THR . . . 156.51 -135.03 4.3 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.489 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.24 -117.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.698 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HZ2' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.87 -57.24 5.83 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.878 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 m -150.89 165.57 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.954 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 14.7 t -160.07 12.22 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.061 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -113.64 160.41 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.24 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.625 ' HZ1' ' N ' ' A' ' 2' ' ' CYS . 3.4 ptpt -140.58 124.44 17.26 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.777 ' ND2' ' NE2' ' A' ' 86' ' ' HIS . 21.7 t-20 -90.78 157.54 17.34 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.886 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -149.96 109.72 4.06 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.72 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -91.63 109.97 21.29 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.136 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -96.71 137.36 35.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -149.47 102.47 3.19 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.759 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -88.74 164.48 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.048 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.6 tp -89.59 147.47 23.91 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.327 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--N 1.304 -1.413 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.969 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.704 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 111.328 0.121 . . . . 0.0 111.328 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 15.6 Cg_exo -67.96 168.83 17.79 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.046 1.164 . . . . 0.0 111.649 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -84.19 122.5 28.94 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.525 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -144.76 156.66 44.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.877 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 m -147.5 131.72 17.42 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.023 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -142.67 134.74 27.25 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -94.81 105.64 17.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.547 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG13 HD13 ' A' ' 105' ' ' LEU . 1.1 p -94.22 141.68 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.84 147.29 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.603 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HZ2' ' A' ' 15' ' ' LYS . . . -152.13 166.01 30.92 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 13' ' ' SER . 4.8 m -137.85 90.45 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 12' ' ' VAL . 39.6 t 31.41 79.69 0.02 OUTLIER 'General case' 0 N--CA 1.526 3.352 0 CA-C-O 122.735 1.255 . . . . 0.0 110.413 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.657 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 146.87 64.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 1 N-CA-C 100.066 -5.213 . . . . 0.0 100.066 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.651 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -125.05 75.6 67.27 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -90.51 100.76 0.27 Allowed 'Trans proline' 0 N--CA 1.439 -1.683 1 N-CA-C 97.023 -5.799 . . . . 0.0 97.023 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.13 162.92 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.534 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -115.69 98.59 6.78 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 112.755 -2.02 . . . . 0.0 108.67 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 19' ' ' LEU . 2.7 tp -87.69 140.21 29.75 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -154.6 92.27 2.95 Favored Pre-proline 0 N--CA 1.507 2.379 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -67.97 118.89 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 O-C-N 122.631 0.806 . . . . 0.0 110.528 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -111.95 162.56 15.21 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.489 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 59.82 80.62 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.97 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -162.29 147.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.461 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.425 ' H ' ' HG2' ' A' ' 25' ' ' GLN . 15.4 mm100 -46.45 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.331 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.8 p -75.94 71.06 2.73 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.865 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -143.58 -177.74 5.55 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.383 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.29 117.68 3.23 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.819 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 91' ' ' ILE . 5.3 p -153.96 152.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.73 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.4 t -88.52 140.7 29.19 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.596 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.87 140.84 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -151.88 134.99 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.991 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.558 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 10.8 p-90 -140.95 136.1 31.88 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 118.451 -1.299 . . . . 0.0 109.98 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -128.37 151.62 49.14 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.838 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 141.21 34.09 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.083 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.1 m -95.85 101.18 12.83 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.317 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE1' HD12 ' A' ' 44' ' ' ILE . 42.1 mt-10 -87.37 103.81 15.84 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.101 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -103.22 156.74 17.5 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.323 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.53 -60.97 0.64 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.427 ' H ' ' H ' ' A' ' 41' ' ' HIS . 15.6 m -155.02 -21.57 0.12 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.427 ' H ' ' H ' ' A' ' 40' ' ' SER . 84.6 m-70 -74.52 -145.04 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.072 -1.876 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 26.9 ttt180 -168.24 -150.9 0.1 Allowed 'General case' 0 N--CA 1.507 2.411 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.669 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HG2' ' A' ' 42' ' ' ARG . 1.8 tppp? -87.61 128.39 35.27 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 121.578 0.704 . . . . 0.0 111.118 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.453 HD12 ' OE1' ' A' ' 37' ' ' GLU . 5.1 mt -131.63 128.9 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.477 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -86.37 -14.46 43.4 Favored 'General case' 0 N--CA 1.506 2.344 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.017 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.558 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 10.4 mm 61.07 -83.17 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 48' ' ' ASN 0.324 8.4 tt -145.57 159.7 42.73 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 47' ' ' LEU . 34.6 t30 -138.08 106.73 5.89 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 113.527 -1.669 . . . . 0.0 108.531 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -93.23 137.82 32.2 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.007 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -145.3 97.1 2.94 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.519 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t30 73.57 -68.0 0.24 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.099 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.47 28.55 0.07 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.95 88.9 0.36 Allowed Glycine 0 C--N 1.303 -1.283 0 CA-C-N 113.327 -1.76 . . . . 0.0 110.146 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -83.4 138.09 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.231 1.287 . . . . 0.0 110.327 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 m -143.82 127.25 16.85 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.328 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.799 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 4.0 m95 -88.31 154.29 20.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.438 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -160.75 104.58 1.37 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.913 1.339 . . . . 0.0 112.636 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 60' ' ' SER . 4.0 m120 136.72 91.6 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 111.194 -2.73 . . . . 0.0 104.603 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.38 71.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 117.5 2.408 . . . . 0.0 117.5 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' ASN . 9.7 m -128.32 -5.04 5.44 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -63.16 75.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 112.188 -2.278 . . . . 0.0 113.453 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 63' ' ' ASP . 41.6 t -145.44 -4.82 0.68 Allowed 'General case' 0 N--CA 1.523 3.219 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' H ' ' H ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -139.7 106.48 5.38 Favored 'General case' 0 C--N 1.274 -2.679 1 N-CA-C 98.851 -4.5 . . . . 0.0 98.851 175.95 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -138.83 -178.72 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.163 0 N-CA-C 121.034 3.716 . . . . 0.0 121.034 -178.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -112.3 161.82 16.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 108.766 -3.834 . . . . 0.0 111.032 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.1 131.35 5.94 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 25.2 t80 -94.27 158.9 15.37 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.261 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.502 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 12.6 t70 -139.92 147.94 41.28 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.969 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.507 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 55.1 t80 -114.03 166.76 11.28 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 123.026 1.393 . . . . 0.0 114.433 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 149.95 -42.8 0.77 Allowed Glycine 0 N--CA 1.51 3.586 1 N-CA-C 102.293 -4.323 . . . . 0.0 102.293 -179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 31.5 m-20 -144.14 -106.91 0.12 Allowed 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 100.484 -3.895 . . . . 0.0 100.484 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 88.8 m-85 -154.75 105.87 2.63 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.32 148.29 46.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.892 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -147.72 137.63 22.77 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.471 ' N ' HD13 ' A' ' 74' ' ' LEU . 59.6 m -131.49 141.22 49.73 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.439 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -91.55 153.07 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -150.17 83.92 1.38 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 101.631 -3.47 . . . . 0.0 101.631 179.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.6 m -141.41 -53.93 0.46 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 112.108 -2.315 . . . . 0.0 108.689 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.657 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 60.32 36.21 20.61 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 111.697 -2.501 . . . . 0.0 115.38 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -140.27 162.55 35.01 Favored 'General case' 0 N--CA 1.507 2.415 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.842 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.818 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 mm? -43.32 -30.28 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.035 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.22 -29.57 68.83 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.015 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 0.5 OUTLIER -67.63 -33.29 74.68 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.2 p -59.42 117.51 4.93 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.119 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.49 162.6 32.86 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -88.74 101.31 13.88 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -87.75 160.16 18.18 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.569 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.98 111.77 4.01 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.68 -1.6 . . . . 0.0 106.905 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.559 HD13 ' H ' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -87.5 143.4 27.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.876 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.559 ' H ' HD13 ' A' ' 89' ' ' LEU . 49.0 mt-10 -141.66 154.55 45.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.396 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.439 HD11 HG11 ' A' ' 29' ' ' VAL . 2.7 tt -136.32 151.81 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m 57.99 -126.04 1.59 Allowed 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.267 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -160.92 89.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.896 -1.121 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 50.1 m -158.02 115.84 3.01 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.64 -160.15 19.32 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.337 -1.411 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.18 -153.58 45.52 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.58 -1.295 . . . . 0.0 111.349 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.08 178.74 3.09 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.492 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' C ' HD22 ' A' ' 100' ' ' ASN . 2.8 t 62.4 157.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.651 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 85.5 m 48.7 50.04 17.85 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.286 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.611 HD22 ' C ' ' A' ' 98' ' ' VAL . 5.9 p30 -151.11 130.4 12.8 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.183 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' HZ3' ' N ' ' A' ' 100' ' ' ASN . 3.0 mptp? -133.4 113.74 12.89 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -93.63 138.75 31.55 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.922 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -140.96 108.18 5.5 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -94.72 109.54 21.48 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.555 HD13 HG13 ' A' ' 9' ' ' VAL . 4.4 mm? -88.79 100.28 13.03 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.79 95.53 6.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -117.21 161.26 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.773 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.0 tp -147.12 132.98 19.03 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.964 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--N 1.294 -1.832 0 CA-C-O 116.531 -1.699 . . . . 0.0 112.411 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.885 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--O 1.212 -0.897 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 1.9 Cg_endo -71.38 166.79 28.22 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 121.481 1.454 . . . . 0.0 111.466 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.9 129.55 42.36 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 p -146.75 114.24 6.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 m -149.13 119.28 7.23 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.625 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.71 159.68 43.54 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -117.16 112.21 20.54 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -92.53 127.31 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.409 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.69 149.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.225 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' C ' ' HB ' ' A' ' 107' ' ' ILE . . . -152.24 166.8 31.17 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.621 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -146.33 94.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.828 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.472 ' C ' ' O ' ' A' ' 12' ' ' VAL . 2.0 t 37.91 79.17 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.478 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 134.45 67.24 0.07 OUTLIER Glycine 0 C--N 1.288 -2.092 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 16' ' ' PRO . 6.8 tppt? -114.18 46.27 0.37 Allowed Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 3.1 Cg_endo -67.9 99.35 0.55 Allowed 'Trans proline' 0 N--CA 1.433 -2.086 0 N-CA-C 105.615 -2.494 . . . . 0.0 105.615 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 p -121.32 162.18 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.397 -0.921 . . . . 0.0 113.368 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.24 109.26 20.15 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.555 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -88.92 107.34 18.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -124.03 96.01 43.1 Favored Pre-proline 0 N--CA 1.506 2.35 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -74.54 124.16 8.65 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 N-CA-C 109.129 -1.143 . . . . 0.0 109.129 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 23' ' ' ASN . 66.5 p -125.89 161.04 28.36 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.186 -0.605 . . . . 0.0 111.461 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 22' ' ' SER . 1.4 t-20 75.98 83.78 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.516 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -176.65 152.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.623 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 24' ' ' ILE . 6.3 pt20 -64.06 69.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.882 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.892 HG21 ' OD1' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -86.51 91.11 8.45 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.707 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' CG ' ' C ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -172.42 15.61 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.19 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -176.78 2.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.406 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 15.1 m -101.98 153.71 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.736 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.484 ' H ' ' HB ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -94.01 160.85 14.54 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.217 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.3 t -116.04 131.85 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.669 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.159 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -148.69 124.29 10.42 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.123 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.751 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 7.2 p-90 -136.73 130.17 31.62 Favored 'General case' 0 C--O 1.183 -2.415 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -118.01 160.26 21.78 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.678 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.792 ' NZ ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -148.03 158.36 44.01 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.455 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 m -111.8 113.97 26.65 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.591 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.617 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 2.8 mt-10 -106.57 104.68 14.42 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.339 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 38' ' ' GLN . 16.9 pt20 -105.2 -167.82 1.39 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.453 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.54 -46.55 2.78 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.444 ' H ' ' H ' ' A' ' 41' ' ' HIS . 4.4 m -169.56 -10.53 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.444 ' H ' ' H ' ' A' ' 40' ' ' SER . 55.8 m-70 -93.63 -137.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.25 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 37' ' ' GLU . 12.0 ptt-85 -166.61 -161.98 0.48 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.323 -1.351 . . . . 0.0 111.749 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -88.71 148.12 24.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.901 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 HD12 ' ND2' ' A' ' 58' ' ' ASN . 4.3 mm -141.54 144.96 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 119.402 -0.919 . . . . 0.0 112.319 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.75 -30.55 17.93 Favored 'General case' 0 C--O 1.207 -1.144 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 8.3 mm 73.33 -98.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.631 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.2 OUTLIER -121.32 155.99 33.53 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.1 m-80 -137.83 99.15 3.83 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 112.336 -2.211 . . . . 0.0 107.693 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 8.3 t90 -97.47 134.54 40.58 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.93 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' ASP . 13.3 m-85 -139.59 96.94 3.17 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.152 -1.019 . . . . 0.0 110.565 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.556 ' O ' ' CH2' ' A' ' 49' ' ' TRP . 4.6 m-80 62.01 -64.27 0.09 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.307 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' TYR . 4.2 m-20 -155.01 30.97 0.4 Allowed 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.739 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.58 87.04 0.37 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -86.0 114.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.091 1.861 . . . . 0.0 110.289 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.08 161.57 26.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.65 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 69.5 m95 -107.55 165.33 11.49 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.036 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -150.57 67.73 0.95 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.337 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 61' ' ' PHE . 1.8 t30 169.44 162.81 0.05 Allowed 'General case' 0 CA--C 1.497 -1.077 0 O-C-N 125.527 1.767 . . . . 0.0 106.305 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.48 6.23 7.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.546 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 62' ' ' SER . 0.4 OUTLIER -86.44 0.61 53.78 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.7 ' HA ' HD13 ' A' ' 64' ' ' ILE . 25.5 m-85 -62.7 37.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.921 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 60' ' ' SER . 6.6 t -94.0 -17.93 22.4 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -148.62 94.84 2.34 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 103.679 -2.712 . . . . 0.0 103.679 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.861 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -155.47 -173.31 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.697 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.861 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.41 162.7 22.47 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 112.498 -2.137 . . . . 0.0 114.504 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.53 6.89 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 9.6 t80 -89.7 158.18 17.66 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.983 -1.087 . . . . 0.0 112.684 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 21.6 m-20 -142.66 143.36 32.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.016 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -100.98 177.62 4.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.528 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 71' ' ' ASP . . . 116.75 9.26 11.24 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 106.418 -2.673 . . . . 0.0 106.418 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.892 ' OD1' HG21 ' A' ' 26' ' ' THR . 1.7 m-20 153.13 -101.49 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 71' ' ' ASP . 16.3 m-85 -154.13 109.48 3.16 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -147.13 122.2 10.11 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.791 -1.164 . . . . 0.0 112.16 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.843 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -120.66 135.67 55.05 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.986 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.801 ' N ' HD13 ' A' ' 74' ' ' LEU . 12.2 p -125.23 139.06 54.06 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.614 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -90.15 134.04 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.159 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -144.65 93.06 2.36 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 82' ' ' GLN . 13.2 t -155.88 -36.57 0.08 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.5 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 52.05 88.0 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' GLN . 0.2 OUTLIER 172.02 159.2 0.1 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.432 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.865 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -47.49 -13.27 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.671 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' LYS . 10.1 pt20 -69.04 -27.4 65.61 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.214 -1.394 . . . . 0.0 109.109 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 1.1 m-20 -70.02 -27.5 64.73 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.474 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 103.92 1.04 Allowed 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.062 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.37 163.99 36.26 Favored Glycine 0 N--CA 1.485 1.935 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -86.19 108.47 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.918 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.792 ' CE1' ' NZ ' ' A' ' 35' ' ' LYS . 2.4 m-30 -91.1 153.55 20.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.447 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.745 HD21 HD21 ' A' ' 100' ' ' ASN . 0.4 OUTLIER -150.05 111.62 4.49 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.195 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -88.94 109.75 20.51 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.18 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -105.54 116.57 32.16 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.73 119.28 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.6 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.599 HG22 ' N ' ' A' ' 93' ' ' ASN . 93.2 m -47.82 168.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.005 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.599 ' N ' HG22 ' A' ' 92' ' ' THR . 1.5 m-80 60.72 95.23 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.218 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 95' ' ' GLY . 2.0 t -98.18 -174.83 2.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.717 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 94' ' ' THR . . . -170.81 -176.46 40.11 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.454 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -44.28 -26.0 0.86 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.4 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -80.97 -154.22 0.1 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.77 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.39 80.06 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.885 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 21.3 m -71.68 78.17 0.83 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.774 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.745 HD21 HD21 ' A' ' 88' ' ' LEU . 45.2 t30 -150.09 119.08 6.68 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.551 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -110.46 134.82 51.99 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.14 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -117.19 114.65 23.98 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -114.0 108.91 17.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.889 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -89.27 109.95 20.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.879 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 9' ' ' VAL . 2.0 mm? -89.37 106.74 18.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.4 tp -110.61 98.48 7.65 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.421 ' HB ' ' C ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -125.94 161.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.21 -179.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.9 tt -140.26 154.38 46.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.64 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.305 -1.349 0 CA-C-O 116.386 -1.769 . . . . 0.0 110.949 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 2' ' ' CYS . 6.3 Cg_exo -61.91 155.88 52.4 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.302 1.335 . . . . 0.0 111.479 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.52 114.06 3.03 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.395 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -148.56 150.27 33.05 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.318 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.0 p -149.62 143.27 25.43 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.301 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.22 156.05 45.96 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -109.13 99.09 8.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.371 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HG ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -93.52 158.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.319 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 106' ' ' LEU . 3.6 p -150.99 155.3 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.241 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' HZ3' ' A' ' 15' ' ' LYS . . . -152.22 171.03 31.53 Favored Glycine 0 N--CA 1.484 1.864 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.839 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.6 m -135.59 95.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.485 ' C ' ' O ' ' A' ' 12' ' ' VAL . 71.1 p 39.68 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.555 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 140.6 68.7 0.04 OUTLIER Glycine 0 C--N 1.291 -1.971 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HZ3' ' HA3' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -111.8 41.05 0.2 Allowed Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 2.8 Cg_endo -67.99 99.98 0.6 Allowed 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 106.141 -2.292 . . . . 0.0 106.141 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.61 160.7 34.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.613 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -99.93 104.66 16.3 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.245 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 3.1 tp -91.14 99.3 12.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -131.46 102.1 15.58 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -69.21 136.75 35.3 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 120.853 1.035 . . . . 0.0 110.033 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.3 p -143.22 102.79 4.04 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.804 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 23' ' ' ASN . 2.6 t30 -173.62 -7.29 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.891 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.791 ' CG1' ' H ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -102.01 153.56 5.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.247 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.688 ' C ' HG23 ' A' ' 26' ' ' THR . 11.7 pt20 -90.88 3.21 55.14 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.303 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.791 ' H ' ' CG1' ' A' ' 24' ' ' ILE . 1.1 p 63.54 130.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.209 0.528 . . . . 0.0 111.597 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' H ' HG13 ' A' ' 29' ' ' VAL . 8.5 pttt -177.91 100.51 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.398 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER 38.15 70.46 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.891 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.448 HG13 ' H ' ' A' ' 27' ' ' LYS . 3.1 m -117.98 176.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.759 0.79 . . . . 0.0 112.601 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -143.4 121.96 12.49 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.498 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 1.5 t -96.06 136.79 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 118.477 -1.289 . . . . 0.0 113.127 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -149.07 124.81 10.49 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.691 ' CZ2' HD21 ' A' ' 74' ' ' LEU . 7.8 p-90 -135.02 114.27 12.29 Favored 'General case' 0 C--O 1.192 -1.927 0 C-N-CA 118.126 -1.429 . . . . 0.0 112.473 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 13.5 tttm -100.85 157.05 17.01 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.39 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.05 161.02 42.22 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 118.726 -1.19 . . . . 0.0 112.014 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.413 HG23 ' HD3' ' A' ' 43' ' ' LYS . 1.7 m -119.97 103.38 9.26 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.712 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.5 108.8 20.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.781 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -111.47 148.67 32.65 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 129.52 -5.57 6.25 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 163.51 -9.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.446 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 82' ' ' GLN . 90.0 m-70 -114.45 -132.54 0.33 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -174.25 -151.98 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.715 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 9.6 mmtt -89.85 143.46 26.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.789 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.559 HG23 ' CB ' ' A' ' 58' ' ' ASN . 8.1 mt -146.37 156.7 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 79.2 mm-40 -88.64 -39.02 14.35 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.642 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 33' ' ' TRP . 15.3 mm 81.72 -98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.698 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -122.4 157.43 31.9 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 36.3 t30 -139.94 98.53 3.48 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.527 -2.124 . . . . 0.0 106.65 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.567 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 13.2 t90 -95.61 125.6 40.32 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.042 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.674 ' CE2' ' ND2' ' A' ' 51' ' ' ASN . 56.3 t80 -139.77 98.61 3.51 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.674 ' ND2' ' CE2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 61.66 -162.28 0.28 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.48 39.9 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.148 -1.421 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 51' ' ' ASN . . . -131.49 81.86 0.32 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.718 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -87.09 137.66 4.57 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.447 2.098 . . . . 0.0 110.446 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.8 p -143.52 156.98 44.77 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.545 -1.262 . . . . 0.0 112.12 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 50.9 m95 -99.4 164.69 12.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.559 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -160.35 73.37 0.51 Allowed 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.699 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.559 ' CB ' HG23 ' A' ' 44' ' ' ILE . 1.7 m120 152.51 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.568 1.167 . . . . 0.0 108.884 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -45.65 103.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.849 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 62' ' ' SER . 89.7 p -179.74 -7.76 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 64' ' ' ILE . 27.4 m-85 -66.95 34.58 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.542 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 60' ' ' SER . 12.0 t -84.94 -32.16 23.22 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -132.59 94.28 3.38 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.886 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -155.95 -172.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.699 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.886 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.2 163.62 22.33 Favored 'General case' 0 C--N 1.269 -2.919 0 CA-C-N 112.222 -2.263 . . . . 0.0 115.131 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.65 122.55 3.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -89.92 143.85 26.44 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.166 -1.014 . . . . 0.0 112.643 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 32.3 t70 -131.59 160.66 34.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 20.0 t80 -95.68 -175.16 3.36 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.264 -0.974 . . . . 0.0 112.917 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 114.84 -1.37 23.05 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 106.609 -2.596 . . . . 0.0 106.609 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 2.0 m-20 150.61 -88.31 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 71' ' ' ASP . 70.0 m-85 -153.58 106.25 2.9 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.491 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . . . -132.21 99.79 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.151 -1.019 . . . . 0.0 112.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 74' ' ' LEU . 1.3 tm? -105.9 110.75 23.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 74' ' ' LEU . 16.3 m -103.28 134.99 45.75 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.458 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.427 HD13 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -90.21 132.18 35.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.301 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -143.12 93.27 2.48 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 122.553 1.168 . . . . 0.0 107.996 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.8 p -152.18 -42.0 0.11 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.218 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.555 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 58.62 28.24 16.88 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.698 -2.046 . . . . 0.0 114.185 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -113.46 -167.97 1.27 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.017 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 81' ' ' LEU . 32.8 tp -83.88 -14.96 49.8 Favored 'General case' 0 C--N 1.286 -2.176 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.681 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' HB3' ' CE1' ' A' ' 41' ' ' HIS . 3.2 pp0? -67.25 -30.31 70.17 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.226 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -63.17 -30.25 71.44 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.946 -1.501 . . . . 0.0 108.527 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.508 ' CB ' HG13 ' A' ' 107' ' ' ILE . 3.4 p -57.29 107.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.587 -1.245 . . . . 0.0 108.393 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.66 161.78 33.3 Favored Glycine 0 C--N 1.284 -2.324 0 C-N-CA 117.569 -2.253 . . . . 0.0 111.518 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.507 ' NE2' ' HB3' ' A' ' 102' ' ' ASN . 18.7 t-160 -89.1 101.19 13.85 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 119.416 -0.913 . . . . 0.0 108.945 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -88.79 160.53 17.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.355 -1.338 . . . . 0.0 110.301 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 115.18 7.03 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.669 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.573 HD22 ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -89.29 129.63 35.81 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.427 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -136.16 118.34 15.52 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.088 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG22 ' ND2' ' A' ' 93' ' ' ASN . 3.0 mt -108.47 113.77 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.494 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.1 m -63.6 130.92 46.33 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.54 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' ND2' HG22 ' A' ' 91' ' ' ILE . 54.9 m-20 -161.76 -101.68 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.063 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.3 p -61.31 -13.56 20.13 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.23 60.17 3.38 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.529 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.19 -154.86 14.66 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.366 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -75.91 -142.12 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t 47.1 28.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.083 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.7 OUTLIER -158.76 15.88 0.19 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.687 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -111.25 130.17 55.74 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.044 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' CE ' ' N ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -132.75 159.56 39.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.925 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 1.9 m-80 -138.08 144.16 40.79 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.454 -0.898 . . . . 0.0 112.016 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.71 111.57 8.83 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.555 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 104' ' ' GLN . 9.7 pt20 -97.18 113.61 25.22 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.443 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.741 ' HG ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.57 120.19 41.01 Favored 'General case' 0 CA--C 1.468 -2.197 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.5 tp -117.36 98.59 6.5 Favored 'General case' 0 C--N 1.266 -3.051 0 CA-C-N 112.717 -2.038 . . . . 0.0 108.734 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.586 ' CD1' ' OD2' ' A' ' 83' ' ' ASP . 1.0 OUTLIER -100.01 161.35 3.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.324 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -103.85 150.54 24.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.952 -179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.739 ' H ' HD13 ' A' ' 108' ' ' LEU . 3.1 p30 . . . . . 0 C--N 1.303 -1.436 0 CA-C-O 116.317 -1.801 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.854 0.359 . . . . 0.0 111.771 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 2.9 Cg_endo -68.09 145.54 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 121.221 1.281 . . . . 0.0 111.247 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 4' ' ' ASP . 12.4 p-10 -67.03 126.88 30.55 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.796 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 m -150.02 144.57 25.88 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -130.9 153.72 48.86 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -146.18 159.9 42.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -133.63 98.92 4.33 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' CG2' HD13 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -99.79 141.76 16.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.076 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -114.8 151.86 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.811 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -153.11 167.01 31.7 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.016 -1.088 . . . . 0.0 111.54 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.7 p -141.45 94.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 62.2 p 36.81 78.32 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.627 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 136.94 67.47 0.05 OUTLIER Glycine 0 C--N 1.291 -1.956 0 N-CA-C 104.933 -3.267 . . . . 0.0 104.933 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' H ' ' HA ' ' A' ' 79' ' ' ALA . 10.7 tppt? -113.64 45.32 0.32 Allowed Pre-proline 0 C--O 1.207 -1.176 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -66.75 102.88 0.65 Allowed 'Trans proline' 0 N--CA 1.436 -1.908 0 N-CA-C 105.283 -2.622 . . . . 0.0 105.283 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 18' ' ' GLN . 8.6 p -121.98 161.6 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.504 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.1 tt0 -104.51 101.66 11.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.675 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 1.8 tp -89.88 107.92 19.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -147.57 100.23 3.79 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 118.089 -1.445 . . . . 0.0 113.861 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -68.53 143.48 57.34 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 120.652 0.902 . . . . 0.0 109.949 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -147.68 105.18 3.67 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.609 -0.837 . . . . 0.0 111.249 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 24' ' ' ILE . 4.0 p30 -179.98 0.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.646 ' CG1' ' H ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -102.43 142.66 16.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.948 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' NE2' ' HD2' ' A' ' 27' ' ' LYS . 10.3 pt20 -76.26 27.85 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.646 ' H ' ' CG1' ' A' ' 24' ' ' ILE . 33.0 p 42.11 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.553 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HD2' ' NE2' ' A' ' 25' ' ' GLN . 3.4 mmpt? -119.79 -174.72 2.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -67.38 100.32 0.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.609 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 30' ' ' SER . 3.9 m -148.07 -155.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.475 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.564 ' N ' HG23 ' A' ' 29' ' ' VAL . 9.3 m -150.09 161.67 41.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.2 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 49' ' ' TRP . 2.2 t -127.96 111.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.889 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.262 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -134.9 132.81 38.94 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.445 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.779 ' CE2' HG21 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -135.32 148.18 49.39 Favored 'General case' 0 C--O 1.193 -1.878 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.66 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -133.28 158.84 41.93 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.759 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.704 ' CE ' HD11 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -150.72 163.16 39.23 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.818 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 36' ' ' THR . 1.0 OUTLIER -127.99 108.73 10.92 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.694 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -107.38 121.66 45.03 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.48 -166.2 1.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.361 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' C ' ' OG ' ' A' ' 40' ' ' SER . . . 87.17 -9.1 74.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' OG ' ' C ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 163.89 -13.02 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.995 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 82' ' ' GLN . 16.6 m-70 -101.59 -144.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HG2' ' C ' ' A' ' 41' ' ' HIS . 11.3 mmt180 -151.54 -163.8 1.84 Allowed 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 118.853 -1.139 . . . . 0.0 111.538 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -89.66 157.29 18.07 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 46' ' ' ILE . 36.1 mt -150.28 142.68 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 117.871 -1.532 . . . . 0.0 113.25 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -90.54 -31.13 16.86 Favored 'General case' 0 C--O 1.201 -1.454 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.779 HG21 ' CE2' ' A' ' 33' ' ' TRP . 13.9 mm 74.48 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.943 HD23 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -151.01 159.38 44.6 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.328 -1.349 . . . . 0.0 113.415 -179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.656 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.2 p-10 -127.97 118.04 22.84 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.555 ' CH2' ' O ' ' A' ' 51' ' ' ASN . 16.9 t90 -104.48 117.61 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 52' ' ' ASP . 7.5 m-85 -124.22 97.63 5.41 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.657 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.714 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.0 OUTLIER 64.25 -60.92 0.19 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.279 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' TYR . 42.0 m-20 -159.29 33.05 0.2 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.883 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -125.59 85.84 0.35 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -87.12 112.35 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.276 1.984 . . . . 0.0 110.405 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.601 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 3.8 p -125.34 162.31 25.06 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.668 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 59.8 m95 -109.93 161.36 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.486 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.456 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.2 p -159.79 82.52 0.73 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.585 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.747 ' C ' HG23 ' A' ' 59' ' ' VAL . 64.0 t30 -174.1 -26.63 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.599 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.747 HG23 ' C ' ' A' ' 58' ' ' ASN . 0.9 OUTLIER 68.79 -4.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.795 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.603 ' OG ' ' ND2' ' A' ' 58' ' ' ASN . 1.0 OUTLIER -100.89 11.92 38.64 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.739 ' HA ' HD13 ' A' ' 64' ' ' ILE . 45.9 m-85 -72.33 42.91 0.1 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.694 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 t -98.5 -15.53 19.54 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.548 ' O ' HD12 ' A' ' 64' ' ' ILE . 7.6 t0 -147.71 93.58 2.23 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.88 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -157.24 -173.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.428 0 C-N-CA 117.051 -1.86 . . . . 0.0 115.724 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.88 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.81 165.4 19.79 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 111.89 -2.414 . . . . 0.0 114.644 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.4 131.28 5.87 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 7.2 t80 -98.26 143.83 28.34 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.231 -0.987 . . . . 0.0 113.14 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.9 t70 -133.62 156.8 47.21 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 56.1 t80 -97.03 176.55 5.91 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.286 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.723 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 127.98 -13.16 6.42 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.613 ' OD1' ' CG2' ' A' ' 26' ' ' THR . 1.8 m-20 166.06 -89.4 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' CZ ' HD13 ' A' ' 24' ' ' ILE . 47.6 m-85 -152.24 99.2 2.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.18 108.52 10.11 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.79 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -119.95 115.43 23.76 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.453 -1.249 . . . . 0.0 108.821 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.3 t -105.97 138.38 42.26 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.243 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.501 ' HB ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -90.19 133.0 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.135 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -143.04 93.87 2.56 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.466 1.127 . . . . 0.0 108.499 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 80' ' ' LYS . 11.6 t -153.59 -25.33 0.14 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.693 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 44.01 11.67 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 112.393 -2.185 . . . . 0.0 114.128 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.7 mmtp -97.91 152.85 18.79 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 118.894 -1.123 . . . . 0.0 110.639 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD12 HG12 ' A' ' 107' ' ' ILE . 26.6 tp -49.7 -18.63 0.49 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.894 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.529 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 32.9 mt-30 -59.01 -22.02 59.98 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.801 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 107' ' ' ILE . 37.3 t0 -64.47 -39.93 94.73 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 118.056 -1.457 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ILE . 78.3 p -46.37 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -170.87 165.04 38.24 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -85.59 109.34 18.47 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.27 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 35' ' ' LYS . 2.6 m-30 -95.82 142.16 28.41 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 89' ' ' LEU . 9.3 tp -151.9 117.19 5.28 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.703 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 33' ' ' TRP . 3.1 mt -88.51 155.73 19.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.667 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -135.38 109.44 8.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.938 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 29' ' ' VAL . 10.4 tt -89.17 154.56 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.071 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 93' ' ' ASN . 4.9 m 58.03 -147.72 0.5 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.46 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.688 ' H ' HG22 ' A' ' 92' ' ' THR . 65.4 m-80 -142.42 -32.02 0.51 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.678 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.1 m -146.42 135.38 22.48 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.582 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.71 123.06 1.08 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.384 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -52.23 -26.5 21.25 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.297 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -72.65 175.85 6.02 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 98' ' ' VAL . 11.1 m -95.3 61.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.72 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.853 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.5 m -69.0 84.77 0.33 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.38 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -150.58 139.26 20.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.507 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 88' ' ' LEU . 1.2 mttt -132.72 102.95 5.87 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -98.33 146.13 25.99 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.38 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -137.97 117.16 12.64 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.651 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.87 116.92 27.5 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.78 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.545 HD13 ' CG2' ' A' ' 9' ' ' VAL . 1.6 mm? -103.97 128.33 51.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.0 tp -146.06 100.25 3.36 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.175 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.599 HG12 HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -119.8 163.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.792 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 54.1 tp -104.13 159.54 15.6 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.517 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 CA-C-O 116.306 -1.807 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 2' ' ' CYS . 5.0 Cg_exo -65.36 133.58 35.47 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.334 1.356 . . . . 0.0 111.003 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' H ' HG11 ' A' ' 98' ' ' VAL . 13.2 p-10 -43.06 122.05 2.33 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.972 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.8 p -146.25 137.24 24.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.9 p -140.15 110.63 6.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.34 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 8' ' ' GLU . 31.3 tt0 -123.89 160.36 27.66 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.211 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' C ' ' CD ' ' A' ' 8' ' ' GLU . 12.3 tm-20 -126.85 121.94 33.29 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.521 HG13 HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -114.81 136.37 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.284 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 11' ' ' GLY . 14.8 p -102.72 152.61 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.366 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 107' ' ' ILE . . . -152.23 167.61 31.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' SER . 94.8 t -147.39 97.08 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.574 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.837 ' H ' ' NZ ' ' A' ' 15' ' ' LYS . 2.0 t 27.49 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.908 ' HA2' ' HB1' ' A' ' 79' ' ' ALA . . . 131.34 55.5 0.09 OUTLIER Glycine 0 C--N 1.287 -2.176 1 N-CA-C 103.025 -4.03 . . . . 0.0 103.025 -179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.837 ' NZ ' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -118.57 57.54 3.13 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 14' ' ' GLY . 4.1 Cg_endo -69.44 112.28 2.98 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 104.96 -2.746 . . . . 0.0 104.96 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.51 161.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 118.776 -1.17 . . . . 0.0 112.521 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -105.07 112.38 25.5 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 103' ' ' PHE . 5.3 tp -91.85 125.55 36.6 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -147.97 98.32 3.83 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 117.06 -1.856 . . . . 0.0 115.071 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.12 131.53 22.34 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 120.965 1.11 . . . . 0.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.8 m -116.01 162.08 17.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' A' ' 23' ' ' ASN . 2.7 t-20 64.73 83.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.85 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' H ' HD12 ' A' ' 24' ' ' ILE . 1.1 pp -119.31 -179.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.209 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 26' ' ' THR . 8.1 tt0 -138.88 -12.03 1.28 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.209 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.934 HG21 ' CE1' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -19.18 -99.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.859 -1.519 . . . . 0.0 113.504 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.913 ' H ' HG23 ' A' ' 26' ' ' THR . 11.8 mtmt 44.15 18.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.3 OUTLIER 166.6 40.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.0 175.84 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -115.47 148.03 39.93 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.192 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.594 ' H ' ' HB3' ' A' ' 49' ' ' TRP . 2.4 t -105.35 119.56 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.992 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -134.87 131.64 37.6 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.717 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.805 ' CZ2' HG21 ' A' ' 46' ' ' ILE . 5.5 p-90 -136.02 116.29 13.54 Favored 'General case' 0 C--O 1.184 -2.367 0 C-N-CA 118.776 -1.169 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -103.65 153.91 20.11 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.417 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.814 ' NZ ' ' CZ ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -150.54 160.42 43.8 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 118.306 -1.357 . . . . 0.0 113.432 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.4 m -113.37 99.99 8.2 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.775 ' CD ' HD12 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -95.07 137.1 34.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -97.53 147.77 23.93 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.688 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.82 ' H ' ' CD2' ' A' ' 41' ' ' HIS . . . 122.91 -33.73 3.97 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 104.802 -3.319 . . . . 0.0 104.802 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 m -130.71 -5.17 4.1 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.82 ' CD2' ' H ' ' A' ' 39' ' ' GLY . 1.3 m80 36.94 46.92 0.54 Allowed 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 112.566 -2.107 . . . . 0.0 111.67 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -108.76 145.58 34.92 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.966 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.94 136.92 32.75 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.835 HD13 HD22 ' A' ' 58' ' ' ASN . 94.3 mt -144.83 147.04 19.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.942 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -89.51 -26.78 20.71 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.229 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.805 HG21 ' CZ2' ' A' ' 33' ' ' TRP . 12.1 mm 72.44 -93.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HB2' ' HE1' ' A' ' 33' ' ' TRP . 0.4 OUTLIER -123.54 156.84 34.91 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' N ' HD23 ' A' ' 47' ' ' LEU . 64.0 t30 -137.67 97.41 3.44 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 112.597 -2.092 . . . . 0.0 105.943 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.594 ' HB3' ' H ' ' A' ' 31' ' ' VAL . 2.9 t90 -94.55 132.28 39.4 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.723 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.579 ' C ' ' ND2' ' A' ' 51' ' ' ASN . 34.3 p90 -148.52 99.87 3.06 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.84 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.579 ' ND2' ' C ' ' A' ' 50' ' ' TYR . 4.1 p30 44.22 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.901 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' CG ' ' C ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER 40.83 26.95 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.764 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 50' ' ' TYR . . . -127.16 81.9 0.35 Allowed Glycine 0 N--CA 1.502 3.093 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.393 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -87.31 127.1 2.4 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.139 1.892 . . . . 0.0 111.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.3 p -130.23 142.67 50.54 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.293 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.644 ' CD1' ' N ' ' A' ' 56' ' ' TRP . 18.7 m95 -101.09 160.77 14.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.481 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.521 ' H ' ' HZ ' ' A' ' 61' ' ' PHE . 41.3 t -158.64 82.28 0.81 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.243 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.835 HD22 HD13 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -176.13 -23.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.828 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.722 HG23 ' C ' ' A' ' 58' ' ' ASN . 1.1 t 68.08 -46.88 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.183 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 58' ' ' ASN . 23.8 m -62.91 15.28 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.78 ' O ' ' N ' ' A' ' 63' ' ' ASP . 45.9 m-85 -56.99 -84.68 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.928 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.567 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 63' ' ' ASP . 39.0 p 32.77 -83.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.78 ' N ' ' O ' ' A' ' 61' ' ' PHE . 9.6 t0 -88.77 92.03 9.05 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.881 HG23 ' N ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -154.79 -173.18 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.881 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.04 163.69 19.41 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.598 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.07 130.35 5.13 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 68' ' ' ASP . 11.6 t80 -89.32 155.73 19.18 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.784 -1.166 . . . . 0.0 112.446 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 4.1 m-20 -142.14 152.7 43.47 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.576 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.521 ' CG ' ' N ' ' A' ' 70' ' ' GLY . 18.9 t80 -101.06 -179.49 4.06 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.115 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 69' ' ' TYR . . . 121.8 -1.97 10.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 105.07 -3.212 . . . . 0.0 105.07 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.652 ' CG ' ' N ' ' A' ' 72' ' ' PHE . 1.8 t70 161.15 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 111.159 -2.52 . . . . 0.0 105.178 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.934 ' CE1' HG21 ' A' ' 26' ' ' THR . 46.2 m-85 -150.14 106.36 3.47 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.62 149.58 45.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.094 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.9 tm? -144.58 116.35 8.23 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.228 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.417 ' H ' ' HG ' ' A' ' 75' ' ' SER . 30.0 p -102.59 140.7 36.52 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.114 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -95.82 125.57 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.727 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ILE . 24.5 ttpt -135.69 93.78 2.99 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 80' ' ' LYS . 3.7 t -154.96 -30.05 0.1 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 113.301 -1.772 . . . . 0.0 107.097 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.908 ' HB1' ' HA2' ' A' ' 14' ' ' GLY . . . 41.35 14.81 0.0 OUTLIER 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 111.957 -2.383 . . . . 0.0 113.499 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 78' ' ' SER . 7.6 mmtt -103.45 148.45 25.9 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.388 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 80' ' ' LYS . 11.3 tp -41.89 -25.91 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.084 -1.047 . . . . 0.0 109.688 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.51 HE21 ' HB2' ' A' ' 80' ' ' LYS . 7.5 pt20 -57.32 -17.73 13.6 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -64.59 -57.14 9.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.586 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.793 ' H ' ' CD1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -40.91 118.39 0.98 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.662 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.03 163.92 35.03 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -85.33 102.67 13.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.553 ' OH ' HD11 ' A' ' 76' ' ' ILE . 2.1 m-30 -89.27 149.6 23.0 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.656 -0.817 . . . . 0.0 112.254 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.56 110.25 5.31 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.677 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 33' ' ' TRP . 0.0 OUTLIER -88.49 100.41 13.03 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.338 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -106.63 120.49 42.09 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.899 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mm -97.13 109.45 23.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.104 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.9 m 52.59 -101.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.271 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.796 HD22 ' N ' ' A' ' 94' ' ' THR . 0.5 OUTLIER -173.73 -37.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.1 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.796 ' N ' HD22 ' A' ' 93' ' ' ASN . 11.1 p 44.35 -154.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.13 170.52 43.62 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.668 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.06 -83.16 0.41 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.45 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -78.46 176.25 9.55 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG11 ' H ' ' A' ' 4' ' ' ASP . 15.0 p -95.05 152.43 3.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.066 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 34.3 m -156.05 58.33 0.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.741 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.37 160.2 43.91 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -133.35 130.29 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.596 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ASN . 1.9 m120 -107.01 114.34 28.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.179 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.638 ' CD2' HD11 ' A' ' 19' ' ' LEU . 7.1 m-85 -112.67 107.12 15.68 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.349 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -90.57 101.64 14.38 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.676 -0.809 . . . . 0.0 111.858 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 9' ' ' VAL . 3.4 mm? -91.04 113.89 26.27 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.8 tp -118.56 100.38 7.41 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.966 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.793 ' CD1' ' H ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -116.42 161.51 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.685 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 109' ' ' ASP . 63.8 tp -107.0 154.45 21.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.645 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 108' ' ' LEU . 33.1 t70 . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 116.315 -1.802 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 stop_ save_